Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3004789	fp-transf	g/l (g/l)	43741	113159	0.04%
3004789	fs-transf	g/l (g/l)	11144	21288	0.00%
3004789	fp-transf	— (—)	7329	10294	100.00%	Distribution not available
3004789	fs-transf	— (—)	481	745	100.00%	Distribution not available
3004789	-transf	— (—)	303	321	100.00%	Distribution not available
3004789	fp-transferriini	g/l (g/l)	157	185	0.00%
3004789	fs-transferriini	g/l (g/l)	91	112	0.00%
3004789	-transf	g/l (g/l)	84	143	0.00%
3004789	fp-trans	g/l (g/l)	46	56	0.00%
3004789	transferriini	g/l (g/l)	46	57	0.00%
3004789	-transferriini	g/l (g/l)	34	36	0.00%
3004789	transferriini(fp-transf)	g/l (g/l)	21	25	0.00%
3004789	transferriini(4567fp-transf)	g/l (g/l)	18	20	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Disorders of choroid and retina

8239

37911

1.66

322.70

3.6

2.4

2.23

2.33

g/l

42.69

7559

34974

Gastric ulcer

2201

9665

2.72

320.75

3.3

2.4

2.32

2.26

g/l

4.40

2043

8867

Other specific joint derangements/joint disorders

7117

28581

1.72

319.20

2.6

2.3

2.40

2.38

g/l

1.37

6592

26429

Other diseases of anus and rectum

3237

16389

2.22

318.38

3.0

2.3

2.36

2.30

g/l

7.32

2978

15055

Obesity related asthma

3653

19359

2.13

318.32

2.7

2.5

2.46

2.33

g/l

32.26

3409

17931

Intracranial trauma

5530

22685

1.84

317.67

2.5

2.3

2.36

2.37

g/l

1.01

5077

21129

Diabetic maculopathy, excluding more controls

1383

4868

3.56

316.79

6.1

2.2

2.08

2.28

g/l

34.22

1288

4490

Persons encountering health services for examination and investigation

6354

18919

1.79

316.45

2.7

2.1

2.35

2.33

g/l

1.72

5927

17296

Other specified/unspecified arthritis

2911

14290

2.31

313.56

2.9

2.3

2.30

2.35

g/l

4.52

2718

13187

Cardiodefibrillation

4043

22385

2.07

312.85

2.9

2.6

2.35

2.25

g/l

24.33

3779

20618

Peripheral arterial reconstruction

2247

10189

2.72

311.66

4.5

2.5

2.14

2.25

g/l

13.31

2103

9329

Statin medication

6365

21550

1.77

311.06

3.2

2.0

2.36

2.37

g/l

0.74

5927

19914

Other noninfective gastroenteritis and colitis

2757

13353

2.37

310.08

3.1

2.4

2.31

2.35

g/l

3.84

2591

12321

Volume depletion

1297

4481

3.71

309.47

3.8

2.2

2.15

2.28

g/l

10.28

1187

4090

Benign neoplasms

9710

35732

1.58

307.81

2.8

2.3

2.36

2.35

g/l

1.49

9048

32935

Other cataract

4544

19385

1.96

307.75

3.6

2.3

2.23

2.32

g/l

21.00

4219

17932

Acute tubulo-interstitial nephritis

7551

30873

2.41

307.65

3.5

1.8

2.21

2.41

g/l

149.33

6991

28151

Hypertensive heart and/or renal disease

3637

9062

3.73

307.65

4.6

1.9

2.22

2.26

g/l

4.94

3397

8218

General examination and investigation of persons without complaint and reported diagnosis

6377

18862

1.89

307.65

2.9

2.1

2.39

2.33

g/l

9.85

5923

17254

Hypothyroidism and >3 levothyroxin purchases

2582

3251

5.09

307.65

2.6

1.5

2.45

2.53

g/l

6.44

2362

3027

Fever of other and unknown origin

7959

26799

3.15

307.65

3.5

2.2

2.24

2.39

g/l

83.76

7498

24638

Other bacterial intestinal infections

2253

9824

2.75

307.65

4.1

2.3

2.19

2.32

g/l

21.56

2118

9013

Osteopathies and chondropathies

6154

32042

1.99

307.65

3.3

2.4

2.28

2.35

g/l

20.15

5685

29525

IBD patients in KELA-register

2823

11497

2.92

307.65

2.7

2.5

2.43

2.37

g/l

5.86

2693

10716

Hypertensive diseases

8882

22743

2.47

307.65

3.6

1.8

2.34

2.38

g/l

6.30

8377

20923

Ulcerative colitis

2808

12831

2.54

307.65

2.7

2.5

2.40

2.36

g/l

3.61

2672

11913

Any reimbursement code in KELA

5924

11097

2.95

307.65

2.7

1.6

2.41

2.48

g/l

12.30

5549

10132

Viral Sepsis

3025

10420

3.76

307.65

4.6

2.1

2.19

2.35

g/l

37.71

2834

9511

Disorders resulting from impaired renal tubular function

1000

1605

21.05

307.65

11.9

2.5

1.98

2.32

g/l

64.32

990

1490

Heart failure and coronary heart disease

7572

16652

4.48

307.65

3.8

2.3

2.29

2.25

g/l

6.79

7158

15127

Diarrhoea and gastroenteritis of presumed infectious origin

10476

44586

1.65

307.65

3.1

2.3

2.33

2.37

g/l

8.41

9721

41119

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

6397

36672

1.94

307.65

3.4

2.4

2.32

2.34

g/l

1.79

5946

33798

Pain in joint

5980

21330

1.94

307.65

2.6

2.3

2.39

2.35

g/l

6.74

5543

19701

Type 2 diabetes, strict (exclude DM1)

10623

33592

2.04

307.65

2.6

2.2

2.45

2.32

g/l

74.51

9833

30947

Septicaemia

6596

22221

3.52

307.65

4.5

2.2

2.14

2.35

g/l

131.87

6185

20288

Pain, not elsewhere classified

2994

13495

2.52

307.65

2.9

2.2

2.36

2.40

g/l

2.65

2791

12423

Myocardial infarction

5579

18819

2.39

307.65

3.5

2.2

2.26

2.28

g/l

1.60

5211

17181

Other bacterial intestinal infections

2692

12624

2.49

307.65

3.8

2.3

2.22

2.34

g/l

20.97

2525

11600

Antihypertensive medication - note that there are other indications

6046

14076

2.49

307.65

3.1

1.7

2.41

2.46

g/l

6.50

5643

12978

Dilated cardiomyopathy

2002

6273

4.72

307.65

3.4

2.6

2.33

2.26

g/l

7.50

1912

5819

Care involving dialysis

2588

3337

33.02

307.65

13.0

1.9

1.89

2.34

g/l

269.97

2571

3083

All-cause Heart Failure

9948

22895

4.12

307.65

3.6

2.2

2.27

2.28

g/l

0.31

9381

20854

Disorders of lens

6776

25171

1.83

307.65

3.7

2.3

2.24

2.34

g/l

34.84

6282

23368

Other CVD (FINNGEN)

1563

2671

5.94

307.65

3.5

1.6

2.21

2.32

g/l

8.47

1430

2426

Hypertension

8868

22721

2.47

307.65

3.6

1.8

2.34

2.38

g/l

6.24

8363

20901

Diseases of arteries, arterioles and capillaries

8298

31261

2.25

307.65

3.9

2.3

2.23

2.31

g/l

25.64

7762

28662

Dyspnoea

11426

42239

2.27

307.65

3.0

2.4

2.35

2.34

g/l

0.27

10614

38941

Ascites

1189

3398

5.03

307.65

3.6

2.4

2.09

2.31

g/l

20.01

1128

3150

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

10934

34056

2.14

307.65

3.2

2.2

2.38

2.33

g/l

16.20

10093

31404

Implicit viral Sepsis

4112

15581

3.29

307.65

4.1

2.1

2.21

2.35

g/l

42.24

3851

14241

Certain infectious and parasitic diseases

7603

21484

1.90

307.65

2.8

2.0

2.32

2.42

g/l

32.69

7084

19723

Anaemias

5792

3073

20.13

307.65

3.9

1.6

2.43

2.52

g/l

12.57

5546

2866

Other retinal disorders

6771

32470

1.77

307.65

3.8

2.4

2.21

2.31

g/l

37.97

6182

29872

First line medication for Crohn's disease

14340

35877

2.44

307.65

3.1

2.1

2.31

2.39

g/l

43.59

13492

32813

Hard cardiovascular diseases

9482

27975

2.27

307.65

3.3

2.2

2.35

g/l

0.06

8936

25729

Mood disorders, excluding more controls

9621

35758

1.72

307.65

2.6

2.5

2.40

2.35

g/l

10.67

8739

33337

Asthma, unspecified (mode), excluding more controls

5815

18736

2.62

307.65

2.6

2.0

2.40

g/l

0.25

5412

17202

Depression medications

2719

3452

4.39

307.65

2.3

1.6

2.47

2.53

g/l

4.30

2510

3222

Hypo-osmolality and hyponatraemia

2346

8718

3.36

307.65

3.1

2.2

2.21

2.31

g/l

11.51

2146

7934

Care involving use of rehabilitation procedures

7031

33548

2.14

307.65

3.1

1.9

2.34

2.39

g/l

9.01

6623

30730

Bacterial Sepsis

7598

22937

3.63

307.65

4.2

2.1

2.15

2.34

g/l

127.70

7132

20940

Transplanted organ and tissue status

2469

4008

13.86

307.65

8.9

2.1

2.06

2.35

g/l

109.22

2434

3725

Second line medication for Crohn's disease

6818

34087

2.28

307.65

2.9

2.5

2.32

2.37

g/l

9.35

6451

31514

Type 2 diabetes

11576

34619

2.17

307.65

3.0

2.2

2.41

2.33

g/l

30.17

10717

31899

Hypertension, essential

8786

22088

2.53

307.65

3.3

1.8

2.35

2.37

g/l

3.17

8284

20314

Ischaemic heart disease, wide definition

8367

28145

2.05

307.65

3.3

2.3

2.33

2.32

g/l

1.34

7803

25915

Gastro-oesophageal reflux disease

7189

35561

1.91

307.65

2.7

2.4

2.39

2.33

g/l

16.46

6597

32873

Persons encountering health services in other circumstances, wide

13579

39386

1.94

307.65

3.0

2.3

2.34

2.35

g/l

1.47

12704

36148

Major coronary heart disease event excluding revascularizations

6688

22704

2.21

307.65

3.3

2.3

2.28

2.29

g/l

0.56

6248

20744

Asthma, hospital admission 2, infections

6322

36239

1.87

307.65

2.7

2.5

2.38

2.34

g/l

7.79

5893

33346

Explicit Sepsis

6804

23411

3.41

307.65

4.4

2.1

2.15

2.35

g/l

125.81

6376

21397

Persons encountering health services for specific procedures and health care

14272

38627

2.53

307.65

3.8

1.9

2.27

2.41

g/l

124.12

13456

35381

Percutaneous Coronary Intervention

9650

27172

2.50

307.65

3.3

2.2

2.35

2.33

g/l

3.61

9087

24952

Presence of other functional implants

6083

24086

1.93

307.65

3.1

2.2

2.26

2.30

g/l

7.71

5446

22131

Acute renal failure

4267

11093

5.97

307.65

4.9

1.8

2.07

2.32

g/l

122.54

4078

10070

Cardiomyopathy, other and unspecified

1229

2981

5.95

307.65

3.5

2.1

2.30

g/l

0.01

1167

2746

Hypertensive Renal Disease

716

1362

8.92

307.65

8.6

1.8

2.02

2.25

g/l

21.33

692

1228

Myocardial infarction, strict

5049

17874

2.29

307.65

3.4

2.2

2.26

2.27

g/l

0.61

4726

16308

Other arrhythmias

6542

24929

2.18

307.65

2.6

2.1

2.37

2.38

g/l

0.40

6106

22878

Diabetes mellitus

12093

36278

2.16

307.65

3.1

2.2

2.40

2.34

g/l

17.43

11204

33447

Symptoms and signs involving cognition, perception, emotional state and behaviour

9950

43984

1.65

307.65

2.6

2.5

2.33

2.35

g/l

3.03

9127

40705

Other special examinations and investigations of persons without complaint or reported diagnosis

6832

18919

1.97

307.65

2.9

2.1

2.37

2.33

g/l

4.09

6377

17296

Other medical care

5939

23332

2.70

307.65

2.7

2.0

2.18

2.35

g/l

80.71

5585

21228

Presence of cardiac and vascular implants and grafts

6353

19479

2.96

307.65

3.3

2.2

2.31

2.27

g/l

5.00

5952

17888

Coronary atherosclerosis

7308

22609

2.32

307.65

3.4

2.2

2.31

2.30

g/l

1.59

6825

20682

Persons encountering health services for other counselling and medical advice, not elsewhere classified

12861

39118

1.96

307.65

3.1

2.3

2.35

g/l

0.61

12120

35945

Medical observation and evaluation for suspected diseases and conditions

7457

18911

2.21

307.65

2.9

2.1

2.34

2.33

g/l

0.60

6929

17289

Examination and observation for other reasons

7501

18663

2.64

307.65

3.0

2.1

2.36

2.34

g/l

1.86

7102

17088

Hypertensive Heart Disease

2975

8545

3.29

307.65

3.9

1.9

2.26

g/l

0.02

2752

7750

Persons encountering health services in other circumstances

4182

21930

2.10

307.65

2.8

2.2

2.37

g/l

0.22

3815

20197

Alcoholic liver disease

1373

4811

3.76

307.65

2.5

2.6

2.09

2.28

g/l

15.78

1241

4492

Preparatory care for dialysis

1367

2020

38.69

307.65

12.5

2.3

1.91

2.30

g/l

130.76

1360

1884

Cardiomyopathies, Primary/intrinsic

2171

4992

6.54

307.65

3.5

2.2

2.33

2.28

g/l

3.81

2073

4578

Crohn disease

1695

6037

3.52

307.65

3.0

2.4

2.41

2.37

g/l

1.94

1616

5614

Other gastritis (incl. Duodenitis)

2697

12118

2.63

307.65

3.4

2.4

2.34

2.29

g/l

3.70

2524

11191

Autoimmune diseases excluding thyroid diseases, strict definition

12536

33886

2.26

307.65

3.1

2.2

2.30

2.37

g/l

26.21

11780

31235

Malignant neoplasm of colon

1991

7700

3.27

307.65

2.2

2.6

2.44

2.29

g/l

21.51

1912

7013

Glomerular disorders in diseases classified elsewhere

2631

5811

8.57

307.65

8.8

2.2

1.97

2.32

g/l

187.01

2559

5357

Factors influencing health status and contact with health services

2857

6252

2.48

307.65

2.7

1.7

2.30

2.36

g/l

5.60

2654

5718

Other diseases of intestine

1762

6919

3.12

307.65

3.4

2.4

2.33

2.29

g/l

2.01

1667

6396

Oesophageal varices

785

1900

7.23

307.65

3.3

2.5

2.26

2.30

g/l

0.80

725

1780

AV-block

2280

7063

3.45

307.65

3.2

2.1

2.27

2.25

g/l

0.84

2120

6356

Asthma

8110

23027

2.00

307.65

2.5

2.1

2.42

2.40

g/l

2.30

7570

21196

Asthma (only as main-diagnosis)

7287

23027

1.98

307.65

2.5

2.1

2.41

2.40

g/l

1.86

6786

21196

Paroxysmal tachycardia

2441

6542

3.65

307.65

3.1

1.7

2.36

2.41

g/l

4.03

2300

6000

Diaphragmatic hernia

4080

21558

2.16

307.65

2.9

2.4

2.39

2.31

g/l

15.38

3790

19820

ILD differential diagnosis

7809

23218

1.80

307.65

2.8

2.1

2.34

2.40

g/l

11.40

7283

21374

Valvular operations

1850

6050

3.87

307.65

3.1

2.2

2.34

2.27

g/l

6.60

1748

5509

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

4371

11036

2.79

307.65

3.0

1.6

2.35

2.44

g/l

18.76

4090

10160

Atherosclerosis, excluding cerebral and coronary sclerosis

5094

20749

2.25

307.65

4.2

2.3

2.19

2.27

g/l

18.34

4756

18922

Extracorporeal dialysis

1832

2835

26.01

307.65

14.3

2.2

1.86

2.31

g/l

212.52

1818

2649

Secondary hypertension

1667

2222

12.73

307.65

8.9

1.6

2.05

2.36

g/l

76.07

1626

2035

Asthma, hospital admissions 3, pneumonia

4104

22242

2.07

307.65

3.0

2.5

2.31

2.30

g/l

0.81

3846

20374

Complications of medical and surgical care

8654

43398

2.05

307.65

3.4

2.3

2.31

2.35

g/l

7.95

8062

39982

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

6985

38400

2.00

307.65

3.4

2.3

2.31

2.34

g/l

4.52

6497

35364

Any death

6613

28608

1.83

307.65

3.1

2.4

2.09

2.35

g/l

187.36

6155

26429

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

7215

37907

1.88

307.65

2.9

2.5

2.30

2.32

g/l

2.30

6729

34854

Biguanides

10082

37198

1.79

307.65

2.5

2.4

2.45

2.31

g/l

94.50

9242

34347

Implicit Sepsis

10842

33018

2.97

307.65

3.7

2.1

2.22

2.38

g/l

129.17

10114

30311

Other nutritional deficiencies

7996

36570

2.35

307.65

2.9

2.4

2.47

2.36

g/l

48.42

7416

33888

General symptoms and signs

12831

31393

2.27

307.65

2.9

2.2

2.32

2.40

g/l

36.60

11952

28889

Autoimmune diseases related-to ILD

9991

46119

2.06

307.65

2.8

2.4

2.35

2.36

g/l

0.17

9331

42501

Type 1 diabetes

2920

12210

2.78

307.65

5.3

2.2

2.13

2.34

g/l

72.62

2717

11299

Other heart diseases, wide

11023

30257

2.51

307.65

3.2

2.1

2.35

2.40

g/l

16.97

10375

27837

Fall on same level

11672

41675

1.62

307.65

2.7

2.4

2.31

2.38

g/l

26.38

10746

38674

Hypertensive diseases (excluding secondary)

6040

11892

3.40

307.65

3.9

1.6

2.36

2.45

g/l

18.63

5730

10956

Excluding asthma or asthma-COPD overlap

7877

23221

1.82

307.65

2.8

2.1

2.34

2.40

g/l

11.58

7350

21375

Obesity due to excess calories

5375

26402

2.32

307.65

3.0

2.4

2.48

2.37

g/l

34.99

4964

24531

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

12000

41635

2.20

307.65

3.3

2.2

2.26

2.40

g/l

106.92

11218

38402

Malignant neoplasm, wide definition for exclusion

8541

31913

1.68

307.65

2.5

2.31

2.38

g/l

18.34

8052

29389

Exposure to unspecified factor

10243

48166

1.63

307.65

2.8

2.4

2.32

2.37

g/l

10.41

9355

44612

Condition for Implicit Sepsis (Organ dysfunction codes)

11350

35346

2.62

307.65

3.5

2.1

2.23

2.39

g/l

133.68

10589

32467

Iron deficiency anaemia secondary to blood loss (chronic)

2820

8088

5.01

307.65

4.1

2.3

2.40

2.27

g/l

23.40

2609

7394

Symptoms and signs involving the urinary system

8245

37743

1.82

307.65

3.1

2.4

2.27

2.34

g/l

21.36

7534

34863

Asthma (mode)

7887

23218

1.97

307.65

2.5

2.1

2.42

2.40

g/l

2.67

7361

21374

Asthma-related pneumonia or sepsis

4104

22242

2.07

307.65

3.0

2.5

2.31

2.30

g/l

0.81

3846

20374

Other and unspecified iron deficiency

7913

18108

7.32

307.65

3.4

2.3

2.50

2.30

g/l

127.89

7416

16595

Certain infectious and parasitic diseases

10833

29188

2.02

307.65

3.0

2.0

2.31

2.42

g/l

65.18

10106

26804

Implicit viral Sepsis

3023

10405

3.76

307.65

4.6

2.1

2.19

2.35

g/l

37.50

2832

9496

Malignant neoplasm

8266

31126

1.68

307.65

2.4

2.5

2.30

2.38

g/l

22.53

7778

28650

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

12271

38400

2.35

307.65

3.8

2.0

2.31

2.38

g/l

35.91

11455

35435

Complications of surgical and medical care, not elsewhere classified

11989

44058

2.07

307.65

3.3

2.3

2.31

2.36

g/l

14.89

11167

40558

Inflammatory bowel disease

3800

17183

2.58

307.65

2.7

2.5

2.41

2.36

g/l

5.26

3608

15968

Diabetes, varying definitions

12025

36253

2.16

307.65

3.1

2.2

2.40

2.34

g/l

17.65

11140

33426

COPD/asthma related infections

10764

32587

1.77

307.65

2.9

2.2

2.33

2.39

g/l

20.27

9979

30015

Obesity, other/unspecified

3812

17983

2.43

307.65

2.8

2.4

2.50

2.38

g/l

31.34

3551

16701

Other and unspecified anaemias

9621

22922

6.38

307.65

3.6

2.2

2.25

2.30

g/l

9.59

9032

20882

Codes for special purposes

6716

32750

2.36

307.65

3.4

2.4

2.27

2.36

g/l

26.28

6301

30166

Provisional assignment of new diseases of uncertain etiology

6703

32704

2.36

307.65

3.4

2.4

2.27

2.36

g/l

26.76

6289

30125

Anaemia in chronic diseases classified elsewhere

629

930

20.71

307.65

10.6

2.2

1.94

2.30

g/l

42.89

616

863

Sleep apnoea

9613

39606

1.69

307.65

2.7

2.5

2.41

2.32

g/l

47.33

8858

36755

11020

32582

2.30

307.65

3.3

2.2

2.26

2.39

g/l

81.97

10298

30011

COPD differential diagnosis

7812

23227

1.80

307.65

2.8

2.1

2.34

2.40

g/l

11.41

7286

21382

Pneumonias (Asthma/COPD co-morbidities)

12271

41587

2.22

307.65

3.3

2.2

2.26

2.40

g/l

113.45

11476

38338

Other anaemias

9684

23069

6.35

307.65

3.6

2.2

2.25

2.30

g/l

9.81

9092

21013

Implicit bacterial Sepsis

6793

20819

3.77

307.65

4.3

2.1

2.14

2.32

g/l

112.51

6377

18988

Nutritional anaemias

10518

27493

5.47

307.65

3.3

2.3

2.45

2.29

g/l

114.31

9831

25128

Implicit Sepsis

11305

34940

2.78

307.65

3.6

2.1

2.23

2.39

g/l

136.04

10540

32090

Intestinal infectious diseases

10513

47028

1.85

307.65

3.4

2.3

2.30

2.37

g/l

29.04

9759

43362

Hypothyroidism, drug reimbursement

1302

1992

5.27

307.65

2.9

1.5

2.43

2.49

g/l

2.77

1200

1855

Diabetes medication

11722

38836

1.96

307.65

3.0

2.2

2.40

2.34

g/l

19.97

10816

35856

Heart failure,strict

9454

18147

5.12

307.65

3.7

1.8

2.28

2.31

g/l

5.92

8928

16467

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

19870

35104

5.33

307.65

3.4

2.0

2.34

2.36

g/l

3.79

18699

32109

Symptoms and signs involving the digestive system and abdomen

10619

32468

1.75

307.65

2.8

2.3

2.34

2.35

g/l

1.23

9819

29965

Hypothyroidism, levothyroxine purchases

2582

3251

5.09

307.65

2.6

1.5

2.45

2.53

g/l

6.44

2362

3027

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

11020

32582

2.30

307.65

3.3

2.2

2.26

2.39

g/l

81.97

10298

30011

Anxiety disorders

8679

39400

1.63

307.65

2.6

2.4

2.43

2.37

g/l

16.57

7960

36573

11533

40363

1.56

307.65

2.9

2.3

2.35

g/l

0.10

10630

37177

Disorders of thyroid, IBD co-morbidities

1836

4502

3.23

307.65

2.6

1.8

2.40

g/l

0.09

1691

4183

Implicit bacterial Sepsis

7295

22166

3.67

307.65

4.1

2.1

2.15

2.33

g/l

109.35

6850

20215

Other bacterial diseases

13623

37441

2.89

307.65

3.6

2.1

2.20

2.40

g/l

233.43

12773

34403

Condition for Implicit Sepsis (Organ dysfunction codes)

11599

35812

2.56

307.65

3.4

2.1

2.25

2.40

g/l

128.10

10842

32898

All pneumoniae

12320

41695

2.21

307.65

3.3

2.2

2.26

2.40

g/l

109.42

11520

38440

Gastroduodenal ulcer

3137

14948

2.43

307.65

3.4

2.4

2.30

2.24

g/l

5.03

2909

13706

Abnormal findings on examination of blood, without diagnosis

6005

27018

2.39

307.65

2.9

2.6

2.28

2.29

g/l

0.72

5653

24891

Symptoms and signs involving the circulatory and respiratory systems

10760

30438

1.91

307.65

2.7

2.3

2.38

2.36

g/l

2.53

9998

28084

Type 1 diabetes, wide definition, subgroup 1

2428

9656

2.95

307.65

5.2

2.2

2.12

2.36

g/l

77.62

2252

8967

Adjustment and management of implanted device

2901

9739

4.00

307.65

3.4

2.0

2.29

g/l

0.08

2735

8845

Angina pectoris

5911

20871

2.11

307.65

3.0

2.2

2.35

2.29

g/l

11.33

5520

19069

All chronic kidney diseases

10998

24118

5.32

307.65

5.6

1.8

2.12

2.38

g/l

307.65

10501

21985

Benign neoplasm: Colon

6330

32785

2.10

307.65

3.2

2.5

2.35

2.29

g/l

14.85

5916

30126

Other septicaemia

5936

20308

3.59

307.65

4.6

2.2

2.13

2.34

g/l

120.69

5568

18539

Other arthritis (FG)

3298

16558

2.25

307.65

2.9

2.3

2.29

2.36

g/l

8.93

3088

15290

Sleep disorders (combined)

11462

40354

1.58

307.65

2.5

2.41

2.33

g/l

35.49

10536

37327

Diverticular disease of intestine

8143

27404

2.11

307.65

3.0

2.3

2.33

2.30

g/l

3.57

7530

25213

Neoplasms

7286

22804

1.80

307.65

2.7

2.3

2.37

2.41

g/l

5.99

6829

20943

Complications of procedures, not elsewhere classified

9428

42714

2.03

307.65

3.3

2.3

2.32

2.35

g/l

5.36

8811

39343

Liquid cancers, helper endpoint

5244

18290

3.06

307.65

2.8

2.5

2.22

2.32

g/l

30.56

4977

16672

Asthma-related infections

6322

36239

1.87

307.65

2.7

2.5

2.38

2.34

g/l

7.79

5893

33346

Dialysis, with operation codes

3622

5711

17.29

307.65

10.9

1.8

1.94

2.36

g/l

319.79

3575

5255

Aplastic and other anaemias

10361

24330

6.28

307.65

3.8

2.2

2.24

2.30

g/l

17.90

9745

22175

Other diseases of liver

2862

8833

4.45

307.65

2.6

2.5

2.43

2.34

g/l

11.86

2648

8220

Other (not insulin) diabetes medications

10489

36197

1.87

307.65

2.7

2.3

2.44

2.32

g/l

70.14

9655

33401

Dipeptidyl peptidase 4 (DPP-4) inhibitors

7192

26557

2.56

307.65

3.3

2.4

2.35

2.26

g/l

31.91

6626

24445

Type 1 diabetes, wide definition

2477

10506

2.73

307.65

5.2

2.2

2.12

2.35

g/l

73.05

2300

9733

Endocrine, nutritional and metabolic diseases

8981

19795

2.54

307.65

2.9

1.8

2.39

2.38

g/l

1.46

8360

18267

Type 2 diabetes, definitions combined

10586

33358

2.05

307.65

2.6

2.2

2.45

2.32

g/l

74.96

9797

30722

Type 2 diabetes, wide definition

10349

29068

2.65

307.65

3.4

2.2

2.37

2.30

g/l

23.32

9597

26740

Chronic gastritis

3196

15406

2.41

307.65

2.8

2.4

2.33

2.27

g/l

6.39

2920

14150

Other functional intestinal disorders

4938

24150

2.11

307.65

2.8

2.3

2.32

2.33

g/l

0.60

4551

22162

Finngen Rheumatological endpoints

10132

34616

1.79

307.65

2.7

2.3

2.35

2.38

g/l

4.24

9437

31930

Covid-19 confirmed case

5138

22099

2.84

307.65

3.7

2.4

2.22

2.33

g/l

32.91

4813

20318

Fibrosis and cirrhosis of liver

1495

3633

7.10

307.65

3.2

2.6

2.33

2.30

g/l

0.93

1405

3383

Malaise and fatigue

7552

22446

3.28

307.65

2.9

2.2

2.25

2.36

g/l

50.42

6965

20562

Other diseases of the digestive system

4480

19562

2.79

307.65

3.6

2.4

2.31

2.27

g/l

3.22

4188

17930

Hyperkalaemia

1037

2538

6.45

307.65

6.3

2.2

2.13

2.27

g/l

11.86

989

2326

Haemorrhage from respiratory passages

4215

17149

2.57

307.65

3.3

2.3

2.32

2.28

g/l

3.14

3907

15702

Venous thromboembolism

5867

33775

1.85

307.65

3.0

2.4

2.27

2.31

g/l

5.44

5478

30983

Pain in throat and chest

9335

29510

2.08

307.65

2.7

2.3

2.37

2.36

g/l

0.84

8626

27239

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

3477

7098

2.66

307.65

2.6

1.9

2.37

2.44

g/l

9.57

3221

6567

Headache

6418

28427

1.95

307.65

2.5

2.2

2.43

2.41

g/l

2.04

5953

26194

Heart failure, strict

10191

23204

4.18

307.65

3.6

2.3

2.28

g/l

0.17

9616

21140

Obesity and other hyperalimentation

7166

35903

2.16

307.65

2.9

2.4

2.48

2.36

g/l

48.08

6625

33280

Nausea and vomiting

3494

14315

2.83

307.65

3.8

2.3

2.28

2.35

g/l

10.06

3234

13125

Syncope and collapse

4965

21051

2.26

307.65

2.8

2.2

2.29

2.35

g/l

12.73

4545

19270

Hyperlipidaemia, other/unspecified

4427

20161

2.32

307.65

3.5

2.2

2.29

2.30

g/l

0.45

4137

18433

Diabetic nephropathy

2597

10971

3.29

307.65

7.7

2.4

2.04

2.37

g/l

182.80

2498

10076

Any gastric operation

9369

18745

2.79

307.65

2.8

1.8

2.36

2.43

g/l

17.62

8713

17149

Use of hypnotics and sedatives

10696

41414

1.57

307.65

2.7

2.5

2.35

g/l

0.01

9795

38395

Other bacterial diseases

13761

37826

2.67

307.65

3.5

2.1

2.23

2.41

g/l

201.06

12909

34777

Iron deficiency

590

998

11.29

307.65

3.3

2.2

2.57

2.46

g/l

3.88

558

903

Gout, idiopatic and unspecified

3589

14938

3.07

307.65

4.4

2.4

2.19

2.25

g/l

9.29

3376

13734

Diabetic nephropathy, excluding more controls

2576

7548

4.11

307.65

7.7

2.2

2.04

2.43

g/l

221.81

2480

6934

Metabolic disorders

12254

34149

2.50

307.65

3.4

2.2

2.30

2.37

g/l

29.82

11462

31411

Gout, FINNGEN

4217

17358

3.05

307.65

4.4

2.4

2.19

2.26

g/l

14.28

3968

15907

Abnormalities of breathing

10886

30381

2.32

307.65

2.8

2.3

2.38

2.36

g/l

2.16

10088

28033

Diarrhoea and gastroenteritis of presumed infectious origin

7933

40190

1.95

307.65

3.5

2.3

2.30

2.37

g/l

24.40

7373

37040

Used for control exclusion in common control thyroid runs

12137

32643

2.06

307.65

2.9

2.2

2.34

2.37

g/l

5.84

11294

30077

Oedema, not elsewhere classified

4066

16433

2.90

307.65

3.3

2.2

2.27

2.36

g/l

17.18

3798

15040

Other disorders of skin and subcutaneous tissue

7919

39616

1.98

307.65

3.6

2.3

2.25

2.34

g/l

36.12

7368

36450

Asthma (only as main-diagnosis), excluding more controls

7031

19929

2.20

307.65

2.5

2.0

2.42

2.41

g/l

0.90

6548

18299

Oxycodone

5375

18871

3.14

307.65

2.9

2.3

2.20

2.31

g/l

25.66

4971

17336

Tramadol

9923

27629

2.50

307.65

3.1

2.3

2.33

2.36

g/l

5.04

9189

25477

Systemic connective tissue disorders

3986

20680

2.20

307.65

3.0

2.4

2.28

2.35

g/l

10.66

3732

18963

Cirrhosis of liver, NAS

1107

2536

8.43

307.65

3.3

2.6

2.29

g/l

0.02

1039

2366

Azathioprine

2231

6621

4.44

307.65

4.3

2.4

2.31

2.37

g/l

4.76

2159

6113

Other heart diseases

6106

11978

3.94

307.65

3.5

1.7

2.35

2.45

g/l

33.40

5815

11049

Depression

9599

41648

1.67

307.65

2.5

2.42

2.36

g/l

14.86

8712

38714

Paralytic ileus and intestinal obstruction

2877

13802

2.39

307.65

3.0

2.3

2.29

2.28

g/l

0.21

2689

12672

Anxiety disorders, excluding more controls

8147

32637

1.74

307.65

2.6

2.5

2.42

2.37

g/l

13.26

7480

30451

COPD/asthma/ILD related infections

10764

32587

1.77

307.65

2.9

2.2

2.33

2.39

g/l

20.27

9979

30015

Parasetamol

7910

20529

2.11

307.65

2.7

2.2

2.35

2.37

g/l

1.72

7365

19035

5-aminosalicylic acid

2486

10012

2.92

307.65

2.6

2.3

2.42

2.37

g/l

4.08

2352

9259

Asthma, excluding more controls

7765

19929

2.22

307.65

2.5

2.0

2.43

2.41

g/l

1.43

7255

18299

Cardiovascular diseases (excluding rheumatic etc)

6855

15686

2.81

307.65

3.3

1.7

2.38

2.49

g/l

32.73

6467

14430

Benzodiazepine use

10180

47018

1.58

307.65

2.4

2.5

2.37

2.35

g/l

4.83

9180

43602

Opioids

10968

30080

2.07

307.65

2.7

2.2

2.35

2.38

g/l

6.74

10194

27733

Autoimmune diseases

12974

35132

2.06

307.65

3.0

2.2

2.33

2.37

g/l

11.15

12060

32384

Erysipelas

6770

28217

2.43

307.65

3.4

2.1

2.24

2.36

g/l

52.19

6293

25854

Disorders of iron metabolism

437

573

26.80

307.65

7.3

2.1

2.15

2.38

g/l

12.44

417

537

Continuous positive airway pressure

2257

5196

4.44

307.65

3.5

2.0

2.34

2.29

g/l

2.84

2082

4804

Cerebrovascular diseases (FINNGEN)

3111

7681

3.26

307.65

3.4

1.6

2.30

2.40

g/l

16.49

2935

7069

Abdominal and pelvic pain

10266

32465

1.69

307.65

2.7

2.3

2.36

2.35

g/l

0.54

9475

29962

Neurotic, stress-related and somatoform disorders

8591

39003

1.64

307.65

2.6

2.4

2.43

2.37

g/l

16.81

7879

36204

L04AA Selective immunosuppressants

3720

11383

4.52

307.65

6.1

2.3

2.17

2.39

g/l

97.89

3601

10575

Abnormalities of heart beat

3767

18721

2.20

307.65

2.6

2.2

2.38

2.34

g/l

4.10

3468

17193

Influenza and pneumonia

12669

41366

2.17

307.65

3.3

2.2

2.27

2.40

g/l

98.28

11848

38120

Disorders of other endocrine glands

4885

25445

2.12

307.65

4.5

2.3

2.32

2.38

g/l

7.82

4533

23446

Infections of the skin and subcutaneous tissue

5996

35201

1.84

307.65

3.6

2.4

2.29

2.36

g/l

20.52

5600

32601

Type 2 diabetes, definitions combined, including avohilmo

10463

33332

2.00

307.65

2.6

2.2

2.45

2.33

g/l

76.47

9671

30722

Oral corticosteroids

13383

39475

2.26

307.65

2.7

2.4

2.33

2.36

g/l

8.51

12496

36239

Codeine

10452

29706

2.09

307.65

2.6

2.2

2.37

2.38

g/l

0.47

9675

27397

Budesonide

1859

6300

3.71

307.65

2.7

2.3

2.39

2.36

g/l

1.20

1766

5809

Autoimmune diseases excluding thyroid diseases

12988

34936

2.26

307.65

3.1

2.2

2.30

2.37

g/l

26.66

12203

32209

Other pulmonary diagnosis

7925

23221

1.83

307.65

2.8

2.1

2.34

2.40

g/l

11.78

7391

21375

Other diseases of intestines

12237

37165

2.06

307.65

2.8

2.3

2.38

2.36

g/l

1.62

11387

34262

L04AX Other immunosuppressants

6486

33242

2.21

307.65

2.9

2.5

2.32

2.37

g/l

9.46

6133

30742

Intestinal infectious diseases

12283

44478

1.69

307.65

3.1

2.3

2.31

2.36

g/l

14.96

11393

41012

Hernia of abdominal wall, postoperative

2228

6819

3.98

307.65

3.6

1.9

2.34

2.35

g/l

0.21

2072

6245

Coagulation defects, purpura and other haemorrhagic conditions

2441

10484

2.82

307.65

3.5

2.5

2.27

2.35

g/l

8.76

2322

9698

Pacemaker

4524

19871

2.67

307.65

3.2

2.5

2.30

2.25

g/l

8.91

4229

18116

Benign neoplasm of colon, rectum, anus and anal canal

7543

34919

2.13

307.65

3.1

2.4

2.35

2.29

g/l

15.25

7050

32086

GASTRO-related operations

9369

18745

2.79

307.65

2.8

1.8

2.36

2.43

g/l

17.62

8713

17149

Anxiety (asthma-related co-morbidities)

5745

25612

1.87

307.65

2.4

2.46

2.40

g/l

9.66

5248

23993

Depression or dysthymia

6845

22848

1.77

307.65

2.5

2.6

2.38

2.32

g/l

11.32

6213

21431

Cardiovascular diseases

6218

13656

2.70

307.65

3.1

1.6

2.40

2.50

g/l

25.48

5853

12551

Heart failure, not strict

13076

25401

4.67

307.65

4.3

1.8

2.25

2.36

g/l

66.65

12397

23209

Colectomy operation

2541

9347

3.63

307.65

2.6

2.5

2.43

2.28

g/l

27.78

2444

8594

Bacterial infection, other or unspecified

8600

26433

3.59

307.65

3.9

2.2

2.13

2.36

g/l

213.79

8076

24176

Emergency coronary revascularization (for ACS)

10506

30513

2.39

307.65

3.3

2.3

2.34

2.31

g/l

4.81

9875

27954

Diseases of oesophagus, stomach and duodenum

13018

40180

2.16

307.65

2.9

2.3

2.37

2.34

g/l

5.09

12071

37110

Low back pain

7730

34594

1.72

307.65

2.6

2.4

2.39

2.35

g/l

7.00

7142

31932

Other disorders of urethra and urinary system

7427

32369

1.80

307.65

3.0

2.3

2.30

2.37

g/l

15.21

6868

29801

Other antidepressants

11260

34636

1.80

307.65

2.4

2.6

2.38

2.33

g/l

13.93

10232

32294

Calcific aortic valvular stenosis, diagnosis (helper)

3866

18129

2.48

307.65

3.4

2.4

2.26

2.24

g/l

1.80

3615

16479

Mood [affective] disorders

10305

43804

1.62

307.65

2.5

2.41

2.36

g/l

14.36

9355

40660

Cardiomyopathy (excluding other)

2205

5220

6.26

307.65

3.5

2.2

2.33

2.28

g/l

3.83

2105

4792

Gout

4217

13763

3.44

307.65

4.4

2.4

2.19

2.26

g/l

11.26

3968

12621

Dialysis

1152

1513

27.46

307.65

13.4

1.8

1.91

2.37

g/l

129.06

1147

1410

Heart failure and antihypertensive medication

4873

5248

9.09

307.65

4.1

1.7

2.30

2.31

g/l

0.28

4652

4823

Operations 2 for CAVS

3866

18129

2.48

307.65

3.4

2.4

2.26

2.24

g/l

1.80

3615

16479

Calcific aortic valvular stenosis, including rheumatic fever

3875

18184

2.47

307.65

3.4

2.4

2.26

2.24

g/l

1.73

3624

16528

Non-invasive ventilation

2766

7056

4.16

307.65

2.9

1.9

2.40

2.34

g/l

4.46

2656

6548

Malignant neoplasm of digestive organs

4787

17408

2.56

307.65

2.2

2.6

2.36

2.30

g/l

7.39

4556

15889

Calcific aortic valvular stenosis

3871

18153

2.48

307.65

3.4

2.4

2.26

2.24

g/l

1.71

3619

16502

STROKE

5362

18486

2.17

307.65

3.1

2.0

2.31

2.35

g/l

4.03

5000

16974

Glomerulonephritis

1526

4870

4.36

307.65

7.7

2.4

2.06

2.33

g/l

66.22

1496

4515

Diseases of arteries, arterioles and capillaries (FINNGEN)

3249

5342

5.29

307.65

4.5

1.6

2.24

2.37

g/l

22.98

3068

4900

Episodal and paroxysmal disorders

11127

37479

1.60

307.65

2.5

2.4

2.40

2.34

g/l

20.25

10266

34595

Unspecified kidney failure

2103

4836

7.39

307.65

5.9

1.8

2.05

2.30

g/l

67.90

2001

4391

Pain in limb

9274

34279

1.99

307.65

2.9

2.4

2.34

2.36

g/l

1.78

8592

31613

Neurological diseases, wide definition

2845

5930

2.61

307.65

2.5

1.8

2.42

2.44

g/l

0.54

2647

5509

Other systemic involvement of connective tissue (FG)

2849

13407

2.40

307.65

2.5

2.3

2.32

2.35

g/l

2.45

2648

12245

Chronic kidney disease

7809

16339

8.76

307.65

7.0

1.8

2.06

2.31

g/l

263.91

7517

14768

Gout, strict definition

2720

10427

3.48

307.65

4.7

2.5

2.19

2.25

g/l

6.96

2560

9608

Heart failure and bmi 25plus

5663

12230

4.22

307.65

3.6

2.3

2.30

2.32

g/l

1.23

5310

11093

Polyarthropathies

8960

26589

2.52

307.65

3.4

2.3

2.26

2.35

g/l

41.20

8398

24536

Recurrent or chronic depression

3920

14065

2.14

307.65

2.3

2.5

2.46

2.38

g/l

13.58

3564

13260

Insulin, intermediate and long-acting

7342

32950

2.55

307.65

3.9

2.3

2.27

2.32

g/l

8.49

6817

30397

Renal failure

10471

22959

6.51

307.65

5.8

1.8

2.08

2.33

g/l

313.11

10016

20836

Genitourinary diseases

5654

15605

1.95

307.65

3.3

1.7

2.29

2.42

g/l

46.84

5285

14416

Disorders of lipoprotein metabolism and other lipidaemias

9521

29812

2.21

307.65

3.1

2.2

2.31

2.34

g/l

5.21

8901

27372

Codeine or tramadol medication

12535

41186

1.80

307.65

2.6

2.4

2.37

2.34

g/l

4.12

11591

38004

Nephropathy related operations

3434

5993

15.58

307.65

11.1

2.0

1.94

2.33

g/l

286.89

3387

5548

L04AD Calcineurin inhibitors

2562

4842

10.80

307.65

8.3

2.3

2.08

2.38

g/l

115.20

2519

4526

Other diseases of blood and blood-forming organs, wide

2937

12020

3.04

307.65

2.9

2.5

2.28

2.34

g/l

5.14

2774

11124

Asthma-related pneumonia

4100

22199

2.08

307.65

3.0

2.5

2.31

2.30

g/l

0.82

3842

20333

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

2446

7641

4.62

307.65

3.0

2.7

2.22

2.28

g/l

4.47

2264

7128

Pulmonary heart disease, diseases of pulmonary circulation

3666

19342

2.17

307.65

3.0

2.5

2.29

2.30

g/l

0.05

3453

17726

Nonischemic cardiomyopathy

1579

4338

5.22

307.65

3.1

2.3

2.34

2.27

g/l

5.43

1507

3980

Renal tubulo-interstitial diseases

14182

37483

3.50

307.65

4.5

1.8

2.17

2.42

g/l

307.65

13386

34292

Ischemic heart diseases

9649

28136

2.33

307.65

3.3

2.2

2.35

2.33

g/l

2.96

9074

25846

Kidney transplant status

1591

2147

29.73

307.65

11.4

2.1

1.97

2.37

g/l

134.37

1582

2000

Non-rheumatic valve diseases

6149

16426

3.25

307.65

3.4

2.1

2.31

2.32

g/l

0.99

5777

14998

Gout, unspecified

2971

11905

3.24

307.65

4.5

2.4

2.19

2.26

g/l

9.14

2796

10965

Insulin, fast-acting or short human

4761

21766

2.58

307.65

4.5

2.4

2.21

2.34

g/l

39.90

4428

20084

Other diseases of urinary system

10306

37904

1.63

307.65

2.8

2.4

2.31

2.36

g/l

17.75

9505

35024

Other disorders of kidney and ureter

1957

6828

3.90

307.65

8.1

2.4

2.11

2.30

g/l

45.24

1885

6311

Conduction disorders

3700

11372

3.15

307.65

3.0

2.1

2.30

2.29

g/l

0.05

3430

10328

Insulin medication

8032

29848

2.65

307.65

4.0

2.3

2.27

2.30

g/l

4.85

7461

27508

Any mental disorder

11137

36880

1.60

307.65

2.5

2.35

g/l

0.02

10161

34359

Non-ischemic cardiomyopathy

4690

12248

4.04

307.65

3.2

2.2

2.28

2.27

g/l

0.30

4402

11139

Bronchitis

10965

46144

1.59

307.65

3.0

2.3

2.35

g/l

0.13

10099

42574

Insulin, fast-acting

4748

20668

2.74

307.65

4.5

2.3

2.21

2.34

g/l

40.40

4416

19081

Asthma (diagnoses ohter than nonallergic)

8864

48004

1.64

307.65

2.5

2.41

2.35

g/l

17.76

8272

44218

Colorectal adenocarcinoma

2377

10535

2.71

307.65

2.1

2.6

2.42

2.28

g/l

23.66

2269

9598

Hypothyroidism (congenital or acquired)

2614

3274

5.12

307.65

2.7

1.5

2.45

2.53

g/l

7.27

2391

3050

Sleep apnoea, including avohilmo

10015

40571

1.63

307.65

2.6

2.5

2.42

2.32

g/l

52.30

9219

37648

Myocardial infarction, without ST-elevation

4885

23572

2.18

307.65

3.5

2.5

2.22

2.26

g/l

4.52

4548

21554

Diseases of the digestive system

6208

28438

2.57

307.65

3.4

2.4

2.33

2.30

g/l

2.02

5792

26150

ILD medications

14650

37579

2.38

307.65

3.3

2.1

2.31

2.39

g/l

41.84

13763

34451

Inflammatory bowel disease treatment related agents

14540

40340

2.26

307.65

2.8

2.4

2.33

2.37

g/l

10.47

13625

37033

All kidney diseases

14680

38758

3.09

307.65

4.3

1.7

2.20

2.43

g/l

307.65

13832

35516

ILD medications: azathioprine

2231

6357

4.64

307.65

4.3

2.1

2.31

2.39

g/l

7.47

2159

5868

Constipation

9639

40738

1.78

307.65

2.7

2.5

2.31

2.34

g/l

6.00

8781

37732

Infections, IBD-co-morbidities

2307

3749

5.53

307.65

4.6

1.8

2.20

2.35

g/l

22.32

2194

3473

Calcific aortic valvular stenosis, operated

3871

18153

2.48

307.65

3.4

2.4

2.26

2.24

g/l

1.71

3619

16502

Diseases of liver

5743

19071

4.04

307.65

2.7

2.5

2.35

2.32

g/l

1.78

5318

17663

Erysipelas

8696

31509

2.39

307.65

3.3

2.1

2.26

2.38

g/l

59.66

8096

28909

Disorders of gallbladder, biliary tract and pancreas

10688

41672

1.75

307.65

2.8

2.4

2.34

g/l

0.08

9924

38424

Insulin, combination of fast acting with intermediate-acting or long-acting

8041

35382

2.40

307.65

4.0

2.3

2.27

2.32

g/l

11.26

7468

32578

Other soft tissue disorders, not elsewhere classified

10655

35083

1.95

307.65

2.8

2.4

2.36

g/l

0.15

9877

32346

Gastrointestinal diseases

6089

13824

2.40

307.65

2.6

1.8

2.39

g/l

0.01

5661

12642

Coronary revascularization (ANGIO or CABG)

9566

27183

2.47

307.65

3.3

2.2

2.35

2.33

g/l

3.85

9023

24963

ILD medications: prednisolone, methylprednisolone, prednisone

14261

37174

2.43

307.65

3.3

2.1

2.30

2.38

g/l

45.64

13374

34078

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

1297

2474

4.51

307.65

2.8

1.9

2.27

2.29

g/l

0.63

1206

2292

Pneumonia, organism unspecified

11238

38825

2.29

307.65

3.4

2.2

2.25

2.39

g/l

107.67

10476

35780

Obesity

7133

35765

2.16

307.65

2.9

2.4

2.48

2.36

g/l

47.80

6595

33152

ILD medications: immunosuppressive drugs

9258

32670

3.17

307.65

4.0

2.1

2.26

2.39

g/l

84.30

8821

30069

Bacterial pneumonia, not elsewhere classified

4192

20095

2.04

307.65

3.3

2.3

2.22

2.34

g/l

29.89

3972

18423

Reimbursement for rheumatic diseases

5966

35025

1.86

307.65

2.6

2.5

2.31

2.36

g/l

8.89

5591

32268

Asthma, unspecified (mode)

6033

21674

2.34

307.65

2.6

2.1

2.39

g/l

0.17

5612

19947

Caries of dentine

3249

10920

3.62

307.65

5.4

2.3

2.20

2.34

g/l

28.76

3095

10169

Other diseases of pleura

5056

25610

1.94

307.65

3.3

2.5

2.20

2.28

g/l

17.40

4671

23531

Bleeding

10117

37086

2.19

307.65

3.5

2.3

2.29

2.33

g/l

9.25

9426

34159

Glomerular diseases

3603

9527

6.00

307.65

8.2

2.2

2.01

2.33

g/l

220.65

3507

8789

Major coronary heart disease event

9911

29348

2.31

307.65

3.3

2.3

2.35

2.32

g/l

3.27

9322

26929

Diabetes, insulin treatment (Kela reimbursement)

11589

38395

2.01

307.65

3.2

2.3

2.38

2.33

g/l

13.41

10700

35469

Nonalcoholic fatty liver disease

1640

4373

5.58

307.65

2.3

2.5

2.53

2.35

g/l

26.43

1522

4064

Cardiac arrhythmias

6603

17419

2.77

307.65

2.9

1.9

2.38

2.40

g/l

1.07

6208

16070

Cardiomyopathy

2939

7489

5.55

307.65

3.4

2.1

2.32

2.28

g/l

2.74

2794

6841

Bacterial infection, other or unspecified

9142

27767

3.50

307.65

3.8

2.1

2.14

2.37

g/l

224.44

8587

25416

Mood disorders

10317

43863

1.62

307.65

2.5

2.41

2.36

g/l

14.22

9365

40711

Hypothyroidism, strict autoimmune

7365

28981

1.80

307.65

2.6

2.2

2.39

2.36

g/l

2.83

6670

26646

Disorders of mineral metabolism

1382

3652

5.53

307.65

5.5

2.2

2.18

2.34

g/l

18.74

1305

3372

GI-bleeding

4442

19637

2.74

307.65

3.6

2.4

2.31

2.27

g/l

3.27

4155

17998

Dental caries

3663

12394

3.53

307.65

5.4

2.3

2.21

2.34

g/l

31.58

3492

11539

Ulcer of lower limb, not elsewhere classified

2366

7882

4.23

307.65

5.2

2.4

2.10

2.29

g/l

45.98

2237

7226

Other disorders of fluid, electrolyte and acid-base balance

4682

15982

3.55

307.65

3.8

2.2

2.20

2.31

g/l

28.07

4336

14582

Malignant neoplasm of colon, including Hilmo

2591

10080

3.25

307.65

2.2

2.6

2.43

2.29

g/l

24.88

2491

9182

Iron deficiency anaemia

9490

23464

6.23

307.65

3.4

2.3

2.47

2.29

g/l

123.92

8876

21488

Colorectal cancer

2867

12486

2.69

307.65

2.2

2.6

2.41

2.29

g/l

22.48

2737

11376

Valvular heart disease excluding rheumatic fever

6196

16546

3.26

307.65

3.4

2.1

2.31

2.32

g/l

1.11

5823

15115

Inflammatory bowel disease, strict (require KELA)

2823

11775

2.85

307.65

2.7

2.5

2.43

2.37

g/l

6.27

2693

10980

Atrial fibrillation and flutter with reimbursement

3256

5194

4.90

307.65

2.8

1.6

2.36

2.35

g/l

0.16

3078

4760

Colon adenocarcinoma

1593

5956

3.45

307.65

2.1

2.6

2.45

2.28

g/l

22.74

1530

5419

Diseases of the skin and subcutaneous tissue

10400

33223

1.67

307.65

2.9

2.2

2.33

2.37

g/l

12.79

9612

30599

Peripheral artery disease

5497

21989

2.32

307.65

4.3

2.3

2.18

2.27

g/l

22.89

5145

20073

Atrial fibrillation and flutter

3824

6808

4.36

307.65

3.3

1.6

2.33

2.39

g/l

5.36

3620

6254

Bacterial pneumoniae

4418

21159

2.05

307.65

3.3

2.3

2.22

2.34

g/l

32.34

4180

19429

Pure hypercholesterolaemia

8336

28064

2.17

307.65

2.9

2.2

2.30

2.33

g/l

4.52

7768

25756

Noninfective enteritis and colitis

5654

27231

2.38

307.65

2.9

2.4

2.37

2.36

g/l

0.50

5330

25138

Pain (limb, back, neck, head abdominally)

7248

22528

1.71

306.75

2.7

2.3

2.34

g/l

0.24

6719

20747

Soft tissue disorders

10222

35451

1.57

305.71

2.7

2.4

2.36

g/l

0.03

9462

32664

Vascular disorders of the intestines

1028

3146

4.51

305.49

4.6

2.3

2.36

2.24

g/l

7.75

967

2881

Hypokalaemia

1480

5508

3.33

305.47

3.1

2.2

2.23

2.33

g/l

6.86

1366

5040

Substance abuse, excluding more controls

5487

27904

1.81

305.09

2.5

2.31

2.33

g/l

1.71

4981

26098

All anxiety disorders

5829

27796

1.78

304.35

2.4

2.46

2.40

g/l

12.17

5323

25913

Other diseases of blood and blood-forming organs

1042

3247

4.54

304.30

2.6

2.5

2.42

2.31

g/l

8.48

975

3007

Intestinal stricture

3484

18547

2.15

303.64

3.0

2.5

2.30

g/l

0.05

3268

17063

Dorsalgia

9858

35454

1.57

302.74

2.5

2.4

2.38

2.35

g/l

4.40

9154

32708

Bacterial intestinal infections, IBD co-morbidities

2240

10208

2.62

300.01

4.1

2.4

2.19

2.32

g/l

19.58

2102

9383

Amputation

1422

5318

3.49

298.36

6.2

2.4

2.02

2.25

g/l

44.15

1348

4887

Neurological diseases

8352

27140

1.63

297.70

2.6

2.4

2.39

2.36

g/l

5.72

7736

25209

Mucosal proctocolitis

1532

5864

3.17

297.36

2.6

2.4

2.41

2.36

g/l

2.08

1463

5466

4502

25669

1.90

295.79

2.7

2.4

2.43

2.36

g/l

10.90

4181

23673

Coronary artery bypass grafting

2888

10609

2.33

295.47

3.2

2.2

2.26

2.21

g/l

4.03

2704

9613

COPD (mode)

3200

12834

2.20

295.45

2.9

2.2

2.27

2.32

g/l

4.50

2941

11725

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

9572

41565

1.57

293.51

2.8

2.4

2.31

2.34

g/l

5.23

8830

38427

Myeloproliferative diseases

1205

4190

3.93

292.71

2.6

2.5

2.41

2.29

g/l

10.26

1145

3861

Any event in cancer register

8808

34423

1.60

292.60

2.5

2.32

2.38

g/l

18.84

8260

31723

Hernia

9186

41471

1.58

292.55

2.9

2.4

2.36

2.34

g/l

1.05

8510

38248

Spondylopathies

7940

30853

1.64

291.94

2.5

2.34

2.32

g/l

3.65

7305

28448

Certain disorders involving the immune mechanism

2172

9887

2.60

290.38

4.5

2.5

2.28

2.35

g/l

7.26

2080

9193

Senile cataract

6050

22698

1.77

289.93

3.5

2.3

2.24

2.32

g/l

19.50

5590

21048

DVT of lower extremities and pulmonary embolism

4524

26265

1.91

289.37

2.8

2.5

2.28

2.30

g/l

1.79

4231

24085

All influenza

2716

13435

2.29

286.98

3.8

2.3

2.30

2.36

g/l

5.50

2530

12360

Unspecified haematuria

4547

21865

1.91

286.53

3.4

2.5

2.23

2.29

g/l

7.87

4213

20186

Psychiatric diseases

9733

32905

1.56

286.50

2.5

2.35

2.34

g/l

0.47

8920

30701

1511

5881

3.04

280.34

3.6

2.1

2.32

2.40

g/l

6.50

1426

5422

Unstable angina pectoris

3746

16235

2.03

279.26

3.0

2.3

2.30

2.25

g/l

7.43

3482

14737

Myeloproliferative diseases (CML excluded)

1108

3784

4.05

278.58

2.6

2.5

2.42

2.29

g/l

11.69

1050

3487

Explicit bacterial Sepsis

1324

4879

3.37

278.54

4.3

2.1

2.18

2.33

g/l

16.36

1253

4476

Chronic lower respiratory diseases

11771

44305

1.49

277.50

2.6

2.5

2.39

2.35

g/l

10.31

10945

40867

Other anxiety disorders

4317

21455

1.88

275.71

2.3

2.4

2.46

2.42

g/l

5.25

3957

20000

Alcohol use disorder, Swedish definition

5488

30997

1.76

275.66

2.6

2.26

2.32

g/l

9.97

4999

28834

Injuries to the head

10875

46889

1.50

275.57

2.6

2.5

2.33

2.36

g/l

6.98

9958

43408

Falls/tendency to fall

10508

36336

1.52

275.44

2.6

2.4

2.34

2.38

g/l

11.97

9686

33745

Other Crohn's disease

938

2871

4.29

274.08

3.1

2.3

2.39

g/l

0.08

900

2661

Peripheral artery operations in Hilmo

1653

6882

2.95

273.97

5.7

2.3

2.07

2.25

g/l

31.90

1560

6289

Personality disorders, excluding more controls

2381

11305

2.33

273.54

2.3

2.4

2.48

2.43

g/l

4.07

2126

10663

Dizziness and giddiness

7466

39010

1.62

272.87

2.6

2.5

2.34

g/l

0.02

6870

36041

Bacterial pneumonia (organism specified)

4744

25657

1.84

272.35

3.3

2.4

2.22

2.31

g/l

20.72

4480

23476

Cystic kidney disease

599

1391

7.47

271.82

9.5

2.4

2.04

2.34

g/l

38.71

591

1303

Symptoms and signs concerning food and fluid intake

1275

4642

3.36

271.56

2.9

2.3

2.24

2.36

g/l

9.83

1172

4273

Nephrotic syndrome

581

1315

7.67

271.51

9.7

2.2

2.00

2.35

g/l

38.69

574

1217

Disorders of the thyroid gland

9371

41862

1.54

271.28

2.6

2.4

2.38

2.34

g/l

9.02

8561

38720

Lower back pain or/and sciatica

10313

47099

1.51

269.40

2.6

2.5

2.38

2.35

g/l

8.43

9550

43452

Ulcerative colitis, NAS

1616

6679

2.89

267.52

2.9

2.4

2.39

2.35

g/l

1.95

1548

6213

Amiodarone users

1369

5360

3.37

266.11

3.4

2.6

2.33

2.26

g/l

4.75

1306

4973

Nerve, nerve root and plexus disorders

10433

44808

1.50

265.86

2.8

2.4

2.37

2.34

g/l

5.70

9629

41351

Other acute lower respiratory infections

5413

31992

1.74

265.86

3.3

2.4

2.33

2.34

g/l

0.35

5014

29447

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

548

1205

8.00

265.26

8.1

2.6

2.05

2.34

g/l

29.21

533

1122

Other disorders involving the immune mechanism, not elsewhere classified

570

1292

7.51

264.90

8.0

2.6

2.05

2.34

g/l

30.45

555

1202

Follow-up examination after treatment for conditions other than malignant neoplasms

4195

15718

1.90

264.87

2.5

2.1

2.37

2.35

g/l

1.44

3923

14343

Pulmonary embolism

3227

17499

2.09

264.78

2.8

2.5

2.27

2.30

g/l

1.27

3024

16045

Streptococcal septicaemia

1139

3999

3.64

264.49

4.3

2.2

2.16

2.33

g/l

18.81

1081

3679

Concussion

4651

22376

1.81

264.43

2.4

2.3

2.38

2.37

g/l

0.48

4252

20846

Primary_lymphoid and hematopoietic malignant neoplasms

2733

14105

2.25

263.38

2.8

2.5

2.16

2.30

g/l

30.00

2593

12959

5726

32572

1.71

262.16

2.6

2.26

2.32

g/l

10.17

5202

30292

Enterocolitis due to Clostridium difficile

1421

5646

3.17

262.04

4.9

2.4

2.10

2.30

g/l

28.83

1342

5171

Crohn's disease of small intestine

925

2894

4.19

261.30

3.1

2.3

2.44

2.38

g/l

2.24

886

2685

Purpura and other haemorrhagic conditions

1648

7007

2.87

260.98

3.3

2.5

2.25

2.33

g/l

6.57

1570

6478

Hypothyroidism, other/unspecified

8773

39413

1.55

260.29

2.6

2.4

2.39

2.35

g/l

9.45

7980

36460

Osteoporosis

2865

14022

2.19

260.14

3.1

2.3

2.26

2.33

g/l

6.92

2603

12786

Pulmonary heart disease

3227

17600

2.08

260.12

2.8

2.5

2.27

2.30

g/l

1.42

3024

16146

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

1968

8956

2.55

259.76

2.7

2.5

2.43

2.37

g/l

5.60

1868

8351

5961

33397

1.69

259.63

2.6

2.27

2.33

g/l

10.05

5416

31060

Other dorsopathies, not elsewhere classified

9817

35538

1.52

258.02

2.5

2.4

2.38

2.35

g/l

4.94

9101

32781

Vocal cord dysfunction

1181

3665

3.24

257.72

2.6

1.7

2.36

2.37

g/l

0.19

1082

3401

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

1800

7924

2.66

257.58

2.7

2.5

2.43

2.36

g/l

5.35

1713

7386

Ulcerative colitis (strict definition, require KELA)

1847

8219

2.62

257.49

2.7

2.5

2.43

2.36

g/l

5.49

1757

7663

Other reaction to severe stress, and adjustment disorders

3403

18706

1.98

257.41

3.0

2.3

2.43

2.42

g/l

0.47

3128

17460

Cholelithiasis, broad definition with cholecystitis

8512

39057

1.56

256.68

2.7

2.4

2.36

2.34

g/l

4.20

7846

35962

Rheumatoid arthritis

3272

15959

2.04

255.39

2.4

2.3

2.26

2.33

g/l

11.64

3052

14671

Retention of urine

3759

17525

1.97

255.35

2.8

2.5

2.19

2.27

g/l

14.10

3439

16147

Solid cancers, helper endpoint

7815

30746

1.59

254.89

2.4

2.5

2.31

2.37

g/l

17.53

7332

28287

Other CVD

2384

11903

2.36

254.27

3.2

2.5

2.20

2.27

g/l

7.62

2168

10869

Cystic kidney disease

611

1513

6.64

253.93

9.4

2.4

2.04

2.34

g/l

39.61

602

1411

Polycystic kidney disease

518

1139

8.42

253.21

9.7

2.4

2.01

2.36

g/l

45.23

511

1066

Chronic nephritic syndrome

655

1705

6.00

252.63

8.8

2.2

2.02

2.33

g/l

45.31

646

1579

Hypothyreosis and Thyroxine purchase for inclusion criteria

9038

41007

1.53

251.54

2.6

2.4

2.39

2.35

g/l

9.01

8221

37944

Selective serotonin reuptake inhibitors

9624

34795

1.52

250.92

2.3

2.6

2.38

2.33

g/l

16.76

8731

32446

Implicit fungal Sepsis

920

2962

4.16

250.78

4.1

2.1

2.21

2.35

g/l

9.01

858

2735

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

2774

14493

2.15

250.59

2.9

2.4

2.53

2.31

g/l

72.09

2569

13520

Glucagon-like peptide-1 (GLP-1) analogues

2774

14493

2.15

250.59

2.9

2.4

2.53

2.31

g/l

72.09

2569

13520

Cough

3847

20922

1.89

248.67

2.8

2.3

2.37

2.34

g/l

2.20

3552

19286

Other or unspecified ileus, impaction or obstruction

2029

9521

2.46

247.81

3.1

2.4

2.28

2.27

g/l

0.11

1895

8750

Chronic pancreatitis

1484

6176

2.95

246.38

3.3

2.6

2.21

2.30

g/l

5.36

1415

5732

IgA nephropathy (IgA glomerulonephritis)

473

985

9.05

246.05

8.8

2.5

2.04

2.33

g/l

27.59

462

921

Sub-endpoint used in defining T1D endpoints

3088

16504

2.04

245.97

5.2

2.4

2.13

2.35

g/l

80.99

2875

15205

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

1098

3974

3.65

245.87

3.3

2.4

2.17

2.29

g/l

8.49

1022

3631

Nonorganic sleeping disorders, excluding more controls

1903

8692

2.47

243.91

2.4

2.3

2.43

2.40

g/l

1.95

1763

8171

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1785

7774

2.60

242.30

5.4

2.5

2.29

2.38

g/l

10.17

1716

7253

Endocarditis

545

1249

6.42

241.96

4.8

2.0

2.13

2.29

g/l

7.59

525

1151

Other systemic involvement of connective tissue

2911

15723

2.09

240.87

2.5

2.4

2.32

2.35

g/l

1.76

2706

14415

Cardiac arrest

723

1650

4.55

239.33

3.8

1.6

2.23

2.30

g/l

2.33

680

1498

Laparoscopic right hemicolectomy

877

2916

4.43

235.67

2.2

2.6

2.54

2.27

g/l

28.40

854

2693

Cerebrovascular diseases

7224

34223

1.59

234.98

3.1

2.4

2.26

2.32

g/l

10.83

6692

31525

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

743

2214

4.92

234.62

3.9

2.5

2.18

2.28

g/l

4.51

712

2024

Amputation of toe

1023

3690

3.77

233.21

6.4

2.5

2.02

2.26

g/l

32.69

977

3404

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1861

8386

2.50

233.10

5.3

2.5

2.29

2.38

g/l

9.82

1782

7820

Abnormal findings on diagnostic imaging of lung

4920

29648

1.74

232.98

2.9

2.5

2.27

2.29

g/l

1.35

4588

27240

Disorders of parathyroid gland

2292

11436

2.29

232.98

6.3

2.2

2.21

2.33

g/l

18.38

2123

10439

Hypotension

2082

10230

2.42

232.92

3.2

2.5

2.18

2.26

g/l

7.42

1886

9335

Cystitis

8274

33822

1.54

232.22

2.6

2.3

2.34

2.37

g/l

4.69

7626

31166

Congenital malformations of the urinary system

815

2563

4.33

231.86

8.4

2.4

2.11

2.37

g/l

34.71

798

2367

Other external causes of accidental injury

7886

26648

1.56

231.65

2.6

2.4

2.33

2.38

g/l

11.43

7270

24805

Acute bronchitis

4148

24497

1.81

230.59

3.3

2.4

2.33

2.32

g/l

0.26

3822

22501

Cholelithiasis

8097

38540

1.53

229.68

2.6

2.4

2.37

2.33

g/l

6.41

7458

35470

Polyneuropathies and other disorders of the peripheral nervous system

2421

12576

2.23

229.31

3.8

2.5

2.21

2.29

g/l

8.89

2258

11607

Chronic hepatitis, not elsewhere classified

556

1376

6.24

227.81

2.5

2.3

2.43

2.36

g/l

1.61

524

1279

Acute peritonitis

905

3079

3.97

226.90

8.8

2.5

2.03

2.30

g/l

35.93

879

2847

Vitamin B12 deficiency anaemia

1262

5052

3.05

225.53

2.9

2.3

2.35

2.24

g/l

7.73

1181

4607

Chronic apical periodontitis

10748

44313

1.45

224.46

2.8

2.4

2.35

g/l

0.17

9881

40990

Congenital malformations of the urinary system

841

2746

4.10

224.27

8.2

2.4

2.11

2.37

g/l

36.19

822

2537

L01XX Other antineoplastic agents

860

2897

4.24

223.80

2.5

2.35

2.28

g/l

2.68

825

2679

Status post-ami

2690

10867

2.12

223.77

3.4

2.2

2.28

2.22

g/l

6.40

2493

9855

Essential (haemorrhagic) thrombocythaemia

589

1554

5.73

221.43

2.5

2.4

2.35

2.33

g/l

0.51

563

1436

Biological medication for rheuma

1753

8107

2.48

221.22

2.4

2.5

2.40

2.41

g/l

0.21

1676

7567

Noninfectious colitis NAS

1547

6838

2.67

220.86

3.1

2.4

2.30

2.35

g/l

1.94

1464

6311

Viral pneumonia

1454

6248

2.75

220.81

3.9

2.2

2.24

2.35

g/l

10.88

1370

5757

Arthropathies

8482

29709

1.51

220.46

2.6

2.3

2.36

2.38

g/l

0.87

7883

27423

Acute upper respiratory infections of multiple and unspecified sites

7120

35857

1.56

219.86

2.9

2.4

2.38

2.36

g/l

1.35

6576

33140

Diseases of the respiratory system

6039

19469

1.64

219.73

2.6

2.1

2.36

2.39

g/l

3.37

5616

17891

Cutaneous abscess, furuncle and carbuncle

2589

13810

2.09

219.68

3.9

2.4

2.27

2.37

g/l

12.16

2420

12843

Idiopathic gout

1203

4850

3.18

218.17

4.4

2.5

2.18

2.26

g/l

4.49

1130

4486

Dermatitis

5893

38966

1.61

216.44

3.1

2.4

2.33

2.35

g/l

2.39

5465

36013

Mental and behavioural disorders due to psychoactive substance use

5674

34500

1.63

216.40

2.5

2.6

2.31

2.33

g/l

1.92

5147

32085

Other and unspecified polyneuropathies, also in other diseases

2148

10940

2.30

216.23

4.0

2.5

2.21

2.28

g/l

7.63

2003

10099

Sequelae of external causes of morbidity and mortality

2699

14753

2.07

215.84

3.4

2.5

2.26

2.33

g/l

5.76

2526

13593

Accidents

7791

26648

1.54

215.43

2.6

2.4

2.34

2.38

g/l

9.65

7186

24805

Diseases of the musculoskeletal system and connective tissue

5044

15673

1.70

212.68

2.6

2.2

2.38

2.40

g/l

1.21

4701

14463

Crohn disease (strict definition, require KELA, min 2 HDR)

811

2652

3.94

212.61

2.7

2.3

2.43

2.40

g/l

0.71

781

2464

Crohn disease (strict definition, require KELA)

817

2686

3.91

212.12

2.8

2.3

2.43

2.40

g/l

0.68

787

2494

Other diseases of pericardium

596

1603

5.05

211.75

4.3

2.0

2.19

2.32

g/l

5.81

567

1479

Haemolytic anaemias

575

1551

5.71

211.17

4.6

2.4

2.19

2.34

g/l

6.91

544

1441

Cholangitis (primary sclerosing, PSC)

851

2911

3.86

209.62

2.9

2.5

2.33

2.31

g/l

0.41

799

2694

Asthma, including avohilmo

11243

46537

1.42

208.98

2.5

2.41

2.34

g/l

26.17

10461

42888

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

1935

9576

2.34

208.23

2.1

2.6

2.29

2.31

g/l

0.88

1849

8762

Crohn's disease NAS

824

2754

3.83

208.08

3.3

2.4

2.38

2.37

g/l

0.19

783

2552

Substance abuse

5487

33902

1.62

207.82

2.5

2.6

2.31

2.33

g/l

1.66

4981

31537

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

849

2887

3.73

207.53

2.7

2.3

2.43

2.40

g/l

0.90

817

2683

Disorders of calcium metabolism

812

2719

3.88

205.53

4.8

2.2

2.18

2.33

g/l

10.40

765

2515

Irritable bowel syndrome

2539

13690

2.04

205.46

2.3

2.2

2.43

2.38

g/l

4.91

2343

12634

Convulsions, not elsewhere classified

2138

10750

2.15

202.86

2.8

2.2

2.27

2.39

g/l

15.09

1946

9929

Dermatitis and eczema

10446

47581

1.42

201.88

2.8

2.4

2.36

g/l

0.01

9673

43913

Hydronephrosis

1246

5201

2.85

201.76

3.9

1.8

2.13

2.36

g/l

32.51

1184

4760

Hypothyroidism, strict autoimmune, 3 medication purchases required

7989

38026

1.50

201.70

2.6

2.4

2.39

2.35

g/l

6.03

7228

35163

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

2421

12900

2.10

201.22

2.1

2.6

2.18

2.30

g/l

18.50

2294

11830

Other and unspecified dermatitis

4921

32000

1.65

199.14

3.1

2.4

2.33

2.35

g/l

2.32

4572

29552

Hyperparathyroidism

1996

10039

2.27

198.86

6.8

2.2

2.19

2.32

g/l

19.34

1854

9160

Viral hepatitis, IBD co-morbidity

550

1415

4.61

198.22

2.5

1.8

2.44

2.40

g/l

0.53

506

1310

Sulfasalazine

2675

14840

1.98

198.03

2.3

2.29

2.36

g/l

8.44

2498

13653

Dorsopathies

9714

35695

1.44

197.94

2.5

2.38

2.35

g/l

6.07

9006

32935

Asthma, hospital admissions , main diagnosis only

7694

48005

1.49

197.81

2.5

2.41

2.35

g/l

17.55

7156

44299

Sequelae with surgical and medical care as external cause

2173

11432

2.18

197.26

3.5

2.5

2.25

2.32

g/l

5.17

2028

10542

Benign neoplasm: Colon, unspecified

2658

14954

2.02

195.64

3.4

2.5

2.33

2.28

g/l

3.64

2454

13783

Injuries to the abdomen, lower back, lumbar spine and pelvis

3919

24032

1.75

195.59

2.8

2.4

2.28

2.33

g/l

7.39

3550

22111

Diseases of the eye and adnexa

7307

25134

1.52

195.27

2.9

2.2

2.36

2.41

g/l

11.13

6809

23398

Thrombocytopenia, unspecified

929

3478

3.46

194.32

3.2

2.5

2.21

2.32

g/l

5.65

879

3220

Diseases of peritoneum

1212

5133

2.89

193.98

7.2

2.4

2.12

2.31

g/l

25.00

1164

4743

Cellulitis

2228

11832

2.12

193.04

4.0

2.4

2.25

2.34

g/l

10.81

2089

10978

Disorder of lipoprotein metabolism, unspecified

1444

6583

2.58

191.77

3.3

2.2

2.27

2.28

g/l

0.29

1345

6016

Pleural effusion

1779

8871

2.36

190.20

3.4

2.5

2.13

2.26

g/l

16.61

1662

8131

Persons encountering health services for specific procedures, not carried out

927

3439

3.24

190.07

3.2

1.8

2.32

2.41

g/l

4.43

851

3157

Other joint disorders

7979

29627

1.48

189.67

2.5

2.3

2.39

2.37

g/l

0.78

7367

27342

Spinal stenosis

4941

24503

1.65

189.09

2.6

2.5

2.33

2.28

g/l

8.02

4515

22546

Left bundle-branch block

813

2846

3.51

186.59

2.5

2.1

2.31

2.30

g/l

0.35

757

2597

Osteomyelitis

850

3107

3.57

186.22

5.9

2.5

2.09

2.30

g/l

21.70

808

2885

External causes of morbidity and mortality

6138

20589

1.57

186.19

2.6

2.2

2.35

2.39

g/l

6.56

5697

19131

Fungal Sepsis

584

1720

4.79

185.36

4.7

2.2

2.14

2.34

g/l

11.79

555

1592

Benign neoplasm of other and ill-defined parts of digestive system

1904

9813

2.25

184.26

3.3

2.5

2.39

2.32

g/l

5.66

1780

9061

Cytomegalovirus infection, IBD co-morbidity

399

912

7.46

183.96

8.0

2.3

2.07

2.37

g/l

20.30

389

852

Diabetic retinopathy, excluding more controls

2970

9613

1.99

183.89

5.0

2.2

2.18

2.46

g/l

110.29

2760

8830

Injuries to the hip and thigh

4712

27936

1.64

183.63

2.8

2.5

2.23

2.31

g/l

18.19

4309

25669

Sulfonylureas

3524

17119

1.80

183.05

3.6

2.4

2.27

2.21

g/l

6.61

3216

15632

Later onset COPD, excluding more controls

2171

8903

2.13

181.58

2.8

2.2

2.23

2.29

g/l

4.36

1991

8088

Implicit fungal Sepsis

551

1588

4.98

181.34

4.7

2.1

2.14

2.34

g/l

12.18

526

1470

Enlarged lymph nodes

1523

7177

2.39

181.23

2.6

2.2

2.31

2.38

g/l

5.65

1446

6631

Insulin, fast-acting (human)

1448

6707

2.46

181.21

5.6

2.2

2.06

2.37

g/l

86.78

1362

6214

Dysphagia

2436

13551

1.99

181.19

2.6

2.4

2.30

2.31

g/l

0.27

2236

12487

Other/unspecified cytomegaloviral diseases

360

775

8.48

179.85

8.6

2.2

2.05

2.37

g/l

21.68

353

726

Diseases of oral cavity, salivary glands and jaws

5901

20397

1.57

179.27

2.6

2.3

2.29

2.32

g/l

3.04

5423

18794

Cytomegaloviral disease

404

952

7.03

178.70

8.0

2.4

2.07

2.36

g/l

19.25

394

888

Tumor necrosis factor alpha inhibitors

1516

7204

2.40

178.26

2.3

2.4

2.41

g/l

0.05

1451

6714

6-mercaptopurine

463

1173

5.33

177.70

2.4

2.3

2.40

2.43

g/l

0.61

444

1079

Combinations of oral blood glucose lowering drugs

2686

15508

1.92

177.53

2.5

2.48

2.25

g/l

75.05

2498

14405

Hepatic failure, not elsewhere classified

554

1635

4.88

176.60

3.2

2.5

2.09

2.31

g/l

9.89

513

1511

Other disorders of skin and subcutaneous tissue, not elsewhere classified

1547

7502

2.40

176.00

4.0

2.3

2.25

2.33

g/l

6.35

1427

6925

Seropositive rheumatoid arthritis

2376

13166

1.98

175.77

2.4

2.3

2.25

2.35

g/l

12.85

2231

12053

Other neurological diseases

6853

38125

1.50

174.95

2.8

2.5

2.31

2.32

g/l

0.79

6356

35050

Ulcerative colitis (strict definition, all Crohn cases excluded)

1452

6854

2.43

174.36

2.5

2.44

2.36

g/l

5.49

1384

6379

Other inflammatory liver diseases

800

2914

3.49

174.11

2.7

2.5

2.35

2.33

g/l

0.22

761

2696

Acquired haemolytic anaemia

427

1082

6.57

173.27

4.9

2.4

2.16

2.33

g/l

8.26

406

1012

Arthropathies in other diseases classified elsewhere

517

1470

4.90

171.85

6.3

2.5

2.15

2.32

g/l

8.22

480

1372

Functional dyspepsia

2467

13967

1.94

171.67

2.6

2.3

2.39

2.34

g/l

4.47

2281

12907

Artificial opening status

689

2338

3.87

171.60

3.3

2.2

2.23

2.31

g/l

2.57

666

2167

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

2310

12691

1.96

171.06

2.3

2.4

2.46

2.42

g/l

2.28

2075

11950

Mental and behavioural disorders due to alcohol, excluding acute intoxication

4112

26456

1.66

170.55

2.5

2.6

2.27

2.31

g/l

4.28

3734

24651

Chronic ulcer of skin, not elsewhere classified

873

3384

3.29

170.12

4.7

2.4

2.14

2.30

g/l

12.42

816

3126

Charcot foot

303

577

8.71

169.23

7.5

1.9

2.04

2.32

g/l

13.51

286

529

Arthrosis

6471

24652

1.51

168.72

2.4

2.3

2.36

2.33

g/l

2.99

5955

22733

Personality disorders

2381

13375

1.94

168.58

2.3

2.4

2.48

2.42

g/l

5.34

2126

12506

COPD

4381

23486

1.65

168.38

2.9

2.6

2.28

2.26

g/l

0.66

4033

21586

Viral infections characterized by skin and mucous membrane lesions

3884

24866

1.68

168.05

3.4

2.4

2.32

2.36

g/l

4.50

3655

22967

Abnormal serum enzyme levels

3067

18209

1.82

167.90

2.6

2.7

2.30

2.26

g/l

4.31

2911

16835

Stroke, excluding SAH

5730

28867

1.55

167.58

3.1

2.5

2.25

2.29

g/l

6.06

5279

26540

Polyarthrosis

1956

9630

2.11

167.38

2.4

2.36

2.32

g/l

1.62

1770

8815

Undetermined asthma, excluding more controls

1196

5261

2.56

167.13

2.5

2.0

2.39

g/l

0.03

1111

4825

Myocarditis

473

1240

4.59

167.11

2.9

1.6

2.32

2.38

g/l

1.65

456

1145

ILD, hospital admission 2, with pulmonary infections

1110

4820

2.77

166.72

2.9

2.3

2.22

2.30

g/l

4.94

1034

4421

Myelodysplastic syndrome, including Hilmo

472

1307

5.46

166.70

2.9

2.5

2.01

2.24

g/l

15.45

459

1196

Open wound of head

5064

33091

1.57

166.40

2.7

2.5

2.28

2.32

g/l

4.22

4604

30633

Mental and behavioural disorders due to alcohol

4695

30143

1.59

165.78

2.5

2.6

2.28

2.32

g/l

4.34

4251

28061

Ischaemic Stroke, excluding all haemorrhages

5433

27737

1.56

164.83

3.1

2.5

2.25

2.29

g/l

4.33

4999

25479

Other abnormal findings of blood chemistry

613

1999

4.13

164.41

2.7

2.5

2.37

2.33

g/l

0.91

589

1845

Gonarthrosis [arthrosis of knee](FG)

6696

27406

1.49

164.31

2.4

2.36

2.33

g/l

2.54

6150

25265

Other/unspecified dorsalgia

3502

21784

1.71

164.29

2.6

2.4

2.38

2.34

g/l

3.04

3232

20041

Viral infections characterized by skin and mucous membrane lesions

7843

49061

1.43

164.26

2.8

2.4

2.34

2.36

g/l

2.34

7315

45303

Total colectomy

571

1788

4.36

163.87

3.2

2.4

2.40

2.33

g/l

1.80

550

1666

Total colectomy operation

571

1788

4.36

163.87

3.2

2.4

2.40

2.33

g/l

1.80

550

1666

Other necrotizing vasculopathies (FG)

737

2663

3.53

163.10

3.9

2.4

2.17

2.31

g/l

8.94

695

2454

Intracranial injury

5430

35393

1.54

163.09

2.5

2.34

g/l

0.22

4942

32726

Rheumatoid arthritis, including avohilmo

3591

22810

1.71

162.94

2.4

2.5

2.27

2.35

g/l

11.83

3348

20937

Exclusions for E4_PCOS_BROAD

1695

8708

2.20

161.86

2.9

2.5

2.37

2.38

g/l

0.16

1582

8099

Unspecified fall

4736

31444

1.58

161.82

2.7

2.5

2.29

2.34

g/l

7.34

4305

29028

Spondylosis

4988

27520

1.57

161.67

2.4

2.5

2.36

2.31

g/l

9.52

4560

25387

Use of pramipexole

2224

12536

2.00

161.62

3.1

2.5

2.37

2.31

g/l

5.67

2016

11555

Stroke, including SAH

5952

30198

1.52

161.53

3.1

2.5

2.25

2.30

g/l

7.52

5493

27780

Migraine

4144

21780

1.63

160.88

2.2

2.3

2.47

2.41

g/l

9.99

3827

20219

Decubitus ulcer and pressure area

801

3065

3.36

160.73

4.9

2.3

2.02

2.28

g/l

27.27

731

2803

Crohn's disease of large intestine

632

2108

3.83

160.06

3.2

2.3

2.41

2.38

g/l

0.68

603

1954

Crohn disease (strict definition, all UC cases excluded)

624

2066

3.86

160.06

2.7

2.4

2.44

2.38

g/l

2.16

600

1917

Congenital malformations, deformations and chromosomal abnormalities

5079

32971

1.55

160.03

3.5

2.3

2.37

2.40

g/l

4.00

4759

30555

Non-selective monoamine reuptake inhibitors

3427

20739

1.71

159.95

2.4

2.5

2.40

2.32

g/l

11.05

3118

19271

Diseases of pulp and periapical tissues and dental caries

6535

23501

1.50

159.05

2.6

2.3

2.31

2.32

g/l

0.51

5964

21719

Secondary right heart disease

599

1985

4.21

158.83

3.9

2.5

2.41

2.27

g/l

8.48

585

1820

Nonorganic sleeping disorders

1903

10209

2.07

158.22

2.4

2.43

2.40

g/l

2.03

1763

9494

Alcohol use disorder, ICD-based

3782

24433

1.66

157.65

2.5

2.6

2.27

2.31

g/l

3.51

3431

22777

Other disorders of glucose regulation and pancreatic internal secretion

964

4031

2.88

157.16

4.4

2.5

2.20

2.33

g/l

9.17

903

3722

Fracture of lumbar spine and pelvis

2255

12857

1.96

156.09

2.8

2.4

2.22

2.30

g/l

8.44

2049

11727

Multiple myeloma, including Hilmo

597

1984

4.07

155.74

3.2

2.5

2.10

2.28

g/l

12.26

570

1816

Early onset COPD, excluding more controls

1822

9667

2.08

155.18

3.0

2.3

2.34

2.33

g/l

0.54

1684

8929

Symptoms and signs involving the skin and subcutaneous tissue

6428

45162

1.47

154.97

2.9

2.4

2.35

g/l

0.06

6006

41677

Dental caries, including avohilmo

7161

26272

1.46

154.59

2.6

2.4

2.31

2.32

g/l

0.63

6558

24275

Caries of dentine, including avohilmo

7611

28185

1.44

154.30

2.6

2.4

2.32

2.33

g/l

0.38

6975

26075

Coxarthrosis [arthrosis of hip](FG)

4896

23315

1.57

154.14

2.6

2.4

2.29

2.31

g/l

1.38

4504

21451

Asthma/COPD (KELA code 203)

8648

44227

1.40

153.76

2.5

2.40

2.35

g/l

13.37

8028

40800

Other diseases of stomach and duodenum

763

2898

3.28

152.78

3.6

2.4

2.34

2.27

g/l

2.05

722

2679

Other chronic obstructive pulmonary disease

4172

22798

1.63

152.55

2.9

2.6

2.28

2.26

g/l

0.89

3834

20941

Missing teeth due to accident, extraction or parodontitis

5447

35954

1.52

152.42

2.9

2.5

2.34

2.32

g/l

1.88

4936

33239

Disorders of adult personality and behaviour

2443

14224

1.86

152.39

2.3

2.4

2.48

2.42

g/l

4.64

2179

13297

Congenital malformations, deformations and chromosomal abnormalities

5552

35770

1.50

152.36

3.4

2.3

2.37

2.40

g/l

3.94

5192

33139

Other pulmonary heart/vessel disease

635

2223

3.86

152.28

3.9

2.5

2.42

2.27

g/l

8.90

621

2044

Other ulcerative colitis

678

2418

3.50

152.02

3.0

2.4

2.44

2.35

g/l

3.29

655

2244

Diseases of pulp and periapical tissues, including avohilmo

9849

38594

1.37

151.52

2.6

2.4

2.36

2.35

g/l

1.70

9061

35709

Intestinal adhesions without obstruction

927

3871

2.87

151.05

3.1

2.4

2.31

2.28

g/l

0.97

868

3566

Restless leg syndrome

1390

6876

2.35

150.54

2.4

2.5

2.43

2.34

g/l

7.52

1270

6368

Other necrotizing vasculopathies

861

3527

3.07

149.87

4.3

2.5

2.16

2.30

g/l

12.02

814

3255

Abnormal results of function studies

968

4148

2.80

149.51

3.1

2.5

2.37

2.35

g/l

0.57

889

3849

Elevated blood glucose level

929

3914

2.87

149.37

3.4

2.5

2.27

2.33

g/l

1.94

855

3626

Myalgia

2149

12168

1.93

148.86

2.5

2.3

2.42

2.38

g/l

2.70

1984

11219

Dental operations

5992

21557

1.50

147.77

2.6

2.3

2.30

2.31

g/l

0.76

5493

19874

Other intervertebral disc disorders

7492

33001

1.43

147.73

2.4

2.5

2.39

2.33

g/l

13.33

6929

30459

Periodontitis

8738

44011

1.39

146.58

3.2

2.4

2.31

2.35

g/l

9.84

8081

40708

Injuries to the thorax

4231

28493

1.59

145.61

2.8

2.5

2.28

2.31

g/l

2.36

3864

26326

Acute upper respiratory infections

9563

44861

1.36

145.25

2.8

2.4

2.38

2.35

g/l

5.46

8829

41350

Chronic periodontitis, including avohilmo

8705

43980

1.38

145.18

3.2

2.4

2.31

2.35

g/l

9.77

8048

40681

Coxarthrosis

4516

20071

1.57

144.31

2.6

2.3

2.30

g/l

0.33

4157

18477

Hyperkinetic disorders, excluding more controls

917

3619

2.68

144.18

2.4

2.2

2.55

2.53

g/l

0.82

838

3417

Shoulder lesions

6857

30134

1.44

143.28

2.6

2.4

2.36

2.33

g/l

3.51

6346

27778

Gingivitis and periodontal diseases

9543

37394

1.37

143.17

2.8

2.3

2.33

2.35

g/l

2.25

8817

34549

Other coagulation defects

842

3461

2.96

142.88

3.8

2.4

2.33

2.38

g/l

1.60

798

3213

Fracture of femur

2741

15271

1.78

141.72

2.9

2.5

2.16

2.28

g/l

19.48

2495

13878

COPD related to multimorbidity

3870

21740

1.63

141.26

2.9

2.5

2.28

2.26

g/l

1.55

3560

19988

Other symptoms and signs involving cognitive functions and awareness

4307

26628

1.57

141.00

2.5

2.28

2.30

g/l

1.64

3927

24508

Cholangitis (primary sclerosing, PSC), with reimbursement 202

313

725

6.99

140.65

3.4

2.4

2.42

2.39

g/l

0.45

306

679

Haemorrhage, not elsewhere classified

508

1617

4.15

140.64

5.0

2.2

2.22

2.32

g/l

3.17

474

1489

Agranulocytosis

1156

5476

2.48

140.48

2.9

2.5

2.16

2.34

g/l

18.91

1101

5076

Acute pancreatitis

1890

10542

2.00

140.32

3.1

2.5

2.24

2.30

g/l

3.97

1753

9737

Any operation in hilmo

302

234

7.08

140.14

2.2

1.2

2.41

2.58

g/l

3.69

278

221

Symptoms and signs involving the nervous and musculoskeletal systems

5293

37474

1.50

139.38

2.6

2.5

2.36

2.34

g/l

1.95

4889

34624

Other diseases of biliary tract

980

4367

2.70

139.38

2.8

2.4

2.28

2.30

g/l

0.54

925

4016

Osteoporosis with pathological fracture (FG)

792

3206

3.03

139.26

2.8

2.2

2.30

2.34

g/l

1.09

720

2889

Injury, poisoning and certain other consequences of external causes

4901

16666

1.54

139.25

2.6

2.2

2.35

2.38

g/l

2.78

4544

15448

Other arthrosis

4608

21784

1.55

138.30

2.6

2.3

2.36

2.32

g/l

3.53

4250

20109

Hernia of abdominal wall

4187

28472

1.57

138.15

3.2

2.5

2.34

2.31

g/l

1.63

3882

26344

Collagenous colitis

980

4384

2.67

137.53

3.0

2.4

2.30

2.33

g/l

0.88

920

4051

Other diseases of hard tissues of teeth

5553

20111

1.50

137.51

2.7

2.3

2.31

2.32

g/l

0.68

5097

18566

Left ventricular outflow tract obstruction (LVOTO), broad definition

1024

4650

2.59

137.46

3.7

2.7

2.39

2.34

g/l

2.05

987

4379

Cholecystectomy

6461

40772

1.44

137.11

2.6

2.4

2.39

2.33

g/l

14.61

5978

37555

Weight loss

1091

5117

2.54

137.07

2.5

2.6

2.24

2.32

g/l

4.75

998

4729

Non-allergic asthma (mode), excluding more controls

1560

8090

2.07

136.09

2.5

2.0

2.41

2.38

g/l

1.12

1455

7394

Gonarthrosis

5685

22893

1.48

135.83

2.4

2.3

2.36

2.32

g/l

4.09

5214

21097

Fibromyalgia

886

3771

2.71

135.63

2.2

2.52

2.42

g/l

6.19

827

3469

Disorders of eyelid, lacrimal system and orbit

7774

44351

1.39

135.47

2.6

2.5

2.34

g/l

0.12

7153

40948

Other chronic obstructive pulmonary disease, including avohilmo

4982

28940

1.52

134.97

2.8

2.6

2.29

2.28

g/l

0.79

4572

26672

Specific personality disorders

2006

11444

1.90

134.80

2.2

2.4

2.49

2.42

g/l

5.68

1792

10693

Need for other prophylactic measures

682

2617

3.27

134.54

3.7

2.5

2.28

2.34

g/l

2.09

659

2439

Undetermined asthma

1196

5776

2.31

133.19

2.5

2.1

2.39

2.38

g/l

0.13

1111

5326

Other diseases of arteries and capillaries

963

4330

2.63

132.99

5.3

2.2

2.27

2.31

g/l

1.14

905

3979

Other respiratory diseases principally affecting the interstitium

1866

10611

1.99

132.78

3.3

2.5

2.24

2.27

g/l

1.55

1739

9729

Poisoning by drugs, medicaments and biological substances

2062

11934

1.88

132.08

2.4

2.43

2.41

g/l

0.90

1859

11143

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

460

1423

4.16

131.71

7.0

2.2

2.01

2.44

g/l

55.63

435

1344

Primary biliary cholangitis (PBC)

328

821

5.96

131.65

2.7

2.1

2.44

2.38

g/l

0.96

311

757

ILD, hospital admissions 3, with pneumonia sepsis

937

4213

2.66

130.31

3.1

2.3

2.19

2.29

g/l

6.20

874

3864

Menorrhagia

2986

10324

1.72

129.59

2.3

2.49

2.40

g/l

13.29

2746

9461

Seronegative rheumatoid arthritis

1131

5442

2.37

129.57

2.3

2.25

2.34

g/l

5.11

1053

4999

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

2989

19172

1.68

129.37

2.7

2.4

2.38

2.37

g/l

0.60

2788

17722

Excessive, frequent and irregular menstruation

3292

11511

1.66

128.05

2.5

2.2

2.49

2.43

g/l

6.70

3005

10545

Abnormal weight loss

1004

4689

2.56

127.93

2.5

2.6

2.23

2.31

g/l

4.17

920

4338

Other blood glucose lowering drugs, excl. Insulins

1572

8549

2.07

127.78

3.2

2.5

2.41

2.25

g/l

22.20

1453

7834

Nonalcoholic steatohepatitis

190

314

13.98

127.70

2.5

2.3

2.53

2.40

g/l

1.74

183

292

Behavioural syndromes associated with physiological disturbances and physical factors

8014

43129

1.37

127.61

2.3

2.5

2.43

2.36

g/l

20.38

7376

39903

Other headache syndromes

3546

23558

1.59

127.46

2.3

2.4

2.44

2.37

g/l

12.00

3286

21782

Viral and other specified intestinal infections

2311

13379

1.78

126.90

3.4

2.2

2.37

2.44

g/l

6.24

2151

12382

KRA_PSY_EATING, excluding more controls

726

2859

2.84

126.89

2.4

2.0

2.54

2.55

g/l

0.22

659

2673

Other symptoms and signs involving the digestive system and abdomen

1504

8034

2.07

126.11

2.8

2.3

2.39

2.37

g/l

0.55

1380

7410

Mycoses

2443

15053

1.77

126.05

3.3

2.5

2.30

2.34

g/l

2.51

2275

13904

Other viral diseases

3126

20147

1.64

125.34

3.6

2.4

2.36

2.42

g/l

5.68

2927

18763

Acute posthaemorrhagic anaemia

449

1423

4.15

124.99

4.4

2.1

2.29

2.31

g/l

0.32

420

1295

Fracture of rib(s), sternum and thoracic spine

2833

18141

1.70

124.84

2.8

2.5

2.25

2.29

g/l

4.02

2574

16729

Hypoglycaemia, other or unspecified

761

3177

2.89

124.67

4.4

2.5

2.21

2.34

g/l

6.63

709

2936

Other and unspecified diseases of blood and blood-forming organs

387

1140

4.95

124.39

3.3

2.4

2.32

2.33

g/l

0.10

371

1059

Other viral diseases

2483

15282

1.74

124.36

4.1

2.4

2.34

2.41

g/l

6.15

2320

14246

Aortic valve malfunction, age under 60 years

939

4291

2.57

124.28

3.7

2.7

2.38

2.34

g/l

1.67

905

4035

Other pleural conditions

1124

5543

2.38

123.88

3.8

2.5

2.11

2.26

g/l

14.73

1047

5100

Acute sinusitis

4359

28043

1.51

123.69

2.9

2.3

2.39

g/l

0.10

4034

25995

Ventral hernia

2239

13572

1.81

123.45

3.1

2.4

2.36

2.31

g/l

3.03

2078

12513

Visual disturbances and blindness

4652

32922

1.50

122.97

2.8

2.5

2.35

2.34

g/l

0.74

4254

30374

Other respiratory disorders and diseases

2040

12119

1.87

122.87

3.4

2.5

2.29

2.26

g/l

0.90

1881

11096

Other diseases of the respiratory system

2040

12119

1.87

122.87

3.4

2.5

2.29

2.26

g/l

0.90

1881

11096

Other extrapyramidal and movement disorders in other diseases

2238

13613

1.81

122.77

2.4

2.5

2.39

2.32

g/l

7.38

2033

12567

Poisoning by medicine

1858

10666

1.89

122.59

2.4

2.43

2.41

g/l

0.88

1671

9963

Persons with potential health hazards related to communicable diseases

3076

19839

1.63

121.91

3.5

2.4

2.38

2.44

g/l

7.05

2865

18509

Candidiasis

2541

15914

1.73

121.75

2.8

2.4

2.36

2.38

g/l

0.56

2319

14695

Complications of internal orthopaedic prosthetic devices, implants and grafts

2116

12725

1.83

121.03

2.9

2.3

2.26

2.30

g/l

2.90

1928

11623

Zoster [herpes zoster]

1776

10200

1.94

120.62

3.1

2.4

2.28

2.31

g/l

1.75

1659

9350

Colitis, primary sclerosing

240

506

7.81

120.42

3.1

2.3

2.46

2.41

g/l

0.50

230

469

Adrenocortical insufficiency

459

1515

4.02

120.33

3.3

2.3

2.29

2.36

g/l

1.59

427

1406

Sciatica+with lumbago

4419

28505

1.50

120.25

2.5

2.40

2.34

g/l

10.59

4128

26334

Other (seronegative) rheumatoid arthritis, wide

1802

10417

1.93

119.40

2.5

2.4

2.25

2.34

g/l

8.50

1672

9596

Other diseases of pancreas

875

3976

2.63

118.90

3.3

2.5

2.26

2.30

g/l

1.26

827

3687

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

923

4260

2.53

118.88

3.2

2.3

2.34

2.36

g/l

0.48

862

3936

Invasive ventilation

804

3531

2.76

118.74

3.9

2.5

2.19

2.30

g/l

5.89

745

3279

Adalimumab

919

4229

2.50

117.90

2.5

2.4

2.41

2.40

g/l

0.23

882

3941

Substance use, excluding alcohol

1683

9496

1.93

117.86

2.4

2.6

2.42

2.38

g/l

2.13

1513

8897

Phlebitis and thrombophlebitis (not including DVT)

2068

12430

1.82

117.53

3.2

2.4

2.30

2.33

g/l

1.98

1913

11493

Chronic tubulo-interstitial nephritis

448

1462

3.89

117.47

6.6

1.8

2.10

2.40

g/l

24.87

430

1339

Amputation of foot

391

1216

4.81

117.22

7.3

2.5

1.95

2.25

g/l

24.54

374

1119

Multiple myeloma and malignant plasma cell neoplasms

606

2386

3.33

116.63

3.3

2.5

2.10

2.28

g/l

12.44

580

2199

Aortic aneurysm

2219

13372

1.79

116.39

3.0

2.4

2.23

2.24

g/l

0.36

2051

12257

Acute pancreatitis (for exclusion)

1890

11172

1.87

115.19

3.1

2.5

2.24

2.31

g/l

4.08

1753

10335

COPD, hospital admissions

4191

24890

1.52

114.95

2.9

2.5

2.27

g/l

0.35

3850

22901

Chronic periodontitis, complicated

4732

33716

1.47

114.63

3.4

2.5

2.28

2.33

g/l

6.72

4378

31246

Polycystic ovarian syndrome, consortium definition

5825

25252

1.43

114.56

2.4

2.2

2.47

2.43

g/l

5.89

5309

23204

Unspecified privation

1086

5415

2.31

114.53

3.6

2.5

2.26

2.33

g/l

3.70

1035

5020

Isolated proteinuria

393

1227

4.45

114.29

6.9

2.5

2.14

2.32

g/l

9.07

376

1142

Generalized anxiety disorder

1307

6861

2.08

113.95

2.1

2.2

2.50

2.45

g/l

2.85

1181

6388

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

706

2976

2.87

113.67

2.5

2.6

2.28

2.27

g/l

0.24

668

2723

COPD, early/later onset

4219

25074

1.51

113.26

2.9

2.6

2.27

g/l

0.25

3878

23077

Abnormal findings on examination of urine, without diagnosis

540

2021

3.43

112.92

5.8

2.5

2.19

2.31

g/l

5.60

517

1869

Heart failure and hypertrophic cardiomyopathy

307

842

6.04

112.81

4.5

2.4

2.32

2.28

g/l

0.68

289

777

Laparoscopic left hemicolectomy

298

803

6.30

112.71

1.8

2.4

2.43

2.28

g/l

4.64

293

746

Transient ischemic attack

4750

27645

1.47

112.43

2.8

2.5

2.29

g/l

0.02

4402

25370

Other complications of surgical and medical care, not elsewhere classified

952

4535

2.41

112.40

3.2

2.2

2.34

2.36

g/l

0.65

892

4193

Pericarditis

396

1225

4.05

112.33

4.1

2.1

2.14

2.32

g/l

7.33

378

1134

COPD, hospital admission 2, with asthma infections

3082

17583

1.63

112.28

3.0

2.6

2.25

g/l

0.02

2832

16141

Misadventures to patients during surgical and medical care

1363

7381

2.08

112.04

3.8

2.3

2.28

2.33

g/l

2.63

1288

6836

Disorders of skin appendages

4009

28020

1.51

111.67

3.1

2.4

2.37

2.38

g/l

1.30

3736

25984

Other and unspecified coagulation defects

565

2160

3.24

111.65

3.9

2.3

2.33

2.39

g/l

1.85

540

2016

Sleep disorders

7559

41909

1.35

111.53

2.2

2.5

2.44

2.37

g/l

22.22

6976

38777

Thiazolidinediones

1130

5787

2.25

111.32

3.3

2.5

2.38

2.23

g/l

14.41

1042

5346

Bipolar affective disorders

1548

8653

1.94

111.12

2.3

2.4

2.45

2.40

g/l

2.00

1378

8126

Speech therapy

2412

15301

1.72

110.95

2.9

2.5

2.31

2.33

g/l

0.73

2327

14082

SLE (Finngen)

401

1267

4.04

110.94

3.5

2.0

2.21

2.41

g/l

10.00

387

1179

Other metabolic disorders

1151

5871

2.18

110.87

3.0

2.1

2.37

2.41

g/l

1.22

1078

5424

Superficial injury of head

2159

13295

1.76

110.69

2.5

2.31

2.34

g/l

1.75

1986

12258

Other disorders of adrenal gland

524

1943

3.39

110.32

3.3

2.3

2.28

2.37

g/l

2.49

490

1805

Allergic asthma (mode), excluding more controls

1742

9827

1.84

109.63

2.2

1.9

2.46

2.45

g/l

0.29

1643

9081

Problems related to lifestyle

925

4370

2.37

109.31

2.6

2.2

2.39

2.38

g/l

0.21

830

4071

Spondyloarthritis

1602

9124

1.92

109.18

2.8

2.4

2.31

2.34

g/l

1.09

1479

8444

Intestinal malabsorption

527

1971

3.34

108.87

3.7

2.3

2.27

2.35

g/l

2.19

498

1828

Visual disturbances

4232

30126

1.49

108.53

2.7

2.5

2.37

2.34

g/l

1.59

3887

27828

Vitreous haemorrhage

1037

5207

2.31

108.27

6.0

2.5

2.09

2.30

g/l

28.33

984

4815

Rheumatism, unspecified

1221

6428

2.12

108.04

2.3

2.47

2.37

g/l

7.05

1135

5909

Polycythaemia vera

430

1459

3.92

108.01

2.6

2.4

2.57

2.29

g/l

17.23

407

1343

Polymyalgia rheumatica

1352

7435

2.08

107.93

2.5

2.4

2.23

2.28

g/l

2.60

1242

6786

Respiratory insufficiency

825

3763

2.52

107.69

3.2

2.2

2.34

2.29

g/l

1.49

757

3424

Degeneration of macula and posterior pole

4366

24828

1.49

107.58

2.9

2.4

2.25

2.28

g/l

2.48

3937

22724

Thoracic aortic aneurysm

1358

7471

2.06

107.55

2.9

2.4

2.26

2.27

g/l

0.20

1259

6906

Diabetic retinopathy, strict definition

1968

10730

1.87

106.90

6.0

2.6

2.08

2.40

g/l

116.88

1830

9948

Zoster [herpes zoster]

4386

31022

1.47

106.76

2.7

2.4

2.31

2.33

g/l

1.65

4078

28473

Other and unspecified drugs and medicaments

871

4112

2.48

106.75

3.2

2.4

2.33

2.34

g/l

0.26

815

3795

Diagnoses used for exclusion with ILD

2364

15062

1.70

106.41

2.9

2.5

2.28

2.30

g/l

0.45

2188

13882

Abnormal findings on diagnostic imaging of other body structures

1294

7016

2.08

106.26

2.8

2.4

2.33

2.34

g/l

0.09

1217

6490

Injuries to the knee and lower leg

10559

46919

1.29

105.96

2.7

2.4

2.35

2.36

g/l

0.27

9736

43360

Exclusions for E4_PCOS_CONSORTIUM

5986

27934

1.40

105.95

2.4

2.3

2.43

2.42

g/l

1.45

5469

25818

Mycoses

7366

49548

1.34

105.49

2.5

2.36

g/l

0.31

6755

45858

All influenza (not pneumonia)

1312

7108

2.03

105.38

3.7

2.2

2.34

2.37

g/l

1.16

1218

6578

Colitis, primary sclerosing, strict definition

189

363

8.87

105.35

3.0

2.3

2.46

2.44

g/l

0.14

181

338

Hepatocellular carcinoma, including Hilmo

382

1230

4.21

105.10

2.7

2.4

2.34

2.24

g/l

2.30

361

1126

Other and unspecified local infections of skin and subcutaneous tissue

950

4651

2.35

105.03

4.3

2.4

2.26

2.34

g/l

3.56

893

4302

Methotrexate

1247

6669

2.07

104.62

2.4

2.3

2.30

2.36

g/l

3.24

1173

6123

Other disorders of lacrimal gland

3012

20267

1.59

104.56

2.7

2.4

2.36

g/l

0.09

2779

18680

COPD-related respiratory insufficiency

1215

6537

2.13

103.93

3.6

2.6

2.30

2.24

g/l

3.15

1123

5998

Diabetic retinopathy

3738

16381

1.57

103.90

4.7

2.6

2.18

2.40

g/l

92.36

3461

15155

Other local infections of skin and subcutaneous tissue

991

4946

2.29

103.74

4.2

2.4

2.27

2.34

g/l

3.14

929

4579

ILD, hospital admissions

1514

8720

1.96

103.59

2.8

2.6

2.25

2.27

g/l

0.67

1411

8024

Seropositive rheumatoid arthritis, wide

2375

15246

1.69

103.49

2.4

2.5

2.25

2.34

g/l

11.46

2231

14001

Delirium, not induced by alcohol and other psychoactive substances

1264

6885

2.09

103.21

2.8

2.6

2.17

2.26

g/l

5.60

1124

6326

Immunodeficiencies

540

2106

3.19

103.19

3.8

2.4

2.36

g/l

0.04

517

1950

Viral and other specified intestinal infections

1709

9768

1.83

103.08

3.8

2.2

2.35

2.44

g/l

8.18

1586

9020

Sequelae of cerebrovascular disease

3361

19959

1.56

103.02

3.1

2.5

2.21

2.27

g/l

8.20

3062

18286

Extreme obesity with alveolar hypoventilation

479

1765

3.47

102.89

3.0

2.4

2.49

2.31

g/l

7.01

420

1641

Non-Hodgkin lymphoma, all, including Hilmo

1217

6537

2.09

102.60

2.5

2.6

2.16

2.30

g/l

11.98

1146

5975

Other infectious diseases

940

4641

2.35

102.47

4.4

2.5

2.16

2.31

g/l

12.31

895

4277

Other disorders of veins

3435

23651

1.53

102.44

2.7

2.4

2.34

2.35

g/l

0.85

3147

21811

Fentanyl

981

4880

2.25

101.60

3.1

2.3

2.19

2.28

g/l

3.88

893

4447

Persistent mood disorders

1655

9717

1.85

101.24

2.4

2.39

2.36

g/l

1.57

1506

9026

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

987

4979

2.28

100.87

3.8

2.6

2.12

2.28

g/l

14.57

928

4562

Benign neoplasm: Stomach

988

5018

2.30

100.53

3.2

2.5

2.42

2.31

g/l

7.09

921

4625

Psoriatic and enteropathic arthropathies

1024

5198

2.20

100.35

2.5

2.4

2.39

2.36

g/l

0.93

967

4828

Panic disorder

1200

6390

2.04

100.31

2.2

2.51

2.45

g/l

3.14

1094

5935

Other interstitial pulmonary diseases

1525

8880

1.94

100.27

2.8

2.5

2.25

2.27

g/l

0.72

1422

8170

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1536

7785

1.88

100.19

2.5

2.3

2.54

2.51

g/l

1.39

1399

7256

Ulcerative ileocolitis

451

1618

3.46

100.09

3.2

2.4

2.38

2.36

g/l

0.41

435

1506

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

2299

14765

1.69

100.03

2.4

2.5

2.25

2.34

g/l

10.93

2159

13578

Other embolism and thrombosis

1229

6683

2.07

99.75

3.4

2.4

2.27

2.32

g/l

2.01

1141

6169

Benign neoplasm: Sigmoid colon

1781

10810

1.83

99.54

3.1

2.6

2.34

2.29

g/l

3.30

1685

9960

Interstitial lung disease

1525

8905

1.93

99.30

2.8

2.6

2.25

2.27

g/l

0.72

1422

8190

Interstitial lung disease endpoints

1525

8905

1.93

99.30

2.8

2.6

2.25

2.27

g/l

0.72

1422

8190

Haemorrhoids and perianal venous thrombosis

2690

17784

1.61

99.24

2.7

2.3

2.39

2.30

g/l

14.12

2479

16292

Other/unspecified seropositive rheumatoid arthritis

2335

15078

1.68

99.14

2.4

2.5

2.25

2.34

g/l

11.08

2192

13850

Benign neoplasm: Ascending colon

1352

7640

2.01

98.82

3.2

2.6

2.35

2.28

g/l

4.06

1279

7061

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

4030

19406

1.48

98.58

2.9

2.6

2.26

2.32

g/l

7.97

3690

17720

DVT of lower extremities

1742

10496

1.82

98.57

3.0

2.4

2.28

2.31

g/l

1.04

1626

9672

Other disorders of white blood cells

601

2526

2.91

98.20

3.2

2.5

2.30

2.32

g/l

0.41

565

2339

Somatoform disorder

1397

7892

1.94

98.16

2.4

2.44

2.37

g/l

4.42

1279

7333

Viral pneumonia (unknown virus, not influenza)

691

3069

2.64

97.60

3.9

2.5

2.25

2.33

g/l

3.10

657

2848

Rotator cuff syndrome

5233

27884

1.41

97.53

2.5

2.4

2.36

2.32

g/l

6.57

4843

25721

ILD, hospital admissions 1, main diag only

1358

7720

2.00

97.45

2.8

2.6

2.25

2.27

g/l

0.71

1268

7105

Phobic anxiety disorders

1058

5455

2.11

96.67

2.6

2.2

2.48

2.45

g/l

1.02

962

5085

Insomnia

7260

41146

1.33

96.64

2.2

2.5

2.44

2.37

g/l

20.49

6705

38048

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

978

5006

2.25

96.56

3.9

2.5

2.22

2.32

g/l

5.37

926

4649

Candidiasis

1249

6891

2.02

96.54

3.3

2.4

2.31

2.36

g/l

2.19

1158

6373

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

1343

7575

1.97

96.36

2.2

2.6

2.20

2.31

g/l

9.66

1264

6946

Deforming dorsopathies

2349

15217

1.65

96.34

2.4

2.42

2.35

g/l

7.10

2173

14047

Disorders of lacrimal system

3643

25745

1.49

96.03

2.6

2.4

2.36

g/l

0.15

3362

23693

Other or ill-defined heart diseases

502

1919

3.03

95.79

3.9

2.1

2.23

2.33

g/l

3.76

465

1763

Extrapyramidal and movement disorders

3374

23658

1.52

95.44

2.3

2.5

2.35

2.30

g/l

5.77

3043

21796

Other sleep disorders

1036

5395

2.15

95.09

2.8

2.5

2.40

2.31

g/l

6.19

972

5003

Non-allergic asthma (mode)

1561

9062

1.83

94.67

2.5

2.1

2.41

2.37

g/l

1.55

1456

8309

Chronic myeloproliferative disease

239

626

6.64

94.33

3.0

2.3

2.22

2.29

g/l

0.93

227

572

Abnormalities of gait and mobility

1201

6641

2.06

94.25

2.7

2.6

2.25

2.29

g/l

1.27

1103

6129

Open wound of lower leg

1386

7939

1.93

94.08

3.3

2.4

2.27

2.34

g/l

4.36

1279

7330

Familial hypercholesterolemia

1367

7802

1.94

93.97

3.3

2.2

2.29

2.27

g/l

0.44

1269

7109

Irregular menses

3623

20135

1.49

93.75

2.5

2.2

2.51

2.46

g/l

5.42

3317

18605

Fitting and adjustment of other devices

2989

18440

1.55

93.70

2.6

2.0

2.30

2.32

g/l

0.60

2730

16708

Vitamin deficiency

520

2080

3.04

93.44

3.1

2.4

2.34

2.31

g/l

0.58

498

1921

Vitamin deficiency, wide

520

2080

3.04

93.44

3.1

2.4

2.34

2.31

g/l

0.58

498

1921

Other viral diseases, not elsewhere classified

2157

13721

1.67

93.20

3.4

2.4

2.39

2.41

g/l

1.13

2018

12784

Other viral diseases, not elsewhere classified

1580

9364

1.83

92.70

3.8

2.4

2.36

2.39

g/l

0.98

1474

8730

COPD, hospital admissions 3, with asthma pneumonia sepsis

2598

14845

1.62

92.65

3.0

2.6

2.22

2.24

g/l

0.55

2392

13597

Immunodeficiency with predominantly antibody defects

333

1066

4.19

92.13

3.8

2.3

2.34

2.39

g/l

0.78

324

993

L04AC Interleukin inhibitors

571

2393

2.81

91.72

2.7

2.4

2.40

2.39

g/l

0.21

545

2231

Polyuria

2026

12919

1.71

91.37

2.7

2.4

2.28

2.29

g/l

0.37

1840

11909

Soft tissue disorders related to use, overuse and pressure

2285

14910

1.64

91.19

2.8

2.4

2.33

g/l

0.05

2111

13761

Malignant neoplasm of stomach, including Hilmo

623

2730

2.70

91.18

2.2

2.5

2.41

2.26

g/l

6.55

583

2497

Unspecified jaundice

542

2240

2.90

90.61

2.5

2.4

2.22

2.29

g/l

1.47

497

2066

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

2310

15098

1.62

90.31

2.3

2.4

2.46

2.42

g/l

2.54

2075

14096

Exposure to other specified factors

6303

44819

1.34

89.81

2.7

2.5

2.36

2.37

g/l

1.08

5775

41560

Diseases of the myoneural junction and muscle

1161

6429

2.04

89.67

2.7

2.5

2.25

2.30

g/l

1.63

1045

5939

Acidosis

282

832

4.74

89.41

4.0

2.2

2.16

2.30

g/l

3.19

264

774

Injuries to the shoulder and upper arm

7224

45827

1.32

89.18

2.6

2.5

2.31

2.34

g/l

5.30

6618

42378

Malignant neoplasm of urinary organs

911

4666

2.23

89.08

3.8

2.6

2.10

2.28

g/l

17.11

857

4276

Ulcerative enterocolitis

364

1242

3.71

88.91

3.0

2.3

2.46

2.35

g/l

2.59

345

1153

In situ neoplasms

3362

23882

1.50

88.33

2.9

2.4

2.30

2.32

g/l

2.26

3076

21921

Migraine with aura

1894

11874

1.69

88.20

2.1

2.3

2.46

2.43

g/l

2.41

1748

11014

Coeliac disease

1082

5863

2.06

88.13

2.7

2.4

2.38

2.37

g/l

0.28

995

5431

Fissure and fistula of anal and rectal regions

1935

12231

1.69

88.03

2.5

2.3

2.37

2.33

g/l

2.82

1790

11337

Postprocedural disorders of digestive system, not elsewhere classified

391

1407

3.58

87.90

3.0

2.4

2.40

2.31

g/l

1.77

369

1307

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

337

1121

4.03

87.88

3.3

2.4

2.09

2.27

g/l

7.27

322

1025

Multiple myeloma

337

1121

4.03

87.88

3.3

2.4

2.09

2.27

g/l

7.27

322

1025

Postprocedural endocrine and metabolic disorders, not elsewhere classified

1017

5382

2.08

87.85

2.9

2.1

2.37

2.41

g/l

1.08

953

4970

Other infectious diseases

789

3870

2.37

87.77

4.8

2.5

2.15

2.30

g/l

11.60

750

3564

Other general symptoms and signs

484

1883

2.96

87.69

2.3

2.1

2.45

2.44

g/l

0.17

432

1751

Isolated proteinuria with specified morphological lesion

195

456

7.18

87.60

6.7

2.0

2.17

2.37

g/l

4.95

189

418

Hypertrophic cardiomyopathy

487

1974

3.12

87.25

3.8

2.6

2.34

2.30

g/l

1.17

461

1825

Supplementary factors related to causes of morbidity and mortality classified elsewhere

2654

18059

1.56

86.81

3.1

2.5

2.34

2.35

g/l

0.20

2424

16743

Malignant neoplasm of skin

4055

20185

1.44

86.74

2.8

2.6

2.26

2.32

g/l

9.32

3716

18455

Hypocalcemia

306

975

4.38

86.63

5.8

2.3

2.14

2.37

g/l

8.98

295

907

Fracture of shoulder and upper arm

3072

21474

1.51

86.59

2.7

2.5

2.27

2.34

g/l

7.97

2791

19812

Diseases of the ear and mastoid process

10164

41494

1.26

86.54

2.6

2.4

2.38

2.36

g/l

4.73

9369

38421

Unspecified acute lower respiratory infection

1346

7828

1.89

86.32

3.4

2.4

2.29

2.33

g/l

1.51

1265

7265

Systemic lupus erythematosus

401

1472

3.42

86.11

3.5

2.2

2.21

2.39

g/l

8.23

387

1361

Other malignant neoplasms of skin (=non-melanoma skin cancer)

3748

18465

1.46

85.83

2.8

2.6

2.26

2.32

g/l

8.10

3427

16842

Malignant neoplasm of kidney, except renal pelvis

838

4227

2.27

85.71

3.9

2.6

2.11

2.28

g/l

15.34

789

3887

Duodenal ulcer

1039

5626

2.07

85.37

3.6

2.5

2.24

2.23

g/l

0.16

951

5178

Allergic asthma (mode)

1742

10520

1.71

85.27

2.2

2.0

2.46

2.44

g/l

0.74

1643

9740

Hypopituitarism

662

3050

2.50

85.14

2.8

2.4

2.39

2.36

g/l

0.68

623

2846

Ulcerative proctitis

597

2636

2.63

85.12

2.5

2.4

2.41

2.37

g/l

0.94

559

2451

Vascular diseases of the intestine

457

1811

3.16

85.01

4.3

2.3

2.22

2.27

g/l

0.94

429

1644

Pain and other conditions associated with female genital organs and menstrual cycle

1522

8344

1.79

85.01

2.0

2.2

2.50

2.46

g/l

1.57

1392

7694

Secondary polycythaemia

307

985

4.22

85.01

2.2

2.4

2.57

2.31

g/l

13.03

284

913

Benign neoplasm: Rectum, anus and anal canal

1833

11641

1.73

84.96

2.9

2.5

2.35

2.29

g/l

4.37

1720

10714

Spondylopathies (FG)

1128

6237

1.97

84.57

2.4

2.39

2.38

g/l

0.38

1036

5802

Emotionally unstable personality disorder

994

5276

2.06

84.52

2.1

2.2

2.52

2.47

g/l

1.88

878

4910

Injuries to the ankle and foot

5687

38920

1.35

84.14

2.9

2.4

2.37

2.39

g/l

1.58

5292

36102

Schizophrenia or delusion, excluding more controls

2247

14648

1.60

83.90

2.2

2.4

2.40

2.38

g/l

0.73

1999

13748

Attention to artificial openings

436

1690

3.17

83.80

3.1

2.0

2.28

2.32

g/l

0.75

411

1555

Osteonecrosis

623

2845

2.60

83.63

3.3

2.5

2.25

2.33

g/l

2.55

585

2654

Ulcerative rectosigmoiditis

754

3675

2.33

83.59

2.8

2.4

2.42

2.35

g/l

2.69

720

3421

Artrosis, including avohilmo

7255

31272

1.31

83.59

2.3

2.6

2.36

2.32

g/l

7.53

6667

29022

Chronic sinusitis

3520

25319

1.46

83.59

2.4

2.5

2.39

2.35

g/l

3.25

3247

23384

Other and unspecified effects of external causes

2221

14671

1.61

83.26

2.6

2.4

2.40

2.39

g/l

0.34

2021

13669

Disturbances of skin sensation

2244

14872

1.61

83.09

2.4

2.42

2.39

g/l

1.55

2071

13805

Barrett oesophagus

523

2227

2.86

83.08

2.6

2.4

2.38

2.26

g/l

4.15

494

2074

Alcohol dependence

2245

14902

1.61

83.05

2.5

2.7

2.28

2.30

g/l

0.69

2039

13892

Disorders of synovium and tendon

4338

28230

1.40

82.49

2.7

2.4

2.38

2.36

g/l

1.80

4006

26108

SLE, ICD10

387

1433

3.41

82.02

3.5

2.2

2.20

2.39

g/l

8.57

373

1320

SLE, strict definition

387

1433

3.41

82.02

3.5

2.2

2.20

2.39

g/l

8.57

373

1320

Amputation of ankle bones

306

1009

4.21

82.02

8.5

2.4

1.91

2.26

g/l

22.08

292

932

Pyogenic arthritis

640

2955

2.49

81.78

4.2

2.4

2.21

2.29

g/l

3.14

601

2737

Thyrotoxicosis, other and/or unspecified

1651

10251

1.74

81.76

2.5

2.3

2.40

2.37

g/l

1.29

1515

9472

Hypercalcemia

489

2051

2.99

81.51

4.1

2.4

2.18

2.32

g/l

5.74

453

1896

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1329

7794

1.85

81.46

2.4

2.46

2.42

g/l

1.38

1189

7271

Malignant neoplasm of rectum, including Hilmo

1100

6156

1.99

81.40

2.2

2.6

2.35

2.29

g/l

2.78

1038

5621

Benign neoplasm: Caecum

1032

5710

2.07

81.33

3.0

2.6

2.37

2.28

g/l

4.96

967

5269

Covid-19 suspected case

1758

11087

1.70

80.94

2.9

2.3

2.42

2.41

g/l

0.14

1657

10279

Urticaria and erythema

2934

20590

1.50

80.87

2.7

2.4

2.41

2.39

g/l

1.28

2698

19093

Benign neoplasm: Transverse colon

1031

5712

2.06

80.78

3.3

2.6

2.37

2.28

g/l

4.51

975

5302

Migraine without aura

1497

9045

1.76

80.66

2.4

2.2

2.48

2.46

g/l

0.97

1393

8406

Folate deficiency anaemia

169

383

7.67

79.32

2.9

2.3

1.95

2.21

g/l

5.83

160

356

Lumbar disc prolapse

5250

30855

1.35

79.22

2.4

2.5

2.40

2.33

g/l

13.30

4862

28543

Benign neoplasm: Rectum

1634

10287

1.75

78.95

2.9

2.6

2.35

2.29

g/l

4.64

1537

9483

Congenital malformations of the circulatory system

1214

6813

1.90

78.87

3.0

2.6

2.41

2.38

g/l

1.08

1146

6361

Post-traumatic stress disorder

677

3221

2.32

77.97

2.2

2.1

2.52

2.48

g/l

0.80

608

3007

Familial hypercholesterolemia, with ischemic heart disease

884

4711

2.14

77.45

3.4

2.3

2.28

2.24

g/l

1.24

817

4277

Crystal arthropathies, rheuma endpoint

264

824

4.51

77.36

3.1

2.3

2.18

2.26

g/l

1.62

243

747

Injuries to the elbow and forearm

5814

39924

1.33

77.31

2.6

2.4

2.35

2.37

g/l

1.39

5309

36895

Right hemicolectomy

626

2971

2.52

77.23

2.9

2.5

2.37

2.28

g/l

3.33

592

2738

Tubulo-interstitial nephritis, not specified as acute or chronic

627

2931

2.43

77.17

4.0

1.8

2.21

2.38

g/l

10.74

586

2670

Pruritus

979

5367

2.03

77.03

3.9

2.3

2.34

2.36

g/l

0.62

922

4938

Diabetic neuropathy

1300

7871

1.92

77.02

5.1

2.9

2.14

2.34

g/l

31.46

1217

7294

Other abnormalities of plasma proteins

231

667

5.13

77.00

3.7

2.5

2.11

2.32

g/l

5.29

223

611

Other crystal arthropathies

264

831

4.46

76.37

3.1

2.4

2.18

2.26

g/l

1.72

243

758

Disturbance of activity and attention

882

4540

2.06

76.36

2.4

2.3

2.55

2.52

g/l

1.10

804

4225

Gingival hyperplasia

400

1567

3.21

76.34

7.0

2.5

2.22

2.36

g/l

4.93

389

1453

Suicide or other Intentional self-harm

1907

12420

1.63

76.19

2.4

2.5

2.43

2.39

g/l

1.81

1713

11617

Arterial embolism and thrombosis

605

2828

2.51

76.13

4.4

2.3

2.17

2.27

g/l

3.28

559

2588

Need for immunization against other single viral diseases

260

810

4.45

76.04

10.6

2.5

2.07

2.34

g/l

11.78

251

757

Complications of cardiac and vascular prosthetic devices, implants and grafts

278

903

4.22

76.00

7.2

2.2

2.12

2.27

g/l

3.81

265

832

Chronic rhinitis, nasopharyngitis and pharyngitis

2586

17946

1.52

75.80

2.5

2.39

2.36

g/l

1.74

2380

16636

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

503

2184

2.75

75.77

2.5

2.24

2.26

g/l

0.35

473

1999

Carpal tunnel syndrome

5038

34178

1.35

75.67

2.6

2.4

2.40

2.34

g/l

9.25

4627

31562

Transport accidents

3650

22978

1.42

75.60

2.5

2.4

2.37

2.39

g/l

0.97

3377

21437

Drug-induced adrenocortical insufficiency

251

772

4.62

75.47

3.4

2.4

2.37

2.36

g/l

0.17

237

718

Type of accident

2425

16667

1.55

75.45

3.0

2.5

2.35

g/l

0.12

2218

15448

2734

16754

1.52

75.40

2.7

2.4

2.25

g/l

0.16

2433

15274

Mixed and other personality disorders

682

3319

2.31

75.31

2.5

2.4

2.45

2.40

g/l

1.28

602

3100

Congenital malformations of heart and great arteries

1085

5972

1.94

75.23

3.1

2.6

2.43

2.39

g/l

2.00

1027

5575

Cardiomyopathy, Hypertrophic obstructive

222

618

4.77

75.19

4.4

2.0

2.34

2.36

g/l

0.19

212

574

Other disorders of ear

7858

41586

1.28

75.03

2.6

2.5

2.34

g/l

0.32

7177

38498

Sicca syndrome [Sjögren]

775

3989

2.21

74.75

2.4

2.3

2.36

2.37

g/l

0.19

719

3675

Follow-up examination after treatment for malignant neoplasms

902

4859

2.06

74.45

2.4

2.2

2.36

2.27

g/l

4.47

844

4406

Superficial injury of lower leg

2044

13598

1.60

74.43

2.9

2.4

2.39

2.37

g/l

0.97

1880

12582

Other and unspecified disorders of white blood cells

439

1819

2.97

74.26

3.2

2.5

2.31

2.32

g/l

0.20

413

1680

Traumatic subdural haemorrhage

1218

6889

1.86

74.15

2.9

2.4

2.22

2.25

g/l

1.02

1097

6368

Eating disorder

728

3632

2.21

73.93

2.4

2.1

2.54

2.53

g/l

0.04

661

3348

Subjective visual disturbances

2095

14061

1.59

73.90

2.5

2.4

2.39

2.36

g/l

1.95

1928

12993

Basal cell carcinoma, including avohilmo

3673

18580

1.43

73.82

2.7

2.6

2.26

2.32

g/l

7.16

3347

16947

Special screening examination for other diseases and disorders

897

4805

2.03

73.75

3.3

2.2

2.36

2.32

g/l

1.08

867

4373

Superficial injury of hip and thigh

1333

8083

1.80

73.48

2.8

2.4

2.24

2.31

g/l

4.26

1219

7386

Sarcoidosis

1147

6701

1.89

73.07

3.1

2.5

2.35

2.33

g/l

0.42

1093

6228

Other and unspecified myopathies

842

4509

2.13

72.91

2.7

2.5

2.21

2.28

g/l

2.53

745

4162

Hyperkinetic disorders

925

4908

1.99

72.81

2.4

2.56

2.52

g/l

1.46

846

4566

Papulosquamous disorders

3190

23177

1.45

72.62

2.6

2.5

2.37

2.34

g/l

2.25

2959

21450

Other skin changes

1635

10477

1.70

72.58

3.7

2.5

2.29

2.31

g/l

0.54

1542

9649

Basal cell carcinoma

3544

17974

1.43

72.23

2.7

2.5

2.26

2.31

g/l

6.59

3227

16385

Meniscus derangement

4452

22689

1.37

72.11

2.4

2.3

2.36

2.33

g/l

2.87

4094

20944

Ovarian cyst

2747

11032

1.50

71.51

2.4

2.2

2.44

2.42

g/l

0.63

2521

10117

Other diseases of oesophagus

866

4683

2.07

71.43

3.0

2.5

2.31

2.26

g/l

1.59

786

4327

Malignant neoplasm of stomach

514

2305

2.61

71.29

2.3

2.5

2.41

2.26

g/l

5.55

482

2111

Other viral hepatitis

550

2519

2.49

71.22

2.4

2.43

2.40

g/l

0.56

505

2350

L01XE Protein kinase inhibitors

560

2634

2.56

71.05

2.6

2.21

2.30

g/l

3.04

537

2448

Other diseases of lip and oral mucosa

3208

23412

1.44

70.96

2.4

2.5

2.37

2.36

g/l

0.81

2960

21652

Enteropathic arthropathies

263

846

3.94

70.83

2.7

2.4

2.39

2.35

g/l

0.54

257

792

Pneumocystosis

256

834

4.39

70.80

4.2

2.5

2.12

2.29

g/l

4.84

246

774

Thyrotoxicosis

2059

13901

1.58

70.40

2.6

2.4

2.39

2.37

g/l

0.81

1888

12816

Malignant neoplasm of small intestine, including Hilmo

336

1254

3.38

70.39

2.6

2.4

2.38

2.30

g/l

1.14

326

1159

Other autoimmune haemolytic anaemias

202

574

5.60

70.30

3.2

2.4

2.13

2.33

g/l

5.18

189

536

Other specified and unspecified personality disorders

759

3940

2.14

70.00

2.4

2.48

2.40

g/l

3.24

691

3658

Carcinoma in situ of other and unspecified digestive organs

393

1615

3.12

69.26

2.8

2.5

2.34

2.27

g/l

1.46

380

1494

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

2213

9462

1.56

69.19

2.1

2.54

2.53

g/l

0.37

2029

8770

Disorders of sclera, cornea, iris and ciliary body

4456

34258

1.35

68.73

2.9

2.4

2.32

2.35

g/l

3.75

4116

31685

Paracetamol or NSAID medication

1441

4360

1.74

68.38

2.3

2.7

2.35

g/l

0.01

1325

4046

Gonarthrosis,primary

7585

38006

1.27

68.23

2.4

2.5

2.35

2.31

g/l

10.51

6956

35122

Diabetic maculopathy

1364

8124

1.81

68.01

6.0

2.6

2.09

2.40

g/l

84.47

1272

7525

Neuromuscular dysfunction of bladder

807

4343

2.08

67.71

2.9

2.5

2.26

2.32

g/l

2.14

743

4025

Malnutrition

272

935

3.91

67.50

3.0

2.6

2.19

2.35

g/l

3.19

261

865

3609

24829

1.41

67.49

2.9

2.5

2.25

2.27

g/l

2.11

3317

22690

Psoriasis

2295

15962

1.53

67.26

2.6

2.5

2.37

2.34

g/l

1.95

2127

14811

Other eating disorders

442

1882

2.66

67.11

2.4

2.2

2.58

2.53

g/l

0.93

399

1732

Open wound of ankle and foot

904

5046

1.98

67.06

4.4

2.5

2.24

2.34

g/l

5.86

845

4683

Pneumonia due to other infectious organisms, not elsewhere classified

356

1396

3.12

67.04

3.9

2.3

2.15

2.34

g/l

7.32

337

1290

Speech and linguistic disorders, excluding more controls

599

2691

2.28

67.01

3.0

2.3

2.47

2.45

g/l

0.26

553

2533

Heartburn

892

4941

1.97

66.87

2.7

2.3

2.38

2.36

g/l

0.55

819

4582

Unspecified nephritic syndrome

273

941

3.81

66.81

7.3

2.1

2.05

2.33

g/l

15.08

266

866

Adverse effects, not elsewhere classified

1567

10088

1.66

66.58

2.7

2.4

2.42

2.40

g/l

0.66

1422

9372

Hepatocellular carcinoma

261

879

3.90

66.31

2.5

2.28

2.22

g/l

0.62

245

802

Chronic lymphocytic leukaemia

318

1194

3.38

66.12

2.6

2.4

2.24

2.25

g/l

0.11

303

1093

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

318

1194

3.38

66.12

2.6

2.4

2.24

2.25

g/l

0.11

303

1093

Chronic lymphocytic leukaemia, helper endpoint

318

1194

3.38

66.12

2.6

2.4

2.24

2.25

g/l

0.11

303

1093

Viral hepatitis

623

3084

2.27

66.06

2.4

2.43

2.38

g/l

1.12

570

2879

Umbilical hernia

2217

15378

1.53

66.03

3.4

2.5

2.31

2.32

g/l

0.15

2065

14284

Alcohol abuse, main dg, excluding more controls

1144

6825

1.80

65.66

2.4

2.5

2.32

2.34

g/l

0.44

1035

6430

Other obstetric conditions, not elsewhere classified

2238

9710

1.53

65.63

2.1

2.54

2.53

g/l

0.30

2051

9005

Fracture of lower leg, including ankle

4446

34032

1.34

65.28

2.8

2.5

2.33

2.35

g/l

1.81

4075

31445

Thyroiditis, ILD-related definition

932

5278

1.93

65.24

2.8

2.3

2.40

g/l

0.10

856

4871

Diseases of spleen

237

768

4.24

65.15

4.0

2.4

2.24

2.32

g/l

1.18

226

715

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

1099

6541

1.85

65.09

3.4

2.5

2.18

2.25

g/l

3.14

1015

5920

Eating disorders

840

4606

1.98

64.40

2.6

2.2

2.50

2.49

g/l

0.30

764

4254

Other/unspecified rheumatoid arthritis

1098

6575

1.84

64.39

2.8

2.4

2.21

2.32

g/l

7.38

1016

6026

Drug-induced cataract

277

985

3.66

64.10

6.4

2.3

2.21

2.35

g/l

3.71

267

917

Acute myeloid leukaemia and myelodysplastic syndromes

244

804

3.96

64.05

2.2

2.3

1.94

2.27

g/l

17.40

235

733

Systemic lupus erythematosus, unspecified

324

1245

3.24

63.98

3.3

2.3

2.22

2.39

g/l

6.70

312

1146

Urticaria

2302

16135

1.50

63.91

2.6

2.4

2.43

2.40

g/l

1.44

2123

15000

Disorders of magnesium metabolism

133

296

7.86

63.87

3.6

2.3

2.17

2.32

g/l

1.57

127

276

Other symptoms and signs involving the circulatory and respiratory systems

562

2706

2.33

63.78

3.4

2.2

2.34

2.31

g/l

0.48

526

2500

Malignant neoplasm of small intestine

256

874

3.85

63.67

2.7

2.4

2.38

2.30

g/l

1.15

251

811

Early onset COPD

1822

12274

1.59

63.60

3.0

2.6

2.34

2.29

g/l

2.86

1684

11409

Cholecystitis

1239

7661

1.76

63.43

2.8

2.5

2.28

g/l

0.06

1148

7030

Other and unspecified mood [affective] disorders

571

2762

2.28

63.26

2.3

2.2

2.49

2.44

g/l

0.97

512

2583

Secondary and unspecified malignant neoplasm of lymph nodes

719

3815

2.12

63.11

2.3

2.6

2.19

2.31

g/l

5.88

674

3502

Endometriosis

2602

10791

1.48

62.54

2.2

2.45

2.41

g/l

2.04

2397

9890

Amyloidosis

260

903

3.73

62.47

4.4

2.2

2.11

2.28

g/l

4.82

251

829

Emotional disorders starting during childhood or adolecense, excluding more controls

334

1246

2.90

62.07

2.5

2.2

2.62

2.60

g/l

0.19

302

1167

Inflammatory diseases of female pelvic organs

4585

26189

1.33

62.01

2.3

2.2

2.46

2.44

g/l

1.83

4166

24097

Other diseases of upper respiratory tract

9609

41910

1.22

61.98

2.5

2.37

2.34

g/l

5.24

8898

38606

Anosmia

147

322

5.00

61.63

2.4

1.4

2.35

2.40

g/l

0.48

138

295

Malignant neoplasm of liver and intrahepatic bile ducts

315

1216

3.22

61.59

2.7

2.5

2.25

2.23

g/l

0.13

294

1113

Drug-induced neutropenia

647

3360

2.21

61.39

2.4

2.5

2.16

2.33

g/l

9.72

619

3115

Acute gastritis

669

3499

2.15

61.10

3.0

2.4

2.41

2.29

g/l

5.88

624

3237

Alcohol-induced chronic pancreatitis

595

3007

2.28

61.05

3.0

2.7

2.21

2.29

g/l

2.26

560

2842

Other and unspecified aplastic anaemias

161

421

5.55

61.03

3.9

2.1

2.05

2.34

g/l

8.30

155

386

Mixed connective tissue disease

578

2887

2.30

60.95

2.6

2.3

2.34

2.37

g/l

0.71

548

2673

Skin changes due to chronic exposure to nonionizing radiation

3398

23699

1.40

60.52

3.0

2.5

2.24

2.27

g/l

2.37

3118

21629

Other obstructive and reflux uropathy

390

1655

2.72

60.46

5.0

1.8

2.22

2.41

g/l

8.25

368

1515

Myelodysplastic syndrome

161

427

5.60

60.31

2.6

2.3

1.90

2.20

g/l

9.84

156

386

Disorders of oesophagus in diseases classified elsewhere

254

893

3.73

60.14

3.7

2.3

2.20

2.27

g/l

0.95

242

825

Other specified/unspecified systemic involvement of connective tissue

525

2543

2.37

60.00

2.7

2.3

2.32

2.37

g/l

1.19

498

2356

Suppurative and necrotic conditions of lower respiratory tract

544

2687

2.36

59.85

3.2

2.6

2.08

2.27

g/l

9.27

506

2500

Actinic keratosis

3317

23192

1.40

59.77

3.0

2.5

2.24

2.27

g/l

2.36

3043

21158

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

838

4747

1.96

59.68

2.2

2.6

2.36

2.28

g/l

3.22

790

4342

Non-follicular lymphoma

872

5029

1.95

59.43

2.4

2.6

2.15

2.28

g/l

7.99

822

4660

Secondary uncertain malignant neoplasm

1072

6491

1.80

59.40

2.2

2.6

2.17

2.30

g/l

10.12

1002

5920

Other symptoms and signs involving the nervous and musculoskeletal systems

3348

25271

1.38

59.15

2.6

2.4

2.41

2.35

g/l

7.10

3096

23372

Injuries to unspecified part of trunk, limb or body region

894

5175

1.91

59.05

3.5

2.5

2.29

2.33

g/l

1.41

829

4790

Psoriatic arthropathies

796

4428

1.96

58.96

2.4

2.40

2.35

g/l

1.73

745

4114

Other and unspecified acquired haemolytic anaemias

156

418

6.00

58.91

5.1

2.3

2.18

2.31

g/l

1.82

149

383

Cervicalgia

1652

11050

1.59

58.79

2.4

2.40

2.33

g/l

4.76

1527

10194

Portal vein thrombosis

206

653

4.30

58.49

3.8

2.5

2.21

2.31

g/l

1.25

194

604

Clear cell adenocarcinoma of kidney

433

1975

2.60

58.49

3.2

2.5

2.12

2.29

g/l

6.89

412

1833

Benign neoplasm of other and unspecified endocrine glands

1102

6764

1.78

58.48

2.6

2.5

2.36

2.33

g/l

1.02

1031

6286

Benign neoplasm: Small intestine

425

1940

2.67

58.42

3.7

2.5

2.36

2.30

g/l

1.34

401

1801

Adenocarcinoma and papilloma adenocarcinoma of rectum

807

4552

1.97

58.33

2.2

2.6

2.36

2.28

g/l

3.27

760

4166

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

4152

31370

1.33

58.24

2.5

2.37

2.34

g/l

4.24

3831

29090

Stomatitis and related lesions

1548

10263

1.61

57.88

2.6

2.5

2.36

2.37

g/l

0.10

1430

9503

Disorders of continuity of bone

794

4460

1.96

57.51

3.2

2.4

2.36

2.38

g/l

0.47

750

4131

Migraine with aura and triptan purchases

1157

7163

1.72

57.34

2.0

2.3

2.49

2.47

g/l

0.58

1064

6643

Benign neoplasm: Descending colon

662

3565

2.14

57.04

3.5

2.6

2.35

2.28

g/l

2.40

628

3317

Late syphilis

210

686

4.17

56.95

5.9

2.3

2.13

2.33

g/l

5.22

194

636

Carcinoma in situ of skin of other and unspecified parts of face

826

4779

1.97

56.60

3.3

2.5

2.19

2.26

g/l

2.61

746

4377

Abscess of anal and rectal regions

670

3581

2.05

56.25

3.1

2.4

2.37

2.33

g/l

1.01

632

3336

Internal derangement of knee

2836

20917

1.40

55.84

2.4

2.3

2.37

2.35

g/l

1.87

2592

19341

Other specified/unspecified bacterial intestinal infections

601

3141

2.18

55.76

3.0

2.4

2.33

2.32

g/l

0.12

557

2912

Chronic viral hepatitis

438

2021

2.45

55.66

2.6

2.4

2.43

2.39

g/l

0.47

398

1879

Unspecified mental disorder

3054

22917

1.39

55.55

2.3

2.5

2.41

2.38

g/l

2.73

2732

21291

Hepatomegaly and splenomegaly, not elsewhere classified

140

354

5.75

55.44

3.5

2.3

2.35

g/l

0.05

133

336

Paralytic ileus

371

1616

2.70

55.21

2.9

2.4

2.25

2.27

g/l

0.21

344

1481

Primary gonarthrosis, bilateral

4252

28620

1.33

55.13

2.4

2.6

2.35

2.29

g/l

10.06

3845

26416

Right bundle-branch block

327

1338

2.84

55.10

2.9

2.0

2.29

2.30

g/l

0.17

304

1226

Asthma and allergy, excluding more controls

871

4958

1.83

55.07

2.3

1.9

2.49

2.48

g/l

0.33

828

4593

Other abnormal uterine and vaginal bleeding

1759

8563

1.55

54.75

2.3

2.42

2.38

g/l

2.69

1580

7835

Superficial injury of abdomen, lower back and pelvis

1215

7728

1.69

54.65

2.6

2.4

2.34

2.36

g/l

0.91

1095

7152

Postmenopausal osteoporosis with pathological fracture

607

3231

2.18

54.47

2.7

2.3

2.31

2.34

g/l

0.65

545

2922

Carcinoma in situ of colon

248

921

3.67

54.46

2.7

2.5

2.41

2.28

g/l

2.91

239

855

Sleep disorders, other/unspecified

327

1350

2.83

54.21

2.6

2.3

2.42

2.41

g/l

0.11

301

1244

Lymphoid leukaemia

547

2815

2.26

54.11

2.8

2.6

2.23

2.29

g/l

1.97

519

2601

Other postsurgical states

540

2737

2.22

53.92

2.8

2.1

2.48

2.34

g/l

5.63

505

2548

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

2034

14189

1.48

53.85

2.8

2.3

2.44

2.45

g/l

0.26

1873

13196

Cyst of kidney

659

3607

2.09

53.77

4.1

2.4

2.25

2.29

g/l

1.18

615

3348

Protozoal diseases

322

1353

2.96

53.52

3.9

2.4

2.16

2.31

g/l

4.89

303

1260

Other problems related to primary support group, including family circumstances

861

4898

1.85

53.21

3.4

2.3

2.47

2.48

g/l

0.19

804

4559

ILD-related respiratory insufficiency

367

1645

2.77

53.21

3.4

2.5

2.26

2.27

g/l

0.05

346

1519

Drug-induced osteoporosis with pathological fracture

214

742

4.00

53.16

3.5

2.2

2.25

2.33

g/l

1.17

200

681

Discitis, unspecified

206

692

3.97

53.01

4.1

2.5

2.11

2.27

g/l

2.97

194

644

Ulcer of oesophagus

624

3358

2.10

53.00

3.4

2.5

2.36

2.24

g/l

5.09

583

3114

Myocardial infarction, with ST-elevation

1546

10479

1.59

53.00

3.2

2.6

2.24

g/l

0.04

1438

9614

1903

12607

1.52

52.92

2.7

2.4

2.27

2.26

g/l

0.37

1663

11449

Personal history of other diseases and conditions

817

4691

1.87

52.91

3.2

1.9

2.40

2.49

g/l

4.46

752

4345

Other symptoms and signs involving the urinary system

888

5293

1.84

52.78

3.1

2.4

2.30

2.29

g/l

0.04

836

4901

Wegener granulomatosis

199

660

4.09

52.66

4.2

2.3

2.11

2.34

g/l

7.06

193

612

Viral warts

803

4649

1.89

52.51

4.8

2.4

2.32

2.38

g/l

2.64

770

4299

Infliximab

190

600

3.95

52.47

2.1

2.2

2.42

g/l

0.01

182

561

Disorders of conjunctiva

6619

43930

1.24

52.10

2.6

2.4

2.39

2.38

g/l

1.02

6153

40568

Disease of hard tissues of teeth, NOS

4614

19051

1.31

52.07

2.4

2.3

2.39

2.33

g/l

10.09

4230

17641

Conductive and sensorineural hearing loss

6575

36615

1.25

51.99

2.6

2.5

2.33

2.32

g/l

1.56

5983

33843

Primary hyperparathyroidism

923

5599

1.82

51.84

3.4

2.4

2.35

2.34

g/l

0.18

843

5147

Type 1 diabetes, definitions combined

691

3799

1.95

51.84

3.8

2.2

2.21

2.44

g/l

20.22

643

3552

Migraine without aura and triptan purchases

1170

7443

1.67

51.69

2.2

2.3

2.50

2.48

g/l

0.61

1087

6900

Sensorineural hearing loss

6287

35103

1.25

51.66

2.5

2.33

2.31

g/l

1.86

5716

32425

Lesion of ulnar nerve

1100

6942

1.71

51.43

2.6

2.5

2.41

2.32

g/l

6.20

1010

6492

Type 1 diabetes, strict (exclude DM2)

688

3789

1.95

51.37

3.8

2.3

2.21

2.44

g/l

19.48

640

3541

Viral pneumonia (known virus, not influenza)

291

1188

3.05

51.31

4.8

2.5

2.18

2.31

g/l

3.04

278

1096

Symptoms and signs involving speech and voice

2644

19733

1.41

51.14

2.6

2.5

2.34

g/l

0.02

2427

18207

Late syphilis

178

567

4.37

50.63

6.3

2.3

2.11

2.32

g/l

4.97

168

524

Oesophagitis

487

2444

2.27

50.52

3.3

2.5

2.30

2.28

g/l

0.40

450

2275

Faecal incontinence

737

4211

1.92

50.50

2.7

2.2

2.36

2.35

g/l

0.24

681

3879

Chronic hepatitis NAS

169

522

4.44

50.09

2.6

2.1

2.30

2.37

g/l

0.63

156

480

Congenital malformations of cardiac chambers and connections

103

225

7.53

49.96

4.0

3.0

2.47

2.54

g/l

0.59

103

217

Epilepsy

2392

17540

1.42

49.90

2.5

2.30

2.31

g/l

0.53

2199

16198

Convalescence

439

2123

2.33

49.67

2.8

1.9

2.43

2.39

g/l

0.66

410

1960

Hypertension, portal

124

14.72

49.66

3.8

2.3

2.18

2.33

g/l

0.74

115

Infection of intervertebral disc (pyogenic)

178

575

4.33

49.65

4.3

2.4

2.09

2.25

g/l

2.76

167

529

Fall on and from stairs and steps

2055

14805

1.46

49.63

2.6

2.5

2.32

2.34

g/l

0.67

1885

13660

Etanercept

535

2785

2.15

49.47

2.2

2.4

2.38

2.41

g/l

0.66

508

2587

Diseases of male genital organs

4082

16123

1.32

48.92

3.0

2.7

2.27

2.28

g/l

0.36

3815

15061

Disorders of muscles

811

4795

1.84

48.88

2.9

2.4

2.30

2.34

g/l

1.19

768

4437

Other disorders of bladder

1000

6268

1.74

48.84

2.8

2.6

2.22

2.28

g/l

2.57

893

5792

Procreative management

2335

14243

1.42

48.77

2.7

2.5

2.41

2.42

g/l

0.47

2202

13327

Drug-induced osteoporosis

168

529

4.45

48.76

3.3

2.1

2.26

2.37

g/l

1.49

160

483

Coxarthrosis, primary

4926

33807

1.28

48.76

2.5

2.30

2.29

g/l

0.80

4520

31078

Postviral fatigue syndrome

111

256

6.06

48.72

2.8

2.1

2.48

g/l

0.03

106

234

Left ventricular outflow tract obstruction, narrow definition

437

2139

2.34

48.70

2.8

2.6

2.42

2.36

g/l

1.57

421

2003

Arterial embolism and thrombosis of lower extremity artery

356

1616

2.60

48.51

3.7

2.3

2.21

2.27

g/l

1.01

331

1469

Bronchiectasis

703

4040

1.95

48.43

2.4

2.5

2.25

2.27

g/l

0.50

648

3722

Mixed hyperlipidaemia

368

1688

2.53

48.41

3.7

2.2

2.37

2.29

g/l

1.65

343

1570

Malignant neoplasm of rectum

781

4605

1.87

48.28

2.2

2.6

2.36

2.28

g/l

3.16

732

4216

Lichen simplex chronicus and prurigo

549

2921

2.12

48.15

3.7

2.4

2.31

2.32

g/l

0.18

514

2711

Trochanteric bursitis

1087

6952

1.68

47.87

2.7

2.3

2.38

2.35

g/l

0.73

994

6386

Abnormal involuntary movements

1090

6999

1.68

47.78

2.6

2.5

2.33

g/l

0.14

1006

6472

Reactive arthropathies

677

3824

1.93

47.78

2.8

2.4

2.29

2.35

g/l

1.42

638

3558

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

671

3812

1.96

47.75

4.1

2.4

2.27

2.34

g/l

2.19

638

3528

Asthma and allergy

871

5163

1.76

47.64

2.3

1.9

2.49

2.47

g/l

0.66

828

4792

Fracture of foot, except ankle

1803

12769

1.48

47.43

3.2

2.4

2.32

2.38

g/l

4.27

1679

11870

Mental and behavioural disorders due to sedatives or hypnotics

539

2847

2.09

47.41

2.2

2.4

2.42

2.36

g/l

1.20

469

2642

Shock, not elsewhere classified

125

324

5.32

47.32

4.4

2.3

2.17

2.34

g/l

2.06

119

299

Vasculitis limited to skin, not elsewhere classified

278

1151

2.96

47.30

3.3

2.2

2.26

2.34

g/l

1.36

262

1060

Squamous cell neoplasms and carcinomas of the skin

726

4228

1.90

47.18

3.5

2.5

2.17

2.24

g/l

2.80

670

3816

Disorders of psychological development

833

4606

1.79

47.00

2.8

2.4

2.48

2.47

g/l

0.26

765

4283

Nail disorders

663

3756

1.94

46.88

3.9

2.4

2.31

2.36

g/l

1.34

617

3472

Social phobias

587

3172

1.99

46.87

2.4

2.2

2.50

2.47

g/l

0.61

529

2947

Other disorders of the musculoskeletal system and connective tissue

1182

7772

1.64

46.69

2.5

2.34

2.32

g/l

0.45

1106

7183

Other enthesopathies

2189

16047

1.42

46.66

2.3

2.40

2.36

g/l

3.39

2038

14827

Mental disorders, not otherwise specified

636

3555

1.95

46.52

2.4

2.45

2.42

g/l

0.44

588

3301

Other endocrine disorders

448

2142

2.26

46.50

3.6

2.5

2.47

2.45

g/l

0.29

414

1998

Other follicular disorders

581

3175

2.02

46.13

3.5

2.4

2.36

2.37

g/l

0.18

538

2956

Special screening examination for infectious and parasitic diseases

1554

7803

1.52

46.06

2.1

2.0

2.42

2.43

g/l

0.21

1431

7220

Gonarthrosis, primary, with knee surgery

4722

30503

1.28

46.06

2.3

2.6

2.35

2.29

g/l

10.80

4281

28145

Other degenerative diseases of the nervous system

2177

11860

1.43

46.02

2.2

2.3

2.24

2.30

g/l

4.80

1927

10960

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

551

2964

2.06

45.99

2.5

2.3

2.43

2.39

g/l

0.63

496

2733

Psoriasis vulgaris

1440

9868

1.55

45.97

2.8

2.6

2.36

2.34

g/l

0.76

1344

9183

Other disorders of bone

1454

9965

1.54

45.80

2.6

2.4

2.36

2.39

g/l

1.34

1340

9271

Other renal tubulo-interstitial diseases

233

890

3.14

45.79

6.0

1.7

2.20

2.44

g/l

8.36

227

822

Eosinophilic disease (BM)

170

549

3.94

45.79

3.4

2.2

2.26

2.34

g/l

0.98

160

504

Obsessive-compulsive disorder

484

2477

2.12

45.77

2.3

2.1

2.54

2.47

g/l

1.89

427

2304

Leisure time condition

1425

9759

1.55

45.64

2.8

2.5

2.34

2.35

g/l

0.02

1283

9038

Open wound of forearm

774

4622

1.82

45.31

2.9

2.4

2.29

2.34

g/l

1.09

696

4259

Other hearing loss

2385

17481

1.40

45.27

2.8

2.5

2.27

g/l

0.04

2144

16053

Hypoparathyroidism

348

1616

2.55

45.21

3.3

2.2

2.31

2.35

g/l

0.64

322

1494

Fibrosis of liver

116

306

6.15

44.92

3.2

2.2

2.41

2.31

g/l

0.81

106

280

Reactive arthropathies, FINNGEN

553

2997

2.03

44.87

2.6

2.4

2.30

2.36

g/l

1.70

523

2774

COPD, hospital admissions 1, only main diagnosis

2917

19234

1.36

44.81

2.9

2.6

2.27

2.25

g/l

0.85

2675

17659

Deficiency of other B group vitamins

230

894

3.19

44.57

3.0

2.3

2.40

2.30

g/l

1.64

221

823

Injury of unspecified body region

653

3752

1.93

44.50

3.5

2.5

2.30

2.33

g/l

0.70

602

3464

Malignant neoplasm of bladder, including Hilmo

988

6266

1.69

44.42

2.9

2.7

2.23

g/l

0.02

892

5722

Dermatitis due to substances taken internally

472

2450

2.16

44.30

3.0

2.3

2.31

2.37

g/l

1.33

435

2260

Colonic or urogenital fistula

2076

15263

1.43

44.25

2.5

2.36

2.33

g/l

1.66

1922

14161

Acquired absence of limb

132

377

4.92

44.19

7.5

2.3

2.04

2.30

g/l

4.75

126

345

Ankylosing spondylitis

699

4084

1.86

44.08

2.4

2.5

2.36

2.33

g/l

0.78

641

3808

Idiopathic thrombocytopenic purpura

303

1345

2.70

43.93

3.1

2.4

2.39

2.34

g/l

0.86

290

1251

Spondylolisthesis/Spondylolysis

1378

9439

1.55

43.82

2.4

2.5

2.42

2.33

g/l

6.75

1272

8728

Sequelae of other external causes

482

2533

2.14

43.77

3.5

2.4

2.26

2.34

g/l

1.96

460

2347

Coxibs

2470

9655

1.40

43.76

2.1

3.2

2.32

2.28

g/l

3.14

2262

8965

Mouth breathing

3015

23383

1.34

43.59

2.6

2.38

2.33

g/l

5.15

2808

21790

Other and unspecified vasculitis limited to skin

252

1039

2.98

43.34

3.4

2.3

2.27

2.34

g/l

1.10

237

960

Mental and behavioural disorders due to opioids

305

1343

2.57

43.32

2.4

2.3

2.46

2.39

g/l

0.99

274

1243

Malignant neoplasm of rectosigmoid junction, including Hilmo

285

1240

2.75

43.19

2.1

2.4

2.34

2.28

g/l

1.10

276

1141

Diffuse large B-cell lymphoma, helper endpoint

399

1980

2.32

43.18

2.4

2.5

2.10

2.29

g/l

6.94

371

1830

Diffuse large B-cell lymphoma

399

1980

2.32

43.18

2.4

2.5

2.10

2.29

g/l

6.94

371

1830

Diffuse large B-cell lymphoma, including Hilmo

399

1980

2.32

43.18

2.4

2.5

2.10

2.29

g/l

6.94

371

1830

Other specified disorders of kidney and ureter

318

1450

2.60

43.14

6.2

2.3

2.20

2.33

g/l

3.86

303

1346

Chronic Coagulation defects

244

988

2.98

43.11

3.9

2.3

2.44

2.42

g/l

0.29

232

905

Corns and callosities

557

3088

2.01

42.82

4.5

2.3

2.22

2.34

g/l

4.94

524

2848

Disorder of the sleep-wake schedule

190

679

3.45

42.77

2.3

2.4

2.40

g/l

0.02

177

629

Pyothorax

410

2071

2.30

42.70

3.2

2.6

2.08

2.28

g/l

7.42

385

1925

Recurrent aphthous stomatitis , including avohilmo

1104

7281

1.63

42.70

2.6

2.5

2.37

2.36

g/l

0.19

1019

6713

Pain associated with micturition

910

5746

1.71

42.69

2.8

2.3

2.34

2.36

g/l

0.35

822

5300

Atopic dermatitis, strict definition with reimbursement

2084

14807

1.41

42.67

2.5

2.3

2.44

2.45

g/l

0.23

1945

13792

Scoliosis

652

3764

1.88

42.66

2.4

2.46

2.39

g/l

1.98

603

3445

Conjunctivitis

5781

40191

1.23

42.59

2.5

2.4

2.40

2.39

g/l

0.61

5368

37126

Other specified/unspecified necrotizing vasculopathies

169

576

3.90

42.58

5.3

2.4

2.15

2.33

g/l

4.30

164

529

Other chondrocalcinosis

171

596

4.04

42.51

3.2

2.3

2.16

2.28

g/l

2.23

157

543

Benign neoplasm: Adrenal gland

653

3815

1.91

42.50

2.6

2.5

2.39

2.31

g/l

2.73

616

3544

Unspecified/other endometriosis

645

3702

1.87

42.45

2.2

2.49

2.46

g/l

0.64

593

3415

Pain in thoracic spine

1132

7493

1.60

42.32

2.4

2.42

2.35

g/l

4.10

1069

6928

Artificial joint operation, meniscal resection

7449

41107

1.20

42.31

2.4

2.6

2.34

2.32

g/l

3.42

6833

37988

Fracture of forearm

4239

31426

1.27

42.20

2.6

2.4

2.35

2.37

g/l

1.95

3886

28992

Rash and other nonspecific skin eruption

776

4738

1.78

41.99

2.9

2.5

2.32

2.34

g/l

0.52

731

4386

Acute alcohol intoxication, ICD10

1504

10557

1.50

41.95

2.5

2.6

2.33

2.34

g/l

0.40

1356

9874

Necrosis of pulp, including avohilmo

4279

34628

1.27

41.85

2.6

2.5

2.42

2.37

g/l

6.04

3934

32243

Toxic liver disease

177

622

3.64

41.72

3.2

2.2

2.34

2.37

g/l

0.32

165

579

Iridocyclitis

1726

12434

1.46

41.69

2.9

2.5

2.30

2.35

g/l

2.31

1595

11512

Other aneurysm

490

2640

2.10

41.68

4.0

2.3

2.18

2.26

g/l

2.13

466

2430

Other disorders of eyelid

3600

27357

1.30

41.64

2.5

2.30

g/l

0.07

3304

25135

Other disorders starting during childhood or adolecense, excluding more controls

316

1355

2.43

41.63

3.7

2.3

2.54

2.55

g/l

0.01

299

1287

Agoraphobia

260

1085

2.71

41.49

2.2

2.1

2.55

2.46

g/l

1.59

235

1003

Other bursopathies

1021

6659

1.64

41.44

3.0

2.4

2.29

2.31

g/l

0.55

938

6145

Hyperplasia of prostate

2966

12998

1.35

41.43

2.8

2.7

2.24

g/l

0.02

2745

12095

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

501

2689

2.03

41.41

2.2

2.5

2.49

2.39

g/l

2.72

442

2504

Malignant neoplasm of pancreas, including Hilmo

682

4042

1.85

41.38

2.1

2.6

2.22

2.28

g/l

1.80

647

3682

Dronedarone medication

252

1054

2.82

41.15

2.2

2.0

2.42

2.29

g/l

2.80

234

972

Erosion of teeth , including avohilmo

1772

12826

1.45

41.08

3.2

2.4

2.38

2.40

g/l

0.95

1642

11967

Injuries to the neck

1691

12166

1.46

40.85

2.4

2.5

2.37

g/l

0.00

1565

11303

Fall on same level involving ice and snow

4446

36359

1.26

40.79

2.6

2.5

2.35

g/l

0.11

4090

33578

Oter anti-inflammatory and antirheumatic agents, non-steroids

2015

8122

1.44

40.65

2.3

3.2

2.29

2.24

g/l

3.84

1840

7543

Other shoulder lesions

715

4296

1.80

40.50

2.7

2.4

2.40

2.36

g/l

0.80

658

3966

Acquired absence of organs, not elsewhere classified

144

459

4.13

40.20

5.8

2.2

2.20

2.30

g/l

1.34

134

419

Organic, including symptomatic, mental disorders

4269

24727

1.27

40.18

2.4

2.6

2.23

2.28

g/l

5.58

3784

22784

Varicose veins

4897

30472

1.25

40.18

2.6

2.4

2.34

2.32

g/l

2.43

4487

28055

Polyarthritis, unspecified

316

1469

2.46

40.05

2.5

2.4

2.24

2.32

g/l

1.49

301

1356

Congenital malformations of aortic and mitral valves

362

1779

2.33

40.01

2.8

2.6

2.41

2.36

g/l

1.08

349

1665

Keratitis

2683

20748

1.34

39.92

3.0

2.4

2.33

2.36

g/l

1.73

2480

19185

Presbycusis

1254

8553

1.56

39.87

2.6

2.5

2.23

g/l

0.01

1100

7783

Other and unspecified nonorganic psychotic disorders

1323

9133

1.52

39.77

2.1

2.5

2.42

2.40

g/l

0.37

1172

8546

Amenorrhoea

479

2570

2.01

39.36

2.6

2.2

2.48

2.50

g/l

0.23

441

2376

Background retinopathy and retinal vascular changes

222

903

3.02

39.33

5.3

2.4

2.24

2.30

g/l

0.85

205

831

Schizophrenia or delusion

2247

16991

1.37

39.04

2.2

2.5

2.40

2.37

g/l

1.32

1999

15829

Drug-induced hypoglycaemia without coma

182

674

3.40

38.94

4.8

2.4

2.07

2.31

g/l

7.01

171

624

Disorders of tooth development and eruption

1141

6169

1.57

38.94

2.8

2.1

2.42

2.40

g/l

0.66

1059

5765

Gangrene, not elsewhere classified

108

294

5.29

38.93

6.4

2.4

2.02

2.26

g/l

4.06

101

266

Benign neoplasm: Duodenum

271

1219

2.73

38.90

3.7

2.5

2.36

2.31

g/l

0.54

252

1138

Childhood asthma (age<16), excluding more controls

783

3754

1.71

38.87

2.5

1.8

2.52

2.54

g/l

0.39

721

3486

Acute suppurative otitis media

1759

11926

1.43

38.80

3.0

2.3

2.46

g/l

0.06

1637

11117

Diseases of salivary glands

2393

18309

1.36

38.74

2.5

2.4

2.40

2.36

g/l

2.45

2226

16934

Herpesviral [herpes simplex] infections

893

5748

1.67

38.58

3.2

2.4

2.32

2.36

g/l

1.36

842

5316

Seropositive rheumatoid arthritis, strict definition

1141

7746

1.57

38.55

2.2

2.5

2.26

2.35

g/l

5.44

1077

7171

UC patients in KELA-register (code 208), prior to 1994

381

1938

2.25

38.53

3.4

2.5

2.44

2.31

g/l

4.14

364

1807

Pulmonary oedema

210

843

3.11

38.49

6.7

2.4

2.15

2.26

g/l

1.74

196

766

Cervical disc disorders

2724

21220

1.33

38.28

2.4

2.5

2.40

2.31

g/l

13.73

2517

19637

Alcohol withdrawal state with delirium

565

3259

1.92

38.18

2.5

2.7

2.16

2.27

g/l

3.73

515

3070

Lung diseases due to external agents

1161

7933

1.57

38.17

2.7

2.6

2.22

2.26

g/l

1.22

1046

7285

Noninflammatory disorders of female genital tract

2987

11632

1.33

38.08

2.3

2.2

2.46

2.43

g/l

1.71

2742

10660

Other arterial embolism and thrombosis

274

1235

2.61

38.05

5.4

2.3

2.13

2.27

g/l

3.44

249

1125

Small fibre neuropathy

286

1322

2.59

38.00

4.2

2.4

2.25

2.30

g/l

0.77

265

1223

Ingrowing nail

432

2291

2.10

37.95

4.1

2.4

2.31

2.36

g/l

1.26

406

2116

Cerebral palsy and other paralytic syndromes

873

5612

1.67

37.95

2.7

2.5

2.35

2.33

g/l

0.25

803

5198

Prurigo nodularis

248

1079

2.78

37.89

3.6

2.3

2.27

2.34

g/l

0.93

231

992

Syphilis

248

1076

2.74

37.72

5.1

2.4

2.15

2.33

g/l

5.02

235

999

Syphilis

248

1076

2.74

37.72

5.1

2.4

2.15

2.33

g/l

5.02

235

999

Viral warts

1536

11023

1.46

37.65

3.6

2.4

2.37

2.39

g/l

0.68

1447

10258

Redundant prepuce, phimosis and paraphimosis

1468

10335

1.47

37.64

3.0

2.7

2.29

g/l

0.01

1365

9685

Monoamine oxidase A inhibitors

853

5459

1.67

37.44

2.3

2.6

2.38

2.32

g/l

2.30

757

5117

Diseases of external ear

2613

20334

1.34

37.42

2.9

2.5

2.36

2.33

g/l

1.49

2351

18839

Sequelae of injuries, of poisoning and of other consequences of external causes

1714

12545

1.43

37.41

2.6

2.5

2.35

g/l

0.18

1580

11687

Cardiac murmurs and other cardiac sounds

656

3874

1.79

37.40

3.1

2.3

2.43

2.40

g/l

0.57

609

3585

Schizophrenia, schizotypal and delusional disorders

2248

17105

1.36

37.40

2.2

2.5

2.40

2.37

g/l

1.28

2000

15930

Dermatophytosis

1021

6830

1.61

37.31

3.3

2.5

2.30

g/l

0.07

951

6349

Adhesive capsulitis of shoulder

1244

8627

1.53

37.23

3.0

2.4

2.31

2.32

g/l

0.26

1156

7972

Dental pulpitis, including avohilmo

6955

38517

1.20

37.22

2.4

2.5

2.45

2.37

g/l

23.05

6381

35865

Giant cell arteritis

388

2024

2.22

37.11

2.8

2.4

2.23

2.29

g/l

1.27

354

1854

Other juvenile arthritis

309

1458

2.35

36.94

2.9

2.3

2.40

2.49

g/l

1.75

295

1343

Emotional disorders and disorders of social functioning with onset specific to childhood

363

1780

2.18

36.91

2.6

2.3

2.60

2.58

g/l

0.32

329

1654

Speech and linguistic disorders

622

3529

1.81

36.84

3.0

2.5

2.47

g/l

0.04

576

3286

Myeloid leukaemia

268

1222

2.63

36.74

2.4

2.6

2.13

2.31

g/l

6.41

257

1142

Kela-code for severe mental illness

2622

20416

1.33

36.73

2.2

2.5

2.41

2.37

g/l

3.45

2327

18973

Molar incisor enamel hypoplasia

279

1223

2.49

36.69

6.4

2.3

2.43

2.60

g/l

5.13

268

1146

Cardiomyopathy in other diseases

186

6.64

36.62

3.4

1.9

2.31

2.23

g/l

0.51

166

Psychotic depression

439

2351

2.03

36.54

2.3

2.5

2.41

2.36

g/l

0.97

389

2212

Congenital malformations of cardiac septa

532

2943

1.92

36.54

3.2

2.6

2.45

2.42

g/l

0.81

499

2748

Retinal vascular occlusion

996

6677

1.61

36.45

3.5

2.5

2.23

2.26

g/l

1.12

932

6102

Diplopia

1020

6866

1.59

36.07

2.6

2.5

2.35

2.32

g/l

0.74

948

6353

severe traumatic brain injury, does not include concussion

1810

13478

1.41

36.04

2.8

2.6

2.25

2.27

g/l

0.39

1647

12358

Pneumonia derived septicemia

317

1547

2.36

35.96

3.7

2.5

2.19

2.32

g/l

3.37

298

1430

Disorders of vitreous body and globe

3939

30996

1.26

35.87

3.4

2.5

2.28

2.32

g/l

5.07

3629

28612

Superficial injury of thorax

1135

7805

1.54

35.69

2.9

2.5

2.31

2.32

g/l

0.45

1031

7232

Acute alcohol intoxication

1917

14382

1.39

35.59

2.6

2.31

g/l

0.07

1737

13387

Amputation of thigh

301

1454

2.44

35.57

5.5

2.4

2.01

2.23

g/l

8.92

281

1321

Childhood asthma (age<16)

784

3850

1.67

35.53

2.5

1.9

2.52

2.53

g/l

0.23

722

3577

Disorders of ocular muscles, binocular movement, accommodation and refraction

3429

27422

1.28

35.53

2.8

2.4

2.40

2.39

g/l

0.77

3158

25450

Alcohol abuse, main dg

1144

7886

1.54

35.35

2.4

2.6

2.32

2.34

g/l

0.47

1035

7374

Disorders of vitreous body

3822

30204

1.26

35.33

3.4

2.5

2.28

2.32

g/l

4.89

3523

27900

Retinal vascular disorders

1006

6802

1.59

35.24

3.5

2.5

2.23

2.26

g/l

1.19

942

6221

Embolic stroke with flimmer

237

1033

2.66

35.12

3.0

2.3

2.25

2.21

g/l

0.50

222

940

Fracture of skull and facial bones

1558

11339

1.44

35.10

2.7

2.6

2.33

2.34

g/l

0.22

1414

10556

Other epidermal thickening

380

1993

2.16

35.10

3.7

2.2

2.30

2.33

g/l

0.56

363

1844

Wet age-related macular degeneration

1504

10622

1.46

35.08

2.8

2.4

2.23

2.26

g/l

1.08

1343

9623

Triptan medication for migraine, min. 3 purchases

3874

24081

1.26

35.06

2.1

2.4

2.49

2.44

g/l

5.36

3582

22391

Infections with a predominantly sexual mode of transmission

2046

15474

1.37

34.97

2.9

2.3

2.37

2.45

g/l

7.32

1867

14402

Other nutritional anaemias

121

377

4.22

34.97

3.4

2.2

2.19

2.25

g/l

0.53

112

346

Other peripheral vascular diseases

616

3715

1.80

34.87

2.9

2.2

2.36

2.35

g/l

0.23

573

3424

Fibroblastic disorders

1787

13323

1.40

34.80

2.6

2.5

2.30

2.29

g/l

0.50

1662

12284

Juvenile arthritis (FINNGEN)

345

1735

2.19

34.79

2.9

2.3

2.39

2.48

g/l

1.95

328

1597

Trigger finger

1034

7006

1.56

34.75

3.1

2.4

2.34

2.35

g/l

0.25

951

6494

Arthropathic psoriasis

847

5521

1.65

34.74

2.5

2.38

2.34

g/l

1.19

790

5144

Acute and subacute iridocyclitis

1418

10198

1.46

34.71

3.0

2.5

2.30

2.35

g/l

2.20

1316

9468

Spontaneous rupture of synovium and tendon

636

3881

1.78

34.47

2.7

2.5

2.33

2.31

g/l

0.38

583

3588

Vitamin D deficiency

178

688

3.11

34.42

3.4

2.3

2.32

2.36

g/l

0.27

170

635

Visual impairment including blindness (binocular or monocular)

577

3446

1.84

34.38

3.8

2.5

2.26

2.31

g/l

1.03

512

3154

Other and unspecified psoriasis

536

3137

1.88

34.32

2.7

2.5

2.33

2.32

g/l

0.18

498

2922

Other disorders of eye and adnexa

1041

7094

1.56

34.26

2.7

2.5

2.36

2.37

g/l

0.43

960

6563

Vasomotor and allergic rhinitis

2682

20712

1.31

34.22

2.3

2.5

2.46

2.40

g/l

7.78

2499

19222

Anterior Iridocyclitis

1505

10960

1.44

34.21

2.9

2.5

2.30

2.34

g/l

1.86

1395

10159

Seborrhoeic keratosis

1705

12682

1.41

34.20

3.5

2.3

2.29

2.32

g/l

1.26

1594

11657

Asthma and opportunity respiratory infection

406

2205

2.10

34.12

2.5

2.29

2.27

g/l

0.29

383

2027

Other symptoms and signs involving general sensations and perceptions

350

1800

2.20

34.09

2.2

2.4

2.35

2.33

g/l

0.18

306

1651

Suppurative and unspecified otitis media

2485

17137

1.32

34.08

2.9

2.4

2.44

2.42

g/l

0.91

2303

15926

Atopic dermatitis

4139

27921

1.24

34.07

2.3

2.4

2.43

2.41

g/l

1.37

3824

25935

Von Willebrand disease

139

477

3.66

33.92

4.2

2.1

2.47

g/l

0.00

134

437

Excessive attrition of teeth

4097

33840

1.24

33.91

2.7

2.4

2.40

2.38

g/l

1.74

3790

31459

Radiculopathy

1246

8809

1.49

33.73

2.5

2.37

2.29

g/l

4.16

1132

8105

Other specified/unspecified inflammatory spondylopathies

363

1887

2.12

33.48

2.3

2.41

2.40

g/l

0.12

332

1758

Voice disturbances

1989

15161

1.37

33.46

2.5

2.36

2.35

g/l

0.49

1839

14013

Unspecified urinary incontinence

693

4361

1.72

33.41

2.3

2.35

2.36

g/l

0.04

591

3996

Mental and behavioural disorders due to tobacco

658

4086

1.75

33.36

2.9

2.5

2.35

2.33

g/l

0.44

605

3818

Injuries to the wrist and hand

8010

48323

1.17

33.23

2.5

2.37

2.36

g/l

1.17

7355

44748

Hypoplasia of dental enamel , including avohilmo

260

1165

2.45

33.14

6.7

2.4

2.41

2.59

g/l

5.39

250

1094

Later onset COPD

2436

15210

1.34

33.07

2.7

2.5

2.22

g/l

0.31

2228

13875

Systemic sclerosis (FG)

213

913

2.74

33.07

3.3

2.2

2.34

2.36

g/l

0.15

203

842

Fall involving bed

314

1587

2.32

33.04

3.3

2.5

2.20

2.29

g/l

1.55

287

1444

malignant neoplasm of male genital organs

2210

10322

1.36

32.96

2.5

2.8

2.18

2.24

g/l

4.50

2019

9522

Pneumonia due to Streptococcus pneumoniae

336

1717

2.18

32.88

3.1

2.4

2.22

2.34

g/l

2.77

308

1578

Hypermobility syndrome

387

2068

2.05

32.85

2.3

2.2

2.52

2.49

g/l

0.51

368

1911

Artificial joint re-operation

581

3541

1.82

32.65

2.7

2.5

2.28

2.30

g/l

0.17

549

3251

Unspecified misadventure during surgical and medical care

460

2624

1.96

32.62

3.6

2.5

2.27

2.32

g/l

1.07

435

2431

Smoking dependency

658

4111

1.73

32.57

2.9

2.5

2.35

2.33

g/l

0.31

605

3842

Hypogonadotropic hypogonadism

239

1081

2.54

32.49

2.4

2.6

2.50

2.33

g/l

5.65

229

1018

Other condition

1050

7243

1.54

32.49

3.4

2.5

2.35

2.36

g/l

0.07

985

6731

Oesophageal obstruction

314

1587

2.27

32.44

2.4

2.3

2.28

2.26

g/l

0.20

285

1475

Other and unspecified injuries of head

553

3312

1.82

32.38

2.6

2.5

2.33

g/l

0.03

509

3047

Pneumonitis due to solids and liquids

687

4352

1.71

32.33

2.7

2.5

2.16

2.26

g/l

3.70

609

4011

Ankylosing spondylitis, ICD10

661

4138

1.72

32.31

2.4

2.5

2.36

2.35

g/l

0.20

607

3859

Herpesviral [herpes simplex] infections

1731

12976

1.39

32.23

2.7

2.3

2.37

2.40

g/l

1.64

1621

12024

Corticotropin deficiency

111

351

4.41

32.16

3.0

2.2

2.26

2.36

g/l

0.93

102

326

Conjunctivitis (acute, non atopic)

1991

15180

1.36

32.03

2.9

2.5

2.39

2.38

g/l

0.11

1855

14105

Temporomandibular joint disorders, including avohilmo

3033

24072

1.28

31.90

2.2

2.3

2.47

2.43

g/l

4.04

2812

22320

Other and unspecified disorders of skin and subcutaneous tissue

504

2968

1.87

31.57

3.4

2.3

2.35

2.34

g/l

0.07

452

2746

Psoriatic arthropathies, ICD10

776

5071

1.64

31.56

2.5

2.40

2.34

g/l

2.26

726

4718

Other disorders of nervous system

533

3193

1.84

31.48

3.4

2.5

2.29

2.31

g/l

0.25

488

2949

Other psoriatic arthropathies

755

4908

1.65

31.43

2.4

2.5

2.40

2.34

g/l

2.49

705

4564

Malignant neoplasm of oesophagus, including Hilmo

306

1550

2.25

31.29

2.2

2.6

2.31

2.25

g/l

0.82

291

1423

Other and unspecified urticaria

1390

10130

1.44

31.23

2.7

2.4

2.43

2.39

g/l

1.44

1285

9419

Cerebral cysts

444

2525

1.93

31.16

3.4

2.4

2.36

2.35

g/l

0.10

411

2327

Non-Hodgkin lymphoma, all

359

1921

2.10

31.15

2.4

2.5

2.02

2.26

g/l

11.66

340

1760

Acne

658

4113

1.69

31.13

3.3

2.2

2.41

2.51

g/l

4.14

610

3810

Infections with a predominantly sexual mode of transmission

2607

19239

1.30

31.11

2.7

2.3

2.39

2.46

g/l

7.49

2380

17913

Emphysema

593

3662

1.77

31.04

2.6

2.5

2.24

2.23

g/l

0.13

559

3390

Pure hyperglyceridaemia

202

871

2.71

30.94

3.6

2.3

2.40

2.31

g/l

1.29

188

811

Postmenopausal bleeding

1936

7813

1.38

30.94

2.3

2.40

2.35

g/l

2.36

1737

7147

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

2543

20044

1.30

30.85

2.4

2.43

g/l

0.29

2367

18670

Other congenital malformations

613

3800

1.73

30.83

2.9

2.5

2.39

2.43

g/l

0.84

570

3538

Eosinophilia

171

694

3.05

30.71

3.5

2.4

2.26

2.32

g/l

0.63

161

645

Idiopathic pulmonary fibrosis

664

4246

1.72

30.67

2.4

2.5

2.24

2.25

g/l

0.10

618

3899

Type 1 diabetes, strict definition, subgroup 1

477

2750

1.84

30.63

3.7

2.2

2.24

2.49

g/l

15.91

442

2570

Hypersplenism

158

6.77

30.60

3.9

2.2

2.32

2.36

g/l

0.18

142

Acute generalized exanthematous pustulosis

370

2013

2.06

30.53

2.9

2.4

2.29

2.35

g/l

1.21

338

1860

Neuralgia and neuritis, unspecified

394

2176

1.99

30.48

2.7

2.4

2.35

2.33

g/l

0.25

365

2014

Retinal detachments and breaks

2720

21826

1.29

30.45

3.2

2.4

2.25

2.30

g/l

4.22

2529

20121

Other hammer toe(s) (acquired)

1220

8050

1.47

30.43

2.5

2.3

2.32

g/l

0.10

1095

7351

Other specified/unspecified soft tissue disorders

394

2180

1.99

30.40

2.5

2.3

2.39

2.31

g/l

2.15

364

1987

Striking against or struck by other objects

2328

18286

1.31

30.31

2.6

2.36

g/l

0.13

2157

17050

Explicit fungal Sepsis

263

4.90

30.21

5.7

2.0

2.00

2.32

g/l

5.08

245

Acetic acid derivatives and related substances

2367

9559

1.33

30.20

2.2

3.2

2.32

2.27

g/l

3.72

2158

8875

Osteonecrosis due to drugs

164

667

3.18

30.02

2.9

2.4

2.24

2.31

g/l

0.81

155

619

Emotional disorders starting during childhood or adolescence

338

1757

2.07

30.01

2.5

2.62

2.58

g/l

0.58

306

1634

Atopic dermatitis, strict definition

1952

14694

1.34

29.95

2.5

2.4

2.44

2.45

g/l

0.46

1825

13698

Generalized skin eruption due to drugs and medicaments

331

1750

2.14

29.91

3.0

2.4

2.28

2.34

g/l

1.13

304

1623

Somnolence, stupor and coma

358

1937

2.06

29.81

3.2

2.5

2.31

g/l

0.05

329

1780

Olecranon bursitis

495

2950

1.84

29.71

3.2

2.6

2.27

2.28

g/l

0.20

454

2749

Testicular hypofunction

261

1268

2.33

29.67

3.2

2.4

2.40

2.30

g/l

2.35

235

1191

Pneumococcal septicemia

298

1528

2.23

29.66

3.5

2.6

2.20

2.31

g/l

2.79

280

1413

Melanocytic naevi

2122

16563

1.33

29.61

3.5

2.4

2.34

2.37

g/l

1.76

2027

15334

Anankastic personality disorder

291

1465

2.20

29.61

1.9

2.3

2.51

2.41

g/l

2.25

264

1362

Chronic laryngitis and laryngotracheitis

1043

7320

1.51

29.60

2.6

2.5

2.43

2.32

g/l

7.77

942

6780

Carcinoma in situ of skin

711

4661

1.67

29.47

3.4

2.5

2.24

2.28

g/l

0.88

670

4283

Inflammatory disease of uterus

940

6456

1.53

29.41

2.1

2.2

2.49

2.46

g/l

0.84

842

5975

Benign neoplasm: Rectosigmoid junction

362

1993

2.07

29.39

2.6

2.5

2.37

2.29

g/l

1.52

342

1849

Endometriosis of pelvic peritoneum

1028

6822

1.50

29.37

2.0

2.3

2.49

2.43

g/l

3.02

942

6302

D07AA Corticosteroids, weak (group I)

1089

7679

1.49

29.36

2.5

2.41

g/l

0.15

1000

7131

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

3907

31644

1.23

29.22

2.3

2.4

2.41

g/l

0.09

3620

29259

Seborrhoeic dermatitis

722

4727

1.64

29.20

3.1

2.4

2.31

g/l

0.05

669

4396

Other surgical follow-up care

256

1238

2.31

29.07

3.1

1.9

2.36

2.39

g/l

0.42

245

1130

Type 1 diabetes, strict definition

498

2949

1.79

29.02

3.7

2.2

2.24

2.48

g/l

16.53

463

2752

Temporal arteritis

333

1796

2.13

28.98

2.7

2.4

2.25

2.30

g/l

0.76

305

1653

Other noninfective disorders of lymphatic vessels and lymph nodes

303

1570

2.18

28.96

3.5

2.3

2.26

2.35

g/l

2.01

287

1459

Synovial cyst of popliteal space [Baker]

563

3489

1.75

28.82

2.7

2.4

2.32

2.31

g/l

0.09

522

3205

Abdominal aortic aneurysm (AAA)

823

5508

1.58

28.75

3.5

2.4

2.16

2.19

g/l

0.74

753

4981

Maternal care for other conditions predominantly related to pregnancy

1313

9396

1.42

28.69

2.2

2.53

2.49

g/l

1.52

1198

8761

Adenomyosis (Endometriosis of uterus)

932

6431

1.53

28.68

2.2

2.3

2.41

2.37

g/l

1.54

862

5903

Metatarsalgia

665

4278

1.66

28.64

2.6

2.4

2.37

g/l

0.01

613

3954

Congenital iodine-deficiency syndrome/hypothyroidism

263

1306

2.31

28.61

2.4

2.2

2.37

2.34

g/l

0.30

237

1200

Adenocarcinoma and papillary adenocarcinoma of stomach

238

1133

2.39

28.55

2.3

2.4

2.46

2.23

g/l

5.77

222

1029

Enthesopathies of lower limb, excluding foot

1539

11549

1.39

28.46

2.6

2.5

2.40

2.35

g/l

3.88

1428

10695

Ocular pain

608

3850

1.70

28.36

2.7

2.4

2.41

2.39

g/l

0.39

558

3570

Golimumab

268

1334

2.25

28.34

2.0

2.3

2.42

2.41

g/l

0.08

252

1242

Lack of expected normal physiological development

158

538

2.87

28.21

4.4

2.0

2.54

2.63

g/l

1.31

151

499

Lung cancer and mesothelioma

1369

8638

1.42

28.16

2.3

2.2

2.17

2.30

g/l

12.16

1292

7889

Testicular dysfunction

285

1457

2.19

28.14

3.1

2.4

2.39

2.30

g/l

2.32

256

1368

Carcinoma in situ of skin of scalp and neck

261

1322

2.38

28.08

3.9

2.6

2.18

2.22

g/l

0.56

241

1214

Carbimazole or st.post thyroidectomy, condition for graves disease

1462

10933

1.40

28.00

2.5

2.4

2.40

2.38

g/l

0.66

1348

10120

Other/unspecified reactive arthropathies

490

2955

1.80

27.97

2.7

2.4

2.29

2.36

g/l

1.76

463

2729

Carcinoma in situ of skin of trunk

310

1661

2.18

27.95

3.5

2.5

2.27

2.24

g/l

0.38

284

1521

Rare circulating lymphoid malignancy, including Hilmo

247

1205

2.34

27.95

2.7

2.6

2.13

2.31

g/l

6.15

238

1112

Primary adrenocortical insufficiency

121

431

3.56

27.94

2.8

2.3

2.24

2.39

g/l

2.35

112

397

Postprocedural musculoskeletal disorders, not elsewhere classified

565

3549

1.74

27.94

2.5

2.32

2.30

g/l

0.18

528

3284

Myositis

228

1081

2.43

27.91

3.1

2.4

2.20

2.31

g/l

2.16

220

997

Other other unspecified disorders of the circulatory system

320

1718

2.11

27.86

3.5

2.5

2.29

2.32

g/l

0.41

300

1598

malignant neoplasm of female genital organs

1021

7175

1.49

27.72

2.3

2.22

2.39

g/l

16.20

935

6492

Other enthesopathy of foot (+metatarsalgia)

707

4643

1.62

27.72

2.6

2.4

2.37

g/l

0.09

651

4288

Left hemicolectomy

227

1089

2.48

27.68

2.9

2.4

2.28

g/l

0.03

212

1000

Infective dermatitis

840

5736

1.56

27.64

3.0

2.4

2.33

2.32

g/l

0.08

772

5325

Malignant neoplasm of prostate

2136

9988

1.33

27.60

2.5

2.8

2.18

2.23

g/l

4.05

1951

9209

Other overlap syndromes

171

726

2.82

27.51

2.8

2.3

2.34

2.37

g/l

0.26

160

673

Morphin

180

777

2.70

27.48

2.8

2.2

2.29

2.27

g/l

0.15

165

715

Allergic conjunctivitis

4065

33319

1.22

27.43

2.3

2.4

2.41

g/l

0.18

3768

30830

Other and unspecified injuries of lower leg

549

3417

1.73

27.38

2.8

2.3

2.42

2.39

g/l

0.48

514

3161

Other/unspecified synovitis and tenosynovitis

816

5544

1.56

27.22

2.8

2.4

2.33

2.34

g/l

0.19

762

5117

Symptoms and signs involving emotional state

247

1213

2.29

27.20

2.7

2.3

2.43

2.39

g/l

0.49

227

1126

Giant cell arteritis with polymyalgia rheumatica

333

1835

2.08

27.17

2.7

2.4

2.25

2.30

g/l

0.88

305

1689

Other inflammation of eyelid

984

6944

1.50

27.15

2.5

2.4

2.35

2.34

g/l

0.19

909

6416

Malignant neoplasm of rectosigmoid junction

153

621

2.98

27.14

1.9

2.3

2.31

2.25

g/l

0.63

148

567

Unknown and unspecified causes of morbidity

480

2883

1.78

27.12

3.2

2.2

2.37

g/l

0.02

460

2665

Fenamates

1231

6057

1.44

27.07

2.1

3.2

2.41

2.30

g/l

8.93

1138

5653

Dermatophytosis

4604

39194

1.20

27.04

2.4

2.5

2.36

2.34

g/l

0.78

4228

36324

Dissociative [conversion] disorders

282

1448

2.14

27.01

2.0

2.1

2.53

2.43

g/l

2.06

252

1338

Thyrotoxicosis with diffuse goitre

950

6651

1.50

26.97

2.4

2.3

2.43

2.39

g/l

1.16

867

6169

Nonsuppurative otitis media

1518

9880

1.37

26.77

3.0

2.3

2.42

2.43

g/l

0.37

1424

9166

Periapical abscess

3245

26848

1.24

26.71

2.7

2.5

2.38

2.35

g/l

1.86

3001

24981

Hallux valgus (acquired)

2326

13284

1.30

26.65

2.2

2.3

2.38

2.35

g/l

1.01

2135

12200

Other and unspecified follicular disorders

310

1661

2.07

26.63

4.0

2.4

2.33

g/l

0.03

285

1533

Anorexia (incl.atypical)

422

2464

1.84

26.56

2.8

2.2

2.49

2.46

g/l

0.36

385

2276

Other specified congenital malformation syndromes affecting multiple systems

154

631

2.90

26.52

4.1

2.7

2.35

2.45

g/l

1.27

145

597

Systemic sclerosis

213

1006

2.46

26.50

3.3

2.2

2.34

2.38

g/l

0.43

203

928

Malignant neoplasm of pancreas

510

3155

1.75

26.43

2.0

2.5

2.18

2.27

g/l

2.87

485

2877

Alcohol-induced acute pancreatitis

295

1568

2.12

26.32

3.0

2.6

2.12

2.30

g/l

3.83

270

1466

Other congenital malformations

866

5993

1.52

26.17

2.7

2.5

2.37

2.42

g/l

1.75

808

5569

Other noninflammatory disorders of vulva and perineum

623

4026

1.64

26.15

2.6

2.3

2.39

2.41

g/l

0.43

576

3711

Bicuspidal aortic valve syndrome

292

1549

2.11

26.06

2.4

2.6

2.38

2.35

g/l

0.46

280

1449

Systemic sclerosis, icd10

213

1015

2.44

25.99

3.3

2.3

2.34

2.38

g/l

0.43

203

937

Bulimia nervosa (incl. atypical)

247

1226

2.21

25.95

2.4

2.1

2.47

2.53

g/l

0.96

223

1126

Malignant neoplasm of other connective and soft tissue, including Hilmo

325

1789

2.02

25.80

2.2

2.5

2.22

2.30

g/l

1.60

307

1656

Diabetes mellitus in pregnancy

2015

10074

1.32

25.69

2.4

2.1

2.55

2.51

g/l

2.22

1834

9391

Caries of enamel

6609

41757

1.16

25.50

2.7

2.5

2.40

2.38

g/l

2.87

6137

38730

Hidradenitis suppurativa

269

1390

2.14

25.49

3.1

2.2

2.41

2.42

g/l

0.11

251

1291

Other misadventures during surgical and medical care

214

1032

2.42

25.46

3.9

2.4

2.34

2.32

g/l

0.15

198

955

Diseases of middle ear and mastoid

4137

28643

1.21

25.45

2.8

2.4

2.41

2.39

g/l

1.84

3822

26536

Malignant neoplasm of prostate, including Hilmo

2175

10228

1.31

25.44

2.5

2.8

2.19

2.24

g/l

2.68

1987

9438

Early complications of trauma

341

1912

1.97

25.43

3.2

2.5

2.30

2.32

g/l

0.28

314

1776

!Aliquae complicationes praecoces traumatis

341

1912

1.97

25.43

3.2

2.5

2.30

2.32

g/l

0.28

314

1776

Protein-energy malnutrition of moderate and mild degree

113

415

3.64

25.41

2.9

2.7

2.19

2.35

g/l

1.50

105

376

Assault

846

5857

1.51

25.29

2.7

2.5

2.41

2.40

g/l

0.10

768

5487

Other congenital malformations of the digestive system

343

1917

1.96

25.19

4.4

2.7

2.42

2.41

g/l

0.11

334

1798

Medullary cystic kidney disease, nephronophthisis

14.21

25.09

11.0

2.2

2.11

2.52

g/l

4.13

Progressive vascular leukoencephalopathy

354

2040

1.98

25.09

2.3

2.4

2.19

2.25

g/l

1.40

335

1852

Fracture at wrist and hand level

2407

19390

1.27

25.05

2.6

2.34

2.35

g/l

0.64

2210

18057

Cervicobrachial syndrome

1501

11441

1.36

24.94

2.4

2.42

2.35

g/l

6.08

1406

10574

Otitis externa

1569

12054

1.35

24.91

3.1

2.5

2.36

2.35

g/l

0.23

1438

11200

Other localized connective tissue disorders

176

790

2.61

24.87

4.6

2.0

2.29

2.38

g/l

1.29

159

720

Presence of other devices

1734

13446

1.33

24.83

2.6

2.2

2.32

2.28

g/l

2.22

1619

12353

Acute pharyngitis

954

6708

1.47

24.82

2.7

2.3

2.44

2.43

g/l

0.19

891

6273

Calculus of kidney and ureter

2272

18306

1.29

24.69

2.9

2.6

2.30

2.29

g/l

0.36

2107

16937

Other congenital malformations of the digestive system

389

2266

1.86

24.65

4.3

2.6

2.41

g/l

0.04

376

2123

Dentofacial anomalies [including malocclusion]

4887

33747

1.18

24.63

2.3

2.4

2.45

2.40

g/l

8.14

4499

31336

Malignant immunoproliferative diseases

125

494

3.37

24.61

3.7

2.5

1.99

2.26

g/l

4.87

120

451

Carcinoma in situ of skin of upper limb, including shoulder

249

1300

2.28

24.59

3.7

2.6

2.17

2.25

g/l

1.32

233

1184

Operations for atrial fibrillation

161

713

2.83

24.48

2.8

2.6

2.35

2.27

g/l

1.18

152

662

Autoimmune hyperthyroidism

408

2418

1.81

24.41

2.5

2.1

2.44

2.41

g/l

0.45

377

2242

Exclusion endpoint for clefts

172

766

2.59

24.38

3.9

2.7

2.34

2.43

g/l

1.18

163

716

Other and unspecified types of non-Hodgkin lymphoma, hilmo

347

1992

1.95

24.37

2.6

2.5

2.16

2.28

g/l

3.23

325

1838

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

148

619

2.81

24.37

4.2

2.5

2.32

2.43

g/l

1.46

135

574

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

181

830

2.54

24.25

2.3

2.4

2.23

2.28

g/l

0.41

173

759

Other and unspecified nerve root and plexus disorders, also in other diseases

1356

10243

1.38

24.24

2.3

2.5

2.44

2.34

g/l

8.72

1247

9544

Malignant neoplasm of bladder

527

3352

1.69

24.20

2.7

2.6

2.20

2.22

g/l

0.28

484

3040

Nummular dermatitis

608

4006

1.63

24.11

2.9

2.4

2.30

g/l

0.10

560

3711

Other secondary gonarthrosis

411

2471

1.83

24.10

2.6

2.27

2.30

g/l

0.48

382

2302

Marginal zone B-cell lymphoma, including Hilmo

149

633

2.83

24.08

2.4

2.23

2.31

g/l

0.82

139

585

Abnormality of red blood cells

188

5.10

24.03

2.0

2.33

2.34

g/l

0.02

171

Benign neoplasm: Other and unspecified parts of small intestine

162

721

2.74

23.93

3.7

2.2

2.37

2.33

g/l

0.32

155

665

Bullous disorders

462

2874

1.76

23.84

3.2

2.5

2.26

2.29

g/l

0.53

436

2646

Coxarthrosis, primary, with hip surgery

3664

29027

1.22

23.79

2.5

2.30

2.29

g/l

1.10

3357

26646

Other diseases of gallbladder

353

2042

1.90

23.76

2.6

2.4

2.38

2.32

g/l

1.20

337

1886

Dissection of aorta

274

1473

2.10

23.74

3.0

2.3

2.21

2.26

g/l

0.94

250

1340

Drug-induced systemic lupus erythematosus

253

4.31

23.72

4.1

2.2

2.20

2.50

g/l

4.16

232

Other and unspecified haemorrhagic conditions

153

662

2.75

23.68

3.4

2.4

2.28

2.35

g/l

0.80

148

618

Neovascular glaucoma

336

1922

1.94

23.66

4.9

2.4

2.15

2.29

g/l

4.44

322

1766

Abnormal findings in nipple discharge synovial fluid wound secretions

148

634

2.80

23.53

4.0

2.2

2.30

2.39

g/l

1.00

140

588

Diseases of tongue

441

2703

1.76

23.50

2.6

2.2

2.34

g/l

0.00

404

2487

Glaucoma secondary to other eye disorders

339

1949

1.93

23.48

4.9

2.6

2.15

2.29

g/l

4.13

324

1798

Dermatographic urticaria

466

2898

1.73

23.43

2.1

2.3

2.49

2.41

g/l

2.45

417

2689

Car occupant injured in other and unspecified transport accidents

1278

9619

1.38

23.34

2.6

2.4

2.40

2.38

g/l

0.55

1177

8949

Dislocation, sprain and strain of joints and ligaments at neck level

992

7178

1.44

23.33

2.2

2.4

2.44

2.40

g/l

1.26

924

6666

Disorders of phosphorus metabolism and phosphatases

174

5.19

23.15

5.8

2.2

2.18

2.40

g/l

1.57

163

Superficial injury of forearm

670

4526

1.57

23.09

2.5

2.4

2.40

2.38

g/l

0.28

603

4188

Impotence

425

2610

1.79

23.07

3.9

2.7

2.26

2.25

g/l

0.22

402

2446

therapeutic use

266

1434

2.11

23.06

3.2

2.2

2.26

2.32

g/l

0.83

239

1327

Urolithiasis

2445

20002

1.26

23.04

2.9

2.6

2.29

2.28

g/l

0.48

2257

18505

Melanocytic naevi of trunk

843

5965

1.49

22.99

3.8

2.4

2.29

2.36

g/l

3.20

799

5538

Speech disturbances, not elsewhere classified

684

4676

1.57

22.80

2.9

2.5

2.26

2.28

g/l

0.47

612

4293

Ehlers-Danlos syndrome

114

435

3.13

22.72

3.0

2.1

2.45

2.47

g/l

0.14

103

397

Carrier of infectious disease

203

996

2.32

22.72

3.5

2.3

2.25

2.38

g/l

2.14

185

926

Moderate visual impairment, binocular

265

1431

2.09

22.71

3.9

2.3

2.19

2.30

g/l

1.99

221

1294

Disorders of refraction and accommodation

1783

14015

1.31

22.69

2.8

2.4

2.42

2.40

g/l

0.61

1630

13060

Volvulus

221

1118

2.22

22.65

3.0

2.3

2.24

2.27

g/l

0.22

209

1031

Congenital malformations and deformations of the musculoskeletal system

717

4898

1.53

22.53

2.6

2.4

2.46

2.44

g/l

0.35

665

4553

Other and unspecified rosacea

611

4085

1.60

22.50

2.9

2.4

2.37

2.35

g/l

0.26

571

3795

Other disorders of conjunctiva

1038

7646

1.43

22.48

3.0

2.5

2.34

2.30

g/l

1.15

973

7078

Other and unspecified abdominal hernia

328

1893

1.92

22.46

2.8

2.4

2.38

2.29

g/l

1.67

303

1754

Glaucoma

4397

32604

1.19

22.43

2.8

2.5

2.29

g/l

0.47

3994

29976

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

1070

7884

1.41

22.43

2.4

2.2

2.48

2.46

g/l

0.32

983

7257

Other acute viral hepatitis

123

494

2.99

22.31

2.2

2.5

2.51

2.35

g/l

1.72

118

459

Sacroiliitis, not elsewhere classified

321

1825

1.89

22.28

2.1

2.3

2.46

2.43

g/l

0.56

301

1697

Malignant neoplasm of mesothelium and soft tissue

302

1703

1.96

22.25

2.1

2.4

2.09

2.29

g/l

6.82

288

1574

Endometriosis of ovary

1088

7846

1.41

22.23

2.2

2.3

2.46

2.40

g/l

3.00

994

7240

Cervicocranial syndrome

738

5122

1.52

22.18

2.4

2.41

2.34

g/l

2.48

687

4723

Hyperosmolality and hypernatraemia

132

550

2.87

22.18

2.4

2.1

2.21

2.31

g/l

0.88

121

502

Excessive vomiting in pregnancy

522

3369

1.64

22.16

2.2

2.49

2.47

g/l

0.30

483

3134

Abscess of lung

148

651

2.70

22.14

3.7

2.5

2.06

2.29

g/l

4.10

133

611

Rosacea

798

5634

1.50

22.04

2.8

2.4

2.38

2.37

g/l

0.40

740

5237

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

356

2048

1.82

22.04

3.7

2.5

2.52

2.53

g/l

0.16

337

1910

Monoarthritis, not elsewhere classified

301

1692

1.94

21.97

3.1

2.4

2.26

2.33

g/l

1.36

284

1568

Cramp and spasm

351

2074

1.85

21.87

2.6

2.5

2.35

2.34

g/l

0.02

328

1925

Other disorders of patella

1086

8044

1.40

21.87

2.3

2.41

2.39

g/l

0.64

999

7472

Superficial injury of ankle and foot

791

5568

1.49

21.86

3.0

2.4

2.39

2.41

g/l

0.41

739

5169

Contact with and exposure to communicable diseases

1952

15549

1.28

21.80

2.5

2.3

2.47

2.46

g/l

0.18

1790

14527

Post-traumatic wound infection, not elsewhere classified

225

1166

2.18

21.75

3.3

2.3

2.27

2.33

g/l

0.81

207

1079

Abnormal blood-pressure reading, without diagnosis

310

1761

1.90

21.73

2.9

2.2

2.42

2.35

g/l

1.31

287

1627

conjunctival haemorrhage

576

3847

1.61

21.69

3.4

2.5

2.33

2.29

g/l

1.06

545

3550

Ovarian dysfunction

479

3044

1.67

21.67

2.1

2.0

2.59

2.52

g/l

2.00

443

2812

Septal defects

455

2811

1.71

21.66

2.9

2.7

2.45

2.42

g/l

0.74

424

2622

Bacterial, viral and other infectious agents

577

3835

1.60

21.63

3.3

2.5

2.32

2.36

g/l

0.82

545

3580

Use of disulfiram, acamprosate or naltrexone

592

3960

1.59

21.60

2.2

2.6

2.39

2.34

g/l

1.22

534

3739

Other noninflammatory disorders of uterus, except cervix

1487

7734

1.34

21.55

2.4

2.3

2.39

2.35

g/l

1.46

1364

7065

Bronchitis, not specified as acute or chronic

610

4105

1.58

21.55

2.9

2.4

2.35

2.31

g/l

1.02

550

3797

Other orthopaedic follow-up care

370

2214

1.80

21.55

2.5

1.9

2.32

2.37

g/l

1.06

342

2042

Acne vulgaris

489

3121

1.65

21.49

3.2

2.2

2.40

2.50

g/l

4.00

452

2891

Other disorders of optic [2nd] nerve and visual pathways

466

2970

1.69

21.49

3.5

2.4

2.29

2.35

g/l

1.30

436

2752

Allergic purpura

239

1267

2.10

21.39

3.8

2.3

2.33

2.36

g/l

0.42

227

1174

Benign neoplasm: Liver/bile ducts

213

1089

2.21

21.36

3.0

2.2

2.47

2.38

g/l

1.09

199

1010

Carcinoma in situ of skin of ear and external auricular canal

161

756

2.63

21.36

3.8

2.7

2.14

2.21

g/l

0.86

148

692

Appendectomy

4669

38753

1.17

21.33

2.4

2.5

2.38

g/l

0.24

4342

35921

Status epilepticus

282

1576

1.97

21.27

3.4

2.5

2.24

2.29

g/l

0.63

258

1457

Congenital malformations of the musculoskeletal system, not elsewhere classified

145

637

2.62

21.27

2.9

2.1

2.47

2.45

g/l

0.13

133

583

Specific development disorders of scholastic skills

284

1557

1.94

21.20

3.2

2.4

2.52

2.53

g/l

0.03

267

1454

Adenocarcinoma and Papillary adenocarcinoma of kidney

107

414

3.19

21.19

6.6

2.5

2.16

2.23

g/l

0.57

387

Superficial injury of wrist and hand

1336

10254

1.35

21.19

2.5

2.43

2.39

g/l

1.37

1212

9561

Cushing syndrome

111

436

3.09

21.16

2.5

2.0

2.34

2.38

g/l

0.34

102

405

Thalassaemia

144

5.58

21.12

2.6

2.3

2.35

2.43

g/l

0.38

132

Abnormality of white blood cells, not elsewhere classified

331

3.53

21.03

3.3

2.3

2.25

2.38

g/l

1.25

310

Gastrojejunal ulcer

121

498

2.91

20.91

4.5

2.3

2.38

2.28

g/l

0.88

113

464

Myocardial infarction, unclassifiable

1809

12914

1.30

20.88

3.4

2.5

2.23

g/l

0.25

1679

11713

Wide developmental disorders, excluding more controls

185

874

2.24

20.88

1.9

2.3

2.57

2.51

g/l

0.78

164

825

Endocrine disorders, other/unspecified

168

795

2.44

20.84

2.8

2.2

2.39

g/l

0.02

145

733

Biomechanical lesions, not elsewhere classified

382

2346

1.78

20.78

2.6

2.5

2.33

g/l

0.00

358

2171

Memory loss

708

4972

1.53

20.77

2.2

2.5

2.23

2.28

g/l

1.87

653

4586

L02BX Other hormone antagonists and related agents

463

3005

1.71

20.72

2.1

2.8

2.07

2.21

g/l

6.24

430

2797

Cluster headache, strict

250

1351

2.02

20.69

2.5

2.3

2.37

2.36

g/l

0.11

236

1258

Hypotension due to drugs

148

676

2.66

20.67

2.9

2.4

2.28

g/l

0.00

135

620

Hyperfunction of pituitary gland

343

2038

1.82

20.65

2.6

2.1

2.42

g/l

0.07

313

1901

Adenocarcinoma and ductal carcinoma of pancreas

262

1454

2.01

20.48

1.8

2.5

2.18

2.29

g/l

2.27

257

1333

Localized swelling, mass and lump of skin and subcutaneous tissue

2256

18518

1.25

20.43

2.8

2.4

2.34

g/l

0.04

2113

17113

Atrial septal defect

290

1646

1.93

20.41

3.2

2.6

2.44

2.42

g/l

0.17

274

1540

Brachial plexus disorders

606

4114

1.55

20.37

2.3

2.50

2.40

g/l

4.60

568

3838

Other and unspecified visual disturbances

715

5027

1.51

20.36

2.8

2.4

2.34

2.35

g/l

0.19

654

4651

Disorders of optic nerve and visual pathways

656

4537

1.53

20.32

3.1

2.5

2.33

2.38

g/l

1.31

610

4226

Macular pucker

1145

8711

1.39

20.31

3.0

2.5

2.25

2.27

g/l

0.66

1045

8011

Bacterial, viral and other infectious agents

608

4139

1.55

20.29

3.3

2.5

2.32

2.36

g/l

0.91

573

3874

Allergic rhinitis

1998

15983

1.27

20.28

2.2

2.4

2.49

2.43

g/l

5.29

1865

14921

Traumatic subarachnoid haemorrhage

282

1599

1.93

20.26

2.7

2.3

2.25

2.26

g/l

0.10

259

1477

Inguinal hernia

4443

25716

1.18

20.23

2.8

2.5

2.27

2.30

g/l

2.53

4111

23796

Cluster headache, wide

266

1476

1.96

20.23

2.5

2.3

2.37

2.36

g/l

0.11

251

1370

Postzoster neuralgia

151

699

2.57

20.22

2.9

2.2

2.30

2.31

g/l

0.06

143

647

Benign neoplasm: Liver

192

966

2.26

20.18

2.9

2.2

2.50

2.38

g/l

1.40

179

894

Erythema intertrigo

202

1039

2.22

20.16

3.2

2.4

2.31

2.32

g/l

0.14

188

954

Congenital malformations of great arteries

179

862

2.33

20.14

3.0

2.9

2.49

2.47

g/l

0.19

173

815

Otalgia

552

3699

1.59

20.11

2.5

2.44

2.38

g/l

1.27

497

3428

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

106

425

3.20

20.07

2.3

2.16

2.30

g/l

1.72

100

393

Polyp of the female genital tract

2064

9566

1.27

20.06

2.3

2.43

2.38

g/l

2.94

1888

8776

Suggestive for eosinophilic asthma

647

4479

1.53

20.06

2.3

2.6

2.35

2.29

g/l

1.95

604

4166

Other and unspecified glaucoma

556

3753

1.60

20.03

2.8

2.5

2.21

2.29

g/l

2.55

512

3440

Viral infections of the central nervous system

496

3252

1.63

19.97

2.7

2.4

2.35

2.36

g/l

0.20

454

3023

Complications following infusion, transfusion and therapeutic injection

137

609

2.64

19.93

4.4

2.2

2.28

2.34

g/l

0.60

131

561

Acute laryngitis and tracheitis

722

4983

1.48

19.93

2.7

2.3

2.52

2.45

g/l

2.43

683

4646

Other primary thrombocytopenia

166

5.14

19.87

3.1

2.2

2.45

2.43

g/l

0.09

146

Xerosis cutis

151

705

2.55

19.86

3.5

2.2

2.29

2.34

g/l

0.43

144

645

Viral infections of the central nervous system

529

3521

1.60

19.84

2.6

2.4

2.35

2.36

g/l

0.18

483

3273

Vulvovaginal ulceration/inflammation in other diseases

392

2434

1.72

19.76

2.5

2.2

2.45

2.49

g/l

0.61

359

2259

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

201

4.59

19.75

4.7

2.0

2.25

2.28

g/l

0.19

187

Other secondary gout

140

5.92

19.74

4.6

2.2

2.09

2.23

g/l

1.03

127

Tobacco use

376

2322

1.75

19.72

3.0

2.5

2.40

2.35

g/l

0.71

343

2164

Polyarteritis nodosa and related conditions

130

568

2.71

19.71

3.7

2.3

2.28

2.36

g/l

0.78

122

528

Hydrocele

882

6465

1.43

19.64

3.6

2.7

2.20

2.23

g/l

0.99

817

6002

Open wound of wrist and hand

3150

26117

1.20

19.58

2.5

2.6

2.36

2.35

g/l

0.88

2898

24314

Primary coxarthrosis, bilateral

2159

17760

1.26

19.58

2.4

2.5

2.32

2.28

g/l

2.54

1988

16271

Disorders of purine and pyrimidine metabolism

238

4.12

19.51

4.6

2.0

2.22

2.31

g/l

0.61

223

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

286

1654

1.91

19.48

3.1

2.3

2.32

2.34

g/l

0.31

268

1537

Benign paroxysmal vertigo

2114

17347

1.26

19.46

2.6

2.5

2.36

2.33

g/l

1.85

1894

15977

Other and unspecified tonsillitis

2111

14462

1.25

19.44

2.7

2.3

2.44

2.43

g/l

0.39

1960

13543

Ehlers-Danlos syndrome

336

3.25

19.38

3.2

2.1

2.42

2.47

g/l

0.32

307

Benign neoplasm: Pancreas

234

1287

2.08

19.33

3.4

2.5

2.32

2.31

g/l

0.20

221

1191

Malignant neoplasm of oesophagus

206

1079

2.15

19.31

2.0

2.5

2.25

2.24

g/l

0.15

194

988

Other/unspecified enthesopathies, not elsewhere classified

598

4106

1.54

19.21

2.4

2.35

2.31

g/l

1.14

557

3777

Degenerative macular diseases

907

6718

1.43

19.21

3.1

2.4

2.22

2.28

g/l

2.00

816

6153

Intentional self-harm by unspecified means

107

428

2.89

19.21

2.0

2.2

2.40

2.42

g/l

0.12

392

Parkinson's disease, excluding more controls

960

6724

1.41

19.19

2.1

2.4

2.25

g/l

0.02

857

6254

Complications of genitourinary prosthetic devices, implants and grafts

203

1061

2.15

19.11

3.8

2.1

2.20

2.34

g/l

2.65

185

975

Hyperhidrosis

203

1049

2.10

19.10

2.0

2.50

2.45

g/l

0.68

180

963

Specific development disorders of speech and language

394

2377

1.70

19.05

3.1

2.5

2.45

2.44

g/l

0.11

362

2221

Congenital malformations and deformations of the musculoskeletal system

561

3781

1.55

19.01

2.8

2.5

2.47

2.46

g/l

0.13

524

3525

Other female pelvic inflammatory diseases

1035

7803

1.38

18.94

2.4

2.3

2.47

2.42

g/l

2.14

939

7200

Migraine, single triptan purchase ok & required. ICD-code if available is included

5293

31552

1.15

18.83

2.2

2.5

2.47

2.41

g/l

14.81

4919

29286

Triptan medication for migraine, single purchase ok

5293

31552

1.15

18.83

2.2

2.5

2.47

2.41

g/l

14.81

4919

29286

Urethral stricture

442

2877

1.66

18.80

3.0

2.6

2.23

2.25

g/l

0.31

402

2670

Congenital malformation of biliary tract

113

6.56

18.79

6.7

3.0

2.64

2.50

g/l

0.80

106

Allergic urticaria

553

3757

1.56

18.71

2.6

2.4

2.40

g/l

0.04

504

3488

Fitting and adjustment of external prosthetic device

121

5.94

18.69

7.3

1.9

1.98

2.40

g/l

4.80

109

Other and unspecified vascular occlusions

712

5097

1.49

18.66

3.6

2.5

2.24

2.26

g/l

0.66

660

4672

Atypical facial pain

361

2238

1.74

18.65

2.3

2.4

2.45

2.36

g/l

2.38

336

2075

Other abnormal immunological findings in serum

162

791

2.32

18.42

2.4

2.3

2.41

2.39

g/l

0.12

152

732

Disorders of vestibular function (Vertigo)

3482

29487

1.19

18.39

2.4

2.5

2.37

2.33

g/l

4.68

3153

27127

Atrophic disorders of skin

957

7169

1.39

18.35

2.5

2.3

2.38

2.39

g/l

0.39

871

6594

Hyperaldosteronism

223

1222

2.05

18.34

4.2

2.4

2.30

2.31

g/l

0.14

209

1134

Alzheimer disease, excluding more controls

1305

6673

1.34

18.32

2.1

2.4

2.20

2.25

g/l

2.93

1140

6172

Kyphosis

121

530

2.69

18.24

2.7

2.4

2.36

2.34

g/l

0.20

114

485

Benign neoplasm of mouth and pharynx

764

5548

1.45

18.17

2.6

2.5

2.31

2.32

g/l

0.26

695

5143

Myopia

796

5794

1.43

18.14

2.7

2.3

2.47

2.42

g/l

1.54

725

5385

Restrictive cardiomyopathy

175

5.12

18.11

5.0

2.4

2.40

2.35

g/l

0.29

159

Drug-induced polyneuropathy

391

3.14

18.09

2.8

2.5

2.28

2.35

g/l

0.68

360

Ptosis of eyelid

804

5902

1.44

18.05

2.7

2.5

2.27

2.30

g/l

0.99

750

5445

Lesion of lateral popliteal nerve

353

2197

1.74

18.03

3.0

2.5

2.34

2.30

g/l

0.52

332

2051

Serous carcinoma of ovary, including Hilmo

238

1334

1.97

17.96

2.0

2.4

2.18

2.39

g/l

6.35

224

1226

Campylobacter enteritis

209

1126

2.07

17.94

3.2

2.4

2.29

2.34

g/l

0.68

197

1046

Special screening examination for neoplasms

384

2431

1.68

17.91

3.4

2.2

2.24

2.27

g/l

0.36

355

2234

Other disorders starting during childhood or adolescence

318

1897

1.77

17.91

3.7

2.5

2.55

2.54

g/l

0.06

301

1764

Strabismus

1778

14401

1.27

17.83

2.8

2.5

2.39

2.38

g/l

0.33

1642

13392

Female genital prolapse

1951

8962

1.26

17.76

2.0

2.3

2.45

2.37

g/l

7.71

1777

8207

Collapsed vertebra, not elsewhere classified

334

3.29

17.76

3.4

2.2

2.20

2.29

g/l

0.80

297

Personal history of risk-factors, not elsewhere classified

110

463

2.72

17.76

2.2

1.9

2.31

2.42

g/l

0.95

100

425

Pre-eclampsia or poor fetal growth

1844

14964

1.26

17.75

2.7

2.2

2.48

g/l

0.07

1703

13867

Alcoholic gastritis

129

587

2.56

17.74

3.0

2.5

2.18

2.27

g/l

0.87

120

551

Other predominantly sexually transmitted diseases, not elsewhere classified

1052

8009

1.36

17.73

2.6

2.3

2.40

2.45

g/l

2.23

950

7435

Asthma mixed form (mode), excluding more controls

308

1842

1.77

17.68

2.6

2.0

2.44

2.36

g/l

1.89

293

1685

Other predominantly sexually transmitted diseases, not elsewhere classified

1241

9655

1.32

17.68

2.5

2.3

2.41

2.47

g/l

3.09

1125

8965

Visual field defects

616

4337

1.51

17.65

2.9

2.5

2.33

2.30

g/l

0.43

560

4016

Exposure to other and unspecified inanimate mechanical forces

494

3327

1.58

17.56

3.0

2.5

2.32

2.36

g/l

0.75

466

3093

Personal history of malignant neoplasm

423

2754

1.63

17.51

2.3

2.0

2.35

2.41

g/l

1.51

397

2548

Assault by bodily force

476

3176

1.58

17.40

2.5

2.4

2.40

g/l

0.01

431

2961

Event of undetermined intent

428

2802

1.63

17.37

2.7

2.5

2.38

2.36

g/l

0.29

401

2607

Flat foot [pes planus] (acquired)

595

4157

1.50

17.29

2.4

2.43

2.35

g/l

2.71

537

3834

Lactose intolerance

212

1156

2.00

17.19

2.9

2.1

2.44

2.38

g/l

0.77

193

1070

Salpingitis and oophoritis

1103

8505

1.35

17.18

2.5

2.3

2.42

2.41

g/l

0.23

1002

7852

Other and unspecified mononeuropathies, also in other diseases

227

1273

1.97

17.17

3.5

2.4

2.30

2.31

g/l

0.21

215

1181

Otitis media, unspecified

690

4546

1.45

17.15

3.0

2.3

2.50

2.46

g/l

0.97

640

4242

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

143

689

2.40

17.12

2.4

2.2

2.15

2.35

g/l

3.41

137

638

Congenital malformations of the musculoskeletal system, not elsewhere classified

119

529

2.58

17.09

3.1

2.2

2.45

2.44

g/l

0.04

109

488

Ankylosing spondylitis, strict definition

293

1759

1.80

17.08

2.2

2.5

2.38

g/l

0.04

276

1636

Follicular cysts of skin and subcutaneous tissue

1233

9663

1.32

17.03

3.2

2.5

2.33

2.34

g/l

0.10

1156

8986

Fracture of neck

447

2983

1.61

17.02

2.8

2.6

2.20

2.27

g/l

1.96

409

2758

Chondrocostal junction syndrome [Tietze]

275

1633

1.84

16.98

2.1

2.3

2.38

2.37

g/l

0.09

249

1506

Benign neoplasm of urinary organs

351

2223

1.72

16.94

3.4

2.4

2.32

2.30

g/l

0.36

333

2059

Algoneurodystrophy

225

1258

1.95

16.91

2.9

2.2

2.44

2.42

g/l

0.25

209

1162

Other benign neoplasms of skin

2714

23080

1.21

16.88

2.9

2.5

2.33

2.32

g/l

0.10

2470

21267

Bell's palsy

792

5847

1.42

16.82

2.7

2.4

2.38

2.33

g/l

1.86

729

5424

Other bacterial agents as the cause of diseases classified to other chapters

100

420

2.88

16.81

4.4

2.3

2.10

2.35

g/l

3.58

383

Palmar fascial fibromatosis [Dupuytren]

1126

8755

1.34

16.73

2.7

2.5

2.25

2.24

g/l

0.09

1044

8067

CR(E)ST syndrome

134

636

2.45

16.73

3.4

2.2

2.35

2.40

g/l

0.49

128

591

Malignant neoplasm of other and unspecified parts of biliary tract

123

563

2.54

16.70

2.3

2.2

2.22

2.26

g/l

0.33

117

518

Encephalopathy

102

436

2.85

16.60

4.0

2.3

2.16

2.31

g/l

1.51

403

Erectile dysfunction, exclusion

146

4.82

16.50

5.0

2.3

2.48

2.26

g/l

1.96

134

Parkinson's disease, strict definition, excluding more controls

889

6372

1.39

16.49

2.1

2.4

2.25

g/l

0.01

790

5925

Malignant neoplasm of ovary, including Hilmo

410

2696

1.62

16.42

2.3

2.4

2.20

2.41

g/l

10.21

388

2460

Personal history of certain other diseases

133

625

2.36

16.39

2.6

1.9

2.53

2.50

g/l

0.17

119

571

Acute bronchiolitis

363

2076

1.66

16.30

3.7

2.4

2.49

2.52

g/l

0.51

344

1928

Sequelae of injuries of lower limb

611

4345

1.48

16.29

2.7

2.5

2.31

2.35

g/l

0.97

565

4036

Orchitis and epididymitis

647

4651

1.46

16.27

3.1

2.7

2.25

g/l

0.01

612

4338

Postprocedural disorders of nervous system

453

3039

1.57

16.27

2.1

2.2

2.50

2.45

g/l

1.17

417

2820

Personal history of medical treatment

400

2.86

16.26

3.7

2.1

2.21

2.35

g/l

1.50

365

Juvenile rheumatoid arthirtis

150

740

2.22

16.24

2.5

2.2

2.36

2.43

g/l

0.74

140

687

Drug-induced thyroiditis

6.61

16.16

3.8

2.4

2.45

g/l

0.01

Necrobiosis lipoidica, not elsewhere classified

207

3.79

16.13

4.7

1.9

2.24

2.47

g/l

2.29

191

Short stature, not elsewhere classified

166

790

2.16

16.09

4.2

2.7

2.57

2.59

g/l

0.17

159

743

Viral meningitis

245

1427

1.86

16.02

2.6

2.3

2.39

2.40

g/l

0.15

227

1327

Complications of other internal prosthetic devices, implants and grafts

296

1821

1.76

15.97

3.5

2.2

2.17

2.32

g/l

4.33

275

1670

Other keratitis

738

5431

1.42

15.96

3.2

2.4

2.33

2.36

g/l

0.80

688

5049

Liver disorders in diseases classified elsewhere

102

5.67

15.90

3.8

2.0

2.37

2.43

g/l

0.21

Type1 diabetes, definitions combined, early onset

398

2596

1.61

15.88

4.0

2.5

2.25

2.50

g/l

14.05

373

2423

Other retinal artery occlusion

198

1100

2.03

15.81

3.4

2.5

2.22

2.26

g/l

0.45

191

1011

Other bacterial agents as the cause of diseases classified to other chapters

111

500

2.61

15.80

4.2

2.2

2.12

2.34

g/l

3.26

104

455

Other disorders of penis

652

4717

1.45

15.80

3.2

2.7

2.25

2.28

g/l

0.60

605

4419

Blepharochalasis

2085

17454

1.23

15.74

2.5

2.33

2.31

g/l

0.85

1894

16053

Benign neoplasm: Pituitary gland, craniopharyngeal duct

362

2343

1.66

15.74

2.3

2.4

2.33

2.35

g/l

0.30

334

2178

Implicit parasitic Sepsis

169

4.17

15.72

3.2

1.9

2.21

2.37

g/l

1.04

152

Other/unspecified enthesopathies of lower limb, excluding foot

457

3096

1.56

15.70

2.4

2.41

2.35

g/l

1.62

419

2870

Raynaud syndrome

574

4072

1.49

15.63

2.3

2.4

2.41

2.38

g/l

0.66

523

3784

Overexertion and strenuous or repetitive movements

651

4718

1.45

15.58

2.5

2.4

2.29

2.35

g/l

2.00

610

4398

Autism spe, excluding more controls

130

612

2.28

15.55

1.7

2.1

2.57

2.51

g/l

0.60

116

571

Astigmatism

410

2724

1.60

15.52

3.0

2.5

2.40

g/l

0.06

377

2518

Pre-eclampsia or eclampsia

1302

10374

1.29

15.50

2.9

2.2

2.46

g/l

0.02

1203

9606

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

164

865

2.17

15.45

3.1

2.5

2.32

2.27

g/l

0.47

153

799

Mental and behavioural disorders due to use of other stimulants, including caffeine

176

934

2.04

15.40

2.3

2.4

2.47

2.39

g/l

0.73

153

868

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

223

1278

1.89

15.34

3.7

2.6

2.36

2.44

g/l

1.33

212

1188

Other factor of the environment

115

533

2.53

15.31

4.9

2.3

2.28

2.37

g/l

0.84

108

497

Malignant neoplasm of anus and anal canal, including Hilmo

108

487

2.60

15.31

2.8

2.3

2.28

2.30

g/l

0.15

103

450

Mental and behavioural disorders due to cannabinoids

177

941

2.02

15.29

1.6

2.4

2.51

2.40

g/l

1.19

152

878

Anorexia

121

570

2.42

15.20

2.6

2.2

2.26

2.41

g/l

1.45

109

523

Embolic stroke

372

2447

1.64

15.16

3.0

2.4

2.25

g/l

0.01

345

2231

Autonomic disorders

180

980

2.05

15.11

2.8

2.3

2.35

2.34

g/l

0.08

172

912

Lactose intolerance, other/unspecified

187

1023

1.99

15.09

2.7

2.1

2.44

2.38

g/l

0.84

168

947

Lifestyle-related condition

108

492

2.59

15.06

5.0

2.3

2.25

2.37

g/l

1.17

101

454

Malignant melanoma, including Hilmo

1147

9057

1.31

15.01

2.7

2.6

2.26

2.30

g/l

1.72

1066

8279

Drug-induced obesity

342

2.93

14.96

3.2

2.4

2.57

2.37

g/l

1.95

323

Toxic effect of other and unspecified substances

103

456

2.58

14.95

1.7

2.1

2.42

g/l

0.04

421

Lesion of radial nerve

265

1612

1.78

14.92

2.9

2.4

2.38

2.34

g/l

0.55

248

1497

Pollen allergy

1123

8711

1.31

14.87

2.3

2.4

2.50

2.47

g/l

1.14

1047

8111

Respiratory conditions due to other external agents

173

940

2.09

14.86

2.7

2.4

2.30

2.31

g/l

0.09

160

868

Manic episode

206

1167

1.91

14.82

2.1

2.3

2.41

2.36

g/l

0.51

184

1087

Degeneration of nervous system due to alcohol

184

1022

2.04

14.77

2.3

2.7

2.14

2.24

g/l

1.09

165

952

Malignant neoplasm of endocrine gland

438

2983

1.55

14.76

2.9

2.4

2.35

2.38

g/l

0.67

407

2764

Disorders of speech understanding and production

293

1795

1.72

14.71

3.0

2.5

2.44

g/l

0.01

268

1679

Polycystic ovarian syndrome

336

2159

1.64

14.68

2.0

2.63

2.53

g/l

2.60

313

1995

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

2825

21127

1.18

14.67

2.7

2.2

2.48

2.45

g/l

1.28

2634

19483

Hypertrophy of breast in women and men

1235

9851

1.29

14.67

2.2

2.3

2.47

2.41

g/l

3.18

1139

9110

Otitis externa, unspecified

727

5416

1.40

14.62

3.2

2.5

2.36

2.37

g/l

0.25

669

5025

Secondary systemic amyloidosis

119

5.12

14.61

5.0

2.0

1.93

2.30

g/l

3.84

106

Acute and transient psychotic disorders

725

5393

1.40

14.59

2.4

2.5

2.34

2.37

g/l

0.63

636

5028

Malignant neoplasm of head and neck

528

3736

1.49

14.59

2.3

2.7

2.19

2.28

g/l

2.65

491

3436

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1957

16379

1.22

14.56

2.4

2.6

2.33

2.34

g/l

0.38

1790

15202

Sequelae of infectious and parasitic diseases

504

3538

1.50

14.54

3.0

2.4

2.32

2.33

g/l

0.18

466

3262

Other and unspecified injuries of wrist and hand

264

1613

1.76

14.52

2.8

2.3

2.44

2.38

g/l

0.90

242

1496

Degeneration of the brain due to alcohol

184

1028

2.02

14.50

2.3

2.7

2.14

2.24

g/l

1.12

165

960

Malignant neoplasm of oral cavity, including Hilmo

301

1902

1.70

14.50

2.3

2.5

2.21

2.31

g/l

1.74

277

1755

Additional codes for the location of defect, injury or illness

399

2687

1.59

14.47

2.6

2.5

2.39

2.34

g/l

0.89

388

2488

Hodgkin lymphoma, hilmo

214

1243

1.89

14.46

2.8

2.4

2.28

2.33

g/l

0.67

203

1157

Other noninflammatory disorders of vagina

497

3478

1.50

14.45

2.7

2.3

2.37

2.40

g/l

0.54

447

3202

Female infertility

1737

8654

1.24

14.44

2.1

2.2

2.51

2.45

g/l

4.43

1593

7984

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1835

15275

1.23

14.36

2.4

2.5

2.40

2.39

g/l

0.35

1677

14242

Mantle cell lymphoma, including Hilmo

116

553

2.42

14.33

2.8

2.5

2.08

2.25

g/l

2.64

111

507

Anxious personality disorder

134

667

2.21

14.29

2.3

2.1

2.45

2.43

g/l

0.09

120

620

Meralgia paraesthetica

237

1418

1.82

14.26

2.4

2.43

2.34

g/l

1.71

216

1321

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

606

4419

1.45

14.22

2.5

2.6

2.30

2.31

g/l

0.12

554

4095

Gestational diabetes (for exclusion)

2162

12650

1.21

14.22

2.1

2.2

2.59

2.50

g/l

10.83

1966

11741

Diseases of inner ear

4006

34293

1.15

14.21

2.4

2.5

2.36

2.32

g/l

4.63

3647

31619

Pneumothorax

484

3395

1.51

14.18

2.9

2.5

2.19

2.28

g/l

2.89

447

3151

Motor disorders, excluding more controls

412

2.51

14.13

3.8

2.7

2.58

2.54

g/l

0.26

396

Sacrococcygeal disorders, not elsewhere classified

207

1192

1.88

14.13

2.2

2.47

2.39

g/l

1.36

193

1107

Certain conditions originating in the perinatal period

480

2956

1.50

14.08

3.4

2.4

2.50

2.54

g/l

0.83

449

2757

Hyphaema and other vascular disorders of iris and ciliary body

167

913

2.06

14.03

4.8

2.3

2.14

2.30

g/l

3.29

151

842

Infection due to other mycobacteria

122

595

2.32

14.03

3.8

2.1

2.20

2.32

g/l

1.55

113

542

Deviated nasal septum

2284

19421

1.20

14.02

2.4

2.7

2.34

2.30

g/l

2.61

2116

18063

Pregnancy hypertension

2524

19352

1.19

14.02

2.6

2.2

2.48

2.46

g/l

0.94

2354

17864

Other strabismus

1383

11188

1.27

13.97

2.6

2.4

2.44

2.40

g/l

1.64

1272

10405

Focal brain injury

428

2930

1.54

13.97

2.9

2.4

2.29

2.27

g/l

0.23

389

2725

Allergic contact dermatitis

847

6485

1.35

13.96

2.2

2.3

2.45

2.41

g/l

1.62

778

6015

Corneal ulcer

1200

9602

1.29

13.95

3.1

2.5

2.33

2.36

g/l

0.70

1110

8929

Implicit parasitic Sepsis

203

3.57

13.95

3.4

1.9

2.22

2.38

g/l

1.26

185

Psoriasis (vulgaris), strict definition

229

1366

1.82

13.90

2.4

2.49

2.34

g/l

3.12

213

1269

Renal cell carcinoma of kidney

237

1429

1.80

13.90

4.2

2.4

2.06

2.26

g/l

6.53

221

1305

Cutaneous lupus erythematosus

179

999

1.99

13.89

2.7

2.2

2.28

2.36

g/l

1.09

163

923

Family history of malignant neoplasm

643

4728

1.41

13.88

2.1

2.0

2.45

2.44

g/l

0.18

602

4374

Plantar fascial fibromatosis

609

4446

1.43

13.88

2.3

2.4

2.42

2.35

g/l

2.10

561

4112

Secondary parkinsonism, excluding more controls

178

987

1.97

13.87

2.2

2.3

2.29

2.26

g/l

0.21

152

920

Malignant melanoma

941

7327

1.33

13.87

2.8

2.6

2.26

2.31

g/l

2.21

878

6694

Single spontaneous delivery

2144

13428

0.83

13.86

2.1

2.4

2.42

g/l

0.25

1966

12308

Fistulae involving female genital tract

125

618

2.28

13.85

3.3

2.3

2.35

2.37

g/l

0.19

120

570

Panhypopituitarism

147

774

2.15

13.84

2.4

2.5

2.22

2.34

g/l

1.49

135

722

Focal epilepsy

1451

11867

1.26

13.80

2.6

2.5

2.30

2.34

g/l

1.73

1335

10983

Thyrotoxicosis with toxic multinodular goitre

421

2899

1.55

13.77

2.5

2.4

2.32

2.33

g/l

0.11

386

2664

Cluster headache, strict, including avohilmo

317

2049

1.65

13.74

2.4

2.3

2.40

2.39

g/l

0.05

299

1912

Inflammatory diseases of the central nervous system

549

3955

1.46

13.74

2.9

2.5

2.30

2.34

g/l

1.04

519

3662

Mixed disorders of conduct and emotions, excluding more controls

124

603

2.20

13.71

2.6

2.2

2.59

2.52

g/l

0.83

114

565

Nosocomial condition (hospital)

247

3.33

13.65

3.0

2.1

2.31

2.32

g/l

0.07

222

Ventricular septal defect, a heart condition

169

928

2.01

13.62

3.4

2.6

2.48

2.47

g/l

0.12

161

863

Other maternal disorders predominantly related to pregnancy

3520

19324

1.16

13.62

2.3

2.2

2.50

2.45

g/l

5.36

3225

17920

Sequelae of injuries of neck and trunk

216

1278

1.85

13.62

2.1

2.4

2.34

2.32

g/l

0.11

202

1203

Striae atrophicae

406

2.62

13.61

2.6

2.1

2.48

2.43

g/l

0.40

378

Hypothyroidism due to medicaments and other exogenous substances

101

467

2.53

13.58

2.7

2.1

2.36

2.34

g/l

0.13

427

Bruxism

137

704

2.16

13.56

2.8

2.2

2.50

2.42

g/l

1.11

128

652

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

133

680

2.21

13.54

2.4

2.3

2.19

2.26

g/l

0.61

125

626

Other and unspecified epidermal thickening

198

1147

1.90

13.53

4.2

2.2

2.28

2.36

g/l

1.12

189

1061

Cluster headache, wide,, including avohilmo

333

2185

1.62

13.50

2.3

2.39

g/l

0.05

314

2040

Intracranial and intraspinal abscess and granuloma

105

496

2.49

13.48

3.0

2.2

2.17

2.33

g/l

1.48

458

Other diseases of peritoneum

316

2060

1.65

13.47

2.8

2.3

2.37

2.34

g/l

0.56

294

1899

Dislocation, sprain and strain of joint and ligaments of hip

273

1727

1.72

13.37

2.7

2.4

2.26

2.32

g/l

0.88

252

1590

Ectropion of eyelid

325

2145

1.64

13.28

2.5

2.18

2.22

g/l

0.75

295

1946

Intentional self-harm by sharp object

166

911

1.97

13.25

2.3

2.2

2.53

2.46

g/l

0.75

145

834

Chondropathies

978

7689

1.32

13.25

2.3

2.5

2.38

2.37

g/l

0.25

891

7162

Sequelae of injuries of head

349

2327

1.60

13.24

2.5

2.32

g/l

0.02

314

2163

Congenital malformations of pulmonary and tricuspid valves

278

3.03

13.19

4.8

2.8

2.48

2.52

g/l

0.23

260

Alcohol abuse counselling and surveillance

127

644

2.21

13.16

2.1

2.5

2.33

2.36

g/l

0.18

119

603

Anogenital herpesviral [herpes simplex] infection

631

4665

1.40

13.16

2.2

2.45

2.46

g/l

0.25

583

4310

Other and specified injuries of hip and thigh

175

988

1.96

13.14

3.3

2.3

2.26

2.33

g/l

0.81

162

910

Erectile dysfunction

601

4453

1.43

13.14

3.9

2.8

2.23

2.21

g/l

0.38

570

4136

Chronic iridocyclitis

338

2247

1.61

13.07

2.4

2.37

2.35

g/l

0.20

308

2082

Other prurigo

101

475

2.49

13.06

3.9

2.1

2.31

2.34

g/l

0.16

431

Scleritis and episcleritis

387

2640

1.55

13.05

2.7

2.3

2.36

2.38

g/l

0.42

366

2463

Schizoaffective disorder

465

3281

1.49

12.99

1.9

2.4

2.43

2.39

g/l

0.82

416

3053

Diffuse brain injury

232

1407

1.76

12.97

2.2

2.3

2.32

2.29

g/l

0.29

213

1310

Other disorders of iris and ciliary body

207

1231

1.85

12.95

4.3

2.5

2.17

2.32

g/l

3.33

189

1140

Oxicams

1849

8778

1.23

12.94

2.2

3.2

2.34

2.25

g/l

8.64

1700

8150

136

703

2.09

12.94

2.6

1.9

2.38

2.50

g/l

1.49

121

651

Cystic fibrosis, other manifestations/unspecified

7.51

12.92

5.1

2.2

2.50

g/l

0.01

Other infective otitis externa

399

2749

1.54

12.90

2.9

2.4

2.30

2.34

g/l

0.61

367

2545

Haemorrhagic disorder due to circulating anticoagulants

128

665

2.25

12.88

3.7

2.4

2.20

2.26

g/l

0.45

115

609

Malignant neoplasm of other connective and soft tissue

174

985

1.95

12.87

2.2

2.4

2.13

2.29

g/l

2.84

164

910

Other specified/unspecified hearing loss

590

4355

1.42

12.86

2.7

2.5

2.27

2.28

g/l

0.38

556

4019

Rheumatic fever incl heart disease

230

1407

1.77

12.80

4.2

2.4

2.33

2.28

g/l

0.68

214

1295

Poisoning by narcotics and psychodysleptics [hallucinogens]

111

538

2.28

12.77

2.1

2.3

2.47

2.39

g/l

0.63

100

491

Vascular dementia (mixed)

165

930

2.01

12.74

2.2

2.6

2.20

2.23

g/l

0.33

149

852

Schizophrenia

979

7730

1.31

12.72

2.0

2.5

2.42

2.36

g/l

1.97

876

7246

Other otitis externa (chronic)

435

3055

1.51

12.71

3.0

2.4

2.39

2.34

g/l

1.09

389

2826

Dysplasia of cervi uteri

1409

8336

1.25

12.65

2.4

2.2

2.43

g/l

0.13

1279

7682

Open wound of abdomen, lower back and pelvis

214

1287

1.80

12.62

2.9

2.4

2.38

2.34

g/l

0.34

195

1195

Other mental disorders due to brain damage and dysfunction and to physical disease

845

6592

1.34

12.59

2.6

2.5

2.28

g/l

0.11

756

6069

Other specified/unspecified dorsopathies

239

1480

1.74

12.56

2.4

2.3

2.36

2.33

g/l

0.33

224

1364

Pre-eclampsia

1179

9523

1.27

12.54

2.9

2.2

2.45

2.46

g/l

0.17

1090

8827

Trigeminal neuralgia

376

2574

1.54

12.48

2.2

2.3

2.39

2.34

g/l

1.14

342

2382

Thyroiditis

452

3206

1.48

12.42

2.5

2.3

2.41

2.39

g/l

0.46

411

2973

Ganglion

1311

10716

1.25

12.42

2.3

2.44

2.38

g/l

3.78

1207

9898

Central retinal artery occlusion

183

1070

1.91

12.41

3.8

2.5

2.22

2.23

g/l

0.08

176

974

Hypersomnia

111

549

2.29

12.40

2.1

2.3

2.44

2.38

g/l

0.55

101

508

Mental retardation, excluding more controls

222

1308

1.76

12.40

3.2

2.5

2.43

2.42

g/l

0.12

208

1239

Hemiplegia

344

2323

1.57

12.30

2.8

2.5

2.32

2.31

g/l

0.04

310

2143

Toxic effects of substances chiefly nonmedicinal as to source

718

5479

1.36

12.28

2.4

2.5

2.36

g/l

0.08

659

5103

Pemphigoid

218

1341

1.80

12.24

3.0

2.5

2.24

2.27

g/l

0.35

206

1230

Carcinoma in situ of skin of lower limb, including hip

181

1065

1.93

12.21

3.6

2.3

2.24

2.30

g/l

0.69

164

968

Benign neoplasm: Skin of trunk

287

1872

1.65

12.21

3.5

2.4

2.34

2.33

g/l

0.03

262

1734

Acute lymphadenitis

364

2485

1.54

12.18

2.9

2.3

2.36

2.40

g/l

0.56

339

2305

Superficial injury of shoulder and upper arm

737

5657

1.35

12.13

2.4

2.5

2.38

2.34

g/l

0.95

659

5238

Haemophagocytic lymphohistiocytosis

7.95

12.11

3.5

3.0

1.89

2.43

g/l

2.72

Impingement syndrome of shoulder

1548

12910

1.23

12.10

2.6

2.4

2.37

2.32

g/l

3.25

1448

11978

Other disorders of pigmentation

298

1965

1.62

12.06

2.8

2.2

2.34

2.35

g/l

0.14

271

1813

Melanocytic naevi, other sites/unspecified

512

3729

1.44

12.06

4.5

2.4

2.34

2.36

g/l

0.34

494

3470

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

450

3199

1.47

12.06

2.9

2.1

2.50

2.49

g/l

0.16

421

2964

Other abnormal findings in urine

135

727

2.11

12.04

3.1

2.4

2.29

g/l

0.04

130

670

Other disorders of cornea

630

4745

1.39

11.98

2.8

2.5

2.31

2.33

g/l

0.56

585

4396

Other specified/unspecified spondylopathies

185

1090

1.86

11.96

2.9

2.5

2.20

2.28

g/l

1.05

171

1004

Hyperprolactinaemia

222

1368

1.74

11.84

2.6

2.1

2.47

2.45

g/l

0.26

197

1274

Marginal zone B-cell lymphoma

350

2.67

11.83

2.3

2.1

2.21

2.29

g/l

0.61

321

Entropion and trichiasis of eyelid

617

4654

1.39

11.81

2.7

2.5

2.23

2.25

g/l

0.55

574

4261

Malignant neoplasm of thyroid gland, including Hilmo

448

3199

1.47

11.80

2.7

2.4

2.37

2.39

g/l

0.26

415

2959

Familial erythrocytosis

195

3.41

11.79

2.2

2.1

2.71

2.28

g/l

5.64

178

Delivery

2190

13459

0.84

11.79

2.1

2.4

2.43

2.42

g/l

0.58

2006

12335

Dependent personality disorder

144

791

2.01

11.77

3.0

2.3

2.48

2.36

g/l

1.51

128

738

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

151

843

1.98

11.75

2.5

2.3

2.22

2.31

g/l

0.96

137

776

Scar conditions and fibrosis of skin

261

1677

1.66

11.75

2.7

2.1

2.38

2.41

g/l

0.46

237

1562

Malignant neoplasm of breast, including Hilmo

2643

14859

1.17

11.74

2.0

2.3

2.40

2.44

g/l

2.25

2438

13564

Heterophoria

493

3580

1.44

11.74

2.6

2.3

2.46

2.40

g/l

1.17

452

3327

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

5.37

11.73

3.7

1.9

2.47

g/l

0.01

Malignant neoplasm of breast, HER2-negative, including Hilmo

2642

14859

1.17

11.69

2.0

2.3

2.40

2.44

g/l

2.26

2437

13564

Colitis due to radiation

100

494

2.40

11.66

3.1

2.5

2.22

g/l

0.03

450

Other ill-defined and unspecified causes of mortality

572

4279

1.41

11.65

3.3

2.5

2.21

2.25

g/l

0.78

520

3939

Injury of intra-abdominal organs

175

1021

1.86

11.61

3.1

2.4

2.27

2.36

g/l

0.94

157

947

Endometriosis ASRM stages 1,2

1050

8452

1.28

11.61

2.1

2.2

2.49

2.46

g/l

0.94

962

7830

Combined immunodeficiencies

430

2.45

11.60

3.0

2.2

2.40

2.33

g/l

0.49

396

Benign neoplasm: Kidney

251

1613

1.69

11.60

3.6

2.5

2.34

2.31

g/l

0.31

238

1498

Paraplegia, diplegia of upper limbs

166

959

1.91

11.60

2.7

2.4

2.26

2.31

g/l

0.50

152

901

Anogenital herpesviral [herpes simplex] infection

376

2607

1.51

11.59

2.4

2.2

2.43

2.45

g/l

0.39

346

2411

Cauda equina syndrome

107

538

2.27

11.56

1.9

2.2

2.37

g/l

0.02

501

Acute myeloid leukaemia

384

2.52

11.54

1.5

2.3

2.03

2.28

g/l

4.43

351

Acute myeloid leukaemia, including Hilmo

384

2.52

11.54

1.5

2.3

2.03

2.28

g/l

4.43

351

Acute myeloid leukaemia, helper endpoint

384

2.52

11.54

1.5

2.3

2.03

2.28

g/l

4.43

351

Vascular dementia

715

5320

1.35

11.50

2.3

2.5

2.19

2.22

g/l

0.86

636

4822

L02BB Anti-androgens

711

5503

1.36

11.47

2.1

2.7

2.13

2.19

g/l

2.09

663

5041

Need for immunization against other single infectious diseases

8.40

11.46

13.0

2.0

1.98

2.43

g/l

2.40

Other specified and unspecified disorders of eye and adnexa

258

1667

1.66

11.46

3.0

2.4

2.21

2.34

g/l

3.42

244

1541

Focal epilepsy, strict definition

1330

11005

1.24

11.40

2.6

2.30

2.33

g/l

1.48

1220

10178

Sequelae of other and unspecified infectious and parasitic diseases

339

2316

1.55

11.40

3.0

2.4

2.34

2.38

g/l

0.68

314

2158

Blood alcohol or alcohol intoxication level

162

928

1.89

11.40

2.6

2.5

2.38

2.36

g/l

0.17

146

864

Thyrotropin deficiency

399

2.46

11.36

2.7

2.3

2.38

2.42

g/l

0.27

370

Retinal haemorrhage

190

1148

1.82

11.33

4.2

2.4

2.23

2.30

g/l

0.93

177

1050

Radial styloid tenosynovitis [de Quervain]

334

2274

1.54

11.31

2.4

2.3

2.47

2.40

g/l

1.60

301

2108

Behavioural disorders, excluding more controls

113

572

2.11

11.24

2.6

2.3

2.55

2.48

g/l

0.53

537

Tooth eruption problems

800

6090

1.32

11.24

3.0

2.3

2.50

2.51

g/l

0.16

758

5644

Panniculitis affecting regions of neck and back

239

1520

1.68

11.23

2.7

2.4

2.38

2.34

g/l

0.40

223

1408

Impacted cerumen

697

5386

1.35

11.21

2.8

2.5

2.34

2.29

g/l

1.58

587

4962

Contusion of other and unspecified parts of foot

309

2079

1.57

11.14

3.0

2.3

2.45

2.43

g/l

0.28

290

1920

Chorioretinal inflammation

196

1195

1.78

11.10

2.9

2.3

2.29

2.34

g/l

0.62

176

1110

Previous suicide attempt

363

2.50

11.07

1.8

2.0

2.37

2.42

g/l

0.28

329

Granulomatous disorders of skin and subcutaneous tissue

178

1059

1.83

11.04

3.8

2.1

2.34

2.40

g/l

0.77

168

973

Car occupant injured in noncollision transport accident

235

1496

1.68

11.04

2.8

2.4

2.37

g/l

0.07

217

1380

Injury of other and unspecified intrathoracic organs

430

3094

1.47

11.04

2.6

2.24

2.30

g/l

1.17

400

2870

Malignant neoplasm of ovary

291

1945

1.59

11.00

1.9

2.4

2.19

2.40

g/l

7.10

274

1776

Other bursitis of hip

150

853

1.93

10.99

3.0

2.2

2.36

2.34

g/l

0.18

141

781

Malignant neoplasm of tongue, including Hilmo

179

1070

1.82

10.97

2.3

2.4

2.23

2.31

g/l

0.93

163

988

Lesion of plantar nerve

389

2754

1.49

10.96

2.3

2.4

2.40

2.34

g/l

1.21

364

2554

Lateral epicondylitis

780

6105

1.32

10.94

2.1

2.4

2.47

2.36

g/l

6.61

733

5701

Other bullous disorders

195

1195

1.78

10.93

3.0

2.5

2.34

2.33

g/l

0.07

183

1111

Atrial septal defect, secundum type

197

1205

1.77

10.89

3.3

2.7

2.48

2.44

g/l

0.43

186

1132

Follow-up care involving plastic surgery

234

1493

1.67

10.84

2.3

1.8

2.40

2.39

g/l

0.02

195

1374

Malignant neoplasm of breast

2576

14655

1.17

10.82

1.9

2.3

2.40

2.43

g/l

1.82

2371

13372

Other erythematous conditions

238

1532

1.67

10.82

2.8

2.4

2.37

2.32

g/l

0.65

221

1419

Viral haemorrhagic fevers, not elsewhere classified/unspecified

1040

8443

1.27

10.81

2.7

2.6

2.29

2.34

g/l

2.05

997

7863

Achilles tendinitis

641

4906

1.36

10.80

2.7

2.5

2.39

2.32

g/l

2.74

599

4576

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

477

3500

1.43

10.76

2.9

2.4

2.24

2.27

g/l

0.46

440

3209

Asthma mixed form (mode)

308

2082

1.55

10.74

2.6

2.1

2.44

2.34

g/l

2.47

293

1914

189

1160

1.80

10.73

2.6

2.5

2.14

2.24

g/l

1.59

174

1066

Certolizumab pegol

126

683

2.03

10.72

1.8

2.1

2.39

2.47

g/l

0.76

119

635

Unspecified event, undetermined intent

172

1022

1.82

10.72

3.0

2.5

2.32

2.36

g/l

0.51

164

951

Arthropod-borne viral fevers and viral haemorrhagic fevers

1176

9679

1.25

10.70

2.7

2.6

2.31

2.34

g/l

1.18

1125

9001

All dysplastic lesions of the vulva

271

1800

1.60

10.61

3.6

2.2

2.31

2.44

g/l

3.80

247

1666

Bullous pemphigoid

175

1059

1.84

10.60

3.0

2.5

2.25

g/l

0.08

164

970

Examination and encounter for administrative purposes

295

1989

1.56

10.59

2.7

2.3

2.39

2.27

g/l

3.26

284

1817

Benign neoplasm: Appendix

100

511

2.28

10.59

2.4

2.42

2.32

g/l

0.88

466

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

3983

28348

1.13

10.55

2.5

2.4

2.39

2.40

g/l

0.12

3653

26230

Other salmonella infections

244

1586

1.64

10.55

2.7

2.2

2.28

2.36

g/l

1.10

222

1472

Papilloedema, unspecified

159

931

1.86

10.51

3.9

2.3

2.31

2.39

g/l

0.95

149

865

Burns and corrosions

852

6783

1.30

10.50

2.6

2.5

2.36

g/l

0.07

796

6335

Use of antiglaucoma preparations and miotics

582

4435

1.38

10.45

3.4

2.4

2.19

2.28

g/l

3.35

528

4054

164

967

1.83

10.45

3.1

2.4

2.52

2.40

g/l

1.77

149

898

Lichen simplex chronicus

231

1489

1.67

10.44

3.7

2.4

2.33

2.32

g/l

0.06

219

1374

Malignant melanoma of skin, including Hilmo

919

7397

1.28

10.39

2.7

2.6

2.26

2.31

g/l

1.82

856

6768

Malignant neoplasm of breast, HER2-negative

2537

14515

1.16

10.30

1.9

2.3

2.40

2.43

g/l

1.85

2335

13242

Other and unspecified erythematous conditions

214

1361

1.70

10.28

2.8

2.4

2.38

2.33

g/l

0.63

199

1262

Papillary adenocarcinoma of thyroid gland

299

2036

1.55

10.27

2.9

2.4

2.37

2.38

g/l

0.08

277

1895

Tongue abnormality

404

2919

1.46

10.25

2.6

2.5

2.35

2.33

g/l

0.26

370

2686

Intestinal helminthiases, other/unspecified

134

4.09

10.24

2.3

2.5

2.51

2.35

g/l

0.78

117

Diabetes insipidus

345

2.51

10.22

2.7

2.1

2.38

2.37

g/l

0.06

319

Herpesviral keratitis and keratoconjunctivitis

289

1963

1.57

10.22

3.0

2.4

2.36

2.32

g/l

0.67

269

1817

Other congenital malformations of skin

252

1661

1.61

10.20

2.3

2.4

2.41

2.39

g/l

0.14

235

1534

Ill-defined and unknown causes of mortality

621

4792

1.36

10.19

3.2

2.5

2.21

2.25

g/l

0.85

564

4416

Colorectal neuroendocrine tumor and carcinoma

498

2.20

10.17

2.3

2.45

2.36

g/l

0.65

460

Female infertility, cervical, vaginal, other or unspecified origin

1540

8426

1.21

10.14

2.1

2.2

2.51

2.45

g/l

4.89

1411

7776

Corneal scars and opacities

196

1228

1.74

10.12

4.0

2.3

2.24

2.32

g/l

1.21

178

1141

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

231

1497

1.64

10.10

2.7

2.3

2.38

2.39

g/l

0.05

220

1386

Hypothermia

143

826

1.92

10.10

3.2

2.4

2.23

2.29

g/l

0.47

130

764

Open wound of shoulder and upper arm

142

815

1.90

10.07

3.3

2.4

2.34

2.33

g/l

0.08

132

756

Embedded teeth, including avohilmo

515

3852

1.38

10.05

2.8

2.2

2.46

2.48

g/l

0.28

486

3557

Malignant neoplasm of thyroid gland

388

2783

1.46

10.05

2.8

2.4

2.37

2.38

g/l

0.18

359

2576

Burns and corrosions of external body surface, specified by site

670

5212

1.33

10.04

2.7

2.5

2.36

g/l

0.05

624

4849

Glaucoma suspect

2562

22592

1.16

10.02

2.8

2.5

2.31

g/l

0.22

2337

20790

Other salmonella infections

273

1837

1.57

9.98

2.7

2.2

2.30

2.37

g/l

1.11

248

1701

Other neurotic disorders

311

2152

1.53

9.93

2.5

2.4

2.40

2.31

g/l

1.85

288

1985

Abnormal findings on diagnostic imaging of central nervous system

301

2069

1.54

9.93

2.6

2.3

2.32

2.37

g/l

0.80

284

1916

Viral encephalitis, not elsewhere classified/unspecified

147

859

1.88

9.90

3.1

2.4

2.24

2.32

g/l

0.75

130

795

Acute appendicitis

4939

42127

1.11

9.88

2.5

2.39

2.36

g/l

3.44

4604

39058

Sequelae of injuries of upper limb

593

4551

1.35

9.88

2.6

2.5

2.41

2.34

g/l

1.77

551

4238

Other secondary coxarthrosis

235

1544

1.64

9.84

3.1

2.4

2.21

2.32

g/l

2.15

221

1431

Oligomenorrhoea

211

1343

1.66

9.83

2.5

2.2

2.53

2.45

g/l

1.14

195

1228

Appendicitis, broad definition

5289

43798

1.10

9.82

2.5

2.39

2.36

g/l

3.48

4925

40577

Acute appendicitis, no complications

3760

33728

1.12

9.79

2.5

2.40

2.37

g/l

2.30

3497

31347

Localized skin eruption due to drugs and medicaments

488

2.22

9.77

2.6

2.1

2.44

2.39

g/l

0.31

450

Pleural plaque

713

5639

1.32

9.76

2.5

2.24

2.22

g/l

0.41

622

5160

Muscle strain

203

1286

1.68

9.74

3.0

2.4

2.38

2.36

g/l

0.22

195

1183

Diseases of appendix

5334

44051

1.10

9.74

2.5

2.39

2.36

g/l

3.43

4965

40806

Viral agents as the cause of diseases classified to other chapters

159

954

1.82

9.73

3.0

2.4

2.34

2.37

g/l

0.26

147

886

Perioral dermatitis

143

830

1.87

9.72

2.5

2.1

2.40

2.43

g/l

0.31

129

760

Benign neoplasm: Anus and anal canal

204

1305

1.70

9.70

2.6

2.5

2.29

2.30

g/l

0.08

188

1211

Glucosamine medication

3534

25356

1.13

9.69

2.2

2.5

2.33

2.29

g/l

3.16

3167

23278

Hordeolum and other deep inflammation of eyelid

362

2586

1.47

9.66

2.7

2.4

2.32

2.38

g/l

1.35

340

2393

Malignant neoplasm of corpus uteri

495

3722

1.39

9.65

2.3

2.4

2.28

2.38

g/l

3.45

445

3353

Other disorders of the genitourinary system

821

6595

1.29

9.61

2.7

2.4

2.38

2.34

g/l

1.36

761

6056

Malignant neoplasm of corpus uteri, including Hilmo

566

4341

1.36

9.57

2.2

2.3

2.28

2.39

g/l

3.64

508

3923

Other specified/unspecified disorders of bone/cartilage

187

1173

1.72

9.54

2.7

2.3

2.27

2.36

g/l

1.26

177

1098

Lichen ruber planus, wide definition including periferal and oral lichen planus

1408

11931

1.21

9.44

2.3

2.5

2.39

2.34

g/l

2.15

1297

11042

Maltreatment syndromes

297

2050

1.52

9.43

2.1

2.3

2.42

2.43

g/l

0.07

269

1901

Erythema multiforme

158

953

1.80

9.43

2.6

2.4

2.29

2.35

g/l

0.75

145

886

Recurrent dislocation of patella

282

1924

1.53

9.42

2.6

2.2

2.50

2.48

g/l

0.22

254

1776

Impetigo

268

1817

1.55

9.41

3.0

2.4

2.38

2.43

g/l

0.96

254

1692

Behçet disease

100

4.10

9.40

1.8

2.54

2.45

g/l

0.37

Inflammatory disorders of male genital organs, not elsewhere classified

101

535

2.10

9.37

3.4

2.8

2.22

2.24

g/l

0.17

499

Malignant neoplasm of renal pelvis, including Hilmo

481

2.19

9.36

3.8

2.3

2.06

2.22

g/l

2.00

442

Tinnitus

1534

13099

1.20

9.35

2.3

2.5

2.35

2.33

g/l

0.43

1386

12170

Female infertility, associated with anovulation

400

2905

1.42

9.35

1.8

2.1

2.58

2.52

g/l

1.23

366

2682

Disorders of myoneural junction and muscle in diseases classified elsewhere

327

2.50

9.34

4.0

2.2

2.13

2.40

g/l

2.71

301

Hypertrophy of breast

1017

8361

1.25

9.33

2.0

2.3

2.51

2.45

g/l

3.53

934

7720

Malignant neoplasm of oral cavity

212

1375

1.65

9.32

2.3

2.5

2.16

2.30

g/l

2.77

195

1270

Anomalies of dental arch relationship, including avohilmo

1147

8585

1.23

9.31

2.6

2.4

2.51

2.44

g/l

4.26

1064

8011

Any dementia, excluding more controls

2696

16450

1.15

9.30

2.2

2.5

2.19

2.26

g/l

7.28

2365

15129

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

365

2639

1.46

9.27

2.2

2.4

2.43

2.35

g/l

1.75

330

2441

Inflammatory diseases of prostate (prostatitis)

845

6835

1.28

9.27

2.5

2.6

2.31

2.24

g/l

3.21

765

6367

Paralytic strabismus

463

3474

1.40

9.25

3.1

2.5

2.23

2.29

g/l

1.51

428

3209

Unspecified chronic bronchitis

241

1608

1.59

9.24

3.1

2.4

2.35

2.26

g/l

1.85

219

1468

Episcleritis

318

2239

1.49

9.24

2.7

2.3

2.37

2.39

g/l

0.27

299

2092

Malignant melanoma of skin

679

5355

1.31

9.23

2.6

2.25

2.31

g/l

1.88

632

4899

Disorder of external ear, unspecified

221

1453

1.63

9.23

2.9

2.4

2.38

2.31

g/l

0.90

200

1348

Nontoxic multinodular goitre

1252

10523

1.22

9.22

2.6

2.3

2.38

2.34

g/l

1.24

1166

9666

Erythema nodosum

196

1255

1.68

9.17

3.2

2.2

2.39

2.37

g/l

0.21

180

1154

Localized scleroderma [morphea]

106

575

2.05

9.17

2.4

1.9

2.39

2.42

g/l

0.16

527

Other congenital malformations of skin

476

3581

1.38

9.16

2.3

2.5

2.37

2.40

g/l

0.44

447

3325

Ulcer of vagina/vulva

165

1012

1.75

9.16

2.3

2.2

2.40

2.44

g/l

0.43

150

936

Nephropathy induced by other drugs, medicaments and biological substances

5.49

9.13

9.4

2.3

2.05

2.34

g/l

1.83

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

223

1466

1.61

9.11

4.0

2.3

2.45

2.48

g/l

0.25

209

1364

Other acute skin changes due to ultraviolet radiation

230

1530

1.61

9.07

2.8

2.4

2.34

2.32

g/l

0.21

215

1413

Cryoglobulinemia

5.52

9.07

10.1

1.9

2.02

2.42

g/l

2.97

Retinal detachment with retinal break

854

6935

1.27

9.07

3.4

2.5

2.22

2.29

g/l

2.95

798

6415

Dermatopolymyositis, unspecified

211

2.93

9.05

3.1

2.0

2.28

2.35

g/l

0.41

191

Single delivery by forceps and vacuum extractor

594

4609

0.76

9.02

1.7

2.5

2.57

2.51

g/l

1.47

545

4281

Other leukaemias of specified cell type

4.23

9.00

5.5

2.3

2.09

2.39

g/l

1.33

Lichen planus, including avohilmo

1200

10079

1.22

8.96

2.3

2.5

2.38

2.34

g/l

1.66

1109

9324

Varicella [chickenpox]

279

1928

1.52

8.94

4.5

2.5

2.33

2.39

g/l

1.01

264

1807

Foreign body in alimentary tract

356

2578

1.45

8.92

2.3

2.5

2.39

2.33

g/l

1.14

319

2383

Pediculosis, acariasis and other infestations

361

2615

1.45

8.91

3.1

2.4

2.34

2.36

g/l

0.17

340

2439

Delivery, wide proxy

1879

11495

0.85

8.91

2.1

2.4

2.43

2.42

g/l

0.26

1709

10525

Other inflammation of vagina/vulva

214

1402

1.61

8.89

2.1

2.55

2.47

g/l

1.17

195

1308

Lichen planus

813

6581

1.28

8.89

2.5

2.35

2.33

g/l

0.72

751

6073

Macular hole

386

2844

1.44

8.85

3.0

2.6

2.28

g/l

0.01

352

2626

Other and unspecified injuries of ankle and foot

259

1769

1.54

8.82

2.7

2.2

2.42

2.41

g/l

0.04

233

1629

Other and unspecified nail disorders

148

894

1.80

8.81

4.3

2.2

2.31

2.35

g/l

0.37

134

836

Alzheimer’s disease (Early onset)

144

2343

0.59

8.80

1.9

2.4

2.19

2.27

g/l

0.91

115

2136

Leiomyoma of uterus

4160

21406

1.12

8.80

2.2

2.3

2.44

2.41

g/l

2.27

3792

19698

Malignant neoplasm of other and unspecified parts of tongue

533

2.06

8.77

2.6

2.2

2.21

2.31

g/l

0.85

490

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

463

2.15

8.76

3.9

2.1

2.30

2.38

g/l

0.56

431

Ethmoidectomy

786

6343

1.28

8.74

2.2

2.5

2.41

2.35

g/l

2.46

711

5922

Malignant neoplasm of cervix uteri, including Hilmo

160

987

1.74

8.72

3.2

2.2

2.20

2.44

g/l

4.32

141

910

Injuries involving multiple body regions

241

1632

1.56

8.66

2.9

2.3

2.35

g/l

0.01

225

1504

Malignant neoplasm of breast, ER-positive, including Hilmo

1929

12953

1.17

8.64

2.0

2.3

2.42

2.43

g/l

0.04

1761

11810

Other disorders of bone density and structure

166

1039

1.71

8.52

2.5

2.2

2.41

2.38

g/l

0.32

156

963

Alzheimer’s disease (Atypical or mixed), excluding more controls

604

3765

1.32

8.52

2.2

2.4

2.19

2.23

g/l

0.69

503

3456

Encephalitis

194

1263

1.64

8.47

3.0

2.4

2.33

2.34

g/l

0.06

182

1169

LSIL lesion of the vulva

181

1159

1.67

8.47

3.4

2.1

2.37

2.43

g/l

1.04

169

1079

Varicose veins of other sites

396

2938

1.41

8.45

2.9

2.5

2.37

2.32

g/l

1.05

358

2743

Malignant neoplasm of tongue

127

745

1.86

8.44

2.5

2.4

2.20

2.30

g/l

1.00

116

684

Human immunodeficiency virus [HIV] disease

122

707

1.87

8.42

1.6

2.5

2.49

2.35

g/l

1.78

117

665

Other specified and unspecified retinal disorders

238

1623

1.57

8.41

4.0

2.4

2.26

2.31

g/l

0.59

217

1504

Wide developmental disorders

185

1183

1.64

8.40

1.9

2.6

2.57

2.53

g/l

0.48

164

1103

Family history of certain disabilities and chronic diseases leading to disablement

262

1807

1.51

8.38

2.6

1.9

2.52

2.47

g/l

0.93

248

1663

Other protozoal intestinal diseases

103

571

1.98

8.32

2.6

2.1

2.33

2.41

g/l

0.67

523

Carcinoma in situ of other and unspecified sites

265

1858

1.54

8.31

2.9

2.7

2.31

2.23

g/l

1.40

240

1728

Use of donepezil

1118

12672

0.82

8.31

1.9

2.5

2.22

2.24

g/l

0.52

952

11483

Orthopaedic devices associated with adverse incidents

144

886

1.81

8.30

2.4

2.3

2.30

2.33

g/l

0.21

120

820

Anti-inflammatory and antirheumatic products, non-steroids

2276

10059

1.15

8.27

2.4

3.2

2.33

2.29

g/l

2.65

2081

9359

Vascular dementia (subcortical)

253

1758

1.55

8.27

2.1

2.5

2.21

2.25

g/l

0.46

235

1612

Other diseases of spinal cord

199

1311

1.62

8.26

2.7

2.5

2.27

2.32

g/l

0.49

187

1217

Non-small cell lung cancer, adenocarcinoma

382

2835

1.41

8.24

2.1

2.6

2.15

2.27

g/l

3.30

360

2591

Other haemoglobinopathies

4.61

8.23

3.4

1.9

2.38

2.42

g/l

0.12

Other encephalitis

184

1193

1.65

8.22

3.1

2.4

2.32

2.35

g/l

0.26

173

1103

Malignant neoplasm, without specification of site, including Hilmo

292

2069

1.48

8.20

2.1

2.4

2.14

2.27

g/l

2.64

266

1890

Other congenital malformations of peripheral vascular system

538

2.01

8.19

3.5

2.3

2.51

2.42

g/l

0.92

498

Propionic acid derivatives

2273

10057

1.15

8.14

2.3

3.2

2.34

2.29

g/l

4.47

2075

9357

Viral agents as the cause of diseases classified to other chapters

170

1086

1.68

8.12

2.9

2.5

2.36

2.38

g/l

0.16

156

1013

Bitten or struck by other mammals

670

5355

1.29

8.11

2.7

2.3

2.40

2.41

g/l

0.13

613

4965

Tuberculosis, IBD comorbidity

479

3684

1.35

8.06

2.9

2.4

2.21

2.27

g/l

1.63

441

3357

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

403

2966

1.39

8.06

3.3

2.3

2.49

2.48

g/l

0.19

375

2752

Factitial dermatitis

191

2.86

8.04

3.9

1.9

2.41

2.40

g/l

0.02

175

Respiratory tuberculosis, bacteriologically and histologically confirmed

140

856

1.78

8.03

3.2

2.5

2.15

2.26

g/l

1.36

128

781

Benign neoplasm: Tongue

188

1234

1.64

8.03

2.7

2.3

2.32

g/l

0.01

174

1152

Prepatellar bursitis

283

2006

1.48

8.03

2.6

2.27

2.30

g/l

0.28

262

1864

Rheumatic valve diseases

161

1019

1.70

8.00

4.2

2.3

2.29

2.27

g/l

0.12

147

935

Blindness, monocular

389

2.23

7.99

4.4

2.1

2.25

2.34

g/l

0.62

352

Other mycoses, not elsewhere classified/unspecified

121

714

1.86

7.97

3.2

2.2

2.24

2.36

g/l

1.40

110

666

Other protozoal intestinal diseases

136

823

1.77

7.97

2.5

2.1

2.30

2.40

g/l

1.25

126

757

Persistent delusional disorders

465

3564

1.36

7.97

2.2

2.5

2.37

2.33

g/l

0.76

412

3289

Haemangioma, any site

521

4058

1.33

7.93

2.6

2.5

2.41

2.35

g/l

1.46

486

3763

Haemangioma and lymphangioma, any site

557

4375

1.32

7.92

2.6

2.5

2.41

2.35

g/l

1.63

518

4059

Childhood allergy (age < 16)

731

4844

1.27

7.92

2.6

2.3

2.56

g/l

0.17

678

4482

Adult respiratory distress syndrome

102

576

1.98

7.92

4.8

2.4

2.13

2.29

g/l

1.87

533

Thyroiditis, unspecified

102

572

1.95

7.90

2.5

2.1

2.36

2.37

g/l

0.08

527

Cerebral palsy

106

600

1.91

7.90

3.2

2.5

2.48

2.45

g/l

0.16

563

Scabies

272

1918

1.49

7.89

3.1

2.4

2.40

2.36

g/l

0.37

253

1790

Endometriosis ASRM stages 3,4

1387

11913

1.19

7.88

2.1

2.2

2.46

2.43

g/l

1.50

1265

10975

Delayed milestone in childhood

123

654

1.84

7.86

4.9

3.3

2.50

2.59

g/l

0.90

118

629

Respiratory tuberculosis, confirmed

136

831

1.78

7.85

3.2

2.5

2.14

2.26

g/l

1.53

124

758

Infective bursitis

188

1238

1.62

7.84

3.7

2.5

2.23

2.30

g/l

0.94

173

1159

Simple and mucopurulent chronic bronchitis

275

1949

1.49

7.82

3.0

2.5

2.33

2.27

g/l

1.14

253

1782

Urethritis and urethral syndrome

143

883

1.74

7.79

2.4

2.2

2.45

2.38

g/l

0.72

135

811

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

163

1036

1.67

7.78

2.7

2.3

2.45

2.42

g/l

0.28

153

962

Malignant neoplasm of breast, HER-positive

1877

12821

1.16

7.76

2.0

2.3

2.42

2.43

g/l

0.01

1717

11694

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

425

3219

1.36

7.73

2.4

2.3

2.43

2.40

g/l

0.63

396

2994

Specific developmental disorder of motor function

540

1.94

7.71

3.8

3.0

2.58

2.56

g/l

0.15

520

Achalasia of cardia

123

735

1.82

7.70

2.3

2.4

2.37

2.29

g/l

0.86

115

683

Bursitis of shoulder

159

1012

1.68

7.67

2.4

2.3

2.38

2.34

g/l

0.31

148

933

Other specified disorders of muscle

183

1202

1.62

7.66

3.0

2.5

2.32

2.34

g/l

0.23

173

1106

Drug-induced Cushing's syndrome

6.08

7.66

2.6

2.2

2.21

2.47

g/l

1.29

Endometriosis of rectovaginal septum and vagina

454

3490

1.35

7.58

1.8

2.3

2.48

2.38

g/l

3.36

406

3213

Disorders of orbit

271

1930

1.48

7.53

2.5

2.4

2.39

2.37

g/l

0.31

249

1792

FESS (DNB20)

746

6091

1.26

7.51

2.2

2.5

2.41

2.34

g/l

3.03

675

5679

Crossbite

392

2726

1.38

7.49

3.2

2.6

2.53

2.49

g/l

0.78

373

2547

Evidence of alcohol involvement determined by blood alcohol level

101

575

1.92

7.48

2.5

2.42

2.36

g/l

0.44

534

Unspecified visual impairment (binocular)

114

675

1.85

7.47

3.2

2.3

2.28

2.36

g/l

0.86

107

620

Chronic diseases of tonsils and adenoids

5478

32069

1.09

7.44

2.4

2.5

2.45

2.38

g/l

17.15

5123

29752

Benign neoplasm of middle ear and respiratory system

500

3912

1.33

7.43

2.5

2.32

2.30

g/l

0.47

472

3636

Helminthiases

239

1668

1.51

7.41

2.8

2.4

2.46

2.40

g/l

1.12

230

1546

207

2.75

7.40

3.4

2.3

2.31

2.30

g/l

0.03

185

Other fall from one level to another

1418

12257

1.18

7.40

2.5

2.6

2.36

2.35

g/l

0.21

1323

11385

Focal epilepsy, mode (most common among epilepsy diagnosis)

1213

10368

1.20

7.39

2.5

2.6

2.29

2.34

g/l

2.10

1117

9592

Iridocyclitis in diseases classified elsewhere

134

830

1.75

7.37

2.8

2.3

2.32

2.36

g/l

0.34

122

777

Malignant neoplasm of testis

531

1.93

7.36

3.4

2.4

2.24

2.28

g/l

0.25

494

Other and unspecified nonscarring hair loss

249

2.46

7.35

3.2

2.1

2.21

2.44

g/l

2.05

231

Sexual dysfunction

102

585

1.89

7.35

3.5

2.5

2.27

2.34

g/l

0.69

549

Disorders of optic nerve, not elsewhere classified

149

950

1.71

7.35

4.2

2.4

2.24

2.33

g/l

1.34

141

884

Medial epicondylitis

220

1512

1.53

7.34

2.2

2.4

2.46

2.36

g/l

1.70

205

1410

Pedestrian injured in transport accident

418

3196

1.36

7.33

2.4

2.5

2.37

2.35

g/l

0.33

380

2963

Other and unspecified disorders of pigmentation

263

2.42

7.31

2.6

2.1

2.28

2.41

g/l

0.86

244

Other and unspecified trigeminal disorders

105

609

1.88

7.31

2.4

2.1

2.39

g/l

0.02

566

Marasmic kwashiorkor

108

3.80

7.31

4.4

2.8

2.15

2.48

g/l

1.35

Causalgia

103

593

1.88

7.30

2.9

2.3

2.57

2.41

g/l

1.91

561

Melanocytic naevi of lower limb, including hip

269

1926

1.47

7.27

3.7

2.4

2.30

2.37

g/l

1.27

258

1791

Lichen sclerosus et atrophicus

603

4832

1.29

7.27

2.3

2.2

2.37

2.38

g/l

0.13

551

4432

Excessive earwax

3965

35529

1.10

7.26

2.6

2.5

2.35

2.31

g/l

4.38

3613

32816

Dislocation, sprain and strain of joints and ligaments of thorax

213

1462

1.54

7.26

2.7

2.4

2.39

2.34

g/l

0.50

197

1356

Dislocation of lens

111

657

1.84

7.25

3.6

2.3

2.20

2.26

g/l

0.50

603

Other/unspecified soft tissue disorders related to use, overuse and pressure

172

1128

1.61

7.23

2.5

2.3

2.39

2.36

g/l

0.27

163

1041

Sudden idiopathic hearing loss

645

5221

1.28

7.19

3.3

2.6

2.32

2.30

g/l

0.45

584

4845

Perforation of tympanic membrane

611

4913

1.28

7.16

2.9

2.4

2.39

2.33

g/l

1.43

568

4557

Use of anticholinesterases

2132

18839

0.88

7.15

2.0

2.5

2.23

2.24

g/l

0.59

1848

17171

N06DA Anticholinesterases

2132

18839

0.88

7.15

2.0

2.5

2.23

2.24

g/l

0.59

1848

17171

Hypermetropia

410

3134

1.36

7.13

3.4

2.4

2.43

2.40

g/l

0.44

380

2899

Pyoderma

125

766

1.76

7.11

3.0

2.3

2.32

2.33

g/l

0.07

109

714

Isolated growth hormone deficiency

268

2.40

7.06

4.5

3.6

2.52

2.57

g/l

0.34

257

Hallux rigidus

814

6746

1.24

7.06

2.2

2.4

2.33

2.32

g/l

0.18

728

6228

Other superficial mycoses

136

852

1.71

7.06

3.5

2.4

2.33

2.36

g/l

0.30

129

800

Female infertility, tubal origin

252

1786

1.46

7.02

2.4

2.3

2.44

2.45

g/l

0.10

231

1661

Abnormal findings in secretions and smears from cervix uteri vagina vulva

3000

20531

1.12

7.01

2.4

2.2

2.44

2.46

g/l

0.90

2776

18951

Nonspecific lymphadenitis

333

2478

1.40

6.99

2.4

2.37

2.39

g/l

0.20

304

2315

Malignant neoplasm of other and ill-defined digestive organs

309

2.27

6.98

2.0

2.4

2.12

2.28

g/l

1.36

282

Malignant neoplasm of bone and articular cartilage

350

2.17

6.98

3.5

2.4

2.25

2.33

g/l

0.49

327

Problems related to social environment

184

1236

1.58

6.97

2.7

2.2

2.33

2.35

g/l

0.20

174

1130

Tuberculosis, wide

489

3848

1.32

6.97

2.9

2.5

2.21

2.26

g/l

1.01

449

3508

Autism

134

833

1.69

6.97

1.8

2.3

2.56

2.53

g/l

0.34

120

773

Hypertrophic disorders of skin

325

2412

1.40

6.96

2.6

2.2

2.46

2.42

g/l

0.58

305

2234

Vasomotor rhinitis (mode)

438

3398

1.34

6.96

2.6

2.5

2.37

2.34

g/l

0.47

399

3142

Perineal laceration during delivery

650

6692

0.80

6.96

1.5

2.2

2.60

2.51

g/l

3.86

601

6192

Other drug-induced secondary parkinsonism

417

2.09

6.95

2.0

2.2

2.31

2.35

g/l

0.24

384

Other injuries of spine and trunk, level unspecified

366

2.16

6.94

4.6

2.2

2.33

2.38

g/l

0.22

336

Pyogenic granuloma

118

718

1.78

6.93

2.3

2.2

2.42

2.36

g/l

0.32

113

658

Common variable immunodeficiency with predominant abnormalities of T-cell numbers and function

5.20

6.92

6.9

1.7

2.18

2.46

g/l

1.07

Congenital malformations of trachea and bronchus

410

2.10

6.92

2.8

2.4

2.36

2.39

g/l

0.19

374

Allergic colitis

130

806

1.71

6.88

3.8

2.4

2.56

g/l

0.02

122

744

Other/unspecified disorders of vestibular function

262

1891

1.46

6.87

2.4

2.32

g/l

0.05

245

1751

Pedal cyclist injured in other and unspecified transport accidents

670

5464

1.26

6.87

2.4

2.5

2.37

2.35

g/l

0.30

618

5077

Premenstrual syndrome

370

2.08

6.85

2.3

2.2

2.42

2.49

g/l

0.44

346

Varicella [chickenpox]

308

2273

1.41

6.83

4.3

2.5

2.33

2.41

g/l

1.51

291

2128

Sequelae of intentional self-harm, assault and events of undetermined intent

217

2.49

6.83

2.1

2.2

2.48

2.41

g/l

0.31

202

Carcinoma in situ, bladder

238

1701

1.50

6.81

3.0

2.7

2.31

2.23

g/l

1.21

214

1583

Separation of retinal layers (serosa)

248

1772

1.47

6.81

3.9

2.5

2.29

2.32

g/l

0.39

235

1653

Acute nasopharyngitis (common cold)

650

5244

1.26

6.80

2.8

2.5

2.33

2.37

g/l

0.78

620

4926

Inguinal or femoral hernia, bilateral

725

5986

1.25

6.74

2.9

2.6

2.24

2.25

g/l

0.27

672

5572

Disorders of breast

3126

25851

1.11

6.71

2.2

2.3

2.45

2.43

g/l

1.00

2887

23740

Other superficial mycoses

587

4729

1.28

6.70

2.3

2.4

2.36

2.40

g/l

0.82

533

4397

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

366

2777

1.36

6.70

1.9

2.0

2.52

2.51

g/l

0.11

337

2570

Congenital malformations of the respiratory system

130

819

1.72

6.70

3.2

2.5

2.36

2.41

g/l

0.37

119

760

Ulcer of oesophagus, drug-induced

231

2.56

6.67

2.8

2.5

2.35

2.24

g/l

0.68

211

Malignant neoplasm of other and ill-defined sites, including Hilmo

105

626

1.82

6.67

2.7

2.2

2.10

2.26

g/l

1.99

579

Graves disease, strict definition

585

4718

1.28

6.66

2.1

2.3

2.45

2.41

g/l

0.88

533

4370

Other and unspecified iridocyclitis

276

2017

1.43

6.64

3.1

2.4

2.28

2.35

g/l

1.52

258

1869

Other contact dermatitis

474

3731

1.31

6.63

2.8

2.4

2.37

g/l

0.01

445

3459

Oral lichen planus

170

1141

1.60

6.63

2.1

2.3

2.45

2.37

g/l

1.00

159

1064

Complications of labour and delivery

3294

20077

0.90

6.63

2.2

2.3

2.47

2.44

g/l

2.08

3025

18517

Pulmonary eosinophilia, not elsewhere classified

519

1.92

6.58

3.0

2.2

2.25

2.31

g/l

0.44

475

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

452

3539

1.32

6.56

2.2

2.1

2.48

g/l

0.07

415

3276

Hereditary corneal dystrophies

217

1531

1.51

6.55

2.5

2.4

2.31

2.33

g/l

0.15

200

1426

Motor disorders

579

1.83

6.54

3.8

3.0

2.58

2.57

g/l

0.08

559

Malignant neoplasm of testis, including Hilmo

105

626

1.79

6.54

3.5

2.4

2.24

2.27

g/l

0.17

577

Dementia in Alzheimer disease

986

9770

0.83

6.54

2.1

2.5

2.18

2.23

g/l

1.64

772

8887

Residual foreign body in soft tissue

293

2162

1.41

6.54

2.3

2.4

2.35

2.34

g/l

0.07

273

1997

Other papulosquamous disorders

460

1.97

6.53

3.2

2.2

2.31

2.35

g/l

0.34

422

Contusion of ankle

231

1642

1.47

6.50

2.9

2.2

2.32

2.40

g/l

1.50

221

1525

Aspergillosis

384

2.10

6.49

3.5

2.4

2.14

2.30

g/l

1.73

355

Bicipital tendinitis

285

2101

1.42

6.48

2.8

2.5

2.36

2.31

g/l

0.72

264

1960

Dystonia

324

2437

1.39

6.46

2.1

2.4

2.39

2.35

g/l

0.74

295

2249

Contracture of joint

451

1.95

6.46

2.6

2.2

2.29

2.27

g/l

0.13

424

Spinal instabilities

169

1134

1.58

6.46

2.3

2.4

2.47

2.35

g/l

1.97

159

1059

Alopecia areata

155

1021

1.61

6.46

2.3

2.2

2.44

2.40

g/l

0.36

147

950

Other specific arthropathies, wide

132

839

1.68

6.46

2.3

2.37

2.34

g/l

0.28

125

780

Benign intracranial hypertension

344

2.10

6.45

3.4

2.1

2.43

2.51

g/l

0.55

316

Other and unspecified acute skin changes due to ultraviolet radiation

168

1131

1.59

6.45

3.2

2.4

2.32

2.29

g/l

0.26

158

1039

Dissocial personality disorder

562

1.84

6.45

2.2

2.5

2.43

2.34

g/l

0.74

530

Haemorrhage in early pregnancy

1556

13303

1.16

6.44

2.1

2.2

2.51

2.45

g/l

3.85

1429

12361

Malignant neoplasm of oropharynx, including Hilmo

126

795

1.70

6.42

2.3

2.5

2.25

2.29

g/l

0.31

117

735

Superficial injuries involving multiple body regions

168

1130

1.58

6.40

3.1

2.3

2.36

2.37

g/l

0.06

157

1037

Dislocation, sprain and strain of joints and ligaments of knee

3932

33408

1.09

6.38

2.3

2.4

2.41

2.39

g/l

2.32

3660

31065

Inguinal hernia, bilateral

709

5876

1.25

6.37

2.8

2.6

2.24

2.25

g/l

0.29

657

5468

Carcinoma in situ of skin, other sites/unspecified

115

720

1.78

6.36

3.9

2.5

2.22

2.25

g/l

0.19

101

660

Other disorders of choroid

100

599

1.82

6.33

3.3

2.3

2.22

2.33

g/l

1.23

546

Hypertrophic scar

296

2200

1.40

6.33

2.6

2.1

2.47

2.42

g/l

0.80

279

2038

Disorders of synovium and tendon in diseases classified elsewhere

134

861

1.67

6.32

3.7

2.5

2.27

2.30

g/l

0.32

119

797

Complications associated with artificial fertilization

586

1.79

6.30

2.3

2.2

2.62

2.49

g/l

1.30

546

Open bite

292

2166

1.40

6.30

2.9

2.4

2.53

2.51

g/l

0.25

274

2012

Donors of organs and tissues

476

1.90

6.28

2.1

1.8

2.28

2.43

g/l

1.67

441

Ankylosing hyperostosis [Forestier]

571

1.85

6.27

2.9

2.4

2.36

2.26

g/l

1.27

529

Contact with heat and hot substances

312

2343

1.39

6.27

3.3

2.6

2.32

2.37

g/l

0.67

286

2189

Sixth [abducent] nerve palsy

220

1569

1.49

6.26

2.8

2.5

2.17

2.30

g/l

2.80

203

1457

Benign neoplasm: Skin of eyelid, including canthus

990

8458

1.20

6.25

2.5

2.36

2.31

g/l

1.75

908

7805

128

790

1.67

6.20

4.9

3.1

2.65

2.60

g/l

0.33

123

754

Abscess of Bartholin gland

153

1014

1.59

6.18

2.9

2.1

2.51

2.46

g/l

0.48

141

943

Alzheimer’s disease (Late onset), excluding more controls

1026

5737

1.20

6.17

2.0

2.4

2.16

2.25

g/l

4.52

896

5299

Tonsillectomy and adenotomy

3521

22487

1.10

6.17

2.3

2.4

2.49

2.44

g/l

7.89

3294

20975

Benign neoplasm: Other and unspecified parts of mouth

213

1514

1.49

6.16

2.7

2.4

2.29

2.32

g/l

0.36

193

1406

Normotensive glaucoma

577

4710

1.27

6.14

2.4

2.5

2.32

2.29

g/l

0.55

501

4321

Other and unspecified mononeuropathies of lower limb

172

1174

1.55

6.13

2.5

2.3

2.39

2.34

g/l

0.38

161

1089

Prolonged pregnancy

592

6344

0.80

6.13

1.6

2.2

2.59

2.51

g/l

2.34

535

5894

Pediculosis, acariasis and other infestations

947

8060

1.20

6.12

2.6

2.4

2.40

2.41

g/l

0.19

879

7507

Hypertrichosis

120

754

1.69

6.11

2.7

2.1

2.54

2.48

g/l

0.63

108

687

Pilonidal cyst

459

3633

1.30

6.10

3.3

2.3

2.40

g/l

0.03

428

3399

Universal erythroderma, KELA reimbursement

583

1.81

6.07

2.9

2.3

2.41

2.32

g/l

0.65

541

Dermatitis herpetiformis

120

761

1.70

6.07

2.3

2.4

2.35

2.34

g/l

0.02

110

709

Follicular lymphoma, hilmo

270

2004

1.42

6.05

2.0

2.5

2.24

2.30

g/l

0.87

253

1860

Malignant neoplasm of vulva, including Hilmo

563

1.83

6.00

2.5

2.2

2.20

2.41

g/l

2.33

519

Oral lichen planus and hypothyroidism or thyroxine medication

117

741

1.71

5.99

1.8

2.1

2.47

2.40

g/l

0.68

104

689

Use of rotigotine

490

1.91

5.98

4.5

2.2

2.23

2.35

g/l

1.22

452

Assault by blunt object

523

1.83

5.94

2.4

2.5

2.23

2.36

g/l

0.91

487

Dislocation, sprain and strain of joints and ligaments of head

232

1677

1.44

5.93

2.6

2.3

2.40

2.41

g/l

0.12

210

1558

Whooping cough

441

1.90

5.90

3.6

1.9

2.33

2.47

g/l

1.19

401

Congenital malformations of the respiratory system

119

759

1.70

5.89

3.4

2.5

2.37

2.41

g/l

0.34

110

708

Primary ovarian failure

111

692

1.71

5.89

2.3

2.1

2.51

2.46

g/l

0.38

102

636

Other and unspecified intracranial injuries

190

1332

1.50

5.89

2.6

2.5

2.25

2.28

g/l

0.38

173

1233

Other and unspecified mononeuropathies of upper limb

179

1240

1.52

5.89

2.8

2.5

2.32

2.34

g/l

0.12

169

1159

Injury of muscle and tendon at forearm level

117

741

1.69

5.88

2.2

2.4

2.41

2.34

g/l

0.59

105

697

Pustulosis palmaris et plantaris

248

1821

1.43

5.85

2.1

2.4

2.46

2.37

g/l

1.84

230

1682

Spinal osteochondrosis

393

1.96

5.82

2.4

2.3

2.40

2.37

g/l

0.16

365

Other and unspecified injuries of shoulder and upper arm

187

1310

1.50

5.81

3.0

2.5

2.28

2.32

g/l

0.52

169

1212

Sequelae of hyperalimentation

4.11

5.81

2.6

2.2

2.61

2.39

g/l

0.92

Allergic contact dermatitis due to drugs in contact with skin

142

945

1.61

5.79

2.3

2.2

2.41

2.34

g/l

0.67

132

874

Autism spe

130

842

1.62

5.78

1.7

2.5

2.57

2.52

g/l

0.52

116

784

Malignant neoplasm of tonsil

521

1.83

5.77

1.9

2.5

2.27

2.28

g/l

0.09

481

Injury of muscle and tendon at hip and thigh level

568

4646

1.26

5.77

2.7

2.5

2.36

2.34

g/l

0.28

528

4331

Personal history of allergy to drugs, medicaments and biological substances

409

1.94

5.77

2.2

1.9

2.43

2.39

g/l

0.18

377

Other disorders of male genital organs

217

1561

1.45

5.75

2.9

2.7

2.31

2.28

g/l

0.42

207

1464

Other intracranial haemorrhages

220

1596

1.46

5.74

2.8

2.5

2.19

2.25

g/l

0.73

200

1466

Pleural plaque without asbestos

265

1985

1.42

5.73

2.8

2.6

2.22

g/l

0.08

230

1822

Malignant neoplasm of breast, ER-negative, including Hilmo

1221

10144

1.17

5.72

2.1

2.3

2.35

2.41

g/l

3.10

1115

9204

Amblyopia ex anopsia

246

1811

1.42

5.70

3.4

2.5

2.49

2.43

g/l

0.95

224

1671

Polycystic ovarian syndrome, broad definition

573

4685

1.25

5.70

2.0

2.1

2.59

2.53

g/l

1.78

527

4325

Other disorders of binocular movement

132

865

1.62

5.68

2.3

2.2

2.49

2.41

g/l

0.83

127

792

Other maltreatment syndromes

169

1165

1.52

5.64

2.5

2.4

2.36

2.38

g/l

0.20

159

1087

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

579

1.78

5.64

2.3

2.41

2.35

g/l

0.60

538

Schizoid personality disorder

109

687

1.70

5.62

2.0

2.3

2.45

2.34

g/l

1.00

646

Disorders of pituitary gland, other and/or unspecified

231

2.32

5.61

3.4

2.0

2.26

2.38

g/l

0.63

210

Nutritional marasmus

3.85

5.59

2.2

2.0

2.43

2.37

g/l

0.19

Mixed disorders of conduct and emotions

124

802

1.62

5.56

2.6

2.4

2.59

2.54

g/l

0.51

114

733

Other puerperal infections

407

3216

1.30

5.55

1.8

2.1

2.54

2.51

g/l

0.43

366

2968

Other and unspecified paralytic syndromes

598

1.76

5.54

2.4

2.3

2.35

2.37

g/l

0.09

549

Carcinoma in situ of oral cavity, oesophagus and stomach

262

2.26

5.53

2.7

2.2

2.46

2.26

g/l

1.40

235

Alzheimer’s disease (undefined)

479

0.31

5.51

1.8

2.2

2.23

2.19

g/l

—

427

Other specified/unspecified deforming dorsopathies

109

690

1.68

5.48

2.7

2.2

2.41

2.36

g/l

0.41

101

639

140

893

1.58

5.44

4.8

3.1

2.62

2.61

g/l

0.10

135

850

Foreign body or object entering through skin

351

2735

1.33

5.44

2.5

2.38

2.34

g/l

0.53

317

2544

Other and unspecified disorders of vitreous body

2757

24922

1.11

5.44

2.5

2.34

2.33

g/l

0.88

2512

23028

Intermittent heterotropia

322

2476

1.34

5.44

3.0

2.4

2.46

2.45

g/l

0.15

289

2306

Pustular psoriasis

274

2069

1.38

5.42

2.2

2.4

2.45

2.37

g/l

1.72

254

1911

Assault by unspecified means

117

754

1.64

5.42

2.5

2.4

2.45

2.39

g/l

0.38

108

703

Injury of urinary and pelvic organs

132

878

1.60

5.41

3.0

2.4

2.29

2.32

g/l

0.17

119

814

Cerebral aneurysm, nonruptured

515

4204

1.26

5.40

3.0

2.4

2.34

g/l

0.00

485

3892

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

478

3867

1.27

5.40

3.4

2.2

2.43

g/l

0.02

446

3562

Benign neoplasm: Bladder

430

1.92

5.37

2.6

2.4

2.34

2.29

g/l

0.31

393

Malignant neoplasm of oropharynx

602

1.73

5.36

1.9

2.5

2.26

2.29

g/l

0.17

556

Tuberculosis

405

3225

1.30

5.35

2.9

2.5

2.21

2.25

g/l

0.90

375

2940

Pre-eclampsia superimposed on chronic hypertension

187

2.40

5.34

3.4

2.0

2.47

2.50

g/l

0.10

176

Other and/or unspecified nontoxic goitre

472

3823

1.27

5.32

2.4

2.3

2.40

2.35

g/l

1.40

448

3517

Pseudomembranous colitis

319

2.04

5.32

3.4

2.2

2.37

2.35

g/l

0.06

292

Evidence of alcohol involvement determined by level of intoxication

368

1.94

5.31

2.8

2.2

2.32

2.40

g/l

0.44

345

Malignant neoplasm of eye and adnexa, including Hilmo

101

635

1.71

5.31

2.9

2.4

2.27

2.28

g/l

0.06

587

Epiphora

144

981

1.57

5.31

2.1

2.4

2.36

g/l

0.00

133

899

Secondary parkinsonism+Parkinsonism in other disease

182

1296

1.49

5.30

2.3

2.6

2.28

g/l

0.02

156

1208

Other acquired deformities of ankle and foot

298

2.07

5.27

2.5

2.3

2.29

2.38

g/l

0.53

279

Other and unspecified injuries of thorax

113

730

1.65

5.27

2.6

2.5

2.32

2.33

g/l

0.05

104

680

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

170

1193

1.50

5.25

2.6

2.3

2.35

2.38

g/l

0.36

158

1101

Secondary parkinsonism

178

1265

1.49

5.25

2.2

2.6

2.29

2.27

g/l

0.13

152

1173

Whooping cough

174

2.40

5.25

5.1

1.9

2.40

2.50

g/l

0.30

156

Other deformities of toe(s)

198

1428

1.45

5.23

3.0

2.4

2.38

2.32

g/l

0.74

180

1326

Benign neoplasm: Skin, unspecified

235

1747

1.41

5.20

3.6

2.4

2.28

2.33

g/l

0.58

214

1624

Malignant neoplasm of floor of mouth, including Hilmo

300

2.06

5.19

2.4

2.3

2.28

g/l

0.02

278

Intrahepatic Cholestasis of Pregnancy (ICP)

366

2882

1.31

5.19

1.9

2.2

2.52

2.49

g/l

0.38

337

2677

Deep bite

611

4451

1.23

5.18

3.1

2.4

2.51

2.46

g/l

1.60

563

4156

Malignant neoplasm of vulva

382

1.95

5.17

2.3

2.19

2.41

g/l

1.91

349

Acute epiglottitis

592

1.72

5.16

3.1

2.3

2.28

2.34

g/l

0.41

558

Malignant cancer of tonsil and base of tongue

116

758

1.63

5.15

1.9

2.6

2.23

2.29

g/l

0.43

108

707

604

1.69

5.14

3.0

2.0

2.64

2.60

g/l

0.26

542

Traumatic ischaemia of muscle

509

1.78

5.11

3.3

2.4

2.41

2.35

g/l

0.28

474

Injury of eye and orbit

808

6899

1.19

5.10

2.7

2.6

2.35

2.36

g/l

0.14

742

6453

Monoplegia

101

643

1.69

5.10

2.5

2.2

2.45

2.34

g/l

0.98

591

Other osteochondropathies

393

3133

1.29

5.09

2.4

2.5

2.36

g/l

0.02

360

2917

Nasal polyp

1216

10711

1.16

5.08

2.3

2.6

2.32

2.29

g/l

1.09

1130

9948

Oral lichen planus, including avohilmo , including avohilmo

377

2998

1.30

5.06

2.1

2.5

2.43

2.36

g/l

1.72

346

2774

Embedded and impacted teeth

1442

10556

1.14

5.06

2.8

2.3

2.47

2.48

g/l

0.33

1364

9772

Other, unspecified and serous retinal detachments

198

1442

1.45

5.05

3.3

2.5

2.19

2.29

g/l

1.86

189

1331

Scabies

771

6563

1.20

5.05

2.5

2.4

2.43

g/l

0.09

711

6104

Other acquired deformities of musculoskeletal system and connective tissue

266

2022

1.37

5.05

2.4

2.5

2.40

2.33

g/l

0.99

247

1881

Disturbances of smell and taste

249

1877

1.38

5.03

2.3

2.4

2.37

2.34

g/l

0.33

232

1730

Recurrent dislocation and subluxation of joint

350

2751

1.31

5.00

2.3

2.42

2.40

g/l

0.24

323

2563

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

452

3666

1.27

4.99

2.2

2.48

2.47

g/l

0.24

415

3396

Non-small cell lung cancer, including Hilmo

937

7643

1.18

4.97

2.2

2.6

2.19

2.26

g/l

3.02

885

6960

Flatulence and related conditions

362

1.91

4.95

2.5

2.3

2.20

2.35

g/l

1.42

337

Assault by sharp object

597

1.69

4.94

3.0

2.4

2.40

2.34

g/l

0.30

555

Other lack of coordination

114

753

1.63

4.93

2.1

2.4

2.30

2.33

g/l

0.14

104

704

Dementia, including avohilmo

3429

21875

1.09

4.91

2.2

2.6

2.23

2.26

g/l

2.65

2997

20110

Malignant neoplasm of tonsil, including Hilmo

100

640

1.67

4.89

2.0

2.5

2.29

2.30

g/l

0.04

594

Nontoxic goitre/thyroid nodule

1893

17153

1.12

4.85

2.6

2.4

2.38

2.35

g/l

1.36

1763

15727

Chronic conjunctivitis

177

1272

1.46

4.85

2.3

2.39

2.38

g/l

0.06

171

1181

Aphakia

568

1.70

4.84

3.2

2.3

2.20

2.30

g/l

0.91

524

Cerebral atherosclerosis

579

1.71

4.84

3.2

2.4

2.20

2.24

g/l

0.24

530

Effects of heat and light

316

2.01

4.84

1.8

2.5

2.25

2.33

g/l

0.45

289

Personality and behavioural disorders due to brain disease, damage and dysfunction

635

1.67

4.83

2.4

2.3

2.49

2.31

g/l

1.81

594

Benign neoplasm of major salivary glands

596

5002

1.22

4.78

2.6

2.5

2.29

2.30

g/l

0.16

547

4629

Gluteal tendinitis

217

1614

1.40

4.77

2.5

2.3

2.47

2.34

g/l

3.04

197

1498

Burn and corrosion of trunk

178

1285

1.45

4.77

2.5

2.41

2.34

g/l

0.73

167

1200

473

1.78

4.77

2.6

2.3

2.36

2.32

g/l

0.23

437

Severe visual impairment, binocular

219

2.25

4.75

7.2

2.4

2.19

2.30

g/l

0.55

195

Cysts of oral region, not elsewhere classified

341

2701

1.31

4.75

3.3

2.5

2.30

2.33

g/l

0.37

314

2506

Maternal care for other known or suspected fetal problems

1313

7352

1.15

4.75

2.2

2.56

2.52

g/l

1.57

1202

6830

Mature T/NK-cell lymphomas, hilmo

626

1.69

4.73

2.7

2.4

2.13

2.27

g/l

1.26

579

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

198

2.29

4.72

3.6

2.6

2.18

2.35

g/l

0.97

181

Benign neoplasm: Skin of other and unspecified parts of face

663

5624

1.21

4.70

2.8

2.5

2.31

g/l

0.01

588

5178

All dysplastic lesions of the cervix uteri, vagina or vulva

1633

14469

1.13

4.70

2.5

2.2

2.43

2.48

g/l

3.46

1487

13414

Congenital deformities of hip

117

781

1.58

4.69

2.9

2.4

2.44

2.49

g/l

0.43

109

725

Measles

383

1.85

4.68

3.5

2.4

2.37

2.46

g/l

0.72

357

Open wound of hip and thigh

186

1355

1.43

4.67

2.7

2.4

2.26

2.35

g/l

1.24

165

1249

Malignant neoplasm of penis

133

2.62

4.66

2.8

2.2

2.08

2.23

g/l

0.61

121

Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]

6.32

4.65

5.4

1.8

2.34

2.54

g/l

0.68

Gestational [pregnancy-induced] hypertension

1408

12543

1.14

4.65

2.3

2.1

2.52

2.48

g/l

2.16

1314

11616

Schizotypal disorder

127

864

1.54

4.63

1.9

2.4

2.52

2.38

g/l

1.90

114

804

Contusion of toe(s) without damage to nail

140

973

1.51

4.60

2.7

2.2

2.45

2.43

g/l

0.14

129

898

Effects of foreign body entering through natural orifice

1481

13282

1.13

4.59

2.5

2.6

2.36

2.34

g/l

0.50

1363

12404

Pedestrian injured in collision with pedal cycle

184

1345

1.43

4.58

2.1

2.4

2.35

2.33

g/l

0.20

171

1251

Infectious mononucleosis

412

3338

1.26

4.55

2.4

2.2

2.53

2.49

g/l

0.70

377

3101

Sunburn

3.33

4.53

3.1

1.9

2.30

2.41

g/l

0.32

Secondary malignant neoplasm of respiratory and digestive organs

103

678

1.63

4.52

1.7

2.4

2.12

2.27

g/l

1.77

625

Maternal care for known or suspected abnormality of pelvic organs

1397

8481

1.14

4.49

2.0

2.3

2.54

2.49

g/l

2.94

1282

7879

Pleural plaque with presence of asbestos

515

4307

1.24

4.47

2.5

2.7

2.23

2.19

g/l

0.73

447

3968

Malignant cancer of tonsil and base of tongue, including Hilmo

139

973

1.51

4.47

2.0

2.5

2.25

2.30

g/l

0.36

131

906

Mental retardation

222

1664

1.38

4.47

3.2

2.7

2.43

2.42

g/l

0.10

208

1562

Conduct disorder

113

756

1.56

4.44

2.6

2.5

2.52

2.47

g/l

0.39

697

Lagophthalmos

588

1.68

4.44

3.3

2.3

2.20

2.33

g/l

1.24

543

Hirsutism in women

100

653

1.61

4.43

2.1

2.55

2.49

g/l

0.52

594

Injury of nerves and spinal cord at thorax level

189

2.26

4.43

2.1

2.3

2.00

2.32

g/l

1.99

174

Behavioural disorders

113

757

1.56

4.42

2.6

2.5

2.55

2.48

g/l

0.47

696

Asymptomatic human immunodeficiency virus [HIV] infection status

210

2.18

4.40

1.6

2.2

2.52

2.39

g/l

0.59

198

Other bursitis, not elsewhere classified

377

1.84

4.39

2.0

2.6

2.33

2.30

g/l

0.18

348

Nutritional and metabolic disorders in diseases classified elsewhere

12.75

4.37

11.4

3.4

2.40

2.64

g/l

—

Unspecified severe protein-energy malnutrition

3.19

4.36

1.8

2.6

2.16

2.41

g/l

0.93

Toxic effect of ethanol

216

1628

1.37

4.36

2.7

2.5

2.34

2.37

g/l

0.31

193

1512

Habit and impulse disorders

553

1.66

4.34

1.7

2.4

2.58

2.36

g/l

2.91

519

Atypical mycobacterium lung infection

503

1.72

4.34

3.3

2.4

2.29

g/l

0.04

464

Malignant neoplasm of breast, HER-negative

1075

9319

1.15

4.32

2.1

2.3

2.35

2.41

g/l

2.40

976

8454

Subacute thyroiditis

202

1513

1.39

4.30

2.3

2.2

2.42

2.37

g/l

0.67

186

1406

Alzheimer’s disease (undefined), excluding more controls

409

0.36

4.29

1.8

2.2

2.23

2.22

g/l

—

362

Pregnancy, childbirth and the puerperium

1757

10122

0.89

4.29

2.1

2.3

2.42

g/l

0.00

1588

9228

Injury of nerves at wrist and hand level

210

1582

1.38

4.29

2.4

2.6

2.37

2.33

g/l

0.51

193

1476

Respiratory tuberculosis

338

2711

1.29

4.29

2.8

2.5

2.20

2.26

g/l

1.39

312

2473

Use of biperiden

294

2318

1.31

4.29

2.2

2.5

2.37

2.33

g/l

0.58

262

2154

Other congenital malformations of circulatory system

153

1099

1.47

4.28

2.2

2.4

2.24

2.35

g/l

1.53

142

1025

Paranoid personality disorder

111

750

1.57

4.28

2.2

2.38

2.37

g/l

0.11

701

Intussusception

116

789

1.55

4.28

2.4

2.3

2.49

2.36

g/l

1.69

111

726

Congenital malformations of eye, ear, face and neck

350

2813

1.28

4.28

3.1

2.4

2.41

2.43

g/l

0.30

327

2605

Respiratory tuberculosis, confirmed and not-confirmed

338

2712

1.29

4.28

2.8

2.5

2.20

2.26

g/l

1.37

312

2473

Eclampsia

2.95

4.26

3.6

1.8

2.54

2.50

g/l

0.11

Mixed specific developmental disorders

117

735

1.54

4.24

3.3

3.0

2.61

2.56

g/l

0.34

112

702

Other conjunctival vascular disorders and cysts

144

1027

1.48

4.23

2.4

2.3

2.34

2.33

g/l

0.07

137

954

Injury of muscle and tendon at shoulder and upper arm level

2329

21459

1.10

4.22

2.4

2.6

2.32

2.30

g/l

0.88

2172

19953

Unspecified threat to breathing

382

1.82

4.21

2.9

2.2

2.36

2.40

g/l

0.22

354

Pregnancy examination and test

853

4592

1.17

4.20

1.9

2.2

2.56

2.54

g/l

0.38

789

4265

Acute inflammation of orbit

242

2.05

4.18

3.7

2.3

2.44

2.47

g/l

0.12

223

Benign neoplasm of ovary

987

8699

1.16

4.18

2.5

2.3

2.42

2.39

g/l

0.96

908

7988

Thoracic root disorders

3.47

4.17

1.8

2.2

2.43

2.40

g/l

0.05

Medical abortion

4181

21276

1.07

4.17

2.3

2.2

2.44

2.43

g/l

0.08

3830

19557

Poor fetal growth

632

5385

1.19

4.17

2.4

2.1

2.52

2.53

g/l

0.03

584

4981

Other disorders of Eustachian tube

170

1249

1.42

4.15

2.9

2.3

2.42

2.36

g/l

0.90

152

1156

Autoimmune thyroiditis

107

722

1.56

4.14

2.3

2.1

2.42

2.41

g/l

0.07

666

HSIL lesion of the vulva

103

692

1.59

4.14

3.8

2.1

2.21

2.43

g/l

4.77

637

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

523

1.66

4.10

2.5

2.4

2.28

2.37

g/l

0.66

481

Alzheimer’s disease, strict definition

1537

13970

0.89

4.09

2.0

2.5

2.17

2.24

g/l

4.82

1333

12674

Aneurysms, operations, SAH

1006

8893

1.15

4.09

3.0

2.4

2.29

2.32

g/l

0.67

928

8195

Injury of muscle and tendon at lower leg level

885

7758

1.16

4.07

2.8

2.6

2.32

g/l

0.01

823

7241

Oral leukoplakia, including avohilmo

166

1222

1.43

4.05

2.4

2.31

2.32

g/l

0.04

156

1133

Obstructed labour due to malposition and malpresentation of fetus

955

10106

0.87

4.05

2.0

2.3

2.52

2.49

g/l

1.06

884

9398

Benign neoplasm: Larynx

193

1454

1.39

4.04

2.3

2.5

2.36

2.27

g/l

1.31

187

1357

Inflammatory disorders of breast

341

2752

1.27

4.04

2.4

2.1

2.41

2.46

g/l

0.97

315

2533

Endometriosis diagnosis and infertility diagnosis occurring together

551

4658

1.21

4.04

2.0

2.2

2.50

2.48

g/l

0.55

511

4319

Liposarcoma

260

1.99

4.04

2.5

2.4

2.23

2.27

g/l

0.20

240

Malignant neoplasm of bronchus and lung, including Hilmo

1330

9995

1.13

4.03

2.3

2.6

2.17

2.27

g/l

7.12

1256

9103

Non-small cell lung cancer

594

5019

1.20

4.02

2.0

2.6

2.15

2.25

g/l

3.53

560

4556

Benign neoplasm: Parotid gland

469

3921

1.23

4.01

2.5

2.30

2.31

g/l

0.15

431

3638

Lethal midline granuloma

9.70

4.00

9.4

1.5

2.31

2.20

g/l

—

Suppurative otitis media, unspecified

144

1034

1.45

3.99

3.3

2.2

2.36

2.37

g/l

0.05

133

953

Malignant neoplasm of cervix uteri

591

1.62

3.99

2.9

2.2

2.20

2.44

g/l

2.45

545

Injury of nerves and spinal cord at neck level

137

980

1.48

3.99

2.6

2.4

2.31

g/l

0.01

126

908

Benign neoplasm: Skin of ear and external auricular canal

244

1903

1.34

3.99

2.9

2.5

2.27

2.29

g/l

0.19

218

1753

Eustachian salpingitis and obstruction

405

3331

1.24

3.98

2.7

2.4

2.43

2.42

g/l

0.16

374

3101

Stenosis and insufficiency of lacrimal passages

559

4746

1.21

3.98

2.3

2.4

2.38

2.33

g/l

1.14

510

4369

Supervision of high-risk pregnancy

1106

5893

1.14

3.97

2.0

2.3

2.53

2.51

g/l

0.59

1001

5506

Male infertility

207

1569

1.35

3.97

4.2

2.7

2.32

2.35

g/l

0.27

196

1481

Congenital deformities of hip

103

696

1.56

3.96

3.1

2.4

2.49

2.52

g/l

0.24

646

Congenital malformations of genital organs

488

4064

1.22

3.95

2.5

2.3

2.52

2.47

g/l

1.15

452

3770

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

238

1852

1.34

3.94

2.6

2.5

2.29

2.30

g/l

0.09

221

1723

Benign neoplasm of meninges

616

5284

1.19

3.91

2.6

2.4

2.31

2.33

g/l

0.40

562

4854

Infections of genitourinary tract in pregnancy

490

4115

1.22

3.89

2.5

2.2

2.50

2.45

g/l

0.93

444

3818

Benign lipomatous neoplasm

1872

17154

1.11

3.88

2.4

2.5

2.38

2.33

g/l

3.43

1747

15873

Disorders of aromatic amino-acid metabolism

118

2.55

3.87

3.5

2.3

2.36

2.42

g/l

0.16

109

Fall on and from ladder

462

3874

1.23

3.87

2.3

2.7

2.24

2.27

g/l

0.61

423

3627

Optic neuritis

229

1774

1.34

3.87

2.3

2.2

2.41

2.42

g/l

0.06

208

1654

Other vitreous opacities

237

1849

1.33

3.87

2.6

2.4

2.33

2.32

g/l

0.15

219

1710

Injury of cranial nerves

257

1.98

3.86

1.9

2.39

2.38

g/l

0.06

236

Atopic conjunctivitis

239

1861

1.33

3.86

2.7

2.3

2.47

2.41

g/l

0.81

224

1717

Secondary malignant neoplasm of other and unspecified sites

105

720

1.55

3.85

1.8

2.4

2.07

2.27

g/l

2.84

661

Spinal enthesopathy

168

1240

1.40

3.85

2.4

2.3

2.17

2.25

g/l

1.06

156

1106

Other peripheral vertigo

552

4700

1.20

3.85

2.2

2.5

2.39

2.32

g/l

3.01

504

4351

Tuberculosis of other organs

137

989

1.46

3.82

3.1

2.3

2.21

2.31

g/l

0.94

123

905

Polyhydramnios

238

1854

1.32

3.81

2.6

2.3

2.56

2.49

g/l

0.93

217

1744

Benign leiomyoma with endometriosis

906

7998

1.15

3.80

2.2

2.3

2.40

2.39

g/l

0.33

825

7343

Idiopathic peripheral autonomic neuropathy

146

2.37

3.80

2.8

2.7

2.37

2.35

g/l

0.10

133

Other benign neoplasms of connective and other soft tissue

563

4803

1.20

3.79

2.6

2.5

2.41

2.34

g/l

2.66

525

4444

Early lumbar disc prolapse, operated

478

4010

1.21

3.79

2.3

2.4

2.53

2.43

g/l

3.34

446

3759

Pedal cyclist injured in transport accident

1308

11793

1.12

3.75

2.3

2.5

2.38

2.36

g/l

0.57

1211

10982

Erosion and ectropion of cervix uteri

159

1176

1.41

3.74

2.5

2.38

2.34

g/l

0.36

139

1077

Conductive hearing loss, unspecified

476

4011

1.22

3.72

2.7

2.5

2.36

2.33

g/l

0.45

435

3709

Melanocytic naevi of upper limb, including shoulder

140

1018

1.44

3.71

3.3

2.3

2.30

2.35

g/l

0.57

135

941

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

104

716

1.53

3.70

2.0

2.3

2.10

2.24

g/l

1.68

651

Vascular dementia (other)

346

1.83

3.70

1.8

2.5

2.35

2.23

g/l

0.66

317

Malignant neoplasm of other endocrine glands and related structures

3.48

3.69

6.5

2.2

2.31

2.37

g/l

0.13

Pervasive developmental disorders excl. Autism + Asperger

437

1.68

3.67

2.1

2.8

2.56

2.53

g/l

0.15

414

Family history of other specific disorders

450

1.67

3.66

2.8

1.9

2.54

2.44

g/l

0.84

409

Chromosomal abnormalities, not elsewhere classified

116

814

1.49

3.66

3.0

2.7

2.45

2.48

g/l

0.21

110

763

Tooth agenesis EXCLUDE clefts and syndromes

193

1472

1.35

3.63

3.5

2.3

2.54

g/l

0.03

178

1364

Brain meningioma, including Hilmo

270

2155

1.29

3.62

2.3

2.4

2.29

2.34

g/l

0.62

245

1977

Disorders of puberty

498

1.62

3.61

3.7

2.4

2.53

2.56

g/l

0.24

453

Benign neoplasm: salivary glands, exclude unknown (D119)

515

4385

1.20

3.61

2.5

2.29

2.30

g/l

0.20

475

4068

Contact with other hot fluids

168

1260

1.39

3.61

2.9

2.5

2.40

g/l

0.03

150

1177

Other and unspecified injuries of forearm

269

1.89

3.60

2.8

2.2

2.37

2.41

g/l

0.19

247

Mandibular retrognathia

335

2728

1.25

3.59

2.4

2.55

2.47

g/l

2.14

310

2548

Vertigo of central origin

103

716

1.53

3.58

2.1

2.3

2.38

2.32

g/l

0.44

656

Benign neoplasm: Cerebral meninges

554

4752

1.19

3.56

2.6

2.4

2.31

2.33

g/l

0.42

507

4375

Nontoxic single thyroid nodule

394

3278

1.23

3.56

2.5

2.3

2.37

2.35

g/l

0.42

365

3037

Poisoning by medicine, drug-induced

511

1.62

3.55

2.2

2.34

2.42

g/l

0.44

478

Exposure to other and unspecified animate mechanical forces

163

1220

1.39

3.55

2.6

2.3

2.36

2.41

g/l

0.54

148

1129

Injury of nerves at forearm level

487

1.64

3.54

3.0

2.2

2.48

2.36

g/l

0.97

451

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

637

1.57

3.54

3.6

2.3

2.31

g/l

0.00

584

Disorders of eyelid in diseases classified elsewhere

186

1422

1.36

3.53

3.0

2.3

2.33

2.35

g/l

0.21

174

1312

Glaucoma secondary to eye inflammation

340

1.78

3.52

1.9

2.1

2.33

2.37

g/l

0.23

312

Aggressive periodontitis

127

919

1.46

3.50

2.7

2.4

2.24

2.33

g/l

1.13

122

851

Exposure to unspecified smoke, fire and flames

387

1.72

3.50

2.2

2.3

2.38

2.37

g/l

0.01

359

Other specified and unspecified disorders of conjunctiva

403

1.71

3.50

3.6

2.1

2.23

2.38

g/l

1.24

376

Helminthiases

102

709

1.52

3.50

3.5

2.3

2.42

2.36

g/l

0.50

657

Guillain-Barre syndrome

677

1.54

3.49

2.3

2.4

2.29

2.31

g/l

0.12

628

Any dementia

2897

18822

1.08

3.49

2.2

2.5

2.19

2.25

g/l

6.84

2540

17231

Exposure to smoke, fire and flames

142

1046

1.42

3.48

2.1

2.5

2.37

2.32

g/l

0.43

130

973

Lyme disease

1572

17182

0.90

3.48

2.2

2.5

2.38

2.35

g/l

1.35

1447

15920

Foreign body in respiratory tract

288

2329

1.27

3.46

2.2

2.5

2.38

2.36

g/l

0.27

265

2165

Procedures for purposes other than remedying health state

124

892

1.45

3.45

2.8

1.8

2.39

2.43

g/l

0.31

117

827

Generalized epilepsy

227

1785

1.31

3.44

2.3

2.5

2.39

2.41

g/l

0.21

213

1660

Injury of muscle and tendon at wrist and hand level

772

6791

1.16

3.44

2.4

2.6

2.36

2.32

g/l

1.08

704

6366

Guttate psoriasis

572

1.58

3.44

2.6

2.2

2.52

2.37

g/l

1.14

525

Viral conjunctivitis

197

1522

1.34

3.43

3.0

2.2

2.39

2.40

g/l

0.15

185

1410

Convergent concomitant strabismus

293

2372

1.27

3.43

2.3

2.46

2.42

g/l

0.40

272

2200

Spirochaetal infections, other/unspecified

1587

17325

0.91

3.42

2.2

2.5

2.38

2.35

g/l

1.29

1461

16047

Burn and corrosion of hip and lower limb, except ankle and foot

135

989

1.43

3.42

2.4

2.3

2.37

2.35

g/l

0.13

124

911

Ovarian hyperstimulation (induction)

628

1.54

3.41

2.4

2.0

2.62

2.50

g/l

1.04

583

Normal-pressure hydrocephalus

206

2617

0.76

3.40

2.2

2.5

2.26

g/l

0.02

184

2390

Mental retardation, wide definition

229

1796

1.31

3.40

3.2

2.7

2.42

2.41

g/l

0.08

214

1683

Malignant neoplasm of lip, including Hilmo

429

1.67

3.40

2.6

2.3

2.11

2.19

g/l

0.54

393

Primary open-angle glaucoma, strict

1807

16616

1.10

3.38

2.5

2.26

2.27

g/l

0.26

1606

15166

474

4022

1.20

3.38

2.0

2.1

2.47

2.53

g/l

1.52

428

3739

Brain meningioma

259

2077

1.29

3.36

2.3

2.4

2.28

2.35

g/l

0.84

235

1911

Intracerebral haemorrhage

818

7242

1.15

3.35

3.1

2.5

2.18

2.25

g/l

3.27

745

6604

All dysplastic lesions of the vagina

147

1096

1.40

3.34

3.2

2.1

2.32

2.43

g/l

1.45

136

1014

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

157

2070

0.74

3.33

2.0

2.4

2.35

2.41

g/l

0.70

151

1933

Sequelae of tuberculosis

120

868

1.45

3.33

3.2

2.4

2.30

2.23

g/l

0.76

112

782

Urticaria due to cold and heat

322

1.77

3.33

2.2

2.0

2.38

2.45

g/l

0.40

301

Mild mental retardation

136

1002

1.41

3.32

3.4

2.5

2.42

2.41

g/l

0.07

127

933

Crowding of teeth, including avohilmo

442

3080

1.21

3.31

3.4

2.3

2.55

2.53

g/l

0.20

410

2855

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

336

1.73

3.30

2.9

1.9

2.63

2.51

g/l

0.66

308

Other and unspecified corneal deformities and disorders

182

1403

1.35

3.29

2.6

2.4

2.34

2.36

g/l

0.19

172

1304

False labour

1612

9189

1.10

3.28

1.8

2.3

2.58

2.50

g/l

5.92

1468

8552

Congenital malformations of the nervous system

120

868

1.44

3.27

3.1

2.4

2.48

2.45

g/l

0.27

112

805

Increased secretion of glucagon

9.41

3.27

3.7

1.6

2.09

2.46

g/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

452

3843

1.20

3.26

2.6

2.5

2.39

2.33

g/l

1.54

419

3571

Knuckle pads

3.18

3.26

5.3

2.2

2.37

g/l

0.00

Diseases of thymus

101

2.54

3.25

3.5

2.1

2.36

2.41

g/l

0.16

LSIL lesion of the cervix uteri, vagina or vulva

739

6509

1.15

3.22

2.6

2.2

2.42

2.47

g/l

1.34

682

6045

Benign neoplasm of eye and adnexa

601

5230

1.17

3.22

2.7

2.5

2.30

2.32

g/l

0.39

555

4833

Demyelinating diseases of the central nervous system

450

3824

1.20

3.21

2.3

2.43

2.41

g/l

0.29

413

3546

Effects of other external causes

149

1118

1.38

3.21

2.1

2.4

2.45

2.37

g/l

0.97

139

1040

Nystagmus and other irregular eye movements

573

1.55

3.20

3.1

2.4

2.38

2.40

g/l

0.11

535

Postmenopausal atrophic vaginitis

1547

7800

1.11

3.19

2.2

2.3

2.43

2.36

g/l

5.64

1435

7161

Chronic suppurative otitis media, including avohilmo

454

3869

1.20

3.18

2.6

2.5

2.35

g/l

0.04

419

3580

Macular cyst

178

1380

1.35

3.17

3.3

2.5

2.16

2.28

g/l

2.56

167

1279

Fourth [trochlear] nerve palsy

137

1023

1.41

3.16

2.7

2.4

2.34

2.29

g/l

0.44

129

946

Injury of nerves at shoulder and upper arm level

413

1.65

3.16

2.9

2.5

2.35

2.34

g/l

0.04

383

Other disorders of prostate

211

1669

1.31

3.16

3.2

2.6

2.14

2.21

g/l

1.24

196

1557

Other specified and unspecified disorders of eyelid

601

1.54

3.15

2.0

2.3

2.35

2.34

g/l

0.11

552

Patent foramen ovale

126

928

1.42

3.14

3.0

2.8

2.46

2.39

g/l

0.86

112

879

Contact with nonpowered hand tool

234

1874

1.29

3.12

2.5

2.6

2.32

2.31

g/l

0.15

209

1755

Vascular syndromes of brain in cerebrovascular disorders

280

2293

1.26

3.11

3.1

2.6

2.27

2.26

g/l

0.10

269

2118

Contact with sharp object, undetermined intent

126

928

1.41

3.10

2.4

2.5

2.37

2.34

g/l

0.16

116

865

Ebstein's anomaly

3.12

3.10

4.0

3.0

2.67

2.55

g/l

0.27

Meningitis

266

2162

1.27

3.09

2.8

2.4

2.32

2.35

g/l

0.29

255

2010

Small cell lung cancer, helper endpoint

1156

0.67

3.09

2.2

2.5

2.20

2.22

g/l

0.14

1064

Benign neoplasm of breast

665

5844

1.16

3.08

2.2

2.3

2.40

g/l

0.11

608

5359

Non-small cell lung cancer, squamous, helper endpoint

195

2467

0.77

3.07

1.9

2.6

2.15

2.20

g/l

0.53

183

2242

Other spirochaetal diseases

1599

17356

0.91

3.06

2.2

2.5

2.37

2.35

g/l

1.16

1472

16080

Peritonsillar abscess

1182

10724

1.11

3.06

2.6

2.5

2.42

2.38

g/l

1.37

1106

10000

Malignant neoplasm of bone and articular cartilage of limbs

151

2.13

3.05

3.2

2.9

2.35

2.32

g/l

0.08

139

Biological medicines for asthma

102

728

1.47

3.05

1.8

2.3

2.55

2.40

g/l

1.99

677

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

232

1858

1.28

3.04

2.6

2.3

2.48

2.38

g/l

2.23

215

1724

Certain zoonotic bacterial diseases

171

1324

1.34

3.03

2.8

2.4

2.30

2.32

g/l

0.26

156

1227

Chronic suppurative otitis media

380

3204

1.21

3.02

2.7

2.4

2.34

g/l

0.04

349

2959

Malignant neoplasm, without specification of site

176

1368

1.33

3.00

2.1

2.4

2.15

2.24

g/l

1.07

160

1247

Other lesions of median nerve

162

1248

1.35

3.00

3.3

2.3

2.37

2.33

g/l

0.43

134

1145

Uterine polyps

503

4339

1.18

3.00

2.2

2.4

2.41

2.37

g/l

0.86

462

4001

Other meningitis

639

1.50

2.99

2.8

2.3

2.33

2.36

g/l

0.19

584

Toxic effect of alcohol

115

841

1.43

2.99

3.2

2.5

2.30

2.34

g/l

0.30

104

785

Nocardiosis

4.10

2.99

7.3

1.6

2.38

2.36

g/l

0.05

Drug-induced aplastic anaemia

3.01

2.99

2.9

2.7

1.82

2.31

g/l

2.40

Other spirochaetal diseases

1626

17610

0.91

2.97

2.2

2.5

2.37

2.35

g/l

1.11

1498

16310

Mixed conductive and sensorineural hearing loss

744

6608

1.15

2.96

2.7

2.5

2.35

2.29

g/l

2.35

682

6116

Tuberculosis of other organs, strict

149

1139

1.37

2.94

3.1

2.3

2.25

2.29

g/l

0.36

133

1036

Primary open-angle glaucoma

2218

20034

1.08

2.94

2.5

2.27

g/l

0.09

1984

18314

Osteosarcoma

2.63

2.93

4.4

2.8

2.45

2.37

g/l

0.18

Toxoplasmosis

212

1.91

2.92

3.6

2.2

2.30

2.42

g/l

0.80

195

Femoral hernia

254

2071

1.26

2.92

2.7

2.4

2.38

2.28

g/l

2.15

235

1918

Nontraumatic intracranial haemmorrhage

1301

11900

1.11

2.92

3.0

2.4

2.21

2.27

g/l

3.19

1184

10862

Spermatocele

467

4023

1.19

2.92

2.8

2.7

2.23

g/l

0.01

443

3736

Lumbosacral root disorders, not elsewhere classified

512

1.56

2.91

2.0

2.2

2.33

2.34

g/l

0.08

475

Other osteochondrodysplasias

438

1.60

2.90

1.9

2.3

2.50

2.43

g/l

0.34

405

Contact with sharp glass

195

1541

1.30

2.89

2.6

2.4

2.39

g/l

0.03

172

1435

Burns and corrosions of multiple and unspecified body regions

126

941

1.39

2.88

2.9

2.6

2.32

2.33

g/l

0.00

118

879

Other appendicitis

466

4013

1.18

2.88

2.8

2.5

2.37

2.34

g/l

0.57

429

3731

Dementia

3167

20578

1.07

2.88

2.1

2.6

2.22

2.26

g/l

3.12

2758

18906

Other abnormal auditory perceptions

439

1.60

2.88

1.7

2.1

2.33

2.42

g/l

0.62

410

Congenital malformations of posterior segment of eye

206

1.92

2.88

3.4

2.7

2.42

2.38

g/l

0.22

192

Dementia in other diseases classified elsewhere

282

2331

1.25

2.88

2.2

2.6

2.17

2.26

g/l

1.81

222

2150

Open wound of thorax

611

1.50

2.87

3.3

2.4

2.40

2.33

g/l

0.51

573

Vascular dementia (sudden onset)

170

0.28

2.85

4.8

2.4

2.25

2.19

g/l

—

159

Retinoschisis and retinal cysts

143

1094

1.37

2.84

2.4

2.31

2.29

g/l

0.15

131

1013

Major anomalies of jaw size

141

1073

1.36

2.83

2.1

2.5

2.44

2.41

g/l

0.31

130

996

Maternal care for cervical incompetence

204

1629

1.29

2.82

2.0

2.3

2.48

2.42

g/l

0.68

180

1505

Secondary lactase deficiency

3.50

2.82

5.6

1.5

2.34

2.38

g/l

0.11

Other and unspecified injuries of abdomen, lower back and pelvis

606

1.49

2.81

2.5

2.2

2.30

2.37

g/l

0.53

549

Kissing spine

2.75

2.80

1.9

2.3

2.33

2.31

g/l

0.08

Labour and delivery complicated by fetal stress [distress]

1089

7861

0.90

2.80

1.9

2.2

2.54

2.52

g/l

0.45

991

7283

Long labour

1084

10213

0.90

2.80

1.8

2.3

2.53

2.48

g/l

1.97

1015

9481

Alzheimer’s disease (Early onset), excluding more controls

143

1753

0.75

2.78

1.9

2.3

2.19

2.24

g/l

0.48

115

1601

Habitual aborter

679

1.45

2.78

2.3

2.2

2.51

2.50

g/l

0.01

633

Trichomoniasis

324

1.70

2.77

2.7

2.1

2.31

2.38

g/l

0.40

297

Pedal cyclist injured in noncollision transport accidents

621

5473

1.15

2.77

2.2

2.5

2.39

2.36

g/l

0.62

575

5091

Abnormal findings on antenatal screening of mother

391

3329

1.19

2.74

1.9

2.1

2.65

2.53

g/l

3.90

365

3101

Mild or no visual impairment, binocular

179

1.95

2.74

2.6

2.1

2.39

2.42

g/l

0.09

164

Burn and corrosion of wrist and hand

197

1573

1.29

2.73

2.4

2.5

2.37

2.38

g/l

0.12

181

1461

Other cranial nerve disorders in other disorders

2.40

2.73

2.9

2.3

2.34

2.44

g/l

0.35

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

764

6831

1.14

2.72

2.2

2.5

2.40

2.34

g/l

2.21

704

6361

Acquired clawhand, clubhand, clawfoot and clubfoot

179

1.94

2.72

2.9

2.0

2.26

2.34

g/l

0.51

166

Calcific tendinitis of shoulder

297

2476

1.23

2.71

2.3

2.4

2.47

2.35

g/l

3.17

276

2311

Assault by other specified means

332

1.66

2.70

2.7

2.3

2.52

2.40

g/l

0.49

310

Benign lipomatous neoplasm of other sites/unspecified

510

4451

1.17

2.70

2.5

2.6

2.35

2.30

g/l

1.05

476

4104

Optic atrophy

103

756

1.43

2.69

2.5

2.23

2.37

g/l

1.36

697

Vascular dementia (undefined)

263

2149

1.24

2.69

2.2

2.5

2.14

2.22

g/l

1.26

224

1938

Hand

195

1.89

2.68

3.8

2.1

2.40

2.41

g/l

0.06

176

Deep endometriosis

522

4565

1.16

2.66

1.9

2.3

2.50

2.42

g/l

2.54

468

4191

Use of levodopa decarboxylase inhibitor

894

8086

1.13

2.65

2.2

2.6

2.25

2.26

g/l

0.21

796

7413

Hypertrophy of (infrapatellar) fat pad

366

1.62

2.65

3.4

2.2

2.35

2.36

g/l

0.05

342

Disorder of bilirubin metabolism, other/unspecified

3.12

2.65

5.7

2.3

2.43

2.42

g/l

0.02

Disorders of puberty, all

603

1.47

2.64

3.8

2.6

2.52

2.57

g/l

0.32

551

Transient global amnesia

418

4836

0.85

2.63

2.3

2.6

2.36

2.30

g/l

1.14

384

4480

Trichomoniasis

360

1.63

2.63

2.6

2.1

2.34

2.38

g/l

0.23

330

Other demyelinating diseases of the central nervous system

189

1509

1.29

2.63

2.5

2.2

2.39

2.42

g/l

0.34

176

1407

Scarlet fever

248

1.74

2.61

4.6

1.9

2.58

2.53

g/l

0.29

236

Congenital deformities of feet

127

964

1.36

2.61

3.3

2.3

2.37

2.42

g/l

0.40

119

891

Other deformity of hallux (acquired)

321

1.67

2.60

2.4

2.3

2.38

2.35

g/l

0.11

299

Congenital deformities of feet

192

1537

1.28

2.60

2.9

2.3

2.41

g/l

0.07

176

1421

Use of galantamine

397

4602

0.84

2.60

2.0

2.4

2.27

2.25

g/l

0.31

344

4180

Phakomatoses, not elsewhere classified

433

1.56

2.60

3.5

2.5

2.22

2.41

g/l

1.71

407

Other congenital malformations of respiratory system

2.66

2.60

3.7

2.2

2.14

2.55

g/l

1.81

Torticollis

614

1.46

2.59

2.5

2.2

2.47

2.38

g/l

0.72

569

Thromboangiitis obliterans

154

2.03

2.59

3.4

2.2

2.54

2.29

g/l

1.05

131

Posteruptive colour changes of dental hard tissues

103

2.23

2.57

3.4

2.0

2.49

2.42

g/l

0.37

Optic atrophy

107

797

1.41

2.57

2.5

2.23

2.37

g/l

1.27

738

Inflammatory disease of cervix uteri

334

2834

1.21

2.55

2.1

2.3

2.44

2.38

g/l

1.23

295

2605

Non-allergic asthma

487

4253

1.17

2.52

2.5

2.6

2.39

2.34

g/l

1.15

451

3949

Alzheimer’s disease (Late onset)

1447

13136

0.92

2.51

2.0

2.5

2.17

2.23

g/l

4.42

1250

11904

Femoral hernia, unilateral

154

1210

1.32

2.51

2.7

2.4

2.33

2.29

g/l

0.37

142

1121

Inguinal of femoral hernia, unilateral

154

1210

1.32

2.51

2.7

2.4

2.33

2.29

g/l

0.37

142

1121

Inguinal hernia, unilateral

154

1210

1.32

2.51

2.7

2.4

2.33

2.29

g/l

0.37

142

1121

Other facial nerve disorders

152

1191

1.32

2.51

2.0

2.3

2.43

2.35

g/l

1.11

141

1104

Malignant neoplasm of respiratory system and intrathoracic organs

1265

9682

1.10

2.51

2.1

2.6

2.16

2.27

g/l

8.66

1190

8824

Non-small cell lung cancer, adenocarcinoma, helper endpoint

382

3289

1.19

2.50

2.1

2.5

2.15

2.27

g/l

3.40

360

3034

Disease of thymus, other/unspecified

2.69

2.49

1.7

2.3

2.52

2.36

g/l

0.49

Cholinergic urticaria

185

1.88

2.48

1.7

2.1

2.27

2.47

g/l

1.07

171

Acute appendicitis, with complications

1179

10830

1.10

2.47

2.7

2.6

2.36

2.32

g/l

1.58

1107

10068

Polypectomy (DHB20)

380

3271

1.19

2.46

2.3

2.6

2.31

2.29

g/l

0.38

358

3050

Complications of the puerperium, not elsewhere classified

199

1611

1.27

2.45

2.3

2.2

2.55

2.50

g/l

0.70

184

1501

Superficial injury of neck

104

775

1.39

2.45

1.9

2.3

2.46

2.39

g/l

0.61

710

Other disorders of breast

691

6184

1.13

2.45

2.2

2.3

2.43

2.42

g/l

0.11

637

5673

Crushed, pushed or stepped on by crowd or human stampede

360

3080

1.19

2.45

2.7

2.5

2.40

g/l

0.09

329

2861

Kaposi sarcoma, including Hilmo

2.93

2.44

2.8

2.3

2.27

2.21

g/l

0.10

Use of rasagiline

154

1219

1.32

2.43

1.8

2.6

2.39

2.28

g/l

1.43

129

1133

Scarlet fever

177

1.85

2.43

4.8

1.7

2.57

2.53

g/l

0.15

167

Cellulitis of external ear

507

1.50

2.43

2.9

2.3

2.37

g/l

0.04

465

Pityriasis lichenoides et varioliformis acuta

2.88

2.43

1.9

2.2

2.26

2.29

g/l

0.06

Contact with blunt object, undetermined intent

232

1.76

2.42

2.7

2.2

2.51

2.42

g/l

0.32

214

Impacted teeth

955

7720

1.11

2.42

2.8

2.2

2.48

2.50

g/l

0.57

909

7129

Other melanin hyperpigmentation

128

989

1.35

2.41

3.0

2.2

2.39

2.34

g/l

0.44

114

914

Patellar tendinitis

597

1.44

2.41

2.0

2.3

2.38

2.36

g/l

0.14

559

Other noninflammatory disorders of cervix uteri

257

2143

1.23

2.41

2.7

2.4

2.40

2.35

g/l

0.60

231

1973

Corneal degeneration

704

1.42

2.39

3.6

2.1

2.26

2.36

g/l

0.93

654

Benign neoplasm: Tonsil

501

1.50

2.38

2.1

2.43

2.37

g/l

0.40

464

Benign neoplasm: Skin of upper limb, including shoulder

115

877

1.37

2.38

3.1

2.2

2.28

2.36

g/l

0.95

107

814

Acute otitis externa, noninfective

704

1.41

2.37

3.5

2.2

2.43

2.36

g/l

0.60

656

Complications predominantly related to the puerperium

1377

12747

1.09

2.37

2.1

2.2

2.49

2.47

g/l

0.96

1270

11811

Foreign body entering into or through eye or natural orifice

434

3785

1.17

2.34

2.6

2.33

2.34

g/l

0.04

401

3515

LSIL lesion of the vagina

603

1.44

2.34

2.7

2.1

2.39

2.45

g/l

0.39

558

Vertical strabismus

181

1463

1.28

2.33

2.3

2.42

2.34

g/l

0.92

172

1358

Pituitary-dependent Cushing's disease

123

2.09

2.32

2.1

2.6

2.48

g/l

0.00

110

Sequelae of injuries involving multiple and unspecified body regions

2.42

2.31

1.9

2.0

2.39

2.38

g/l

0.01

HSIL lesion of the cervix uteri, vagina or vulva

1042

9551

1.10

2.29

2.5

2.2

2.43

2.48

g/l

2.71

938

8872

Malignant neoplasm of other and unspecified male genital organs, including Hilmo

2.62

2.27

3.1

2.8

2.11

2.19

g/l

0.21

Spasmodic torticollis

166

1333

1.28

2.27

2.0

2.3

2.41

2.38

g/l

0.32

150

1240

Pathological resorption of teeth

188

1531

1.26

2.27

2.9

2.5

2.34

g/l

0.07

172

1413

Multiple delivery

346

4011

0.85

2.26

2.2

2.6

2.49

2.43

g/l

0.96

315

3730

Other and unspecified disorders of binocular movement

206

1.78

2.25

2.8

2.1

2.29

2.45

g/l

1.00

187

Juvenile osteochondrosis

163

1306

1.28

2.25

2.8

2.3

2.37

2.41

g/l

0.28

148

1205

Injury of blood vessels at abdomen, lower back and pelvis level

185

1.85

2.24

4.4

2.4

2.43

2.31

g/l

0.56

169

Dementia due to Parkinsons disease, excluding more controls

133

1045

1.32

2.22

1.8

2.4

2.11

2.23

g/l

1.68

103

958

Overjet

126

975

1.33

2.21

4.3

2.6

2.59

2.53

g/l

0.44

118

916

Carcinoma in situ of other and unspecified genital organs

102

774

1.37

2.21

3.0

2.1

2.28

2.42

g/l

1.60

706

hereditary angioödema type 3

3.45

2.20

4.2

2.4

2.64

2.66

g/l

—

Benign neoplasm: Other parts of oropharynx

376

1.55

2.20

3.6

2.2

2.29

2.32

g/l

0.21

349

Findings of drugs and other substances, not normally found in blood

170

1.87

2.20

3.7

2.4

2.37

2.29

g/l

0.21

160

Disorders of globe

145

1153

1.30

2.19

3.5

2.3

2.26

2.32

g/l

0.61

132

1058

Congenital obstruction of the pelviureteric junction

319

1.60

2.19

4.5

2.1

2.31

2.42

g/l

0.49

294

Excessive and redundant skin and subcutaneous tissue

2.93

2.19

1.7

2.4

2.37

2.44

g/l

0.13

Pedestrian injured in collision with car, pick-up truck or van

134

1055

1.31

2.18

2.7

2.3

2.36

2.34

g/l

0.11

117

970

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

178

1448

1.27

2.18

2.1

2.4

2.40

2.36

g/l

0.46

163

1344

Immunodeficiency with increased immunoglobulin M [IgM]

6.90

2.18

2.0

1.5

2.46

2.55

g/l

—

Divergent concomitant strabismus

396

3451

1.17

2.18

2.5

2.4

2.43

2.39

g/l

0.91

366

3216

Ectopic pregnancy

907

8286

1.11

2.18

2.2

2.48

2.45

g/l

1.06

832

7727

Use of amantadine

689

1.39

2.17

1.6

2.2

2.41

2.32

g/l

0.66

635

Benign neoplasm of bone and articular cartilage

440

3864

1.16

2.17

2.3

2.4

2.42

2.37

g/l

1.13

410

3601

Injury of blood vessels at forearm level

126

2.02

2.17

3.4

2.5

2.11

2.33

g/l

0.84

116

Benign neoplasm: Skin of scalp and neck

141

1119

1.30

2.17

3.0

2.4

2.34

2.32

g/l

0.12

130

1034

Disorders of lacrimal system and orbit in diseases classified elsewhere

131

1030

1.31

2.16

2.5

2.2

2.43

2.39

g/l

0.31

121

952

Contact with other sharp object(s)

332

2860

1.18

2.13

2.5

2.42

2.39

g/l

0.44

305

2663

Loose body in joint

122

952

1.32

2.12

1.8

2.5

2.34

2.28

g/l

0.66

112

891

Benign neoplasm: Short bones of upper limb

649

1.40

2.12

2.0

2.2

2.40

2.39

g/l

0.05

598

Parkinson's disease, including avohilmo

1017

9369

1.10

2.11

2.1

2.6

2.25

2.26

g/l

0.21

909

8576

Use of rivastigmine

866

9428

0.90

2.10

2.0

2.5

2.21

2.25

g/l

1.06

762

8528

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, including Hilmo

273

1.63

2.10

1.9

2.1

2.36

2.30

g/l

0.29

252

Supervision of normal pregnancy

966

6025

0.91

2.10

1.8

2.3

2.52

g/l

0.06

888

5624

Graves ophthalmopathy, strict

116

903

1.33

2.08

2.6

2.2

2.43

2.40

g/l

0.21

107

833

Carcinoma in situ of cervix uteri

465

4109

1.15

2.08

2.5

2.2

2.44

2.49

g/l

0.99

412

3804

Other complications of labour and delivery, not elsewhere classified

466

4834

0.87

2.07

1.6

2.2

2.59

2.53

g/l

1.97

424

4467

Chronic mastoiditis

150

1208

1.29

2.07

3.4

2.5

2.30

2.29

g/l

0.05

142

1124

Benign neoplasm: Thymus

100

2.17

2.07

2.3

2.2

2.34

2.33

g/l

0.04

Other fibroblastic disorders

143

1.91

2.06

2.9

2.0

2.51

2.37

g/l

0.72

130

Persons encountering health services in circumstances related to reproduction

3427

22044

1.05

2.05

2.5

2.6

2.41

2.40

g/l

0.33

3206

20613

Caries in Clefts patients

347

1.54

2.05

2.6

2.5

2.33

2.44

g/l

0.57

320

Disorders of tyrosine metabolism

2.95

2.05

5.4

2.5

2.08

2.27

g/l

—

Periodontal disease, other/unspecified

140

1119

1.29

2.03

2.6

2.2

2.32

2.35

g/l

0.30

130

1035

Complications of anaesthesia during pregnancy

2.47

2.03

2.1

1.8

2.41

2.45

g/l

0.06

Chylothorax

124

2.07

2.03

2.5

2.3

2.20

2.34

g/l

0.42

111

Impacted maxillary molar

265

2251

1.20

2.02

3.0

2.1

2.48

2.52

g/l

0.59

254

2059

Subclinical iodine-deficiency hypothyroidism

2.78

2.02

2.5

1.9

2.19

2.34

g/l

0.30

Complications following abortion and ectopic and molar pregnancy

178

1463

1.25

2.01

2.1

2.3

2.40

2.39

g/l

0.07

153

1365

Failure in dosage during surgical and medical care

2.63

2.01

4.7

1.9

2.41

2.44

g/l

0.05

Transient retinal artery occlusion

109

2.12

2.00

3.4

2.1

2.19

2.31

g/l

0.33

Melanocytic naevi of other and unspecified parts of face

312

2694

1.18

2.00

2.8

2.3

2.41

2.37

g/l

0.68

295

2492

Hypotony of eye

2.67

2.00

2.9

1.6

2.20

2.41

g/l

0.53

Benign neoplasm: Skin of lower limb, including hip

153

1240

1.27

1.99

3.6

2.3

2.29

2.34

g/l

0.59

145

1148

R07AX Other respiratory system products

6.51

1.99

3.8

3.2

2.75

2.63

g/l

—

Disorders of glycine metabolism

4.43

1.99

5.8

1.4

2.35

2.25

g/l

—

Birth trauma

206

1.70

1.96

3.4

2.8

2.37

2.54

g/l

0.94

190

Other rupture of muscle

230

1.66

1.96

2.8

2.4

2.33

2.32

g/l

0.05

211

Other and unspecified disorders of refraction

3.35

1.96

2.3

2.8

1.99

2.31

g/l

—

Primary angle-closure glaucoma

258

2203

1.20

1.95

2.9

2.5

2.24

2.29

g/l

0.65

229

2018

Calculus of lower urinary tract

320

2784

1.18

1.91

2.8

2.7

2.23

g/l

0.04

287

2583

Torsion of ovary, ovarian pedicle and fallopian tube

105

815

1.32

1.91

1.9

2.2

2.50

2.44

g/l

0.62

752

Spirochaetal infections, other/unspecified

477

4255

1.14

1.91

2.4

2.5

2.33

2.32

g/l

0.15

436

3966

Abnormal spermatozoa

773

7078

1.11

1.91

2.7

2.8

2.24

2.23

g/l

0.12

678

6591

Caught, crushed, jammed or pinched in or between objects

257

2195

1.19

1.90

2.7

2.5

2.37

2.35

g/l

0.29

246

2044

Benign neoplasm: other/unspecified salivary gland

150

1222

1.27

1.89

3.0

2.5

2.26

2.31

g/l

0.54

137

1131

Idiopathic hypoparathyroidism

133

1.92

1.88

4.5

2.3

2.38

2.33

g/l

0.17

122

Certain zoonotic bacterial diseases

100

776

1.34

1.88

2.8

2.2

2.35

2.33

g/l

0.12

720

Glaucoma-related operations

342

2996

1.17

1.87

2.5

2.25

2.29

g/l

0.61

318

2745

Struck by thrown, projected or falling objec

259

2217

1.19

1.87

2.4

2.5

2.38

2.34

g/l

0.68

240

2063

Unspecified lump in breast

852

7833

1.10

1.86

2.3

2.40

g/l

0.00

799

7177

Graves ophthalmopathy

128

1026

1.29

1.85

2.5

2.2

2.42

2.39

g/l

0.24

118

949

Toxic effect of contact with venomous animals

214

1807

1.21

1.84

2.1

2.5

2.36

2.35

g/l

0.15

197

1676

Anisometropia and aniseikonia

166

1370

1.25

1.83

3.0

2.4

2.39

2.36

g/l

0.25

149

1271

Benign neoplasm: Conjunctiva

174

1444

1.24

1.83

2.8

2.4

2.37

2.34

g/l

0.34

167

1342

All dysplastic lesions of the cervix uteri

1354

12564

1.08

1.82

2.4

2.2

2.44

2.49

g/l

2.76

1234

11671

Other osteochondrodysplasias

316

1.53

1.82

2.0

2.2

2.50

2.46

g/l

0.16

292

Generalized epilepsy, mode (most common among epilepsy diagnosis)

156

1280

1.25

1.81

2.3

2.4

2.37

2.40

g/l

0.29

146

1183

Mental and behavioural disorders associated with the puerperium

392

1.46

1.78

2.9

2.2

2.63

2.48

g/l

0.85

360

Erythrasma

2.25

1.77

4.6

2.3

2.49

2.33

g/l

0.41

Dislocation, sprain and strain of joints and ligaments of elbow

312

2722

1.16

1.76

2.5

2.4

2.52

2.42

g/l

2.12

294

2517

Other and unspecified mental retardation

657

1.35

1.74

2.8

2.9

2.48

2.47

g/l

0.06

631

Chronic drug-induced interstitial lung disorders

2.33

1.74

3.2

2.3

2.37

2.29

g/l

0.23

Occupational exposure to risk-factors

186

1563

1.22

1.73

1.9

2.6

2.31

2.28

g/l

0.36

170

1453

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

129

1046

1.27

1.72

2.8

2.4

2.44

2.35

g/l

0.95

117

974

Congenital lactase deficiency

2.13

1.70

3.8

1.9

2.68

2.44

g/l

0.83

Carcinoma in situ of penis

2.17

1.70

3.3

2.2

2.25

2.24

g/l

0.03

Pneumoconiosis due to asbestos and other mineral fibres

134

1094

1.27

1.70

2.8

2.7

2.27

2.16

g/l

1.48

119

1010

Third [oculomotor] nerve palsy

103

816

1.31

1.70

4.7

2.5

2.16

2.29

g/l

1.52

756

Migraine, unspecified, drug-induced

272

1.56

1.70

2.2

2.33

2.45

g/l

0.73

254

Congenital malformations of uterus and cervix

100

787

1.31

1.69

2.3

2.2

2.46

2.49

g/l

0.16

718

Hypothyroidism, autoimmune, DX-based

137

1.81

1.67

2.0

2.1

2.56

2.45

g/l

0.42

124

HSIL lesion of the cervix uteri

921

8535

1.09

1.66

2.4

2.2

2.44

2.49

g/l

1.98

832

7930

Ménière disease

537

4868

1.12

1.65

2.2

2.4

2.40

2.32

g/l

2.84

490

4489

Tetraplegia

308

1.51

1.64

3.6

2.2

2.25

2.34

g/l

0.41

285

Enterohaemorrhagic Escherichia coli infection

2.19

1.63

3.5

1.9

2.46

2.44

g/l

0.05

Hereditary lymphedema

2.35

1.63

1.6

2.5

2.49

2.38

g/l

0.22

Parkinson's disease

961

8943

1.09

1.63

2.1

2.6

2.25

2.26

g/l

0.11

858

8201

MS-disease / Multiple Sclerosis

357

3162

1.15

1.63

2.0

2.3

2.48

2.42

g/l

1.20

325

2932

Von Hippel-Lindau syndrome

3.04

1.63

3.3

1.6

2.26

2.45

g/l

—

Changes in corneal membranes

124

1.86

1.62

2.3

2.2

2.26

2.38

g/l

0.63

115

Other specified disorders of external ear

214

1834

1.20

1.62

2.8

2.6

2.31

2.27

g/l

0.39

192

1704

Amoebiasis

325

1.49

1.61

2.7

2.1

2.35

2.40

g/l

0.23

298

Unspecified abortion

236

2033

1.18

1.61

2.8

2.3

2.44

g/l

0.01

216

1913

Burns and corrosions confined to eye and internal organs

132

1080

1.25

1.61

2.2

2.3

2.33

2.37

g/l

0.28

122

1009

Benign neoplasm: Other/unspecified site

699

1.32

1.59

2.2

2.35

2.34

g/l

0.05

649

Use of glatiramer acetate

609

1.34

1.58

2.3

2.1

2.57

2.45

g/l

1.16

564

Other/unspecified mastoiditis and related conditions

212

1.62

1.57

2.7

2.1

2.16

2.36

g/l

1.47

192

Malignant neoplasms of independent (primary) multiple sites

3.35

1.56

3.5

1.5

1.71

2.29

g/l

—

Deaf mutism, not elsewhere classified

196

1.63

1.55

3.5

2.2

2.47

2.34

g/l

0.49

179

Benign neoplasm of other and unspecified sites

176

1489

1.21

1.55

2.2

2.4

2.36

2.34

g/l

0.21

160

1390

Congenital malformations of ovaries, fallopian tubes and broad ligaments

264

2301

1.17

1.55

2.3

2.2

2.53

2.48

g/l

0.92

245

2138

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

690

1.31

1.54

1.8

2.1

2.49

2.50

g/l

0.06

645

Melanoma in situ

252

2197

1.17

1.54

3.2

2.5

2.25

2.29

g/l

0.66

233

2036

Vestibular neuronitis

491

4450

1.12

1.54

2.6

2.5

2.39

2.32

g/l

2.15

449

4124

Acute alcohol intoxication ICD-9

181

1536

1.21

1.53

2.7

2.6

2.31

2.28

g/l

0.35

163

1436

Sequelae of poliomyelitis

424

1.42

1.53

2.4

2.2

2.22

2.26

g/l

0.20

389

Congenital malformations of breast

613

1.33

1.52

2.1

2.45

2.49

g/l

0.31

554

Disorders of branched-chain amino-acid metabolism, other/unspecified

4.10

1.52

1.4

1.2

2.58

2.54

g/l

—

Chalazion

619

5675

1.10

1.51

2.6

2.5

2.37

2.35

g/l

0.61

569

5265

Malignant neoplasm of parotid gland, including Hilmo

372

1.43

1.51

2.8

2.2

2.18

2.27

g/l

0.57

347

Histrionic personality disorder

198

1.62

1.50

1.9

2.1

2.41

2.38

g/l

0.11

184

Benign neoplasm of male genital organs

118

966

1.26

1.50

2.6

2.8

2.13

2.21

g/l

0.87

105

902

Cardiovascular disorders originating in the perinatal period

142

1.74

1.49

5.9

3.5

2.57

2.62

g/l

0.22

133

Frostbite

424

1.40

1.49

2.7

2.3

2.18

2.32

g/l

1.05

391

Benign neoplasm: Endocrine gland, other/unspecified

135

1.77

1.49

1.7

2.5

2.41

2.32

g/l

0.17

124

Malignant neoplasm of parotid gland

297

1.48

1.49

3.0

2.1

2.16

2.27

g/l

0.66

279

Use of ropinirole

200

1722

1.19

1.47

2.3

2.6

2.33

2.28

g/l

0.54

173

1602

Sequelae of poliomyelitis

350

1.45

1.46

2.5

2.2

2.24

2.27

g/l

0.09

319

Mental and behavioural disorders of puerperium, not classified elsewhere

408

1.40

1.46

2.9

2.1

2.63

2.48

g/l

0.84

372

Congenital retinoschisis

113

1.85

1.45

1.7

2.3

2.41

2.30

g/l

0.48

103

Other degenerative diseases of the basal ganglia

107

873

1.27

1.44

2.1

2.6

2.12

2.25

g/l

1.38

815

Abscess of spleen

2.84

1.43

7.9

1.8

2.00

2.49

g/l

—

Abrasion of teeth

1999

19094

1.05

1.41

2.5

2.4

2.40

2.37

g/l

1.38

1845

17729

Reduction defects of lower limb

121

1.77

1.41

3.2

2.4

2.31

2.39

g/l

0.25

115

Pityriasis rosea

275

1.48

1.40

2.1

2.0

2.60

2.43

g/l

1.04

258

Other bursal cyst

658

1.30

1.40

3.1

2.3

2.27

2.32

g/l

0.42

614

Desensitization to allergens

245

2143

1.16

1.39

2.0

2.3

2.48

2.47

g/l

0.19

233

1985

Syndactyly

2.06

1.38

1.8

2.3

2.58

2.46

g/l

0.37

Prolapse and hernia of ovary and fallopian tube

215

1851

1.17

1.37

2.2

2.3

2.35

2.29

g/l

0.83

197

1654

Benign neoplasm: Lip

119

987

1.24

1.35

2.4

2.3

2.34

2.32

g/l

0.14

105

912

Forearm

2.56

1.35

1.8

1.7

2.40

2.43

g/l

—

Congenital malformations of breast

669

1.29

1.35

2.1

2.45

2.50

g/l

0.43

603

Antepartum haemorrhage, not elsewhere classified

413

3737

1.12

1.34

2.2

2.3

2.51

2.50

g/l

0.15

381

3489

Alzheimer disease

2104

16068

0.95

1.33

2.1

2.5

2.18

2.24

g/l

5.99

1829

14614

Perichondritis of external ear

808

1.27

1.32

2.6

2.4

2.47

2.30

g/l

2.59

748

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

477

1.34

1.32

2.5

2.1

2.44

2.46

g/l

0.10

442

Parkinson's disease, strict definition

889

8330

1.08

1.31

2.1

2.6

2.25

2.26

g/l

0.11

790

7637

Right side

282

1.48

1.31

2.7

2.4

2.51

2.29

g/l

2.05

257

Contact with machinery

599

5529

1.10

1.31

2.8

2.7

2.31

2.28

g/l

0.68

555

5181

Kwashiorkor

2.11

1.30

4.8

2.0

2.23

2.39

g/l

0.38

Exposure to other and unspecified man-made environmental factors

638

1.29

3.1

2.2

2.44

2.36

g/l

0.54

591

Other specified and unspecified disorders of lens

411

1.38

1.28

3.0

2.4

2.39

2.28

g/l

0.54

375

Preterm labour and delivery

1329

12596

1.06

1.28

2.4

2.3

2.48

2.45

g/l

1.51

1211

11697

Foreign body in genitourinary tract

402

1.37

1.27

2.4

2.2

2.23

2.38

g/l

1.15

373

Diaper [napkin] dermatitis

2.14

1.26

7.4

3.2

2.35

2.42

g/l

0.13

Malignant neoplasm of nasal cavity and middle ear, including Hilmo

256

1.47

1.26

1.7

2.2

2.17

2.26

g/l

0.38

235

Pregnancy with abortive outcome

4255

21536

1.03

1.24

2.3

2.2

2.44

g/l

0.31

3887

19782

Bacterial meningitis

172

1484

1.18

1.24

2.8

2.5

2.33

2.35

g/l

0.11

167

1385

HSIL lesion of the vagina

571

1.30

1.24

4.1

2.2

2.22

2.45

g/l

2.51

524

Malignant neoplasm of ureter

1.83

1.23

2.4

2.5

2.06

2.23

g/l

0.35

Soft tissue disorders in diseases classified elsewhere

2.77

1.23

1.7

2.4

2.31

g/l

—

L02BG Aromatase inhibitors

1712

16338

1.05

1.22

2.0

2.4

2.41

2.38

g/l

1.41

1563

14971

Other benign neoplasms of uterus

299

2684

1.13

1.21

2.2

2.3

2.39

2.35

g/l

0.50

252

2446

Other adrenocortical overactivity

208

1.51

1.21

3.9

2.5

2.31

2.53

g/l

1.43

189

Benign neoplasm of brain and other parts of central nervous system

339

3062

1.12

1.21

2.4

2.5

2.33

g/l

0.04

308

2841

Disorders of optic chiasm

2.65

1.20

1.0

2.3

2.14

2.38

g/l

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

509

4687

1.10

1.20

2.8

2.5

2.34

2.32

g/l

0.30

481

4376

Benign neoplasm: Connective and other soft tissue of head, face and neck

681

1.27

1.20

2.0

2.2

2.43

2.36

g/l

0.62

633

Hypergammalglobulinemia, unspecified

2.21

1.17

9.6

1.6

1.95

2.44

g/l

—

Postpartum care and examination

707

4167

1.08

1.17

2.1

2.2

2.57

2.55

g/l

0.48

633

3864

Benign neoplasm of thyroid gland

167

1447

1.18

1.16

2.3

2.2

2.41

2.36

g/l

0.55

153

1334

Acute myringitis

278

1.43

1.16

3.8

2.4

2.42

2.38

g/l

0.15

258

Keratoconus

116

975

1.22

1.16

2.8

2.4

2.37

2.36

g/l

0.05

108

906

Toxic effect of other noxious substances eaten as food

145

1.61

1.14

2.3

2.0

2.36

2.34

g/l

0.05

129

Congenital ovarian cysts

200

1756

1.16

1.14

2.1

2.55

2.48

g/l

0.97

186

1627

Other specified and unspecified strabismus

444

1.32

1.14

2.9

2.1

2.37

2.43

g/l

0.26

408

Disorder of thyroid, unspecified

552

1.29

1.13

3.1

2.0

2.45

2.37

g/l

0.45

503

Actinomycosis

162

1.57

1.12

4.3

2.0

2.32

2.44

g/l

0.42

147

Malignant otitis externa

2.00

1.10

9.5

1.7

2.19

2.49

g/l

0.80

Toxic effect of other gases, fumes and vapours

204

1.49

1.10

4.3

1.9

2.46

2.41

g/l

0.14

191

Foreign body in ear

780

1.23

1.09

3.5

2.3

2.47

2.40

g/l

0.43

728

Myxoedema coma

2.63

1.09

2.6

1.6

2.11

2.45

g/l

—

Carcinoma in situ of anus and anal canal

2.09

1.08

3.1

1.8

2.26

2.40

g/l

—

Contact with hypodermic needle

171

1.52

1.08

1.5

2.2

2.58

2.48

g/l

0.56

155

Benign neoplasm: Spinal meninges

449

1.32

1.08

2.8

2.2

2.28

2.35

g/l

0.39

413

Distal bite

173

1501

1.16

1.08

3.8

2.5

2.54

g/l

0.02

161

1401

Other benign neoplasm of uterus: Other parts/unspecified

234

2091

1.14

1.07

2.0

2.2

2.37

2.34

g/l

0.27

195

1896

Hereditary retinal dystrophy

592

1.27

1.07

3.2

2.2

2.35

2.37

g/l

0.11

548

Other congenital malformations of brain

172

1.52

1.07

3.5

2.7

2.46

2.52

g/l

0.22

159

Viral conjunctivitis

819

1.22

1.06

3.1

2.2

2.33

2.39

g/l

0.46

762

Premature rupture of membranes

995

7521

0.94

1.05

1.8

2.2

2.56

2.50

g/l

3.06

905

6975

Eccrine sweat disorders

1.75

1.05

3.4

2.0

2.59

2.46

g/l

0.27

Mandibular prognathia

593

1.26

1.05

2.8

2.7

2.47

2.44

g/l

0.17

555

Glycogen storage disease

2.23

1.04

8.7

2.2

2.27

2.47

g/l

—

Myopathy due to other toxic agents

2.65

1.03

3.7

1.6

2.21

2.52

g/l

—

Meningitis, viral

166

1.52

1.01

3.9

2.3

2.25

2.47

g/l

1.20

151

Dyshidrosis [pompholyx]

614

1.25

1.01

2.1

2.2

2.39

2.38

g/l

0.07

558

Postpartum hemorraghe, parous women as controls

1244

10094

1.05

1.01

1.9

2.1

2.54

2.50

g/l

1.41

1125

9364

Actinomycosis

142

1.56

0.99

4.7

1.9

2.34

2.44

g/l

0.31

130

Traumatic amputation of forearm

2.48

0.99

4.5

1.4

2.35

2.33

g/l

—

Defect, injury or illness of neck

209

1.45

0.99

1.9

2.3

2.47

2.38

g/l

0.31

191

Dermatitis due to ingested food

151

1261

1.16

0.98

2.7

2.48

2.58

g/l

1.35

145

1184

Lesion of sciatic nerve

241

2168

1.13

0.98

2.3

2.4

2.36

2.26

g/l

2.32

222

1991

Cyst of Bartholin Gland

171

1505

1.15

0.98

2.0

2.2

2.53

2.45

g/l

0.99

160

1400

Other hypertrophic osteoarthropathy

2.40

0.97

2.2

2.5

2.06

2.39

g/l

—

Deformity of finger(s)

227

1.42

0.97

2.8

2.4

2.32

g/l

0.01

214

Other abnormal products of conception

1699

10802

1.05

0.96

2.2

2.50

g/l

0.05

1579

10040

Persistent hyperplasia of thymus

2.35

0.96

3.2

1.8

2.08

2.38

g/l

—

Obstructed labour due to maternal pelvic abnormality

675

7178

0.93

0.96

2.6

2.3

2.43

2.42

g/l

0.13

630

6677

Compression of brain

2.12

0.96

4.6

2.4

1.90

2.48

g/l

—

Other disorders of breast and lactation associated with childbirth

646

1.23

0.95

1.7

2.1

2.49

2.51

g/l

0.18

592

Dysplastic lesion of unknown severity of the cervix uteri

368

1.32

0.94

2.7

2.0

2.52

2.47

g/l

0.24

342

Hydrocephalus

365

3962

0.91

0.94

2.4

2.5

2.24

2.29

g/l

0.87

330

3629

Occupant of pick-up truck or van injured in other and unspecified transport accidents

203

1.44

0.94

2.9

2.2

2.33

2.38

g/l

0.18

189

Use of levodopa decarbox-comt-inhibitor

177

1573

1.15

0.92

2.1

2.6

2.28

2.25

g/l

0.40

160

1455

Benign neoplasm: Long bones of lower limb

155

1364

1.15

0.92

2.4

2.3

2.41

2.38

g/l

0.30

146

1260

Crystalline deposits in vitreous body

425

1.30

0.92

2.4

2.3

2.37

2.27

g/l

0.59

389

Glaucoma, exfoliation

679

6402

1.07

0.91

2.2

2.4

2.25

2.26

g/l

0.26

617

5802

Cardiovascular devices associated with adverse incidents

2.01

0.91

7.0

2.6

2.29

2.33

g/l

—

Other changes in lacrimal passages

1.93

0.91

1.8

2.4

2.60

2.52

g/l

—

Malignant neoplasm of gum

162

1.49

0.91

1.7

2.3

1.93

2.33

g/l

2.63

150

Early lumbar disc prolapse operation

489

4555

1.08

0.91

2.2

2.4

2.53

2.44

g/l

3.07

457

4270

Antenatal screening

1055

6222

0.95

0.91

2.0

2.3

2.51

2.52

g/l

0.04

972

5812

Other congenital musculoskeletal deformities

120

1.57

0.91

2.4

2.5

2.66

2.59

g/l

0.19

114

Intermittent hydrarthrosis

1.74

0.91

2.1

2.5

2.38

2.32

g/l

0.17

Pemphigus vegetans

0.00

0.87

0.0

2.9

—

2.45

—

Circumscribed brain atrophy

1022

0.83

0.87

2.2

2.5

2.25

2.28

g/l

0.15

954

Disorders of acoustic nerve

138

1213

1.16

0.86

2.1

2.3

2.34

2.32

g/l

0.08

124

1127

Contraceptive management

2255

15311

1.04

0.86

2.4

2.5

2.45

2.42

g/l

2.32

2099

14324

Noise effects on inner ear

171

1916

0.88

0.86

2.4

2.8

2.32

2.26

g/l

0.81

159

1798

Other menopausal disorders

1487

8050

1.05

0.85

2.1

2.3

2.45

2.38

g/l

4.27

1358

7430

Other disorders of thyroid

592

1.23

0.85

3.3

2.2

2.44

2.40

g/l

0.24

546

Acute disseminated encephalitis/encephalomyelitis

1.85

0.85

2.4

2.1

2.68

2.48

g/l

—

Senile degeneration of the brain, not elsewhere classified

182

1.45

0.84

2.6

2.3

2.22

2.23

g/l

0.03

159

Abnormal findings on diagnostic imaging of breast

612

1.22

0.83

2.1

2.0

2.47

2.42

g/l

0.27

563

Small cell lung cancer

945

0.83

2.2

2.3

2.20

2.23

g/l

0.21

857

Small cell lung cancer, including Hilmo

945

0.83

2.2

2.3

2.20

2.23

g/l

0.21

857

Single delivery by caesarean section

911

5492

0.95

0.83

2.1

2.5

2.53

2.49

g/l

1.01

838

5117

Puerperal sepsis

616

5810

1.07

0.82

2.2

2.3

2.45

2.42

g/l

0.60

571

5396

Tularaemia

549

1.23

0.82

2.5

2.2

2.46

2.33

g/l

1.25

512

Superficial frostbite

261

1.35

0.81

3.4

2.2

2.12

2.32

g/l

1.32

235

Ophthalmic devices associated with adverse incidents

1.90

0.81

1.7

2.0

2.10

2.36

g/l

—

286

2615

1.10

0.81

3.0

2.2

2.35

2.28

g/l

1.39

263

2340

Burn and corrosion confined to eye and adnexa

106

918

1.17

0.81

2.1

2.4

2.38

g/l

0.02

858

Other congenital musculoskeletal deformities

107

1.57

0.81

2.6

2.7

2.68

2.60

g/l

0.19

101

Traumatic subcutaneous emphysema

1.83

0.81

1.8

2.7

2.00

2.23

g/l

—

Other combined immunodeficiencies

1.81

0.80

3.2

1.7

1.99

2.46

g/l

—

Respiratory tuberculosis, not confirmed

218

1978

1.12

0.80

2.5

2.23

2.25

g/l

0.35

203

1809

Generalized epilepsy, strict definition

106

919

1.17

0.80

2.1

2.4

2.46

2.43

g/l

0.25

848

Hereditary ataxia

569

1.23

0.80

3.0

2.4

2.23

2.32

g/l

0.57

524

Gonococcal infection

145

1285

1.14

0.80

2.4

2.3

2.37

2.38

g/l

0.08

134

1187

Lymphocyte function antigen-1 [LFA-1] defect

2.06

0.80

1.9

3.0

2.43

2.23

g/l

—

Drug-induced fever

1.72

0.78

2.3

2.2

2.29

2.34

g/l

0.09

Photocontact dermatitis [berloque dermatitis]

1.82

0.78

2.1

2.6

2.36

2.48

g/l

—

Injury of heart

109

1.58

0.78

3.4

2.2

2.63

2.22

g/l

1.70

Brain glioblastoma and astrocytoma

623

0.80

0.77

1.4

2.3

2.28

2.33

g/l

0.23

581

Prominent ears

298

1.30

0.77

2.4

2.1

2.52

g/l

0.03

271

Obstructive hydrocephalus

664

1.20

0.76

2.5

2.4

2.27

2.34

g/l

0.49

616

Failed induction of labour

266

2441

1.10

0.76

2.0

2.2

2.65

2.51

g/l

3.67

247

2258

Chronic thyroiditis

160

1.44

0.76

2.0

1.8

2.52

2.39

g/l

0.39

141

Other infestations

110

1.56

0.75

2.0

2.3

2.41

2.29

g/l

0.38

100

Other cestode infections

144

0.60

0.75

1.4

2.0

2.39

2.30

g/l

—

127

Mucinous and mucinous cystic tumor

158

0.61

0.75

2.3

1.9

2.12

2.43

g/l

—

147

Rheumatic fever without mention of heart involvement

135

1.48

0.74

3.7

2.6

2.58

2.35

g/l

0.90

121

Traumatic amputation of wrist and hand

215

1959

1.11

0.74

2.8

2.7

2.34

2.26

g/l

1.06

202

1830

Malignant neoplasm of bronchus and lung

1060

8440

1.05

0.74

2.1

2.6

2.16

2.26

g/l

6.28

993

7675

Nontoxic diffuse goitre

152

1360

1.13

0.74

2.7

2.2

2.35

g/l

0.00

139

1256

Otorrhoea

110

1.54

0.74

5.4

2.8

2.26

2.44

g/l

0.69

102

General autosomal fish scale disease

1.83

0.74

3.0

1.9

2.51

2.47

g/l

—

Injury of muscle and tendon at ankle and foot level

114

1003

1.15

0.72

2.3

2.30

2.37

g/l

0.64

105

929

Cerebral oedema

0.50

0.72

5.4

2.4

2.37

2.39

g/l

—

Diphyllobothriasis and sparganosis

2.00

0.72

1.8

1.3

2.60

2.53

g/l

—

Other or unspecified paralytic strabismus

276

1.31

0.71

2.4

1.9

2.33

2.36

g/l

0.09

252

Viral infections of central nervous system, not elsewhere classified/unspecified

429

1.24

0.71

2.5

2.0

2.38

2.39

g/l

0.05

399

Hair colour and hair shaft abnormalities

171

1.41

0.71

3.3

2.3

2.32

2.23

g/l

0.39

158

Benign neoplasm: Choroid

325

3024

1.09

0.71

2.6

2.5

2.28

2.31

g/l

0.40

293

2807

Environmental-pollution-related condition

1.75

0.71

4.6

2.4

2.67

2.50

g/l

—

Postpartum haemorrhage due to anatomy

461

4335

1.07

0.71

1.9

2.0

2.54

2.55

g/l

0.11

413

3988

Other congenital malformations of ear

429

1.24

0.70

2.3

2.2

2.50

g/l

0.04

396

331

1.28

0.70

3.5

2.4

2.41

2.23

g/l

0.97

293

Melanoma in situ of other and unspecified parts of face

598

1.21

0.70

4.0

2.5

2.22

2.27

g/l

0.43

548

Iodine-deficiency-related thyroid disorders and allied conditions

1.85

0.69

2.4

1.9

2.50

2.44

g/l

—

Other benign neoplasm of uterus: Corpus uteri

323

1.28

0.68

3.0

2.2

2.42

g/l

0.00

296

Disorders of sexual preference

1.59

0.68

1.6

2.4

2.41

2.37

g/l

0.07

Viral haemorrhagic fevers, not elsewhere classified/unspecified

401

3764

1.07

0.68

2.8

2.5

2.31

2.32

g/l

0.12

380

3506

Viral infections of central nervous system, not elsewhere classified/unspecified

561

1.20

0.67

2.4

2.2

2.38

2.37

g/l

0.06

517

Motorcycle rider injured in other and unspecified transport accidents

253

2334

1.09

0.67

2.4

2.5

2.36

2.37

g/l

0.16

239

2176

Other specified/unspecified disorders of tympanic membrane

164

0.64

0.66

4.8

2.2

2.60

2.34

g/l

0.96

148

Rheumatoid lung disease

209

1.35

0.66

1.9

2.5

2.29

2.30

g/l

0.03

189

Carcinoma in situ of skin of eyelid, including canthus

105

1.53

0.66

4.0

2.7

2.27

2.25

g/l

0.05

Other chromosome abnormalities, not elsewhere classified

182

1.37

0.66

1.8

3.4

2.42

2.59

g/l

1.17

177

Congenital retinoschisis

1.58

0.66

1.5

2.4

2.52

2.31

g/l

1.07

Alzheimer disease, including avohilmo

2488

17949

0.97

0.65

2.0

2.5

2.20

2.25

g/l

3.50

2182

16363

Ankylosis of teeth

1.52

0.65

7.2

2.3

2.26

2.46

g/l

0.86

Iodine-deficiency-related goitre

1.69

0.65

2.0

2.1

2.48

2.39

g/l

—

Oesophagitis, drug-induced

114

1.50

0.65

3.3

2.6

2.49

2.30

g/l

0.75

101

LSIL lesion of the cervix uteri

537

5092

1.06

0.65

2.4

2.1

2.44

2.48

g/l

1.10

494

4724

Other/unspecified postprocedural disorders of ear and mastoid process

140

1.44

0.64

2.7

2.3

2.11

2.32

g/l

1.04

127

Congenital heart conduction disorder

1.67

0.64

2.1

2.8

2.52

2.59

g/l

—

Undefined dementia

673

6493

0.95

0.63

2.3

2.4

2.18

2.22

g/l

1.11

582

5817

Anomalies of pupillary function

855

1.15

0.63

1.9

2.3

2.44

2.42

g/l

0.17

794

Xanthelasma of eyelid

382

1.24

0.63

2.9

2.1

2.36

2.37

g/l

0.06

351

Supernumerary ureter

1.66

0.62

7.4

2.4

2.42

2.59

g/l

—

Gonococcal infection

152

1376

1.12

0.62

2.4

2.3

2.35

2.37

g/l

0.17

140

1268

Maxillary prognathism

197

0.69

0.62

2.5

2.61

2.51

g/l

0.39

179

Subarachnoid haemorrhage

565

5375

1.06

0.62

2.9

2.4

2.26

2.29

g/l

0.58

513

4950

Benign neoplasm: Vulva

877

1.15

0.61

2.7

2.2

2.38

2.40

g/l

0.17

811

Otitis media in diseases classified elsewhere

1.82

0.61

1.2

2.4

2.83

2.38

g/l

—

Cleft lip, lip and palate or palate

567

1.18

0.60

2.7

2.4

2.35

2.45

g/l

0.66

523

Malignant neoplasm of nasopharynx, including Hilmo

167

1.36

0.60

2.1

2.2

2.40

2.33

g/l

0.20

153

Birth injury to peripheral nervous system

1.48

0.59

3.1

2.4

2.62

2.53

g/l

0.20

conjunctival degenerations and deposits

107

955

1.14

0.59

2.5

2.3

2.42

2.34

g/l

0.91

100

881

Merkel cell carcinoma of skin

1.60

0.59

2.1

2.4

2.22

2.18

g/l

—

Malignant neoplasm of brain

119

1323

0.89

0.58

1.6

2.6

2.29

2.34

g/l

0.34

110

1226

Dengue fever [classical dengue]

1.58

0.57

1.7

2.5

2.51

g/l

—

Abuse of non-dependence-producing substances

1.54

0.57

1.9

2.3

2.66

2.36

g/l

—

Injury of muscle and tendon at neck level

1.55

0.57

1.3

2.6

2.39

2.42

g/l

—

Other disorders of amniotic fluid and membranes

652

6091

1.05

0.57

1.8

2.3

2.56

2.50

g/l

1.77

588

5657

Placenta praevia

198

1826

1.09

0.56

2.0

2.3

2.54

2.49

g/l

0.66

178

1711

Hydatidiform mole

553

1.18

0.56

2.0

2.2

2.44

2.45

g/l

0.09

517

Use of trihexyphenidyl

1.52

0.56

1.9

2.0

2.14

2.28

g/l

—

Hereditary angioödema type 1

1.64

0.56

3.0

2.0

2.50

2.45

g/l

—

Traumatic secondary and recurrent haemorrhage

1.58

0.56

4.5

1.8

2.48

2.26

g/l

0.54

Pterygium

156

1428

1.11

0.55

2.4

2.5

2.31

2.26

g/l

0.60

140

1323

478

4550

1.06

0.55

2.3

2.6

1.91

2.25

g/l

16.94

431

4229

Malignant neoplasm of nasal cavity and middle ear

162

1.34

0.53

1.6

2.4

2.34

2.26

g/l

0.23

148

Other acantholytic disorders

146

1.38

0.52

6.2

2.4

2.17

2.24

g/l

0.21

129

Other congenital malformations of face and neck

131

1192

1.11

0.52

3.0

2.2

2.34

2.40

g/l

0.54

124

1107

Otosclerosis

350

3698

0.94

0.51

2.6

2.34

2.31

g/l

0.29

334

3430

Medical treatment for female infertility

1020

9814

1.04

0.51

2.0

2.2

2.52

2.51

g/l

0.39

940

9115

Benign neoplasm: Prostate

346

1.22

0.51

2.5

2.08

2.22

g/l

1.23

318

Cleft palate

354

1.21

0.50

2.6

2.4

2.35

2.45

g/l

0.50

323

Benign neoplasm: Spinal cord

607

1.16

0.50

2.1

2.2

2.33

2.36

g/l

0.18

562

Bullous keratopathy

402

1.20

0.50

2.4

2.31

g/l

0.00

360

Postpolio syndrome

1.46

0.50

2.5

2.2

2.43

2.25

g/l

0.71

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

154

1417

1.10

0.50

2.4

2.24

2.25

g/l

0.11

142

1301

Exposure to excessive heat of man-made origin

366

1.20

0.48

3.1

2.2

2.25

2.33

g/l

0.39

334

Chronic postrheumatic arthropathy [Jaccoud]

1.46

0.47

1.4

2.1

2.25

2.38

g/l

—

Benign neoplasm: Ribs, sternum and clavicle

1.44

0.47

2.5

2.3

2.79

2.36

g/l

2.20

Accidental poisoning by and exposure to alcohol

686

1.14

0.46

2.8

2.3

2.45

2.36

g/l

0.63

624

Pedal cyclist injured in collision with motor vehicle

120

1312

0.91

0.46

1.7

2.3

2.45

2.37

g/l

0.87

108

1218

Other and unspecified heterotropia

131

1.35

0.45

3.2

2.0

2.36

2.39

g/l

0.06

122

Benign neoplasm: Renal pelvis

1.48

0.45

3.3

2.6

1.97

2.28

g/l

—

Congenital malformations of ear causing impairment of hearing

140

1.33

0.45

4.1

2.1

2.57

2.43

g/l

0.68

124

Poikiloderma of Civatte

1.51

0.45

1.1

2.4

2.32

2.42

g/l

—

Cholera

1.46

0.44

2.1

2.5

2.20

2.40

g/l

—

Clubfoot

350

1.19

0.44

2.7

2.3

2.33

2.42

g/l

0.53

328

Malignant neoplasm of other and unspecified male genital organs

1.63

0.44

1.8

2.3

2.02

2.14

g/l

—

Sexual assault by bodily force

1.48

0.44

1.2

2.1

2.75

2.56

g/l

—

Benign neoplasm: Cranial nerves

144

1333

1.09

0.43

2.0

2.3

2.33

g/l

0.00

128

1236

Labour and delivery complicated by umbilical cord complications

194

2073

0.93

0.43

2.1

2.3

2.50

2.47

g/l

0.33

176

1930

Alopecia universalis

1.39

0.42

1.7

2.5

2.42

2.50

g/l

0.20

Medicines for HER+ breast cancer

2110

19621

1.02

0.41

2.1

2.4

2.42

2.39

g/l

1.62

1929

17988

Melanoma in situ of trunk

734

1.12

0.40

2.7

2.6

2.32

2.28

g/l

0.23

679

Linear scleroderma

1.45

0.40

3.0

1.6

2.37

2.58

g/l

—

Other and unspecified degenerative diseases of nervous system

137

1272

1.09

0.39

1.9

2.5

2.21

2.26

g/l

0.49

126

1175

Beningn neoplasm: Meninges, unspecified

677

1.12

0.39

2.5

2.2

2.35

2.36

g/l

0.09

625

Cyst of iris, ciliary body and anterior chamber

1.33

0.39

3.4

2.0

2.34

2.51

g/l

—

Postpartum haemorrhage due to retained placenta

544

5248

1.04

0.38

1.7

2.0

2.59

2.51

g/l

2.44

494

4865

Abnormalities of forces of labour

442

4598

0.96

0.38

2.2

2.3

2.52

2.47

g/l

1.25

417

4295

Abnormalities of ear ossicles

0.61

0.38

2.4

2.35

2.44

g/l

—

Multiple congenital exostoses

0.63

0.38

2.2

1.7

2.64

2.49

g/l

—

Open wounds involving multiple body regions

153

1.28

0.37

2.1

2.2

2.62

2.39

g/l

1.02

140

Burn and corrosion of head and neck

851

1.10

0.37

2.1

2.4

2.42

2.35

g/l

0.52

795

Mandibular retrognathia AND surgery (BSSO)

993

0.91

0.36

1.5

2.2

2.60

2.42

g/l

2.49

922

Other mosquito-borne viral fevers

1.40

0.36

1.5

2.2

2.47

2.36

g/l

0.22

Sequelae of other accidents

662

1.12

0.36

2.5

2.3

2.24

2.30

g/l

0.36

619

Benign neoplasm of other and unspecified female genital organs

199

1881

1.07

0.35

2.4

2.3

2.40

2.39

g/l

0.07

180

1731

Occupant of streetcar injured in transport accident

1.46

0.34

2.1

2.37

2.24

g/l

—

Injury of blood vessels at ankle and foot level

1.44

0.33

4.7

2.0

2.02

2.37

g/l

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

212

2012

1.06

0.33

2.7

2.4

2.44

2.34

g/l

1.60

198

1863

Carcinoma in situ of breast, intraductal

402

3874

1.04

0.33

2.3

2.4

2.37

2.39

g/l

0.17

356

3577

Spontaneous abortion

2574

17096

1.02

0.33

2.3

2.2

2.49

2.45

g/l

2.66

2363

15795

Congenital malformations of lung

0.71

0.33

2.9

2.1

2.84

2.53

g/l

—

Other diseases of appendix

504

1.13

0.33

2.9

2.2

2.32

2.33

g/l

0.01

462

Torsion of testis

608

1.11

0.32

2.4

2.7

2.38

g/l

0.04

578

Sequelae of inflammatory diseases of the central nervous system

129

1.28

0.32

2.8

2.3

2.34

2.41

g/l

0.21

113

Exposure to excessive natural cold

467

1.13

0.32

3.9

2.4

2.29

2.30

g/l

0.05

432

Gender identity disorders

463

0.88

0.31

1.8

2.1

2.50

2.56

g/l

0.33

422

Degenerative and vascular disorders of ear

1.29

0.31

1.7

2.4

2.75

2.42

g/l

—

Non-small cell lung cancer, squamous

195

2049

0.95

0.29

1.9

2.4

2.15

2.21

g/l

0.59

183

1856

Epidermolysis bullosa

1.29

0.29

5.3

3.0

2.11

2.60

g/l

—

Unspecific neurodegenerative disorder

2917

20173

0.99

0.29

2.0

2.6

2.21

2.25

g/l

3.61

2537

18484

Traumatic amputation of hip and thigh

1.25

0.28

10.6

1.7

1.99

2.31

g/l

—

Alzheimer’s disease (Atypical or mixed)

643

6220

1.03

0.28

2.1

2.4

2.19

2.23

g/l

0.81

530

5628

Other sexually transmitted chlamydial diseases

240

2505

0.95

0.28

2.5

2.2

2.43

2.49

g/l

0.91

217

2303

Dengue fever [classical dengue]

1.34

0.27

1.6

2.6

2.48

2.49

g/l

—

Retinal breaks without detachment

865

8466

1.02

0.27

2.8

2.4

2.30

2.32

g/l

0.51

791

7844

Postpartum hemorraghe, all women as controls

1244

12025

1.02

0.27

1.9

2.2

2.54

2.50

g/l

1.41

1125

11159

Twin gestation

399

3864

1.04

0.27

2.1

2.3

2.45

2.49

g/l

0.63

364

3615

L02BA Anti-estrogens

858

8398

1.02

0.27

2.0

2.3

2.41

2.40

g/l

0.21

801

7749

Folliculitis decalvans

1.27

0.27

2.6

2.2

2.21

2.39

g/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

329

3178

1.04

0.26

2.4

2.6

2.37

2.30

g/l

1.78

318

2965

Dementia due to Parkinson's disease

133

1259

1.07

0.26

1.8

2.5

2.11

2.24

g/l

1.74

103

1147

Contact with venomous snakes and lizards

445

1.12

0.26

1.8

2.2

2.51

2.35

g/l

1.22

412

Benign neoplasm: Peripheral nerves and autonomic nervous system

676

1.09

0.26

2.2

2.3

2.38

2.35

g/l

0.12

627

Gastric ulcer - Acute with haemorrhage, drug-induced

1.21

0.26

6.4

2.6

1.99

2.28

g/l

—

Benign neoplasm: Connective and other soft tissue of pelvis

1.30

0.25

3.5

2.1

2.49

2.41

g/l

0.19

Fetus and newborn affected by other complications of labour and delivery

1.20

0.25

4.6

3.6

2.56

2.67

g/l

—

Motor neuron disease (with DMD)

773

1.08

0.25

1.6

2.3

2.25

2.27

g/l

0.12

725

Other congenital malformations of upper alimentary tract

322

1.14

0.25

3.8

2.4

2.42

2.35

g/l

0.25

298

Outcome of delivery

761

4810

0.98

0.25

1.8

2.3

2.53

g/l

0.13

698

4477

Other obstructed labour

343

3320

1.04

0.25

2.4

2.3

2.52

2.44

g/l

1.55

316

3092

Motorcycle rider injured in noncollision transport accidents

124

1172

1.06

0.25

2.3

2.4

2.34

2.38

g/l

0.35

118

1089

Erythema in diseases classified elsewhere

1.28

0.24

2.3

2.4

2.32

2.40

g/l

0.14

Use of memantine

1828

15345

0.98

0.24

1.9

2.5

2.21

2.23

g/l

0.99

1571

13926

Use of other anti-dementia drugs

1828

15345

0.98

0.24

1.9

2.5

2.21

2.23

g/l

0.99

1571

13926

Congenital absence of the vagina

1.36

0.24

2.4

2.14

2.48

g/l

—

Palsy of conjugate gaze

1.33

0.24

2.2

2.3

2.64

2.31

g/l

—

Carcinoma in situ of cervix uteri, endocervix

457

1.11

0.24

2.5

2.1

2.43

2.48

g/l

0.29

423

Choroidal detachment

1.26

0.22

3.2

2.4

2.29

2.14

g/l

0.41

Chronic bullous disease of childhood

1.22

0.22

1.8

2.2

2.46

2.38

g/l

—

Multiple congenital exostoses

105

0.74

0.22

1.7

1.9

2.74

2.41

g/l

—

Benign neoplasm: Brain, infratentorial

249

1.14

0.22

1.9

2.5

2.38

2.42

g/l

0.11

228

Benign neoplasm: Trachea

1.29

0.21

3.7

3.0

1.99

2.33

g/l

—

Chromomycosis and phaeomycotic abscess

1.29

0.21

1.3

2.6

1.94

2.37

g/l

—

Fetal death of unspecified cause

1.31

0.21

5.8

2.0

2.43

2.55

g/l

—

Congenital malformations of lung

113

0.78

0.21

2.7

2.1

2.61

2.51

g/l

—

107

Exposure to high and low air pressure and changes in air pressure

1.23

0.20

2.2

1.5

2.07

2.29

g/l

—

Anoxic brain damage

617

1.08

0.20

3.5

2.4

2.31

2.26

g/l

0.29

571

Venous complications and haemorrhoids in pregnancy

636

1.08

0.20

1.8

2.1

2.40

2.51

g/l

0.78

600

Central nervous system disorder causing precocious puberty

1.25

0.20

3.9

2.5

2.57

2.59

g/l

0.02

Other obstetric trauma

227

2194

1.04

0.20

1.8

2.2

2.54

2.49

g/l

0.77

208

2040

Duodenal ulcer - Acute without haemorrhage or perforation, drug-induced

1.28

0.20

4.0

2.2

1.87

2.28

g/l

—

Exposure to ignition of highly flammable material

164

0.84

0.19

2.2

2.3

2.19

2.33

g/l

0.40

153

Transient acantholytic dermatosis [Grover]

110

1.23

0.19

1.7

2.5

2.13

2.19

g/l

0.12

Unspecified pneumoconiosis

1.18

0.19

2.6

2.27

g/l

—

Other assisted single delivery

733

0.93

0.18

2.2

2.5

2.46

2.49

g/l

0.15

680

Diffuse (eosinophilic) fasciitis

0.75

0.18

4.0

2.4

2.47

2.46

g/l

—

Exposure to noise

1.23

0.18

2.0

2.12

2.31

g/l

—

Recurrent cholesteatoma of postmastoidectomy cavity

129

1.19

0.18

2.7

2.3

2.69

2.31

g/l

1.14

113

Other and unspecified water transport accidents

148

1.17

0.18

1.6

2.1

2.45

2.34

g/l

0.31

134

Accident to watercraft causing drowning and submersion

1.17

0.17

2.4

2.3

2.60

2.45

g/l

—

Myasthenia gravis, drug-induced

1.17

0.17

1.6

2.2

2.71

2.47

g/l

—

General hospital and personal-use devices associated with adverse incidents

1.17

0.17

3.5

2.5

2.21

2.32

g/l

—

Maternal care for known or suspected disproportion

181

1750

1.04

0.17

1.8

2.3

2.51

2.50

g/l

0.03

170

1645

Retained placenta and membranes, without haemorrhage

568

5579

1.02

0.17

2.1

2.3

2.47

2.44

g/l

0.62

519

5189

Frontotemporal dementia

264

1.12

0.17

1.4

2.2

2.28

2.29

g/l

0.05

243

Tympanosclerosis

0.77

0.16

5.0

2.2

2.57

2.40

g/l

—

Multiple gestation

410

4015

1.02

0.16

2.0

2.3

2.46

2.49

g/l

0.61

373

3752

Calcification and ossification of muscle

102

1.20

0.16

5.1

2.1

2.03

2.36

g/l

1.43

Maternal care for known or suspected malpresentation of fetus

907

6484

1.01

0.15

2.0

2.2

2.56

2.52

g/l

1.51

833

6012

Presbyopia

296

2892

1.03

0.15

2.9

2.4

2.34

2.36

g/l

0.21

271

2701

Adhesive middle ear disease

645

1.06

0.15

2.2

2.3

2.42

2.35

g/l

0.46

599

Carcinoma in situ of middle ear and respiratory system

212

0.88

0.15

2.1

2.4

2.27

g/l

0.01

193

Mumps

100

1042

0.96

0.14

2.3

2.4

2.36

g/l

0.02

965

Constitutional tall stature

139

0.85

0.14

2.3

2.8

2.59

2.56

g/l

0.09

129

Maternal care related to the fetus and amniotic cavity and possible delivery problems

2343

13638

1.01

0.14

2.0

2.3

2.51

2.47

g/l

2.29

2152

12700

Down's syndrome

122

1.16

0.14

3.4

2.5

2.46

2.55

g/l

0.20

113

Carcinoma in situ of breast, other/unspecified

602

0.94

0.14

2.1

2.2

2.15

2.41

g/l

2.76

553

Malignant neoplasm of nasopharynx

1.19

0.13

2.5

2.4

2.21

2.32

g/l

0.26

Endovascular or surgical operations to intracerebral aneurysms

294

2878

1.02

0.13

3.3

2.4

2.33

2.32

g/l

0.03

273

2666

Unspecified dementia

665

6058

0.99

0.13

2.3

2.5

2.18

2.22

g/l

1.00

577

5490

Benign mammary dysplasia

735

7260

1.01

0.12

2.3

2.40

2.38

g/l

0.37

677

6635

Malignant neoplasm of eye, brain and central nervous system

181

1763

1.03

0.12

1.8

2.5

2.32

2.33

g/l

0.10

166

1628

Unattended death

435

1.07

0.12

2.2

2.4

2.29

2.26

g/l

0.17

394

Melanoma in situ of scalp and neck

134

1.14

0.12

1.9

2.2

2.20

2.26

g/l

0.20

118

Melanoma in situ of lower limb, including hip

299

1.08

0.11

3.7

2.2

2.12

2.36

g/l

1.88

270

Tularaemia

819

1.04

0.11

2.6

2.3

2.45

2.35

g/l

1.26

763

Malignant neoplasm of brain, including Hilmo

209

2044

1.03

0.11

2.1

2.5

2.30

2.33

g/l

0.43

197

1894

Congenital malformations of larynx

115

1.15

0.11

6.6

3.4

2.51

2.57

g/l

0.12

108

Schistosomiasis [bilharziasis]

125

1.14

0.10

2.1

2.2

2.41

2.43

g/l

0.04

114

Lichen nitidus

1.16

0.10

8.0

2.1

2.19

2.51

g/l

—

Frontotemporal dementia, wide, incl. Pick's disease

320

1.07

0.10

1.4

2.4

2.35

2.29

g/l

0.26

295

Cholesteatoma of middle ear

257

2524

1.02

0.10

3.0

2.5

2.31

2.29

g/l

0.30

240

2331

Organic amnesic syndrome, not induced by alcohol and other psychoactive substances

1.12

0.10

3.6

2.2

1.83

2.42

g/l

—

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

565

1.05

0.10

2.4

2.2

2.41

2.35

g/l

0.37

529

Hereditary spastic paraplegia

1.12

0.10

8.6

2.8

2.10

2.41

g/l

—

Melanoma in situ of ear and external auricular canal

1.10

0.10

2.0

1.9

2.40

2.14

g/l

—

Macrocephaly

1.10

0.10

2.0

4.0

2.47

2.63

g/l

—

Urethral discharge

1.10

0.10

7.2

1.4

2.06

2.60

g/l

—

Solar urticaria

1.08

0.09

1.5

2.5

2.42

2.41

g/l

—

Benign neoplasm: Vagina

522

0.95

0.09

2.0

2.34

2.42

g/l

0.38

481

Benign neoplasm: Brain, supratentorial

676

1.04

0.09

3.2

2.2

2.34

2.37

g/l

0.19

626

Degenerative myopia

273

1.07

0.08

3.0

2.2

2.45

2.37

g/l

0.37

248

Chondromalacia

117

1199

0.97

0.08

2.2

2.4

2.44

2.37

g/l

0.86

107

1121

Other sudden death, cause unknown

0.83

0.08

5.5

2.3

2.22

2.26

g/l

—

Bilateral sagittal split ramus osteotomy operation

126

1289

0.98

0.08

1.6

2.2

2.56

2.42

g/l

2.01

115

1201

Disorders of glossopharyngeal nerve

1.06

0.08

2.9

1.8

2.50

2.32

g/l

—

Other sexually transmitted chlamydial diseases

391

3955

0.99

0.07

2.4

2.1

2.44

2.53

g/l

2.08

346

3644

Peripheral retinal degeneration

139

1363

1.02

0.07

2.8

2.3

2.36

2.33

g/l

0.21

129

1257

Crushing injury of lower leg

109

1.12

0.06

1.5

1.8

2.45

2.37

g/l

0.22

Foreign body on external eye

731

7260

1.01

0.06

2.5

2.7

2.34

2.32

g/l

0.44

686

6824

Small plaque parapsoriasis

119

1.11

0.06

2.2

2.53

2.42

g/l

0.22

106

Infections of breast associated with childbirth

146

1436

1.02

0.06

1.8

2.1

2.58

2.48

g/l

1.18

136

1317

Mechanical strabismus

100

1.11

0.05

1.4

2.0

2.29

2.47

g/l

0.66

Degenerative diseases of the nervous system

2441

17979

1.00

0.05

2.1

2.5

2.18

2.25

g/l

7.22

2129

16413

Other and unspecified hydrocephalus

803

1.02

0.05

2.9

2.3

2.25

2.31

g/l

0.46

742

Motor neuron disease

744

1.02

0.04

1.6

2.3

2.23

2.25

g/l

0.14

696

Cervical root disorders

261

0.95

0.04

2.0

2.1

2.41

2.38

g/l

0.12

243

Contact with lifting and transmission devices, not elsewhere classified

766

1.02

0.04

1.9

2.5

2.34

2.32

g/l

0.11

718

LeFortI or BSSO operation

157

1587

0.99

0.03

1.7

2.2

2.57

2.43

g/l

2.19

141

1481

Foreign object accidentally left in body during surgical and medical care

112

1.08

0.03

6.3

2.4

2.17

2.41

g/l

1.25

101

Exposure to ignition or melting of other clothing and apparel

103

1.08

0.02

2.1

2.4

2.34

g/l

0.00

Postpartum haemorrhage

1244

10457

1.00

0.01

1.9

2.3

2.54

2.49

g/l

2.42

1125

9706

Communicating hydrocephalus

958

0.99

0.01

2.8

2.5

2.18

2.32

g/l

1.73

891

Maternal care for known or suspected fetal abnormality and damage

736

6336

1.00

0.00

1.9

2.2

2.47

2.51

g/l

1.07

675

5894

Other and unspecified disease of Bartholin gland

120

1196

1.00

0.00

2.5

2.3

2.32

2.40

g/l

0.75

108

1103

Systemic atrophies primarily affecting the central nervous system

201

2006

1.00

0.00

2.4

2.5

2.24

2.29

g/l

0.60

180

1856

Use of selegiline

227

2266

1.00

0.00

2.1

2.6

2.31

2.27

g/l

0.45

195

2088

Complications following myocardial infarction

301

1.00

0.00

2.9

2.1

2.18

2.22

g/l

0.14

265

Inflammation of lacrimal passages (chronic)

719

1.00

0.00

1.6

2.4

2.31

g/l

0.02

646

Pityriasis lichenoides chronica

175

0.97

0.00

1.8

2.1

2.43

2.40

g/l

0.10

155

Defect, injury or illness of lumbar spine

115

1.05

0.00

2.6

2.1

2.53

2.54

g/l

0.02

103

Carcinoma in situ of larynx

0.99

-0.00

1.9

2.8

2.27

2.22

g/l

—

Erythema annulare centrifugum

0.95

-0.00

3.9

2.3

2.41

2.42

g/l

—

Unspecified hairloss

1.02

-0.00

2.4

1.9

2.51

2.35

g/l

—

Omphalitis of newborn with or without mild haemorrhage

0.00

-0.00

0.0

2.6

—

2.49

—

Congenital absence, occlusion, or narrowing of the ear canal

0.93

-0.00

2.0

2.6

2.58

2.46

g/l

—

Carcinoma in situ of bronchus and lung

1.02

-0.00

1.7

2.9

2.63

2.32

g/l

—

Rifle, shotgun and larger firearm discharge, undetermined intent

0.00

-0.00

0.0

1.0

—

2.51

—

Intentional self-harm by drowning and submersion

0.97

-0.00

1.5

2.1

2.55

2.39

g/l

—

Erysipeloid

0.98

-0.00

3.3

1.9

2.27

2.38

g/l

—

Hyperfunction of pituitary gland, other and/or unspecified

0.98

-0.00

1.6

2.18

2.39

g/l

—

Upper arm

0.99

-0.00

2.9

2.5

2.03

2.37

g/l

—

Use of metixene

0.00

-0.00

0.0

1.6

—

2.30

—

Acrodermatitis chronica atrophicans

0.88

-0.00

4.2

1.8

2.48

2.45

g/l

—

Monkeypox

0.00

-0.00

0.0

1.5

—

2.22

—

Pedestrian injured in collision with other nonmotor vehicle

0.85

-0.00

3.0

2.3

2.50

2.37

g/l

—

Use of bromocriptine

0.90

-0.00

4.5

2.0

2.38

2.42

g/l

—

Carcinoma in situ of trachea

0.00

-0.00

0.0

2.0

—

2.46

—

Toxic liver disease with cholestasis, drug-induced

0.00

-0.00

0.0

1.6

—

2.20

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Transferrin [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS